0000080424-19-000014.txt : 20190123 0000080424-19-000014.hdr.sgml : 20190123 20190123161923 ACCESSION NUMBER: 0000080424-19-000014 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20181231 FILED AS OF DATE: 20190123 DATE AS OF CHANGE: 20190123 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROCTER & GAMBLE Co CENTRAL INDEX KEY: 0000080424 STANDARD INDUSTRIAL CLASSIFICATION: SOAP, DETERGENT, CLEANING PREPARATIONS, PERFUMES, COSMETICS [2840] IRS NUMBER: 310411980 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-00434 FILM NUMBER: 19537622 BUSINESS ADDRESS: STREET 1: ONE PROCTER & GAMBLE PLAZA CITY: CINCINNATI STATE: OH ZIP: 45202 BUSINESS PHONE: 5139831100 MAIL ADDRESS: STREET 1: ONE PROCTER & GAMBLE PLAZA CITY: CINCINNATI STATE: OH ZIP: 45202 FORMER COMPANY: FORMER CONFORMED NAME: PROCTER & GAMBLE CO DATE OF NAME CHANGE: 19920703 10-Q 1 fy1819q2ond10-qreport.htm FY1819 Q2 OND 10-Q Document
false--06-30Q220192018-12-310000080424YesfalseLarge Accelerated FilerPROCTER & GAMBLE CofalsePG0.68961.37920.71721.4344 0000080424 2018-07-01 2018-12-31 0000080424 2018-12-31 0000080424 2017-07-01 2017-12-31 0000080424 2018-10-01 2018-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 2017-10-01 2017-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2018-10-01 2018-12-31 0000080424 us-gaap:RetainedEarningsMember 2018-07-01 2018-12-31 0000080424 us-gaap:RetainedEarningsMember 2018-10-01 2018-12-31 0000080424 2018-06-30 0000080424 us-gaap:RetainedEarningsMember 2017-07-01 2017-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000080424 us-gaap:CommonStockMember 2017-12-31 0000080424 us-gaap:PreferredStockMember 2017-06-30 0000080424 us-gaap:CommonStockMember 2017-07-01 2017-12-31 0000080424 us-gaap:PreferredStockMember 2017-07-01 2017-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2017-07-01 2017-12-31 0000080424 us-gaap:TreasuryStockMember 2017-07-01 2017-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-01 2017-12-31 0000080424 2017-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-07-01 2017-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2017-12-31 0000080424 us-gaap:CommonStockMember 2017-06-30 0000080424 2017-12-31 0000080424 us-gaap:TreasuryStockMember 2017-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-12-31 0000080424 us-gaap:RetainedEarningsMember 2017-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2017-06-30 0000080424 us-gaap:RetainedEarningsMember 2017-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0000080424 us-gaap:TreasuryStockMember 2017-06-30 0000080424 us-gaap:PreferredStockMember 2017-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-07-01 2017-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-12-31 0000080424 us-gaap:CommonStockMember 2018-06-30 0000080424 us-gaap:PreferredStockMember 2018-06-30 0000080424 us-gaap:RetainedEarningsMember 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-12-31 0000080424 us-gaap:TreasuryStockMember 2018-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2018-06-30 0000080424 us-gaap:PreferredStockMember 2018-07-01 2018-12-31 0000080424 us-gaap:PreferredStockMember 2018-12-31 0000080424 us-gaap:CommonStockMember 2018-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000080424 us-gaap:TreasuryStockMember 2018-07-01 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-07-01 2018-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000080424 us-gaap:CommonStockMember 2018-07-01 2018-12-31 0000080424 us-gaap:TreasuryStockMember 2018-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-12-31 0000080424 us-gaap:RetainedEarningsMember 2018-06-30 0000080424 us-gaap:CommonStockMember 2017-10-01 2017-12-31 0000080424 us-gaap:RetainedEarningsMember 2017-10-01 2017-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-10-01 2017-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 0000080424 us-gaap:RetainedEarningsMember 2017-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 0000080424 us-gaap:PreferredStockMember 2017-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-10-01 2017-12-31 0000080424 us-gaap:TreasuryStockMember 2017-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2017-10-01 2017-12-31 0000080424 us-gaap:CommonStockMember 2017-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2017-09-30 0000080424 2017-09-30 0000080424 us-gaap:PreferredStockMember 2017-10-01 2017-12-31 0000080424 us-gaap:TreasuryStockMember 2017-10-01 2017-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-10-01 2017-12-31 0000080424 us-gaap:CommonStockMember 2018-10-01 2018-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-10-01 2018-12-31 0000080424 us-gaap:PreferredStockMember 2018-10-01 2018-12-31 0000080424 us-gaap:TreasuryStockMember 2018-10-01 2018-12-31 0000080424 us-gaap:CommonStockMember 2018-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2018-09-30 0000080424 2018-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-10-01 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-09-30 0000080424 us-gaap:PreferredStockMember 2018-09-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000080424 us-gaap:TreasuryStockMember 2018-09-30 0000080424 us-gaap:RetainedEarningsMember 2018-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-10-01 2018-12-31 0000080424 2018-07-01 2018-09-30 0000080424 2017-07-01 2017-09-30 0000080424 us-gaap:OtherComprehensiveIncomeMember pg:ReclassificationfromAOCItoRetainedEarningsforTaxEffectsDomain 2018-07-01 2018-12-31 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2017-07-01 2018-06-30 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2018-01-01 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member us-gaap:ScenarioForecastMember 2018-07-01 2019-06-30 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2017-10-01 2017-12-31 0000080424 us-gaap:SellingGeneralAndAdministrativeExpensesMember pg:PaymentstoCustomersMember 2018-07-01 2018-12-31 0000080424 us-gaap:RetainedEarningsMember pg:ReclassificationfromAOCItoRetainedEarningsforTaxEffectsDomain 2018-07-01 2018-12-31 0000080424 us-gaap:SellingGeneralAndAdministrativeExpensesMember pg:PaymentstoCustomersMember 2017-07-01 2018-06-30 0000080424 us-gaap:RetainedEarningsMember pg:CustomerandConsumerPromotionalSpendingMember 2018-07-01 2018-12-31 0000080424 pg:HomeCareMember 2017-10-01 2017-12-31 0000080424 pg:HairCareMember 2018-10-01 2018-12-31 0000080424 pg:SkinandPersonalCareMember 2018-10-01 2018-12-31 0000080424 pg:HomeCareMember 2017-07-01 2017-12-31 0000080424 pg:AllOtherMember 2017-07-01 2017-12-31 0000080424 pg:FeminineCareMember 2018-10-01 2018-12-31 0000080424 pg:FabricCareMember 2018-10-01 2018-12-31 0000080424 pg:SkinandPersonalCareMember 2017-10-01 2017-12-31 0000080424 pg:SkinandPersonalCareMember 2017-07-01 2017-12-31 0000080424 pg:FeminineCareMember 2017-07-01 2017-12-31 0000080424 pg:BabyCareMember 2017-07-01 2017-12-31 0000080424 pg:HairCareMember 2017-10-01 2017-12-31 0000080424 pg:FabricCareMember 2017-10-01 2017-12-31 0000080424 pg:BabyCareMember 2017-10-01 2017-12-31 0000080424 pg:HomeCareMember 2018-10-01 2018-12-31 0000080424 pg:OralCareMember 2018-07-01 2018-12-31 0000080424 pg:ShaveCareMember 2017-07-01 2017-12-31 0000080424 pg:FamilyCareMember 2018-10-01 2018-12-31 0000080424 pg:BabyCareMember 2018-07-01 2018-12-31 0000080424 pg:FamilyCareMember 2017-10-01 2017-12-31 0000080424 pg:ShaveCareMember 2018-10-01 2018-12-31 0000080424 pg:ShaveCareMember 2017-10-01 2017-12-31 0000080424 pg:FamilyCareMember 2018-07-01 2018-12-31 0000080424 pg:FamilyCareMember 2017-07-01 2017-12-31 0000080424 pg:OralCareMember 2017-10-01 2017-12-31 0000080424 pg:OralCareMember 2017-07-01 2017-12-31 0000080424 pg:AllOtherMember 2017-10-01 2017-12-31 0000080424 pg:HomeCareMember 2018-07-01 2018-12-31 0000080424 pg:FabricCareMember 2018-07-01 2018-12-31 0000080424 pg:FeminineCareMember 2018-07-01 2018-12-31 0000080424 pg:AllOtherMember 2018-10-01 2018-12-31 0000080424 pg:FabricCareMember 2017-07-01 2017-12-31 0000080424 pg:HairCareMember 2017-07-01 2017-12-31 0000080424 pg:AllOtherMember 2018-07-01 2018-12-31 0000080424 pg:ShaveCareMember 2018-07-01 2018-12-31 0000080424 pg:SkinandPersonalCareMember 2018-07-01 2018-12-31 0000080424 pg:BabyCareMember 2018-10-01 2018-12-31 0000080424 pg:OralCareMember 2018-10-01 2018-12-31 0000080424 pg:HairCareMember 2018-07-01 2018-12-31 0000080424 pg:FeminineCareMember 2017-10-01 2017-12-31 0000080424 pg:BeautySegmentMember 2018-10-01 2018-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-07-01 2018-12-31 0000080424 pg:FabricandHomeCareMember 2017-10-01 2017-12-31 0000080424 pg:HealthCareSegmentMember 2017-10-01 2017-12-31 0000080424 pg:GroomingSegmentMember 2018-07-01 2018-12-31 0000080424 us-gaap:CorporateMember 2018-07-01 2018-12-31 0000080424 us-gaap:CorporateMember 2017-07-01 2017-12-31 0000080424 pg:BeautySegmentMember 2017-10-01 2017-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2017-07-01 2017-12-31 0000080424 us-gaap:CorporateMember 2018-10-01 2018-12-31 0000080424 pg:BeautySegmentMember 2018-07-01 2018-12-31 0000080424 pg:GroomingSegmentMember 2018-10-01 2018-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-10-01 2018-12-31 0000080424 pg:GroomingSegmentMember 2017-07-01 2017-12-31 0000080424 pg:BeautySegmentMember 2017-07-01 2017-12-31 0000080424 pg:FabricandHomeCareMember 2017-07-01 2017-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2017-10-01 2017-12-31 0000080424 pg:FabricandHomeCareMember 2018-07-01 2018-12-31 0000080424 us-gaap:CorporateMember 2017-10-01 2017-12-31 0000080424 pg:GroomingSegmentMember 2017-10-01 2017-12-31 0000080424 pg:HealthCareSegmentMember 2018-07-01 2018-12-31 0000080424 pg:HealthCareSegmentMember 2018-10-01 2018-12-31 0000080424 pg:HealthCareSegmentMember 2017-07-01 2017-12-31 0000080424 pg:FabricandHomeCareMember 2018-10-01 2018-12-31 0000080424 pg:A25bpsDecreaseLongTermGrowthMember us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember 2018-12-31 0000080424 us-gaap:GoodwillMember pg:A25bpsIncreaseDiscountRateMemberMember pg:ShaveCareMember 2018-12-31 0000080424 us-gaap:GoodwillMember pg:A25bpsDecreaseLongTermGrowthMember pg:ShaveCareMember 2018-12-31 0000080424 pg:A25bpsIncreaseDiscountRateMemberMember us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember 2018-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember 2018-12-31 0000080424 us-gaap:FiniteLivedIntangibleAssetsMember 2018-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember 2018-12-31 0000080424 pg:ShaveCareMember 2018-12-31 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-07-01 2018-12-31 0000080424 pg:GroomingSegmentMember 2018-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-06-30 0000080424 pg:BeautySegmentMember 2018-12-31 0000080424 pg:HealthCareSegmentMember 2018-12-31 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-12-31 0000080424 pg:HealthCareSegmentMember 2018-06-30 0000080424 pg:GroomingSegmentMember 2018-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-12-31 0000080424 pg:BeautySegmentMember 2018-06-30 0000080424 us-gaap:EmployeeStockOptionMember 2017-10-01 2017-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2017-07-01 2017-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2018-10-01 2018-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-10-01 2018-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-10-01 2017-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2018-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-01 2017-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2017-07-01 2017-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2018-10-01 2018-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2017-10-01 2017-12-31 0000080424 pg:ForeignCurrencyContractsMember us-gaap:NondesignatedMember 2018-10-01 2018-12-31 0000080424 pg:ForeignCurrencyContractsMember us-gaap:NondesignatedMember 2017-07-01 2017-12-31 0000080424 pg:ForeignCurrencyContractsMember us-gaap:NondesignatedMember 2018-07-01 2018-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-07-01 2018-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-10-01 2018-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2017-07-01 2017-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2017-10-01 2017-12-31 0000080424 pg:ForeignCurrencyContractsMember us-gaap:NondesignatedMember 2017-10-01 2017-12-31 0000080424 us-gaap:CorporateBondSecuritiesMember 2018-06-30 0000080424 us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000080424 us-gaap:OtherInvestmentsMember 2018-06-30 0000080424 us-gaap:CorporateBondSecuritiesMember 2018-12-31 0000080424 us-gaap:OtherInvestmentsMember 2018-12-31 0000080424 us-gaap:USTreasuryAndGovernmentMember 2018-06-30 0000080424 us-gaap:NetInvestmentHedgingMember 2018-10-01 2018-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2017-10-01 2017-12-31 0000080424 us-gaap:FairValueHedgingMember us-gaap:UnderlyingOtherMember 2018-07-01 2018-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2018-07-01 2018-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2017-07-01 2017-12-31 0000080424 us-gaap:NetInvestmentHedgingMember us-gaap:UnderlyingOtherMember 2017-07-01 2018-06-30 0000080424 us-gaap:NetInvestmentHedgingMember us-gaap:UnderlyingOtherMember 2018-07-01 2018-12-31 0000080424 us-gaap:FairValueHedgingMember us-gaap:UnderlyingOtherMember 2017-07-01 2018-06-30 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-06-30 0000080424 us-gaap:NetInvestmentHedgingMember 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember 2018-06-30 0000080424 us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0000080424 us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember 2018-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2018-06-30 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-10-01 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-07-01 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-10-01 2017-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-07-01 2017-12-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-10-01 2018-12-31 0000080424 us-gaap:OtherRestructuringMember 2018-07-01 2018-12-31 0000080424 pg:AssetRelatedCostsMember 2018-06-30 0000080424 us-gaap:OtherRestructuringMember 2018-12-31 0000080424 pg:AssetRelatedCostsMember 2018-07-01 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-07-01 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-07-01 2018-09-30 0000080424 pg:AssetRelatedCostsMember 2018-07-01 2018-09-30 0000080424 us-gaap:OtherRestructuringMember 2018-10-01 2018-12-31 0000080424 us-gaap:OtherRestructuringMember 2018-07-01 2018-09-30 0000080424 us-gaap:OtherRestructuringMember 2018-06-30 0000080424 pg:AssetRelatedCostsMember 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-10-01 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-06-30 0000080424 pg:AssetRelatedCostsMember 2018-10-01 2018-12-31 0000080424 us-gaap:CostOfGoodsSegmentMember 2018-07-01 2018-12-31 0000080424 pg:SellingGeneralAndAdministrativeExpenseMember 2018-10-01 2018-12-31 0000080424 srt:MaximumMember 2018-07-01 2018-12-31 0000080424 srt:MinimumMember 2018-07-01 2018-12-31 0000080424 pg:SellingGeneralAndAdministrativeExpenseMember 2018-07-01 2018-12-31 0000080424 us-gaap:CostOfGoodsSegmentMember 2018-10-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-07-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:CustomerRelationshipsMember 2018-07-01 2018-12-31 0000080424 us-gaap:OtherIntangibleAssetsMember 2018-07-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember pg:PatentsandDevelopedTechnologyMember 2018-07-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:CustomerRelationshipsMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember pg:PatentsandDevelopedTechnologyMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-01-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-01 2018-11-30 0000080424 srt:MaximumMember pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-07-01 2018-12-31 0000080424 srt:MinimumMember pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-07-01 2018-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure pg:employee pg:audit pg:taxable_jurisdiction

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-Q
(Mark one)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended December 31, 2018
OR
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                     to                     
 
pglogoa15.jpg
THE PROCTER & GAMBLE COMPANY
(Exact name of registrant as specified in its charter)
 
 
Ohio
 
1-434
 
31-0411980
(State of Incorporation)
 
(Commission File Number)
 
(I.R.S. Employer Identification Number)
One Procter & Gamble Plaza, Cincinnati, Ohio
 
45202
(Address of principal executive offices)
 
(Zip Code)
(513) 983-1100
(Registrant’s telephone number, including area code)
 
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes þ     No o
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes þ     No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act).
 
Large accelerated filer
 þ
 
 
Accelerated filer
 ¨
 
 
Non-accelerated filer
 ¨
 
 
Smaller reporting company
 ¨
 
 
 
 
 
 
Emerging growth company
 ¨
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes o     No þ
There were 2,501,579,709 shares of Common Stock outstanding as of December 31, 2018.



PART I. FINANCIAL INFORMATION 
Item 1.
Financial Statements


THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
 
Three Months Ended December 31
 
Six Months Ended December 31
Amounts in millions except per share amounts
2018
 
2017
 
2018
 
2017
NET SALES
$
17,438

 
$
17,395

 
$
34,128

 
$
34,048

Cost of products sold
8,919

 
8,709

 
17,403

 
16,978

Selling, general and administrative expense
4,623

 
4,767

 
9,275

 
9,503

OPERATING INCOME
3,896

 
3,919

 
7,450

 
7,567

Interest expense
138

 
122

 
267

 
237

Interest income
63

 
66

 
116

 
115

Other non-operating income, net
95

 
170

 
557

 
339

EARNINGS BEFORE INCOME TAXES
3,916

 
4,033

 
7,856

 
7,784

Income taxes
700

 
1,472

 
1,429

 
2,353

NET EARNINGS
3,216

 
2,561

 
6,427

 
5,431

Less: Net earnings attributable to noncontrolling interests
22

 
66

 
34

 
83

NET EARNINGS ATTRIBUTABLE TO PROCTER & GAMBLE
$
3,194

 
$
2,495

 
$
6,393

 
$
5,348

 
 
 
 
 
 
 
 
NET EARNINGS PER SHARE (1)
 
 
 
 
 
 
 
Basic
$
1.25

 
$
0.96

 
$
2.51

 
$
2.05

Diluted
$
1.22

 
$
0.93

 
$
2.44

 
$
2.00

 
 
 
 
 
 
 
 
DILUTED WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
2,623.0

 
2,669.6

 
2,617.6

 
2,680.1


(1)  
Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.


See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME/(LOSS)
 
Three Months Ended December 31
 
Six Months Ended December 31
Amounts in millions
2018
 
2017
 
2018
 
2017
NET EARNINGS
$
3,216

 
$
2,561

 
$
6,427

 
$
5,431

OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
 
 
 
 
 
 
 
Financial statement foreign currency translation
(370
)
 
188

 
(586
)
 
1,028

Unrealized gains/(losses) on hedges
192

 
(167
)
 
199

 
(630
)
Unrealized gains/(losses) on investment securities
58

 
(61
)
 
53

 
(65
)
Unrealized gains/(losses) on defined benefit retirement plans
98

 
161

 
250

 
128

TOTAL OTHER COMPREHENSIVE INCOME/(LOSS), NET OF TAX
(22
)
 
121

 
(84
)
 
461

TOTAL COMPREHENSIVE INCOME
3,194

 
2,682

 
6,343

 
5,892

Less: Total comprehensive income attributable to noncontrolling interests
23

 
66

 
31

 
83

TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO PROCTER & GAMBLE
$
3,171

 
$
2,616

 
$
6,312

 
$
5,809



See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
Amounts in millions
 
 
 
 
December 31, 2018
 
June 30, 2018
Assets
 
 
 
 
 
 
 
CURRENT ASSETS
 
 
 
 
 
 
 
Cash and cash equivalents
 
 
 
 
$
3,696

 
$
2,569

Available-for-sale investment securities
 
 
 
 
8,421

 
9,281

Accounts receivable
 
 
 
 
5,055

 
4,686

INVENTORIES
 
 
 
 
 
 
 
Materials and supplies
 
 
 
 
1,524

 
1,335

Work in process
 
 
 
 
593

 
588

Finished goods
 
 
 
 
3,164

 
2,815

Total inventories
 
 
 
 
5,281

 
4,738

Prepaid expenses and other current assets
 
 
 
 
1,978

 
2,046

TOTAL CURRENT ASSETS
 
 
 
 
24,431

 
23,320

PROPERTY, PLANT AND EQUIPMENT, NET
 
 
 
 
20,822

 
20,600

GOODWILL
 
 
 
 
46,932

 
45,175

TRADEMARKS AND OTHER INTANGIBLE ASSETS, NET
 
 
 
25,947

 
23,902

OTHER NONCURRENT ASSETS
 
 
 
 
5,555

 
5,313

TOTAL ASSETS
 
 
 
 
$
123,687

 
$
118,310

 
 
 
 
 
 
 
 
Liabilities and Shareholders' Equity
 
 
 
 
 
 
 
CURRENT LIABILITIES
 
 
 
 
 
 
 
Accounts payable
 
 
 
 
$
10,266

 
$
10,344

Accrued and other liabilities
 
 
 
 
8,868

 
7,470

Debt due within one year
 
 
 
 
12,113

 
10,423

TOTAL CURRENT LIABILITIES
 
 
 
 
31,247

 
28,237

LONG-TERM DEBT
 
 
 
 
21,514

 
20,863

DEFERRED INCOME TAXES
 
 
 
 
6,872

 
6,163

OTHER NONCURRENT LIABILITIES
 
 
 
 
9,611

 
10,164

TOTAL LIABILITIES
 
 
 
 
69,244

 
65,427

SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
Preferred stock
 
 
 
 
946

 
967

Common stock – shares issued –
December 2018
 
4,009.2

 
 
 
 
 
June 2018
 
4,009.2

 
4,009

 
4,009

Additional paid-in capital
 
 
 
 
63,679

 
63,846

Reserve for ESOP debt retirement
 
 
 
 
(1,178
)
 
(1,204
)
Accumulated other comprehensive income/(loss)
 
 
 
 
(15,156
)
 
(14,749
)
Treasury stock
 
 
 
 
(99,480
)
 
(99,217
)
Retained earnings
 
 
 
 
101,170

 
98,641

Noncontrolling interest
 
 
 
 
453

 
590

TOTAL SHAREHOLDERS’ EQUITY
 
 
 
 
54,443

 
52,883

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
$
123,687

 
$
118,310


See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY
 
Three Months Ended December 31, 2018
Dollars in millions; shares in thousands
Common Stock
Preferred Stock
Add-itional Paid-In Capital
Reserve for ESOP Debt Retirement
Accumu-lated
Other
Comp-rehensive
Income/(Loss)
Treasury Stock
Retained Earnings
Non-controlling Interest
Total Share-holders' Equity
Shares
Amount
BALANCE SEPTEMBER 30, 2018
2,491,408


$4,009


$951


$63,711


($1,177
)

($15,133
)

($99,956
)

$99,831


$268


$52,504

Net earnings
 
 
 
 
 
 
 
3,194

22

3,216

Other comprehensive income/(loss)
 
 
 
 
 
(23
)
 
 
1

(22
)
Dividends and dividend equivalents ($0.7172 per share):
 
 
 
 
 
 
 
 
 
 
Common
 
 
 
 
 
 
 
(1,790
)
 
(1,790
)
Preferred, net of tax benefits
 
 
 
 
 
 
 
(65
)
 
(65
)
Treasury stock purchases
(8,647
)
 
 
 
 
 
(751
)
 
 
(751
)
Employee stock plans
18,021

 
 
(73
)
 
 
1,222

 
 
1,149

Preferred stock conversions
798

 
(5
)

 
 
5

 
 

ESOP debt impacts
 
 
 
 
(1
)
 
 

 
(1
)
Noncontrolling interest, net
 
 
 
41

 
 
 
 
162

203

BALANCE
DECEMBER 31, 2018
2,501,580


$4,009


$946


$63,679


($1,178
)

($15,156
)

($99,480
)

$101,170


$453


$54,443


 
Six Months Ended December 31, 2018
Dollars in millions; shares in thousands
Common Stock
Preferred Stock
Add-itional Paid-In Capital
Reserve for ESOP Debt Retirement
Accumu-lated
Other
Comp-rehensive
Income/(Loss)
Treasury Stock
Retained Earnings
Non-controlling Interest
Total Share-holders' Equity
Shares
Amount
BALANCE
JUNE 30, 2018
2,498,093


$4,009


$967


$63,846


($1,204
)

($14,749
)

($99,217
)

$98,641


$590


$52,883

Impact of adoption of new accounting standards
 
 
 
 
 
(326
)
 
(200
)
(27
)
(553
)
Net earnings
 
 
 
 
 
 
 
6,393

34

6,427

Other comprehensive income/(loss)
 
 
 
 
 
(81
)
 
 
(3
)
(84
)
Dividends and dividend equivalents
($1.4344 per share):
 
 
 
 
 
 
 
 
 
 
Common
 
 
 
 
 
 
 
(3,581
)
 
(3,581
)
Preferred, net of tax benefits
 
 
 
 
 
 
 
(131
)
 
(131
)
Treasury stock purchases
(24,337
)
 
 
 
 
 
(2,003
)
 
 
(2,003
)
Employee stock plans
25,389

 
 
(53
)
 
 
1,722

 
 
1,669

Preferred stock conversions
2,435

 
(21
)
3

 
 
18

 
 

ESOP debt impacts
 
 
 
 
26

 
 
48

 
74

Noncontrolling interest, net
 
 
 
(117
)
 
 
 
 
(141
)
(258
)
BALANCE
DECEMBER 31, 2018
2,501,580


$4,009


$946


$63,679


($1,178
)

($15,156
)

($99,480
)

$101,170


$453


$54,443



See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY (cont.)

 
Three Months Ended December 31, 2017
Dollars in millions; shares in thousands
Common Stock
Preferred Stock
Add-itional Paid-In Capital
Reserve for ESOP Debt Retirement
Accumu-lated
Other
Comp-rehensive
Income/(Loss)
Treasury Stock
Retained Earnings
Non-controlling Interest
Total Share-holders' Equity
Shares
Amount
BALANCE
SEPTEMBER 30, 2017
2,536,958


$4,009


$991


$63,705


($1,229
)

($14,292
)

($95,563
)

$97,197


$597


$55,415

Net earnings
 
 
 
 
 
 
 
2,495

66

2,561

Other comprehensive income/(loss)
 
 
 
 
 
121

 
 

121

Dividends and dividend equivalents
($0.6896 per share):
 
 
 
 
 
 
 
 
 
 
Common
 
 
 
 
 
 
 
(1,751
)
 
(1,751
)
Preferred, net of tax benefits
 
 
 
 
 
 
 
(62
)
 
(62
)
Treasury stock purchases
(19,409
)
 
 
 
 
 
(1,751
)
 
 
(1,751
)
Employee stock plans
2,791

 
 
51

 
 
189

 
 
240

Preferred stock conversions
664

 
(5
)
1

 
 
4

 
 

ESOP debt impacts
 
 
 
 

 
 
2

 
2

Noncontrolling interest, net
 
 
 
 
 
 
 
 
(54
)
(54
)
BALANCE
DECEMBER 31, 2017
2,521,004


$4,009


$986


$63,757


($1,229
)

($14,171
)

($97,121
)

$97,881


$609


$54,721


 
Six Months Ended December 31, 2017
Dollars in millions; shares in thousands
Common Stock
Preferred Stock
Add-itional Paid-In Capital
Reserve for ESOP Debt Retirement
Accumu-lated
Other
Comp-rehensive
Income/(Loss)
Treasury Stock
Retained Earnings
Non-controlling Interest
Total Share-holders' Equity
Shares
Amount
BALANCE
JUNE 30, 2017
2,553,297


$4,009


$1,006


$63,641


($1,249
)

($14,632
)

($93,715
)

$96,124


$594


$55,778

Net earnings
 
 
 
 
 
 
 
5,348

83

5,431

Other comprehensive income/(loss)
 
 
 
 
 
461

 
 

461

Dividends and dividend equivalents ($1.3792 per share):
 
 
 
 
 
 
 
 
 
 
Common
 
 
 
 
 
 
 
(3,512
)
 
(3,512
)
Preferred, net of tax benefits
 
 
 
 
 
 
 
(124
)
 
(124
)
Treasury stock purchases
(46,736
)
 
 
 
 
 
(4,253
)
 
 
(4,253
)
Employee stock plans
12,239

 
 
113

 
 
830

 
 
943

Preferred stock conversions
2,204

 
(20
)
3

 
 
17

 
 

ESOP debt impacts
 
 
 
 
20

 
 
45

 
65

Noncontrolling interest, net
 
 
 
 
 
 
 
 
(68
)
(68
)
BALANCE
DECEMBER 31, 2017
2,521,004


$4,009


$986


$63,757


($1,229
)

($14,171
)

($97,121
)

$97,881


$609


$54,721




See accompanying Notes to Consolidated Financial Statements.




THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
Six Months Ended December 31
Amounts in millions
2018
 
2017
CASH, CASH EQUIVALENTS AND RESTRICTED CASH, BEGINNING OF PERIOD
$
2,569

 
$
5,569

OPERATING ACTIVITIES
 
 
 
Net earnings
6,427

 
5,431

Depreciation and amortization
1,293

 
1,368

Share-based compensation expense
181

 
157

Deferred income taxes
37

 
(2,008
)
Gain on sale of assets
(370
)
 
(158
)
Changes in:
 
 
 
Accounts receivable
(398
)
 
(547
)
Inventories
(531
)
 
(457
)
Accounts payable, accrued and other liabilities
1,141

 
857

Other operating assets and liabilities
(370
)
 
2,524

Other
164

 
148

TOTAL OPERATING ACTIVITIES
7,574

 
7,315

INVESTING ACTIVITIES
 
 
 
Capital expenditures
(1,781
)
 
(1,900
)
Proceeds from asset sales
18

 
201

Acquisitions, net of cash acquired
(3,848
)
 
(101
)
Purchases of short-term investments
(158
)
 
(3,598
)
Proceeds from sales and maturities of short-term investments
1,117

 
1,643

Change in other investments
(58
)
 
50

TOTAL INVESTING ACTIVITIES
(4,710
)
 
(3,705
)
FINANCING ACTIVITIES
 
 
 
Dividends to shareholders
(3,703
)
 
(3,636
)
Change in short-term debt
1,206

 
1,524

Additions to long-term debt
2,368

 
5,072

Reductions of long-term debt
(978
)
 
(1,281
)
Treasury stock purchases
(2,003
)
 
(4,253
)
Impact of stock options and other
1,486

 
698

TOTAL FINANCING ACTIVITIES
(1,624
)
 
(1,876
)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH
(113
)
 
129

CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
1,127

 
1,863

CASH, CASH EQUIVALENTS AND RESTRICTED CASH, END OF PERIOD
$
3,696

 
$
7,432




See accompanying Notes to Consolidated Financial Statements.



THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Basis of Presentation
These statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2018 and the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18. For additional details on the impacts of adoption, see Note 2. In the opinion of management, the accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries (the "Company," "Procter & Gamble," "P&G," "we" or "our") contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.
2. New Accounting Pronouncements and Policies and U.S. Tax Reform
On July 1, 2018, we adopted ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)." This guidance outlines a single, comprehensive model of accounting for revenue from contracts with customers. We adopted the standard using the modified retrospective transition method, under which prior periods were not revised to reflect the impacts of the new standard. Our revenue is primarily generated from the sale of finished product to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. Accordingly, the timing of revenue recognition is not materially impacted by the new standard. Trade promotions, consisting primarily of customer pricing allowances, in-store merchandising funds, advertising and other promotional activities, and consumer coupons, are offered through various programs to customers and consumers.  The adoption of the new standard impacts the accrual timing for certain portions of our customer and consumer promotional spending, which resulted in a cumulative adjustment to Retained earnings of $534, net of tax, on the date of adoption. The provisions of the new standard also impact the classification of certain payments to customers, moving an immaterial amount of such payments from expense to a deduction from net sales. Had this standard been effective and adopted during fiscal 2018, the impact would have been to reclassify $157 from Selling, General and Administrative expense (SG&A) to a reduction of Net sales for the six months ended December 31, 2017 and $309 for the year ended June 30, 2018, with no impact to operating profit. This guidance included practical expedients, none of which are material to our Consolidated Financial Statements. This new guidance does not have any other material impacts on our Consolidated Financial Statements, including financial disclosures.
On July 1, 2018, we adopted ASU 2017-07, "Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (Topic 715)." This guidance requires an entity to disaggregate the current service cost component from the other components of net benefit costs in the face of the income statement. It requires the service cost component to be presented with other current compensation costs for the related employees in the operating section of the income statement, with other components of net benefit cost presented outside of income from operations. We adopted the standard retrospectively, using the practical expedient which allows entities to use information previously disclosed in their pension and other postretirement benefit plans footnote as the basis to apply the retrospective presentation requirements. As such, prior periods’ results have been revised to report the other components of net defined benefit costs, previously reported in Cost of products sold and SG&A, in Other non-operating income, net.
In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows: Restricted Cash (Topic 230)." This guidance requires the Statement of Cash Flows to present changes in the total of cash, cash equivalents and restricted cash. Prior to the adoption of this ASU, the relevant accounting guidance did not require the Statement of Cash Flows to include changes in restricted cash. We adopted the standard retrospectively on July 1, 2018. We currently have no significant restricted cash balances. Historically, we had restricted cash balances and changes related to divestiture activity. Such balances were presented as Current assets held for sale on the balance sheets, with changes presented as Investing activities on the Statements of Cash Flow. In accordance with ASU 2016-08, such balances are now included in the beginning and ending balances of Cash, cash equivalents and restricted cash for all periods presented.
In February 2018, the FASB issued ASU 2018-02, "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Topic 220)." This guidance permits companies to make an election to reclassify stranded tax effects from the recently enacted U.S. Tax Cuts and Jobs Act included in Accumulated other comprehensive income (AOCI) to Retained earnings.  ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with early adoption permitted. The Company elected to early adopt this guidance in the quarter ended September 30, 2018. The reclassification from the adoption of this standard resulted in an increase of $326 to Retained earnings and a decrease of $326 to AOCI.
In October 2016, the FASB issued ASU 2016-16, "Income Taxes (Topic 740): Intra-Entity transfers of Assets other than Inventory." The standard eliminates the prohibition in ASC 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. We have adopted this standard effective July 1, 2018 on a modified

Amounts in millions of dollars unless otherwise specified.


retrospective basis. The adoption of ASU 2016-16 did not have a material impact on our Consolidated Financial Statements, including the cumulative effect adjustment required upon adoption.
In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)." The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. In July 2018, the FASB issued ASU 2018-11, “Leases (Topic 842) Targeted Improvements”. The updated guidance provides an optional transition method, which allows for the application of the standard as of the adoption date with no restatement of prior period amounts. We plan to adopt the standard on July 1, 2019 under the optional transition method described above. We are currently in the process of implementing lease accounting software as well as assessing the impact that the new standard will have on our Consolidated Financial Statements, which will consist primarily of a balance sheet gross up of our operating leases to show equal and offsetting lease assets and lease liabilities.
In January 2017, the FASB issued ASU 2017-04, "Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The standard simplifies the accounting for goodwill impairment by requiring a goodwill impairment to be measured using a single step impairment model, whereby the impairment equals the difference between the carrying amount and the fair value of the specified reporting units in their entirety. This eliminates the second step of the current impairment model that requires companies to first estimate the fair value of all assets in a reporting unit and measure impairments based on those fair values and a residual measurement approach. It also specifies that any loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. We will adopt the standard no later than July 1, 2020. The impact of the new standard will be dependent on the specific facts and circumstances of future individual impairments, if any.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
U.S. Tax Reform
On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "U.S. Tax Act"). The U.S. Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering the U.S. corporate income tax rates and implementing a hybrid territorial tax system. As the Company has a June 30 fiscal year-end, the lower corporate income tax rate was phased in, resulting in a U.S. statutory federal rate of approximately 28% for our fiscal year ended June 30, 2018, and 21% for subsequent fiscal years. However, the U.S. Tax Act eliminates the domestic manufacturing deduction and moves to a hybrid territorial system, which also largely eliminates the ability to credit certain foreign taxes that existed prior to enactment of the U.S. Tax Act.
There are also certain transitional impacts of the U.S. Tax Act. As part of the transition to the new hybrid territorial tax system, the U.S. Tax Act imposed a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. In addition, the reduction of the U.S. corporate tax rate caused us to adjust our U.S. deferred tax assets and liabilities to the lower federal base rate of 21%. These transitional impacts resulted in a provisional net charge of $602 million for the fiscal year ended June 30, 2018, and $628 million for the three months ended December 31, 2017 (the quarter of enactment), comprised of an estimated repatriation tax charge of $3.8 billion (comprised of U.S. repatriation taxes and foreign withholding taxes) and an estimated net deferred tax benefit of $3.2 billion. We have finalized our assessment of the transitional impacts of the U.S. Tax Act, which did not have a significant impact on tax expense during the six months ended December 31, 2018. Any legislative changes, including the final Section 965 transition tax regulations issued on January 15, 2019, whose impact is currently being assessed due to the complexity and interdependency of the legislative provisions, as well as any other new or proposed Treasury regulations, which have yet to be issued, may result in additional income tax impacts which could be material in the period any such changes are enacted.
3. Segment Information
Under U.S. GAAP, our Global Business Units (GBUs) are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:
Beauty: Hair Care (Conditioner, Shampoo, Styling Aids, Treatments); Skin and Personal Care (Antiperspirant and Deodorant, Personal Cleansing, Skin Care);
Grooming: Shave Care (Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care); Appliances
Health Care: Oral Care (Toothbrushes, Toothpaste, Other Oral Care); Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);
Fabric & Home Care: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and
Baby, Feminine & Family Care: Baby Care (Baby Wipes, Diapers and Pants); Feminine Care (Adult Incontinence, Feminine Care); Family Care (Paper Towels, Tissues, Toilet Paper).

Amounts in millions of dollars unless otherwise specified.


Our business units are comprised of similar product categories. Nine business units individually accounted for 5% or more of consolidated net sales as follows:
 
% of Net sales by Business Unit (1)
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Fabric Care
22%
 
21%
 
22%
 
22%
Baby Care
12%
 
13%
 
12%
 
13%
Home Care
10%
 
10%
 
10%
 
10%
Skin and Personal Care
10%
 
9%
 
10%
 
9%
Hair Care
9%
 
10%
 
10%
 
10%
Family Care
9%
 
8%
 
9%
 
8%
Oral Care
9%
 
9%
 
8%
 
8%
Shave Care
7%
 
8%
 
8%
 
8%
Feminine Care
6%
 
6%
 
6%
 
6%
All Other
6%
 
6%
 
5%
 
6%
Total
100%
 
100%
 
100%
 
100%
(1) 
% of Net sales by business unit excludes sales held in Corporate.
Following is a summary of reportable segment results:
 
 
Three Months Ended December 31
 
Six Months Ended December 31
 
 
Net Sales
 
Earnings/(Loss) Before Income Taxes
 
Net Earnings/(Loss)
 
Net Sales
 
Earnings/(Loss) Before Income Taxes
 
Net Earnings/(Loss)
Beauty
2018
$
3,357

 
$
964

 
$
772

 
$
6,646

 
$
1,911

 
$
1,531

 
2017
3,233

 
853

 
655

 
6,371

 
1,689

 
1,287

Grooming
2018
1,617

 
448

 
378

 
3,179

 
865

 
718

 
2017
1,776

 
531

 
423

 
3,353

 
945

 
752

Health Care
2018
2,220

 
669

 
520

 
4,065

 
1,109

 
852

 
2017
2,212

 
668

 
455

 
4,114

 
1,123

 
760

Fabric & Home Care
2018
5,557

 
1,134

 
860

 
11,045

 
2,278

 
1,737

 
2017
5,434

 
1,101

 
714

 
10,817

 
2,280

 
1,483

Baby, Feminine & Family Care
2018
4,558

 
930

 
707

 
8,948

 
1,832

 
1,399

 
2017
4,613

 
933

 
597

 
9,158

 
1,897

 
1,227

Corporate
2018
129

 
(229
)
 
(21
)
 
245

 
(139
)
 
190

 
2017
127

 
(53
)
 
(283
)
 
235

 
(150
)
 
(78
)
Total Company
2018
$
17,438

 
$
3,916

 
$
3,216

 
$
34,128

 
$
7,856

 
$
6,427

 
2017
17,395

 
4,033

 
2,561

 
34,048

 
7,784

 
5,431


4. Goodwill and Other Intangible Assets
Goodwill is allocated by reportable segment as follows:
 
Beauty
 
Grooming
 
Health Care
 
Fabric & Home Care
 
Baby, Feminine & Family Care
 
Total Company
Goodwill at June 30, 2018
$
12,992

 
$
19,820

 
$
5,929

 
$
1,865

 
$
4,569

 
$
45,175

Acquisitions and divestitures
132

 

 
1,955

 
6

 

 
2,093

Translation and other
(116
)
 
(135
)
 
(36
)
 
(13
)
 
(36
)
 
(336
)
Goodwill at December 31, 2018
$
13,008

 
$
19,685

 
$
7,848

 
$
1,858

 
$
4,533

 
$
46,932



Amounts in millions of dollars unless otherwise specified.


Goodwill from current year acquisitions primarily reflects the acquisition of the over-the-counter (OTC) healthcare business of Merck KGaA (Merck OTC) in the Health Care reportable segment (see Note 11), along with other minor acquisitions in the Beauty and Fabric & Home Care reportable segments. Goodwill increases due to acquisitions was partially offset by the divestiture of the Teva portion of the PGT business in the Health Care reportable segment and currency translation.
Identifiable intangible assets at December 31, 2018 were comprised of:
 
Gross Carrying Amount
 
Accumulated Amortization
Intangible assets with determinable lives
$
8,580

 
$
(5,251
)
Intangible assets with indefinite lives
22,618

 

Total identifiable intangible assets
$
31,198

 
$
(5,251
)

Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist of brands. The amortization expense of intangible assets for the three months ended December 31, 2018 and 2017 was $81 and $75, respectively. For the six months ended December 31, 2018 and 2017, the amortization expense of intangible assets was $154 and $152, respectively.
Goodwill and indefinite lived intangible assets are not amortized, but are tested annually for impairment. The test to evaluate goodwill for impairment is a two-step process. In the first step, we compare the fair value of the reporting unit to its carrying value. If the fair value of the reporting unit is less than its carrying value, we perform a second step to determine the implied fair value of the reporting unit's goodwill. The second step of the impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment.
The business unit valuations used to test goodwill and intangible assets for impairment are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment, margin expansion and Company business plans. We believe these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values. Our annual impairment testing for goodwill and indefinite lived intangible assets occurs during the 3 months ended December 31.
Most of our goodwill reporting units are comprised of a combination of legacy and acquired businesses and as a result have fair value cushions that, at a minimum, exceed two times their underlying carrying values. Certain of our goodwill reporting units, in particular Shave Care and Appliances, are comprised entirely of acquired businesses and as a result, have fair value cushions that are not as high. Both of these wholly acquired reporting units have fair value cushions that currently equal or exceed the underlying carrying values. However, the overall Shave Care goodwill cushion has been reduced in recent years, with the fair value in the current year being reduced to an amount that approximates the reporting unit's carrying value. The related Gillette indefinite-lived intangible asset cushion has also been reduced to below 5%. These reductions are due in large part to an increased competitive market environment in the U.S. and certain other markets, a deceleration of category growth caused by changing grooming habits and significant currency devaluations in a number of countries relative to the U.S. dollar, which collectively have resulted in reduced cash flow projections. The current year reduction in the fair value was primarily caused by further currency devaluations, along with competitive activities. As a result of these factors and the reduction in the fair values and related cushions, goodwill for the Shave Care reporting unit and the related indefinite-lived intangible asset are more susceptible to impairment risk.
The most significant assumptions utilized in the determination of the estimated fair values of Shave Care reporting unit and the Gillette indefinite-lived intangible asset are the net sales and earnings growth rates (including residual growth rates) and discount rate. The residual growth rate represents the expected rate at which the reporting unit and Gillette brand are expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the reporting unit and brand operating plans, and approximates expected long term category market growth rates. The residual growth rate is dependent on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.

Amounts in millions of dollars unless otherwise specified.


While management can and has implemented strategies to address these events, changes in operating plans or adverse changes in the future could reduce the underlying cash flows used to estimate fair values and could result in a decline in fair value that would trigger future impairment charges of the reporting unit's goodwill and indefinite-lived intangibles. As of December 31, 2018, the carrying values of Shave Care goodwill and the Gillette indefinite-lived intangible asset were $19.4 billion and $15.7 billion, respectively.
The table below provides a sensitivity analysis for the Shave Care reporting unit and the Gillette indefinite lived intangible asset, utilizing reasonably possible changes in the assumptions for the shorter term and residual growth rates and the discount rate, to demonstrate the potential impacts to the estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis point increase to discount rate or a 25 basis point decrease to our shorter-term and residual growth rates, both of which would result in impairment charges.
 
Approximate Percent Change in Estimated Fair Value
 
+25 bps Discount Rate
 
-25 bps Growth Rate
Shave Care goodwill reporting unit
(5
)%
 
(6
)%
Gillette indefinite-lived intangible asset
(5
)%
 
(6
)%

5. Earnings Per Share
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends (net of related tax benefits) by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated using the treasury stock method on the basis of the weighted average number of common shares outstanding plus the dilutive effect of stock options and other stock-based awards and the assumed conversion of preferred stock.
Net earnings per share were as follows:
CONSOLIDATED AMOUNTS
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Net earnings
$
3,216

 
$
2,561

 
$
6,427

 
$
5,431

Less: Net earnings attributable to noncontrolling interests
22

 
66

 
34

 
83

Net earnings attributable to P&G (Diluted)
3,194

 
2,495

 
6,393

 
5,348

Preferred dividends, net of tax
(65
)
 
(62
)
 
(131
)
 
(124
)
Net earnings attributable to P&G available to common shareholders (Basic)
$
3,129

 
$
2,433

 
$
6,262

 
$
5,224

 
 
 
 
 
 
 
 
SHARES IN MILLIONS
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
2,499.7

 
2,533.9

 
2,497.8

 
2,542.2

Add: Effect of dilutive securities
 
 
 
 
 
 
 
Conversion of preferred shares (1)
90.7

 
95.5

 
91.3

 
96.0

Impact of stock options and other unvested equity awards (2)
32.6

 
40.2

 
28.5

 
41.9

Diluted weighted average common shares outstanding
2,623.0

 
2,669.6

 
2,617.6

 
2,680.1

 
 
 
 
 
 
 
 
NET EARNINGS PER SHARE (3)
 
 
 
 
 
 
 
Basic
$
1.25

 
$
0.96

 
$
2.51

 
$
2.05

Diluted
$
1.22

 
$
0.93

 
$
2.44

 
$
2.00

(1) 
Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.
(2) 
Weighted average outstanding stock options of approximately 23 million and 24 million for the three months ended December 31, 2018 and 2017, and approximately 35 million and 22 million for the six months ended December 31, 2018 and 2017 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
(3) 
Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.


Amounts in millions of dollars unless otherwise specified.


6. Share-Based Compensation and Postretirement Benefits
The following table provides a summary of our share-based compensation expense and postretirement benefit costs:
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Share-based compensation expense
$
79

  
$
73

 
$
181

 
$
157

Net periodic benefit cost for pension benefits (1)
36

 
52

 
64

 
103

Net periodic benefit cost/(credit) for other retiree benefits (1)
(42
)
 
(38
)
 
(83
)
 
(76
)
(1) 
The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2018, as revised by the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18.
7. Risk Management Activities and Fair Value Measurements
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the six months ended December 31, 2018.
The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were remeasured at fair value on a non-recurring basis for the six months ended December 31, 2018.
The following table sets forth the Company’s financial assets as of December 31, 2018 and June 30, 2018 that are measured at fair value on a recurring basis during the period:
 
Fair Value Asset
 
December 31, 2018
 
June 30, 2018
Investments:
 
 
 
U.S. government securities
$
5,177

 
$
5,544

Corporate bond securities
3,244

 
3,737

Other investments
163

 
141

Total
$
8,584

 
$
9,422


Investment securities are presented in Available-for-sale investment securities and Other noncurrent assets. The amortized cost of U.S. government securities with maturities less than one year was $1,601 as of December 31, 2018 and $2,003 as of June 30, 2018. The amortized cost of U.S. government securities with maturities between one and five years was $3,657 as of December 31, 2018 and $3,659 as of June 30, 2018. The amortized cost of Corporate bond securities with maturities of less than a year was $1,525 as of December 31, 2018 and $1,291 as of June 30, 2018. The amortized cost of Corporate bond securities with maturities between one and five years was $1,760 as of December 31, 2018 and $2,503 as of June 30, 2018. The Company's investments measured at fair value are generally classified as Level 2 within the fair value hierarchy. There are no material investment balances classified as Level 1 or Level 3 within the fair value hierarchy, or that used net asset value as a practical expedient. Fair values are generally estimated based upon quoted market prices for similar instruments.
The fair value of long-term debt was $24,602 and $23,402 as of December 31, 2018 and June 30, 2018, respectively. This includes the current portion of debt instruments ($2,301 and $1,769 as of December 31, 2018 and June 30, 2018, respectively). Certain long-term debt (debt tied to derivatives designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost, but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.

Amounts in millions of dollars unless otherwise specified.



Disclosures about Financial Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2018 and June 30, 2018 are as follows:
 
Notional Amount
 
Fair Value Asset
 
Fair Value (Liability)
 
December 31, 2018
 
June 30, 2018
 
December 31, 2018
 
June 30, 2018
 
December 31, 2018
 
June 30, 2018
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts
$
4,550

 
$
4,587

 
$
118

 
$
125

 
$
(28
)
 
$
(53
)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts
$
1,855

 
$
1,848

 
$
21

 
$
41

 
$
(59
)
 
$
(75
)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS
$
6,405

 
$
6,435

 
$
139

 
$
166

 
$
(87
)
 
$
(128
)
 
 
 
 
 
 
 
 
 
 
 
 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts
$
7,025

 
$
7,358

 
$
49

 
$
30

 
$
(29
)
 
$
(56
)
 
 
 
 
 
 
 
 
 
 
 
 
TOTAL DERIVATIVES AT FAIR VALUE
$
13,430

 
$
13,793

 
$
188

 
$
196

 
$
(116
)
 
$
(184
)

All derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. All derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities.
The fair value of the interest rate derivative asset/liability directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $4,623 and $4,639 as of December 31, 2018 and June 30, 2018, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $17,092 and $15,012 as of December 31, 2018 and June 30, 2018, respectively. All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.
Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows:
 
Amount of Gain/(Loss) Recognized in OCI on Derivatives
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign exchange contracts
$
23

 
$
(89
)
 
$
19

 
$
(262
)

(1) 
For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was $13 and $42 for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) excluded from effectiveness testing was $27 and $73 for the six months ended December 31, 2018 and 2017, respectively.
(2) 
In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments was $228 and $(176), for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $241 and $(745), for the six months ended December 31, 2018 and 2017, respectively.
 
Amount of Gain/(Loss) Recognized in Earnings
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
 
 
 
 
Interest rate contracts
$
42

 
$
(38
)
 
$
18

 
$
(41
)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
 
 
 
 
Foreign currency contracts
$
(5
)
 
$
(1
)
 
$
(7
)
 
$
(2
)

The gain/(loss) on the derivatives in fair value hedging relationships is fully offset by the mark-to-market impact of the related exposure. These are both recognized in the Consolidated Statements of Earnings in Interest Expense. The gain/(loss) on derivatives not designated as hedging instruments is substantially offset by the currency mark-to-market of the related exposure. These are both recognized in the Consolidated Statements of Earnings in SG&A.

Amounts in millions of dollars unless otherwise specified.


8. Accumulated Other Comprehensive Income/(Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) (AOCI), including the reclassifications out of Accumulated other comprehensive income/(loss) by component:
 
Changes in Accumulated Other Comprehensive Income/(Loss) by Component
 
Hedges
 
Investment Securities
 
Pension and Other Retiree Benefits
 
Financial Statement Translation
 
Total AOCI
Balance at June 30, 2018
$
(3,246
)
 
$
(173
)
 
$
(4,058
)
 
$
(7,272
)
 
$
(14,749
)
OCI before reclassifications (1)
199

 
54

 
149

 
(587
)
 
(185
)
Amounts reclassified from AOCI (2)

 
(1
)
 
101

 
1

 
101

Net current period OCI
199

 
53

 
250

 
(586
)
 
(84
)
Reclassification to retained earnings in accordance with ASU 2018-02 (3)
(18
)
 

 
(308
)
 

 
(326
)
Less: Other comprehensive income/(loss) attributable to non-controlling interests

 

 

 
(3
)
 
(3
)
Balance at December 31, 2018
$
(3,065
)
 
$
(120
)
 
$
(4,116
)
 
$
(7,855
)
 
$
(15,156
)

(1) 
Net of tax expense/(benefit) of $61, $0 and $38 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
(2) 
Net of tax expense/(benefit) of $0, $0 and $32 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
(3) 
Adjustment made to early adopt ASU 2018-02: "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income," as discussed in Note 2.

The below provides additional details on amounts reclassified from AOCI into the Consolidated Statements of Earnings:
Investment securities: amounts reclassified from AOCI into Other non-operating income, net.
Pension and other retiree benefits: amounts reclassified from AOCI into Other non-operating income, net and included in the computation of net periodic postretirement costs.
Financial statement translation: amounts reclassified from AOCI into SG&A.
9. Restructuring Program
The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before-tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually.
In fiscal 2017, the Company announced specific elements of a multi-year productivity and cost savings plan to further reduce costs in the areas of supply chain, certain marketing activities and overhead expenses. This program is expected to result in incremental enrollment reductions, along with further optimization of the supply chain and other manufacturing processes.
Restructuring costs incurred consist primarily of costs to separate employees, asset-related costs to exit facilities and other costs. For the three and six month periods ended December 31, 2018, the Company incurred total restructuring charges of $177 and $314, respectively. Of these charges incurred, $25 and $97 were recorded in SG&A and $143 and $207 were recorded in Cost of products sold, respectively. The remainder of these charges were recorded in Other non-operating income, net. The following table presents restructuring activity for the six months ended December 31, 2018:
 
 
 
Charges Previously Reported (Three Months Ended September 30, 2018)
 
Charges for the Three Months Ended December 31, 2018
 
Six Months Ended December 31, 2018
 
 
 
Reserve Balance June 30, 2018
 
 
 
Cash Spent
 
Charges Against Assets
 
Reserve Balance December 31, 2018
Separations
$
259

 
$
53

 
$
56

 
$
(115
)
 
$

 
$
253

Asset-related costs

 
28

 
22

 

 
(50
)
 

Other costs
254

 
56

 
99

 
(180
)
 

 
229

Total
$
513

 
$137
 
$
177

 
$
(295
)
 
$
(50
)
 
$
482


Separation Costs
Employee separation charges for the three and six month periods ended December 31, 2018 relate to severance packages for approximately 500 employees and 970 employees, respectively. The packages were predominantly voluntary and the amounts were calculated based on salary levels and past service periods. Severance costs related to voluntary separations are generally charged to earnings when the employee accepts the offer.
Asset-Related Costs
Asset-related costs consist of both asset write-downs and accelerated depreciation. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or disposal. These assets were written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. These assets relate primarily to manufacturing consolidations and technology standardizations. The asset-related charges will not have a significant impact on future depreciation charges.
Other Costs
Other restructuring-type charges are incurred as a direct result of the restructuring program. Such charges primarily include asset removal and termination of contracts related to supply chain optimization.
Consistent with our historical policies for ongoing restructuring-type activities, the restructuring program charges are funded by and included within Corporate for both management and segment reporting. Accordingly, all of the charges under the program are included within the Corporate reportable segment. However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments:
 
Three Months Ended December 31, 2018
 
Six Months Ended December 31, 2018
Beauty
$
17

 
$
27

Grooming
25

 
31

Health Care
4

 
12

Fabric & Home Care
18

 
31

Baby, Feminine & Family Care
70

 
91

Corporate (1)
43

 
122

Total Company
$177
 
$
314

(1) 
Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities.
10. Commitments and Contingencies
Litigation
The Company is subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark, advertising, contracts, environmental, labor and employment and tax. With respect to these and other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.
We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.
Income Tax Uncertainties
The Company is present in approximately 150 taxable jurisdictions and, at any point in time, has 4050 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2008 and forward. We are generally not able to reliably estimate the ultimate settlement amounts until the close of the audit. While we do not expect material changes, it is possible that the amount of unrecognized benefit with respect to our uncertain tax positions could increase or decrease within the next 12 months. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items.
Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the year ended June 30, 2018.

Amounts in millions of dollars unless otherwise specified.


11. Merck Acquisition

On November 30, 2018, we completed our acquisition of the over the counter (OTC) healthcare business of Merck KGaA (Merck OTC) for $3.7 billion (based on exchange rates at the time of closing) in an all-cash transaction. This business primarily sells OTC consumer healthcare products, mainly in Europe, Latin America and Asia markets. The results of Merck OTC, which are not material to the Company, are reported in our consolidated financial statements beginning December 1, 2018. Total sales for Merck OTC’s most recently completed fiscal year ended December 31, 2017 were approximately $1 billion.
The following table presents the preliminary allocation of purchase price related to the Merck OTC business as of the date of acquisition. The preliminary allocation of the purchase price is based on the best estimates of management and is subject to revision based on final determination of fair values of the assets and liabilities acquired, which will be completed as we complete our analysis of the underlying assets and acquired liabilities, such as pensions, litigation cases, environmental issues, and tax positions.
Amounts in Millions
November 30, 2018
Current assets
$
393

Property, plant and equipment
122

Intangible assets
2,111

Goodwill
2,010

Other non-current assets
143

Total Assets Acquired
$
4,779

 
 
Current liabilities
$
233

Deferred income taxes
661

Non-current liabilities
60

Total Liabilities Acquired
$
954

 
 
Noncontrolling Interest (1)
$
169

 
 
Net Assets Acquired
$
3,656

(1) 
Represents a 48% minority ownership interest in the Merck India company.

The acquisition resulted in $2.0 billion in goodwill, of which approximately $180 million is expected to be deductible for tax purposes. All of this goodwill was allocated to the Health Care Segment. The goodwill is primarily attributable to the assembled workforce and synergies we expect to generate by combining the Merck OTC business with the Company’s existing personal health care business.

We have preliminarily estimated the fair value of Merck OTC’s identifiable intangible assets as $2.1 billion. The preliminary allocation of identifiable intangible assets and their average useful lives is as follows:
Amounts in Millions
Estimated Fair Value
 
Avg Remaining
Useful Life
Intangible Assets with Determinable Lives
 
 
 
   Brands
$
701

 
14
   Patents and technology
118

 
7
   Customer relationships
346

 
20
   Total
$
1,165

 
15
 
 
 
 
Intangible Assets with Indefinite Lives
 
 
 
   Brands
946

 
 
Total Intangible Assets
$
2,111

 
 



Amounts in millions of dollars unless otherwise specified.


The majority of the intangible valuation relates to brand intangibles. Our preliminary assessment as to brand intangibles that have an indefinite life and those that have a definite life was based on a number of factors, including competitive environment, market share, brand history, product life cycles, operating plan and the macroeconomic environment of the countries in which the brands are sold. The indefinite-lived brand intangibles include Neurobion and Dolo Neurobion. The definite-lived brand intangibles primarily include regional or local brands. The definite-lived brand intangibles have estimated lives ranging from 10 to 20 years. The technology intangibles are related to R&D and manufacturing know-how; these intangibles have a 7 year estimated life. The customer relationships intangibles have a 20 year estimated life and reflect the historical and projected attrition rates for Merck OTC’s relationships with health care professionals, retailers and distributors.
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
Certain statements in this report, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives, and expected operating results, and the assumptions upon which those statements are based, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may appear throughout this report, including without limitation, the following sections: “Management's Discussion and Analysis,” “Risk Factors,” and "Notes 4 and 10 to the Consolidated Financial Statements." These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise.
Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial risks, including foreign currency fluctuations, currency exchange or pricing controls and localized volatility; (2) the ability to successfully manage local, regional or global economic volatility, including reduced market growth rates, and to generate sufficient income and cash flow to allow the Company to affect the expected share repurchases and dividend payments; (3) the ability to manage disruptions in credit markets or changes to our credit rating; (4) the ability to maintain key manufacturing and supply arrangements (including execution of supply chain optimizations and sole supplier and sole manufacturing plant arrangements) and to manage disruption of business due to factors outside of our control, such as natural disasters and acts of war or terrorism; (5) the ability to successfully manage cost fluctuations and pressures, including prices of commodities and raw materials, and costs of labor, transportation, energy, pension and healthcare; (6) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to changing consumer habits and technological advances attained by, and patents granted to, competitors; (7) the ability to compete with our local and global competitors in new and existing sales channels, including by successfully responding to competitive factors such as prices, promotional incentives and trade terms for products; (8) the ability to manage and maintain key customer relationships; (9) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, ingredients, efficacy or similar matters that may arise; (10) the ability to successfully manage the financial, legal, reputational and operational risk associated with third-party relationships, such as our suppliers, distributors, contractors and external business partners; (11) the ability to rely on and maintain key company and third party information technology systems, networks and services, and maintain the security and functionality of such systems, networks and services and the data contained therein; (12) the ability to successfully manage uncertainties related to changing political conditions (including the United Kingdom’s decision to leave the European Union) and potential implications such as exchange rate fluctuations and market contraction; (13) the ability to successfully manage regulatory and legal requirements and matters (including, without limitation, those laws and regulations involving product liability, intellectual property, antitrust, data protection, tax, environmental, and accounting and financial reporting) and to resolve pending matters within current estimates; (14) the ability to manage changes in applicable tax laws and regulations including maintaining our intended tax treatment of divestiture transactions; (15) the ability to successfully manage our ongoing acquisition, divestiture and joint venture activities, in each case to achieve the Company’s overall business strategy and financial objectives, without impacting the delivery of base business objectives; and (16) the ability to successfully achieve productivity improvements and cost savings and manage ongoing organizational changes, while successfully identifying, developing and retaining key employees, including in key growth markets where the availability of skilled or experienced employees may be limited.  A detailed discussion of risks and uncertainties that could cause actual results and events to differ materially from those projected herein, is included in the section titled “Economic Conditions and Uncertainties” and the section titled “Risk Factors” (Part II, Item 1A) of this Form 10-Q.
The purpose of Management's Discussion and Analysis (MD&A) is to provide an understanding of Procter & Gamble's financial condition, results of operations and cash flows by focusing on changes in certain key measures from year to year. The MD&A is provided as a supplement to, and should be read in conjunction with, our Consolidated Financial Statements and accompanying notes.
The MD&A is organized in the following sections:
Overview
Summary of Results – Six Months Ended December 31, 2018
Economic Conditions and Uncertainties
Results of Operations – Three and Six Months Ended December 31, 2018
Business Segment Discussion – Three and Six Months Ended December 31, 2018
Liquidity and Capital Resources
Reconciliation of Measures Not Defined by U.S. GAAP
Throughout the MD&A, we refer to measures used by management to evaluate performance, including unit volume growth, net sales and net earnings. We also refer to a number of financial measures that are not defined under accounting principles generally accepted in the United States of America (U.S. GAAP), including organic sales growth, core net earnings per share (Core EPS), adjusted free cash flow and adjusted free cash flow productivity. The explanation at the end of the MD&A provides the definition of these non-GAAP measures as well as details on the use and the derivation of these measures.
Management also uses certain market share and market consumption estimates to evaluate performance relative to competition despite some limitations on the availability and comparability of share and consumption information. References to market share and market consumption in the MD&A are based on a combination of vendor purchased traditional brick-and-mortar and online data in key markets as well as internal estimates. All market share references represent the percentage of sales in dollar terms on a constant currency basis of our products, relative to all product sales in the category. The Company measures fiscal-year-to-date market shares through the most recent period for which market share data is available, which typically reflects a lag time of one or two months.
OVERVIEW
P&G is a global leader in the fast-moving consumer goods industry, focused on providing branded consumer packaged goods of superior quality and value to our consumers around the world. Our products are sold in more than 180 countries and territories primarily through mass merchandisers, e-commerce, grocery stores, membership club stores, drug stores, department stores, distributors, wholesalers, baby stores, specialty beauty stores, high-frequency stores and pharmacies. We have on-the-ground operations in approximately 70 countries.
Our market environment is highly competitive with global, regional and local competitors. In many of the markets and industry segments in which we sell our products, we compete against other branded products as well as retailers' private-label brands. Additionally, many of the product segments in which we compete are differentiated by price tiers (referred to as super-premium, premium, mid-tier and value-tier products). We are well positioned in the industry segments and markets in which we operate, often holding a leadership or significant market share position.
The table below provides detail on our reportable segments, including the product categories and brand composition within each segment.
Reportable Segments
Product Categories (Sub-Categories)
Major Brands
Beauty
Hair Care (Conditioner, Shampoo, Styling Aids, Treatments)
Head & Shoulders, Pantene, Rejoice
Skin and Personal Care (Antiperspirant and Deodorant, Personal Cleansing, Skin Care)
Olay, Old Spice, Safeguard, SK-II
Grooming
Grooming (1) (Shave Care - Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care; Appliances)
Braun, Fusion, Gillette, Mach3, Prestobarba, Venus
Health Care
Oral Care (Toothbrushes, Toothpaste, Other Oral Care)
Crest, Oral-B
Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care)
Metamucil, Prilosec, Vicks
Fabric & Home Care
Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents)
Ariel, Downy, Gain, Tide
Home Care (Air Care, Dish Care, P&G Professional, Surface Care)
Cascade, Dawn, Febreze, Mr. Clean, Swiffer
Baby, Feminine & Family Care
Baby Care (Baby Wipes, Diapers and Pants)
Luvs, Pampers
Feminine Care (Adult Incontinence, Feminine Care)
Always, Tampax
Family Care (Paper Towels, Tissues, Toilet Paper)
Bounty, Charmin, Puffs
(1) 
The Grooming product category is comprised of the Shave Care and Appliances Global Business Units.
The following table provides the percentage of net sales and net earnings by reportable business segment for the three and six months ended December 31, 2018 (excluding net sales and net earnings in Corporate):
 
Three Months Ended December 31, 2018
 
Six Months Ended December 31, 2018
 
Net Sales
 
Net Earnings
 
Net Sales
 
Net Earnings
Beauty
20%
 
24%
 
20%
 
25%
Grooming
9%
 
12%
 
9%
 
11%
Health Care
13%
 
16%
 
12%
 
14%
Fabric & Home Care
32%
 
26%
 
33%
 
28%
Baby, Feminine & Family Care
26%
 
22%
 
26%
 
22%
Total Company
100%
 
100%
 
100%
 
100%
SUMMARY OF RESULTS
Following are highlights of results for the six months ended December 31, 2018 versus the six months ended December 31, 2017:
Net sales were unchanged at $34.1 billion. Organic sales, which exclude the impacts of acquisitions and divestitures and foreign exchange, increased 4%. Organic sales increased 8% in Beauty, 5% in Health Care and Fabric & Home Care and 1% in Baby, Feminine & Family Care. Organic sales were unchanged in Grooming.
Unit volume increased 2%, with organic volume up 3%. Volume increased mid-single digits in Fabric & Home Care, low single digits in Beauty, Health Care and Baby, Feminine & Family Care and was unchanged in Grooming. Excluding the impacts of the PGT Healthcare partnership dissolution and the Merck OTC acquisition, organic volume increased mid-single digits in Health Care.
Net earnings were $6.4 billion, an increase of $996 million, or 18% versus the prior year due to a reduction in current year income tax expense (due primarily to the ongoing impacts of the U.S. Tax Act), a current year gain on the dissolution of the PGT Healthcare partnership and base period charges related to the transitional impacts of the U.S. Tax Act.
Diluted net earnings per share increased 22% to $2.44 due primarily to the increase in net earnings and a reduction in shares outstanding due to share repurchases.
Net earnings attributable to Procter & Gamble increased $1.0 billion or 20% versus the prior year period to $6.4 billion.
Core net earnings attributable to Procter & Gamble, which represents net earnings excluding the current period gain on the dissolution of the PGT Healthcare partnership, incremental restructuring charges in both periods and the base period charges related to the transitional impacts of the U.S. Tax Act, increased 1% to $6.2 billion. Core net earnings per share increased 4% to $2.36 due to the increase in Core net earnings and the reduction in shares outstanding.
Operating cash flow was $7.6 billion. Adjusted free cash flow, which is operating cash flow less capital expenditures and certain other impacts, was $6.0 billion. Adjusted free cash flow productivity was 99%. Adjusted free cash flow and adjusted free cash flow productivity are defined in the section entitled "Reconciliation of Measures not defined by U.S. GAAP."
ECONOMIC CONDITIONS AND UNCERTAINTIES
Global Economic Conditions. Our products are sold in countries around the world including North America, Europe, Latin America, Asia and Africa with more than half our sales generated outside the United States. As such, we are exposed to and impacted by global macro-economic factors, U.S. and foreign government policies and foreign exchange fluctuations. Current macroeconomic factors remain dynamic, and any causes of market size contraction, such as reduced GDP in commodity-dependent economies, greater political unrest in the Middle East, Central & Eastern Europe and the Korean peninsula, economic uncertainty related to the execution of the United Kingdom's exit from the European Union, political instability in certain Latin American markets and overall economic slowdowns, could reduce our sales or erode our operating margin, in either case reducing our earnings.
Changes in Costs. Our costs are subject to fluctuations, particularly due to changes in commodity prices, transportation costs and our own productivity efforts. We have significant exposures to certain commodities, in particular certain oil-derived materials like resins and paper-based materials like pulp, and volatility in the market price of these commodity input materials has a direct impact on our costs. If we are unable to manage commodity fluctuations through pricing actions, cost savings projects and sourcing decisions, as well as through consistent productivity improvements, it may adversely impact our gross margin, operating margin and net earnings. Sales could also be adversely impacted following pricing actions if there is a negative impact on consumption of our products. We strive to implement, achieve and sustain cost improvement plans, including outsourcing projects, supply chain optimization and general overhead and workforce optimization. As discussed later in this MD&A, in 2012 we initiated overhead and supply chain cost improvement projects. In fiscal 2017, we communicated specific elements of an additional multi-year cost reduction program which is resulting in enrollment reductions and other savings. If we are not successful in executing and sustaining these changes, there could be a negative impact on our operating margin and net earnings.
Foreign Exchange. We have both translation and transaction exposure to the fluctuation of exchange rates. Translation exposures relate to exchange rate impacts of measuring income statements of foreign subsidiaries that do not use the U.S. dollar as their functional currency. Transaction exposures relate to 1) the impact from input costs that are denominated in a currency other than the local reporting currency and 2) the revaluation of transaction-related working capital balances denominated in currencies other than the functional currency. In four of the past five fiscal years, as well as the current year, the U.S. dollar has strengthened versus a number of foreign currencies leading to lower sales and earnings from these foreign exchange impacts. Certain countries experiencing significant exchange rate fluctuations, like Argentina, Russia, Turkey, Brazil, China and the United Kingdom have previously had, and could in the future have, a significant impact on our sales, costs and earnings. Increased pricing in response to certain fluctuations in foreign currency exchange rates may offset portions of the currency impacts but could also have a negative impact on consumption of our products, which would affect our sales and profits.
Government Policies. Our net earnings could be affected by changes in U.S. or foreign government tax policies, for example, the U.S. Tax Act enacted in December 2017, the implications and uncertainties of which are disclosed elsewhere in this report. Additionally, we attempt to carefully manage our debt, currency and other exposures in certain countries with currency exchange, import authorization and pricing controls, such as Nigeria, Algeria and Egypt. Further, our earnings and sales could be affected by changes to international trade agreements in North America and elsewhere, including increases of import tariffs, both currently effective and future potential changes. Changes in government policies in these areas might cause an increase or decrease in our sales, operating margin and net earnings.
For information on risk factors that could impact our results, please refer to “Risk Factors” in Part I, Item 1A of the Company's Form 10-K for the fiscal year ended June 30, 2018.
RESULTS OF OPERATIONS – Three Months Ended December 31, 2018
The following discussion provides a review of results for the three months ended December 31, 2018 versus the three months ended December 31, 2017.
 
Three Months Ended December 31
Amounts in millions, except per share amounts
2018
 
2017
 
% Chg
Net sales
$17,438
 
$17,395
 
—%
Operating income
3,896
 
3,919
 
(1)%
Net earnings
3,216
 
2,561
 
26%
Net earnings attributable to Procter & Gamble
3,194
 
2,495
 
28%
Diluted net earnings per common share
1.22
 
0.93
 
31%
Core net earnings per common share
1.25
 
1.19
 
5%
 
 
Three Months Ended December 31
COMPARISONS AS A PERCENTAGE OF NET SALES
2018
 
2017
 
Basis Pt Chg
Gross profit
48.9%
 
49.9%
 
(100)
Selling, general & administrative expense
26.5%
 
27.4%
 
(90)
Operating income
22.3%
 
22.5%
 
(20)
Earnings before income taxes
22.5%
 
23.2%
 
(70)
Net earnings
18.4%
 
14.7%
 
370
Net earnings attributable to Procter & Gamble
18.3%
 
14.3%
 
400
Net Sales
Net sales for the quarter were unchanged versus the previous period at $17.4 billion including a 4% negative impact from foreign exchange. Unit volume increased 2%. Pricing was a 1% favorable impact to net sales. Mix was a 1% positive impact to net sales, driven by disproportionate growth of the premium Skin Care category (behind the SK-II brand) and developed regions, all of which have higher than company average selling prices. Volume increased mid-single digits in Fabric & Home Care and increased low single digits in Beauty, Health Care and Baby, Feminine & Family Care. Volume decreased mid-single digits in Grooming. Excluding the impacts of the PGT Healthcare partnership dissolution and Merck OTC acquisition, Health Care organic volume increased mid-single digits. Excluding the impact of minor acquisitions and divestitures, Beauty organic volume was unchanged. Volume increased low single digits in developed regions and was unchanged in developing regions. Excluding the impact of minor brand divestitures, organic volume in developing regions increased low single digits. Organic sales increased 4% on a 2% increase in organic volume.
 
Net Sales Change Drivers 2018 vs. 2017 (Three Months Ended December 31) (1)
 
Volume with Acquisitions & Divestitures
 
Volume Excluding Acquisitions & Divestitures
 
Foreign Exchange
 
Price
 
Mix
 
Other (2)
 
Net Sales Growth
Beauty
1%
 
—%
 
(4)%
 
2%
 
5%
 
—%
 
4%
Grooming
(4)%
 
(4)%
 
(5)%
 
1%
 
—%
 
(1)%
 
(9)%
Health Care
3%
 
4%
 
(3)%
 
1%
 
—%
 
(1)%
 
—%
Fabric & Home Care
4%
 
4%
 
(3)%
 
1%
 
1%
 
(1)%
 
2%
Baby, Feminine & Family Care
1%
 
1%
 
(4)%
 
1%
 
1%
 
—%
 
(1)%
Total Company
2%
 
2%
 
(4)%
 
1%
 
1%
 
—%
 
—%
(1)    Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2)    Other includes the sales mix impact from acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers" and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin decreased 100 basis points to 48.9% of net sales for the quarter. Gross margin benefited from 150 basis points of gross manufacturing cost savings projects (120 basis points net of product and packaging reinvestments) and 50 basis points of positive pricing impacts. This was offset by:
a 90 basis point decline due to higher commodity costs,
a 120 basis point decline from unfavorable product mix (primarily within segments due to the growth of lower margin products forms in certain categories and due to the disproportionate growth of the Fabric Care category which has lower than company-average margins) and other impacts and
a 60 basis point decline from unfavorable foreign exchange
Total SG&A spending decreased 3% to $4.6 billion due to decreases in marketing spending costs. SG&A as a percentage of net sales decreased 90 basis points to 26.5%. Reductions in marketing spending as a percentage of net sales were partially offset by an increase in overhead costs as a percentage of net sales. Marketing spending as a percentage of net sales decreased 130 basis points due to the positive scale impacts of the organic net sales increase, savings in agency compensation, production costs and advertising spending, and the impact of adopting the new standard on "Revenue from Contracts with Customers" which prospectively reclassified certain customer spending from marketing (SG&A) expense to a reduction of net sales. Overhead costs as a percentage of net sales increased 30 basis points as the fixed cost leverage of increased volume and productivity savings were more than offset by inflation, Merck OTC transition related spending and other costs. Other net operating costs as a percentage of net sales increased 10 basis points. Productivity-driven cost savings delivered 60 basis points of benefit in SG&A.
Non-Operating Expenses and Income
Interest expense was $138 million for the quarter, an increase of $16 million versus the prior year period due to an increase in debt and in weighted average interest rates. Interest income was $63 million for the quarter, a marginal decrease versus the prior year period. Other non-operating income was $95 million, a decrease of $75 million versus the prior year period primarily due to the impact of minor brand divestiture gains in the base period.
Income Taxes
For the three months ended December 31, 2018 the effective tax rate decreased 1,860 basis points versus the prior year period to 17.9% due to:
a 1,550 basis-point reduction due to prior year transitional impacts from the U.S. Tax Act,
a 410 basis-point reduction from the on-going impacts of U.S. Tax reform. The lower blended U.S. federal tax rate on current year earnings was partially offset by the impact of recording a year-to-date (6 month) impact in December 2017 upon passage of the tax reform.
a 150 basis-point reduction from excess tax benefits from share-based compensation (170 basis points in the current year versus 20 basis points in the prior year),
a 90 basis-point reduction from discrete impacts related to uncertain tax positions (90 basis points in the current year versus 0 basis points in the prior year),
a 340 basis-point increase from unfavorable impacts from geographic mix of earnings.
Net Earnings
Net earnings increased $655 million or 26% to $3.2 billion for the quarter. The tax rate reduction discussed above drove a $772 million increase in net earnings. This tax benefit and the decrease in SG&A spending were partially offset by the decrease in gross margin, all of which are discussed above. Foreign exchange had a negative impact of $229 million on net earnings for the quarter, including both transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Net earnings attributable to Procter & Gamble increased $699 million or 28% to $3.2 billion for the quarter. Diluted net earnings per share increased 31% to $1.22. The difference between the change in net earnings and diluted net earnings per share was due to a reduction in the number of shares outstanding. Core net earnings per share increased 5% to $1.25. Core net earnings per share represents diluted net earnings per share excluding the transitional impacts from the U.S. Tax Act in the base period and incremental restructuring charges in both periods related to our productivity and cost savings plans.
RESULTS OF OPERATIONS – Six Months Ended December 31, 2018
The following discussion provides a review of results for the six months ended December 31, 2018 versus the six months ended December 31, 2017.
 
Six Months Ended December 31
Amounts in millions, except per share amounts
2018
 
2017
 
% Chg
Net sales
$34,128
 
$34,048
 
—%
Operating income
7,450
 
7,567
 
(2)%
Net earnings
6,427
 
5,431
 
18%
Net earnings attributable to Procter & Gamble
6,393
 
5,348
 
20%
Diluted net earnings per common share
2.44
 
2.00
 
22%
Core net earnings per common share
$2.36
 
$2.28
 
4%
 
 
Six Months Ended December 31
COMPARISONS AS A PERCENTAGE OF NET SALES
2018
 
2017
 
Basis Pt Chg
Gross profit
49.0%
 
50.1%
 
(110)
Selling, general & administrative expense
27.2%
 
27.9%
 
(70)
Operating income
21.8%
 
22.2%
 
(40)
Earnings before income taxes
23.0%
 
22.9%
 
10
Net earnings
18.8%
 
16.0%
 
280
Net earnings attributable to Procter & Gamble
18.7%
 
15.7%
 
300
Net Sales
Net sales for the six months ended December 31, 2018 were unchanged at $34.1 billion including a 3% negative impact from foreign exchange. Unit volume increased 2%. Mix was a 1% positive impact to net sales, driven by disproportionate organic growth of the Skin and Personal Care and Personal Health Care categories and developed regions, all of which have higher than company average selling prices. Volume increased mid-single digits in Fabric & Home Care and increased low single digits in Beauty, Health Care and Baby, Feminine & Family Care. Volume was unchanged in Grooming. Excluding the impacts of the PGT Healthcare partnership dissolution and Merck OTC acquisition, Health Care organic volume increased mid-single digits. Volume increased mid-single digits in developed regions and low single digits in developing regions. Organic sales increased 4% on a 3% increase in organic volume.
 
Net Sales Change Drivers 2018 vs. 2017 (Six Months Ended December 31) (1)
 
Volume with Acquisitions & Divestitures
 
Volume Excluding Acquisitions & Divestitures
 
Foreign Exchange
 
Price
 
Mix
 
Other (2)
 
Net Sales Growth
Beauty
2%
 
2%
 
(4)%
 
2%
 
4%
 
—%
 
4%
Grooming
—%
 
—%
 
(5)%
 
1%
 
(1)%
 
—%
 
(5)%
Health Care
2%
 
4%
 
(2)%
 
1%
 
(1)%
 
(1)%
 
(1)%
Fabric & Home Care
4%
 
5%
 
(2)%
 
—%
 
—%
 
—%
 
2%
Baby, Feminine & Family Care
1%
 
1%
 
(3)%
 
—%
 
—%
 
—%
 
(2)%
Total Company
2%
 
3%
 
(3)%
 
—%
 
1%
 
—%
 
—%
(1)    Net sales percentage changes are approximations based on quantitative formulas that are consistently applied.
(2)    Other includes the sales mix impact from acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers" and rounding impacts necessary to reconcile volume to net sales.
Operating Costs
Gross margin decreased 110 basis points to 49.0% of net sales for the six months ended December 31, 2018. Gross margin benefited from 130 basis points of gross manufacturing cost savings projects (100 basis points net of product and packaging reinvestments) and 20 basis points of positive pricing impacts. This was offset by:
a 100 basis point decline due to higher commodity costs,
a 70 basis point decline from unfavorable product mix (primarily within segments due to the growth of lower margin products forms and club channels in certain categories and due to the disproportionate growth of the Fabric Care category which has lower than company-average margins) and other impacts and
a 60 basis point decline from unfavorable foreign exchange
Total SG&A spending decreased 2% to $9.3 billion primarily due to decreases in marketing spending costs. SG&A as a percentage of net sales decreased 70 basis points to 27.2%. Reduction in marketing spending as a percentage of net sales was partially offset by an increase in other net operating costs as a percentage of net sales. Overhead costs as a percentage of net sales was unchanged as productivity savings and fixed cost leverage of increased volume, were offset by an increase in inflation and other costs. Marketing spending as a percentage of net sales decreased 110 basis points due to the positive scale impacts of the organic net sales increase, savings in agency compensation, production costs and advertising spending, and the impact of adopting the new standard on "Revenue from Contracts with Customers" which prospectively reclassified certain customer spending from marketing (SG&A) expense to a reduction of net sales. Other net operating costs as a percentage of net sales increased approximately 50 basis points primarily due to an increase in foreign exchange transactional charges. Productivity-driven cost savings delivered 70 basis points of benefit in SG&A.
Non-Operating Expenses and Income
Interest expense was $267 million for the six months ended December 31, 2018, an increase of $30 million versus the prior year period due to an increase in debt and in weighted average interest rates. Interest income was $116 million for the six months ended December 31, 2018, a marginal increase versus the prior year period. Other non-operating income was $557 million, an increase of $218 million versus the prior year period primarily due to the $355 million before-tax gain from the dissolution of the PGT Healthcare partnership, partially offset by the impact of minor brand divestiture gains in the base period.
Income Taxes
For the six months ended December 31, 2018 the effective tax rate decreased 1,200 basis points versus the prior year period to 18.2% due to:
an 810 basis-point reduction due to prior year transitional impacts from the U.S. Tax Act,
a 490 basis-point reduction from the impact of the lower blended U.S. federal tax rate on current year earnings versus the prior year rate,
an 80 basis-point reduction from the tax impact of the gain on the dissolution of the PGT Healthcare partnership,
a 40 basis-point reduction from excess tax benefits from share-based compensation (110 basis points in the current year versus 70 basis points in the prior year),
a 20 basis-point reduction from discrete impacts related to uncertain tax positions (20 basis points in the current year versus 0 basis points in the prior year),
a 240 basis-point increase from unfavorable impacts from geographic mix of earnings.
Net Earnings
Net earnings increased $996 million or 18% to $6.4 billion for the fiscal year to date period. The tax rate reduction discussed above drove a $924 million increase in net earnings. This tax benefit along with the current period gain on the dissolution of the PGT Healthcare partnership and decrease in SG&A spending were partially offset by the decrease in gross margin, all of which are discussed above. Foreign exchange had a $484 million negative impact on net earnings for the fiscal year to date period, including both transactional charges and translational impacts from converting earnings from foreign subsidiaries to U.S. dollars. Net earnings attributable to Procter & Gamble increased $1 billion or 20% to $6.4 billion. Diluted net earnings per share increased 22% to $2.44. The difference between the change in net earnings and diluted net earnings per share was due to a reduction in the number of shares outstanding. Core net earnings per share increased 4% to $2.36. Core net earnings per share represents diluted net earnings per share excluding the current period gain on the dissolution of the PGT Healthcare partnership, incremental restructuring charges in both periods related to our productivity and cost savings plans and the base period charges related to the transitional impacts of the U.S. Tax Act.
BUSINESS SEGMENT DISCUSSION – Three and Six Months Ended December 31, 2018
The following discussion provides a review of results by reportable business segment. Analysis of the results for the three and six months periods ended December 31, 2018 is provided based on a comparison to the same three and six months periods ended December 31, 2017. The primary financial measures used to evaluate segment performance are net sales and net earnings. The

Amounts in millions of dollars unless otherwise specified.


table below provides supplemental information on net sales and net earnings by reportable business segment for the three and six months ended December 31, 2018 versus the comparable prior year period (dollar amounts in millions):
 
Three Months Ended December 31, 2018
 
Net Sales
 
% Change Versus Year Ago
 
Earnings/(Loss) Before Income Taxes
 
% Change Versus Year Ago
 
Net Earnings/(Loss)
 
% Change Versus Year Ago
Beauty
$
3,357

 
4
 %
 
$
964

 
13
 %
 
$
772

 
18
 %
Grooming
1,617

 
(9
)%
 
448

 
(16
)%
 
378

 
(11
)%
Health Care
2,220

 
 %
 
669

 
 %
 
520

 
14
 %
Fabric & Home Care
5,557

 
2
 %
 
1,134

 
3
 %
 
860

 
20
 %
Baby, Feminine & Family Care
4,558

 
(1
)%
 
930

 
 %
 
707

 
18
 %
Corporate
129

 
2
 %
 
(229
)
 
N/A

 
(21
)
 
N/A

Total Company
$
17,438

 
 %
 
$
3,916

 
(3
)%
 
$
3,216

 
26
 %
 
Six Months Ended December 31, 2018
 
Net Sales
 
% Change Versus Year Ago
 
Earnings/(Loss) Before Income Taxes
 
% Change Versus Year Ago
 
Net Earnings/(Loss)
 
% Change Versus Year Ago
Beauty
$
6,646

 
4
 %
 
$
1,911

 
13
 %
 
$
1,531

 
19
 %
Grooming
3,179

 
(5
)%
 
865

 
(8
)%
 
718

 
(5
)%
Health Care
4,065

 
(1
)%
 
1,109

 
(1
)%
 
852

 
12
 %
Fabric & Home Care
11,045

 
2
 %
 
2,278

 
 %
 
1,737

 
17
 %
Baby, Feminine & Family Care
8,948

 
(2
)%
 
1,832

 
(3
)%
 
1,399

 
14
 %
Corporate
245

 
4
 %
 
(139
)
 
N/A

 
190

 
N/A

Total Company
$
34,128

 
 %
 
$
7,856

 
1
 %
 
$
6,427

 
18
 %

Beauty
Three months ended December 31, 2018 compared with three months ended December 31, 2017
Beauty net sales increased 4% to $3.4 billion during the second fiscal quarter on a 1% increase in unit volume. Favorable product mix added 5% to net sales due to the disproportionate growth of the super-premium SK-II and Olay Skin Care brands, which have higher than segment average selling prices. Higher pricing increased net sales by 2%. Unfavorable foreign exchange impacts reduced net sales by 4%. Organic sales increased 8% on flat organic volume. Global market share of the Beauty segment increased 0.1 points. Volume increased low single digits in developed and developing regions. Excluding the impact of minor brand acquisitions, volume decreased low single digits in developed regions.
Volume in Hair Care was unchanged. Developed market volume was unchanged. Volume in developing regions decreased low single digits. Excluding the impact of minor brand divestitures, volume in developing markets was unchanged. Global market share of the Hair Care category was unchanged.
Volume in Skin and Personal Care increased mid-single digits. Excluding the impact of minor brand acquisitions, organic volume increased low single digits. Volume increased low single digits in developed regions. Excluding the impact of minor brand acquisitions, developed regions volume declined low single digits due to price increases in the current period and higher retail inventory to support new product launches in the base period. Volume increased high single digits in developing regions due to premium innovation and increased marketing spending. Global market share of the Skin and Personal Care category increased slightly.
Net earnings increased 18% to $772 million due to the increase in net sales and a 280 basis-point increase in net earnings margin. The net earnings margin increased due to a decrease in SG&A as a percentage of net sales, an increase in gross margin and a reduction in U.S. income tax rates resulting from the U.S. Tax Act. The gross margin increase was primarily driven by manufacturing cost savings and the benefit of increased pricing. The reduction in SG&A as a percentage of sales was primarily driven by the positive scale impacts of the net sales increase and the impacts of adopting the new accounting standard on "Revenue from Contracts with Customers."
Six months ended December 31, 2018 compared with six months ended December 31, 2017
Beauty fiscal year to date net sales increased 4% to $6.6 billion on a 2% increase in unit volume. Favorable product mix added 4% to net sales due to the disproportionate growth of the super-premium SK-II and Olay Skin Care brands, which have higher than segment average selling prices. Higher pricing increased net sales by 2%. Unfavorable foreign exchange impacts reduced net sales by 4%. Organic sales increased 8%. Global market share of the Beauty segment was unchanged. Volume increased low



single digits in developed and developing regions. Excluding the impact of minor brand acquisitions, developed regions volume was unchanged.
Volume in Hair Care increased low single digits. Developed market volume was unchanged. Volume in developing regions increased low single digits due to market growth and product innovation. Global market share of the Hair Care category was unchanged.
Volume in Skin and Personal Care increased mid-single digits. Developed regions volume increased low single digits. Excluding the impact of minor brand acquisitions, developed regions volume was unchanged. Volume increased high single digits in developing regions due to premium innovation, increased marketing spending and market growth. Global market share of the Skin and Personal Care category was unchanged.
Net earnings increased 19% to $1.5 billion due to the increase in net sales and a 280 basis-point increase in net earnings margin. The net earnings margin increased primarily due to a decrease in SG&A as a percentage of net sales, an increase in gross margin and a reduction in U.S. income tax rates resulting from the U.S. Tax Act. Gross margin increase was primarily driven by manufacturing cost savings and the benefit of increased pricing. The reduction in SG&A as a percentage of sales was primarily driven by the fixed cost leverage of increased volume and the impacts of adopting the new accounting standard on "Revenue from Contracts with Customers."
Grooming
Three months ended December 31, 2018 compared with three months ended December 31, 2017
Grooming net sales decreased 9% to $1.6 billion during the second fiscal quarter on a 4% decrease in unit volume. Foreign exchange had a 5% unfavorable impact on net sales. Pricing had a positive 1% impact on net sales due to devaluation related price increases in certain markets. Organic sales decreased 3%. Global market share of the Grooming segment decreased 0.5 points. Volume decreased low single digits in developed regions and decreased mid-single digits in developing regions.
Shave Care volume decreased mid-single digits. Developed regions volume decreased low single digits due to competitive activity. Developing regions volume decreased mid-single digits due to devaluation related price increases and competitive activity. Global market share of the Shave Care category was unchanged.
Volume in Appliances was unchanged. Volume decreased low single digits in developed regions due to competitive activity and lower trade inventories in certain countries. Volume increased low single digits in developing regions due to market growth. Global market share of the Appliances category decreased slightly.
Net earnings decreased 11% to $378 million primarily due to the reduction in net sales and a 40 basis-point decrease in net earnings margin. Net earnings margin decreased primarily due to a reduction in gross margin, partially offset by a reduction in U.S. income tax rates and a reduction in SG&A as a percentage of net sales. Gross margin declined due to the negative impact of unfavorable mix (due to the disproportionate growth of disposable razors and large count packs which have lower than segment average margins) and unfavorable foreign exchange impacts, partially offset by manufacturing cost savings. SG&A as a percentage of net sales decreased due to reductions in both overhead costs and marketing spending and the impacts from adoption of the new accounting standard on "Revenue from Contracts with Customers."
Six months ended December 31, 2018 compared with six months ended December 31, 2017
Grooming fiscal year to date net sales decreased 5% to $3.2 billion on unit volume that was unchanged. Foreign exchange had a 5% unfavorable impact on net sales. Pricing had a positive 1% impact on net sales due to devaluation related price increases in certain markets. Negative mix reduced net sales by 1% due to the growth of lower tier products and club channels which have lower than segment average selling prices. Organic sales were unchanged. Global market share of the Grooming segment decreased 0.6 points. Volume increased low single digits in developed regions and declined low single digits in developing regions.
Shave Care volume was unchanged. Developed regions volume increased low single digits due to increased competitiveness following price reductions in prior quarters and an increase in consumer promotions. Developing regions volume decreased low single digits following devaluation related price increases and competitive activity. Global market share of the Shave Care category was unchanged.
Volume in Appliances increased low single digits. Volume increased low single digits in both developed and developing regions due to market growth. Global market share of the Appliances category decreased nearly half a point.
Net earnings decreased 5% to $718 million due to the reduction in net sales partially offset by a 20 basis-point increase in net earnings margin. Net earnings margin increased primarily due to a reduction in SG&A as a percentage of net sales and a reduction in U.S. income tax rates, partially offset by a decrease in gross margin. Gross margin declined due to the negative impact of unfavorable mix (due to the disproportionate growth of disposable razors and large count packs which have lower than segment average margins), unfavorable foreign exchange impacts and commodity cost increases. SG&A as a percentage of net sales decreased due to reductions in both overhead costs and marketing spending and the impacts from adoption of the new accounting standard on "Revenue from Contracts with Customers."



Health Care
Three months ended December 31, 2018 compared with three months ended December 31, 2017
Health Care net sales was unchanged at $2.2 billion during the second fiscal quarter on a 3% increase in unit volume. Excluding the impact of the dissolution of the PGT Healthcare partnership and the Merck OTC consumer healthcare acquisition, organic volume increased 4%. Unfavorable foreign exchange impacts decreased net sales by 3%. Higher pricing increased net sales by 1%. Organic sales increased 5%. Global market share of the Health Care segment increased 0.5 points. Volume increased low single digits in developed regions and increased high single digits in developing regions. Excluding the impact of the dissolution of the PGT Healthcare partnership and the Merck OTC consumer healthcare acquisition, organic volume increased mid-single digits in both developed and developing regions.
Oral Care volume increased mid-single digits. Volume increased mid-single digits in developed regions due to premium paste and power toothbrush innovation. Volume in developing regions increased mid-single digits due to innovation and base period trade inventory reductions. Global market share of the Oral Care category increased less than half a point.
Volume in Personal Health Care was unchanged. Excluding the impact of the PGT Healthcare partnership dissolution and the Merck OTC consumer healthcare acquisition, organic volume increased low single digits. Developed regions volume decreased high single digits, while organic volume grew low single digits due to product innovation. Volume in developing regions increased double digits and mid-single digits on an organic basis, due to innovation and market growth. Global market share of the Personal Health Care category increased more than half a point.
Net earnings increased 14% to $520 million, primarily due to a 290 basis point increase in net earnings margin. Net earnings margin increased due to a reduction in SG&A as a percentage of sales and a decrease in U.S. income tax rates, partially offset by a reduction in gross margin. Gross margin decreased driven by unfavorable mix due to the disproportionate growth of developing markets and the net impacts of acquisitions and divestitures in personal health care. SG&A as a percentage of net sales decreased primarily due to a reduction in marketing spending and the impacts from adoption of the new accounting standard on "Revenue from Contracts with Customers", partially offset by an increase in overhead costs due to the net impacts of personal health care acquisitions and divestitures.
Six months ended December 31, 2018 compared with six months ended December 31, 2017
Health Care fiscal year to date net sales decreased 1% to $4.1 billion on a 2% increase in unit volume. Excluding the impact of the dissolution of the PGT Healthcare partnership and the Merck OTC consumer healthcare acquisition, organic volume increased 4%. Unfavorable foreign exchange impacts decreased net sales by 2%. Higher pricing increased net sales by 1%. Unfavorable mix impacts reduced net sales by 1% due to the disproportionate growth of developing regions. Organic sales increased 5%. Global market share of the Health Care segment increased 0.4 points. Volume increased low single digits in developed regions and increased mid-single digits in developing regions. Excluding the impact of the dissolution of the PGT Healthcare partnership and the Merck OTC consumer healthcare acquisition, organic volume increased mid-single digits in both developed and developing regions.
Oral Care volume increased low single digits. Volume increased mid-single digits in developed regions due to premium paste and power toothbrush innovation and lower pricing in the form of increased promotional spending. Volume in developing regions increased low single digits due to innovation and trade inventory reduction in the base period. Global market share of the Oral Care category increased less than half a point.
Volume in Personal Health Care decreased low single digits. Excluding the impact of the PGT Healthcare partnership dissolution and Merck OTC consumer healthcare acquisition, organic volume increased high single digits. Developed regions volume decreased mid-single digits, while organic volume grew low single digits due to product innovation. Volume in developing regions increased high single digits and double digits on an organic basis, due to innovation and market growth. Global market share of the Personal Health Care category increased more than half a point.
Net earnings increased 12% to $852 million, as the reduction in net sales was more than offset by a 250 basis point increase in net earnings margin. Net earnings margin increased due to a reduction in SG&A as a percentage of sales and a decrease in U.S. income tax rates, partially offset by a reduction in gross margin. Gross margin decreased driven by unfavorable mix, due to the disproportionate growth of developing markets and the net impacts of acquisitions and divestitures in personal health care and other manufacturing cost increases. SG&A as a percentage of net sales decreased primarily due to a reduction in marketing spending and the impacts from adoption of the new accounting standard on "Revenue from Contracts with Customers", partially offset by an increase in overhead costs due to the net impacts of personal health care acquisitions and divestitures.
Fabric & Home Care
Three months ended December 31, 2018 compared with three months ended December 31, 2017
Fabric & Home Care net sales increased 2% to $5.6 billion during the second fiscal quarter on a 4% increase in unit volume. Unfavorable foreign exchange impacts reduced net sales by 3%. Positive mix impacts increased net sales by 1% due to the disproportionate growth of premium products and higher pricing increased net sales by 1%. Organic sales increased 6%. Global



market share of the Fabric & Home Care segment increased 0.6 points. Volume increased mid-single digits in developed regions and increased low single digits in developing regions. Excluding the impact of minor brand divestitures, developing regions volume increased mid-single digits.
Fabric Care volume increased mid-single digits. Volume in developed regions grew mid-single digits due to product innovation and lower pricing in the form of increased promotional spending. Volume in developing regions increased mid-single digits driven by product innovation. Global market share of the Fabric Care category increased slightly.
Home Care volume increased low single digits. Volume in developed regions increased low single digits due to product innovation and market growth. Volume in developing regions decreased mid-single digits. Excluding the impact of minor brand divestitures, volume in developing regions decreased low single digits following devaluation related price increases. Global market share of the Home Care category increased more than a point.
Net earnings increased 20% to $860 million due to the increase in net sales and a 230 basis point increase in net earnings margin. The net earnings margin increase was primarily due to a reduction in SG&A as a percentage of sales and a decrease in U.S. income tax rates partially offset by a reduction in gross margin. Gross margin decreased due to negative product mix impacts (driven by disproportionate growth of product forms with lower than segment-average margins) and an increase in commodity costs, partially offset by manufacturing cost savings. SG&A as a percentage of net sales was down due to reduction in overhead costs and marketing spending driven by productivity savings, fixed cost leverage of increased volume and the impacts from adoption of the new accounting standard on "Revenue from Contracts with Customers."
Six months ended December 31, 2018 compared with six months ended December 31, 2017
Fabric & Home Care fiscal year to date net sales increased 2% to $11.0 billion on a 4% increase in unit volume. Unfavorable foreign exchange impacts reduced net sales by 2%. Pricing and mix had no impact on net sales. Organic sales increased 5% on a 5% increase in organic volume. Global market share of the Fabric & Home Care segment increased 0.5 points. Volume increased mid-single digits in developed regions and increased low single digits in developing regions. Excluding the impact of minor brand divestitures, volume in developing regions grew mid-single digits.
Fabric Care volume increased mid-single digits. Volume in developed regions grew mid-single digits due to product innovation and lower pricing in the form of increased promotional spending. Volume in developing regions increased low single digits. Excluding the impact of minor brand divestitures, developing regions volume increased mid-single digits driven by product innovation and market growth. Global market share of the Fabric Care category increased nearly half a point.
Home Care volume increased mid-single digits. Volume in developed regions increased mid-single digits due to product innovation and market growth. Volume in developing regions decreased low single digits due to devaluation related price increases and category contraction in certain markets. Global market share of the Home Care category increased less than a point.
Net earnings increased 17% to $1.7 billion due to the increase in net sales and a 200 basis point increase in net earnings margin. Net earnings margin increase was primarily due to a reduction in SG&A as a percentage of sales and a decrease in U.S. income tax rates partially offset by a reduction in gross margin. Gross margin decreased due to negative product mix impacts (driven by disproportionate growth of product forms with lower than segment-average margins) and an increase in commodity costs, partially offset by manufacturing cost savings. SG&A as a percentage of net sales was down due to reduction in overhead costs and marketing spending driven by productivity savings, fixed cost leverage of increased volume and the impacts from adoption of the new accounting standard on "Revenue from Contracts with Customers."
Baby, Feminine & Family Care
Three months ended December 31, 2018 compared with three months ended December 31, 2017
Baby, Feminine & Family Care net sales decreased 1% to $4.6 billion during the second fiscal quarter on a 1% increase in unit volume. Unfavorable foreign exchange impacts decreased net sales by 4%. Higher pricing increased net sales by 1%. Favorable mix increased sales by 1% due to the disproportionate growth of developed regions which have higher than segment average prices. Organic sales increased 3%. Global market share of the Baby, Feminine & Family Care segment increased 0.3 points. Volume increased low single digits in developed regions. Volume in developing regions decreased low single digits.
Volume in Baby Care decreased mid-single digits. Volume in developed regions declined low single digits due to competitive activity. Volume in developing regions declined high single digits due to competitive activity, volume declines following devaluation related price increases and category contraction in certain markets. Global market share of the Baby Care category decreased nearly half a point.
Volume in Feminine Care increased mid-single digits. Volume in developed regions increased low single digits due to product innovation and adult incontinence category growth. Volume increased mid-single digits in developing regions. Excluding the impact of minor brand divestitures, volume in developing regions increased high single digits driven by innovation. Global market share of the Feminine Care category increased less than half a point.



Volume in Family Care, which is predominantly a North American business, increased mid-single digits driven by product innovation and distribution gains. In the U.S., all-outlet share of the Family Care category increased more than a point.
Net earnings increased 18% to $707 million as the reduction in net sales was more than offset by a 260 basis point increase in net earnings margin. Net earnings margin increased primarily due to a decrease in U.S. income tax rates and a reduction in SG&A as a percentage of net sales, partially offset by a reduction in gross margin. Gross margin decreased primarily due to an increase in commodity costs and unfavorable foreign exchange impacts, partially offset by manufacturing cost savings projects. SG&A as a percentage of net sales decreased due to reduced marketing spending and overhead costs, driven by productivity savings and the impacts from adoption of the new accounting standard on "Revenue from Contracts with Customers."
Six months ended December 31, 2018 compared with six months ended December 31, 2017
Baby, Feminine & Family Care fiscal year to date net sales decreased 2% to $8.9 billion on a 1% increase in unit volume. Unfavorable foreign exchange impacts decreased net sales by 3%. Pricing and mix had no impact to net sales. Organic sales increased 1%. Global market share of the Baby, Feminine & Family Care segment increased 0.1 points. Volume increased low single digits in developed regions. Volume in developing regions decreased mid-single digits. Excluding the impact of minor brand divestitures, volume in developing regions decreased low single digits.
Volume in Baby Care decreased mid-single digits. Volume in developed regions declined low single digits due to competitive pricing activity. Volume in developing regions declined high single digits due to competitive activity, volume declines following devaluation related price increases and category contraction in certain markets. Global market share of the Baby Care category decreased more than half a point.
Volume in Feminine Care increased mid-single digits. Volume in developed regions increased low single digits due to product innovation and adult incontinence category growth. Volume increased mid-single digits in developing regions driven by innovation and lower pricing in the form of increased promotional spending. Global market share of the Feminine Care category increased less than half a point.
Volume in Family Care, which is predominantly a North American business, increased mid-single digits driven by product innovation and distribution gains. In the U.S., all-outlet share of the Family Care category increased a point.
Net earnings increased 14% to $1.4 billion as the reduction in net sales was more than offset by a 220 basis point increase in net earnings margin. Net earnings margin increased primarily due to a decrease in U.S. income tax rates and a reduction in SG&A as a percentage of net sales, partially offset by a reduction in gross margin. Gross margin decreased primarily due to an increase in commodity costs and unfavorable foreign exchange impacts, partially offset by manufacturing cost savings projects. SG&A as a percentage of net sales decreased due to reduced marketing spending and overhead costs, driven by productivity savings and the impacts from adoption of the new accounting standard on "Revenue from Contracts with Customers."
Corporate
Corporate includes certain operating and non-operating activities not allocated to specific business segments. These include: the incidental businesses managed at the corporate level; financing and investing activities; certain employee benefit costs; other general corporate items; the gains and losses related to certain divested brands and categories; certain restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Corporate also includes reconciling items to adjust the accounting policies used in the segments to U.S. GAAP. The most significant reconciling item includes income taxes to adjust from blended statutory rates that are reflected in the segments to the overall Company effective tax rate.
Corporate net sales increased $2 million to $129 million for the quarter ended December 31, 2018 and increased $10 million to $245 million for the fiscal year to date. Corporate net earnings increased $262 million in the quarter primarily due to a reduction in income tax expense of $446 million, partially offset by the impact of minor brand divestiture gains in the base period and higher unallocated SG&A costs in the current year. The reduction in income tax expense was driven by the base period charges for the transitional impacts of the U.S. Tax Act, partially offset by the impact of the allocation methodology of the lower U.S. tax rates (in the prior year the net benefit was held in Corporate, whereas the lower rates are included in the reporting segments in the current year). Fiscal year to date Corporate net earnings increased $268 million due to a $270 million reduction in income tax expense (driven by the same factors impacting the quarter ended December 31, 2018) and higher current year divestiture gains (driven by the current year gain on the dissolution of the PGT healthcare partnership), partially offset by higher current year foreign exchange transactional charges (discussed earlier in the Results of Operations section) and higher unallocated SG&A costs in the current year.
Restructuring Program to deliver Productivity and Cost Savings
In 2012, the Company initiated a productivity and cost savings plan to reduce costs and better leverage scale in the areas of supply chain, research and development, marketing and overheads.  The plan was designed to accelerate cost reductions by streamlining management decision making, manufacturing and other work processes to fund the Company's growth strategy. In 2017, the Company communicated specific elements of an additional multi-year productivity and cost savings program.




The current productivity and cost savings plan will further reduce costs in the areas of supply chain, certain marketing activities and overhead expenses.  As part of this plan, the Company incurred $1.1 billion in total before-tax restructuring costs in fiscal 2018, with an additional amount of approximately $0.8 billion expected in fiscal 2019. This program is expected to result in additional enrollment reductions, along with further optimization of the supply chain and other manufacturing processes. Consistent with our historical policies for ongoing restructuring-type activities, the resulting charges are funded by and included within Corporate for segment reporting.

In addition to our restructuring programs, we have additional ongoing savings efforts in our supply chain, marketing and overhead areas that yield additional benefits to our operating margins.

Refer to Note 9 in the Notes to the Consolidated Financial Statements for more details on the restructuring program.
LIQUIDITY & CAPITAL RESOURCES
Operating Activities
We generated $7.6 billion of cash from operating activities fiscal year to date, an increase of approximately $0.3 billion versus the prior year. Net earnings, adjusted for non-cash items (depreciation and amortization, share-based compensation expense, deferred income taxes, and gain on sale of assets), generated $7.6 billion of operating cash flow. Working capital and other impacts had no net impact on operating cash flow in the period. Accounts receivable increased, using $398 million of cash due to sales growth and to a lesser extent, the timing of collections at quarter-end due to the holidays. Inventory consumed $531 million of cash primarily due to product initiatives and business growth. Accounts payable, accrued and other liabilities increased, generating $1.1 billion of cash primarily driven by an increase in payables to support the increase in inventory, increased marketing accruals based on timing of spending and extended payment terms with our suppliers. All other operating assets and liabilities used $370 million of cash, driven primarily by payments of the current year portion of taxes due related to the U.S. Tax Act.
Investing Activities
Cash used by investing activities was $4.7 billion fiscal year to date. Capital expenditures were $1.8 billion, or 5.2% of net sales. Acquisition activity used $3.8 billion of cash, primarily related to the Merck OTC acquisition. We used $158 million for purchases of short-term investments. These uses were partially offset by $1.1 billion of cash generated from sales and maturities of short-term investments.
Financing Activities
Our financing activities consumed net cash of $1.6 billion fiscal year to date. We used $2.0 billion for treasury stock purchases and $3.7 billion for dividends. Cash generated from the net effect of debt issuances and payments was $2.6 billion. Cash from the exercise of stock options and other impacts generated $1.5 billion of cash.
As of December 31, 2018, our current liabilities exceeded current assets by $6.8 billion. We have short- and long-term debt to meet our financing needs. We anticipate being able to support our short-term liquidity and operating needs largely through cash generated from operations. We have strong short- and long-term debt ratings that have enabled and should continue to enable us to refinance our debt as it becomes due at favorable rates in commercial paper and bond markets. In addition, we have agreements with a diverse group of financial institutions that, if needed, should provide sufficient credit funding to meet short-term financing requirements.
RECONCILIATION OF MEASURES NOT DEFINED BY U.S. GAAP
In accordance with the SEC's Regulation G, the following provides definitions of the non-GAAP measures and the reconciliation to the most closely related GAAP measures. We believe that these measures provide useful perspective on underlying business results and trends (i.e., trends excluding non-recurring or unusual items) and provide a supplemental measure of year-on-year results. The non-GAAP measures described below are used by management in making operating decisions, allocating financial resources and for business strategy purposes. These measures may be useful to investors as they provide supplemental information about business performance and provide investors a view of our business results through the eyes of management. These measures are also used to evaluate senior management and are a factor in determining their at-risk compensation. These non-GAAP measures are not intended to be considered by the user in place of the related GAAP measure, but rather as supplemental information to our business results. These non-GAAP measures may not be the same as similar measures used by other companies due to possible differences in method and in the items or events being adjusted.
Organic sales growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers" and foreign exchange from year-over-year comparisons. The impact of the adoption of the new accounting standard for Revenue from Contracts with Customers is driven by the prospective reclassification of certain customer spending from marketing (SG&A) expense to a reduction of Net sales. We believe this measure provides investors with a supplemental understanding of underlying sales trends by providing sales growth on a consistent basis. This measure is used in assessing achievement of management goals for at-risk compensation.
Adjusted free cash flow: Adjusted free cash flow is defined as operating cash flow less capital spending and excluding payments for the transitional tax resulting from the comprehensive U.S. legislation commonly referred to as the Tax Cuts and Jobs Act enacted in December 2017 (the U.S. Tax Act). Adjusted free cash flow represents the cash that the Company is able to generate after taking into account planned maintenance and asset expansion. Management views adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends, share repurchases, acquisitions and other discretionary investments.
Adjusted free cash flow productivity: Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding the gain on dissolution of the PGT Healthcare partnership, which is non-recurring and not considered indicative of underlying cash flow performance. Management views adjusted free cash flow productivity as a useful measure to help investors understand P&G’s ability to generate cash. Adjusted free cash flow productivity is used by management in making operating decisions, allocating financial resources and for budget planning purposes. This measure is also used in assessing the achievement of management goals for at-risk compensation. The Company's long-term target is to generate annual adjusted free cash flow productivity at or above 90 percent.
Core EPS: Core earnings per share, or Core EPS, is a measure of the Company's diluted net earnings per share adjusted as indicated. Management views this non-GAAP measure as a useful supplemental measure of Company performance over time. This measure is also used when evaluating senior management in determining their at-risk compensation.
The Core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:
Incremental Restructuring: The Company has had and continues to have an ongoing level of restructuring activities. Such activities have resulted in ongoing annual restructuring related charges of approximately $250 - $500 million before tax. In 2012, the Company began a $10 billion strategic productivity and cost savings initiative that included incremental restructuring activities. In 2017, we communicated details of an additional multi-year productivity and cost savings plan. This results in incremental restructuring charges to accelerate productivity efforts and cost savings. The adjustment to Core earnings includes only the restructuring costs above what we believe are the normal recurring level of restructuring costs.
Transitional Impact of U.S. Tax Reform: As discussed in Note 2 to the Consolidated Financial Statements, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”) in December 2017.  This resulted in a net charge of $628 million for the quarter ended December 31, 2017, comprised of an estimated repatriation tax charge of $3.8 billion and a net deferred tax benefit of $3.2 billion.  The adjustment to core earnings only includes this transitional impact.  It does not include the ongoing impacts of the lower U.S. statutory rate on current year earnings.
Gain on Dissolution of PGT Healthcare Partnership: The Company finalized the dissolution of our PGT Healthcare partnership, a venture between the Company and Teva Pharmaceuticals Industries, Ltd. (Teva) in the OTC consumer healthcare business, in the quarter ended September 30, 2018. The transaction was accounted for as a sale of the Teva portion of the PGT business; the Company recognized an after-tax gain on the dissolution of $353 million.
We do not view the above items to be part of our sustainable results and their exclusion from Core earnings measures provides a more comparable measure of year-on-year results. These items are also excluded when evaluating senior management in determining their at-risk compensation.
Organic sales growth:
Three Months Ended December 31, 2018
Net Sales Growth
 
Foreign Exchange Impact
 
Acquisition & Divestiture Impact/Other (1)
 
Organic Sales Growth
Beauty
4%
 
4%
 
—%
 
8%
Grooming
(9)%
 
5%
 
1%
 
(3)%
Health Care
—%
 
3%
 
2%
 
5%
Fabric & Home Care
2%
 
3%
 
1%
 
6%
Baby, Feminine & Family Care
(1)%
 
4%
 
—%
 
3%
Total Company
—%
 
4%
 
—%
 
4%
Six Months Ended December 31, 2018
Net Sales Growth
 
Foreign Exchange Impact
 
Acquisition & Divestiture Impact/Other (1)
 
Organic Sales Growth
Beauty
4%
 
4%
 
—%
 
8%
Grooming
(5)%
 
5%
 
—%
 
—%
Health Care
(1)%
 
2%
 
4%
 
5%
Fabric & Home Care
2%
 
2%
 
1%
 
5%
Baby, Feminine & Family Care
(2)%
 
3%
 
—%
 
1%
Total Company
—%
 
3%
 
1%
 
4%
(1)    Acquisition & Divestiture Impact/Other includes the volume and mix impact of acquisitions and divestitures, the impact from the July 1, 2018 adoption of new accounting standards for "Revenue from Contracts with Customers" and rounding impacts necessary to reconcile net sales to organic sales.
Adjusted free cash flow (dollar amounts in millions):
Fiscal Year-to-Date, December 31, 2018
Operating Cash Flow
 
Capital Spending
U.S. Tax Act Payments
 
Adjusted Free Cash Flow
$7,574
 
$(1,781)
$235
 
$6,028
Adjusted free cash flow productivity (dollar amounts in millions):
Fiscal Year-to-Date, December 31, 2018
Adjusted Free Cash Flow
 
Net Earnings
Gain on Dissolution of PGT Partnership
Adjusted Net Earnings
 
Adjusted Free Cash Flow Productivity
$6,028
 
$6,427
$(353)
$6,074
 
99%




THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts)
Reconciliation of Non-GAAP Measures
Three Months Ended December 31, 2018
 
AS REPORTED (GAAP)
 
INCREMENTAL RESTRUCTURING
 
ROUNDING
 
NON-GAAP (CORE)
COST OF PRODUCTS SOLD
$
8,919

 
$
(123
)
 
$

 
$
8,796

SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
4,623

 
38

 
(1
)
 
4,660

OPERATING INCOME
3,896

 
85

 
1

 
3,982

INCOME TAX
700

 
17

 
(2
)
 
715

NET EARNINGS ATTRIBUTABLE TO P&G
3,194

 
77

 
1

 
3,272

 
 
 
 
 
 
 
 Core EPS
DILUTED NET EARNINGS PER COMMON SHARE (1)
$
1.22

 
$
0.03

 
$

 
$
1.25

(1)    Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
 
 
CHANGE VERSUS YEAR AGO
 
 
 
 
 
 
CORE EPS
5
%
 
 
 

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts)
Reconciliation of Non-GAAP Measures
Three Months Ended December 31, 2017
 
AS REPORTED (GAAP)
 
INCREMENTAL RESTRUCTURING
 
TRANSITIONAL IMPACTS OF U.S. TAX REFORM
 
ROUNDING
 
NON-GAAP (CORE)
COST OF PRODUCTS SOLD
$
8,709

 
$
(86
)
 
$

 
$
1

 
$
8,624

SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
4,767

 
19

 

 
(1
)
 
4,785

OPERATING INCOME
3,919

 
67

 

 

 
3,986

INCOME TAX
1,472

 
21

 
(628
)
 

 
865

NET EARNINGS ATTRIBUTABLE TO P&G
2,495

 
51

 
628

 

 
3,174

 
 
 
 
 
 
 
 
 
 Core EPS
DILUTED NET EARNINGS PER COMMON SHARE (1)
$
0.93

 
$
0.02

 
$
0.24

 
$

 
$
1.19

(1)    Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.




THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts)
Reconciliation of Non-GAAP Measures
Six Months Ended December 31, 2018
 
AS REPORTED (GAAP)
 
INCREMENTAL RESTRUCTURING
 
GAIN ON DISSOLUTION OF PGT PARTNERSHIP
 
ROUNDING
 
NON-GAAP (CORE)
COST OF PRODUCTS SOLD
$
17,403

 
$
(169
)
 
$

 
$

 
$
17,234

SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
9,275

 
10

 

 

 
9,285

OPERATING INCOME
7,450

 
159

 

 

 
7,609

INCOME TAX
1,429

 
23

 
(2
)
 
(1
)
 
1,449

NET EARNINGS ATTRIBUTABLE TO P&G
6,393

 
146

 
(353
)
 
1

 
6,187

 
 
 
 
 
 
 
 
 
 Core EPS:
DILUTED NET EARNINGS PER COMMON SHARE (1)
$
2.44

 
$
0.06

 
$
(0.14
)
 
$

 
$
2.36

(1)    Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.

 
 
CHANGE VERSUS YEAR AGO
 
 
 
 
 
 
CORE EPS
4
%
 
 
 

THE PROCTER & GAMBLE COMPANY AND SUBSIDIARIES
(Amounts in Millions Except Per Share Amounts)
Reconciliation of Non-GAAP Measures
Six Months Ended December 31, 2017
 
AS REPORTED (GAAP)
 
INCREMENTAL RESTRUCTURING
 
TRANSITIONAL IMPACTS OF U.S. TAX REFORM
 
ROUNDING
 
NON-GAAP (CORE)
COST OF PRODUCTS SOLD
$
16,978

 
$
(186
)
 
$

 
$
1

 
$
16,793

SELLING, GENERAL AND ADMINISTRATIVE EXPENSE
9,503

 
26

 

 
(1
)
 
9,528

OPERATING INCOME
7,567

 
160

 

 

 
7,727

INCOME TAX
2,353

 
41

 
(628
)
 

 
1,766

NET EARNINGS ATTRIBUTABLE TO P&G
5,348

 
126

 
628

 

 
6,102

 
 
 
 
 
 
 
 
 
 Core EPS:
DILUTED NET EARNINGS PER COMMON SHARE (1)
$
2.00

 
$
0.05

 
$
0.23

 
$

 
$
2.28

(1)    Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.




Item 3.
Quantitative and Qualitative Disclosures About Market Risk
There have been no material changes in the Company’s exposure to market risk since June 30, 2018. Additional information can be found in Note 7 - Risk Management Activities and Fair Value Measurements of the Consolidated Financial Statements.
Item 4.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s Chairman of the Board, President and Chief Executive Officer, David S. Taylor, and the Company’s Vice Chairman and Chief Financial Officer, Jon R. Moeller, performed an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (“Exchange Act”)) as of the end of the period covered by this report. Messrs. Taylor and Moeller have concluded that the Company’s disclosure controls and procedures were effective to ensure that information required to be disclosed in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including Messrs. Taylor and Moeller, to allow their timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the Company’s fiscal quarter ended December 31, 2018 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
PART II. OTHER INFORMATION
Item 1.
Legal Proceedings
The Company is subject, from time to time, to certain legal proceedings and claims arising out of our business, which cover a wide range of matters, including antitrust and trade regulation, product liability, advertising, contracts, environmental issues, patent and trademark matters, labor and employment matters, and tax.
Item 1A.
Risk Factors
For information on risk factors, please refer to “Risk Factors” in Part I, Item 1A of the Company's Form 10-K for the year ended June 30, 2018.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
ISSUER PURCHASES OF EQUITY SECURITIES
Period
Total Number of Shares Purchased (1)
 
Average Price Paid per Share (2)
 
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (3)
 
Approximate Dollar Value of Shares That May Yet Be Purchased Under Our Share Repurchase Program
10/01/2018 - 10/31/2018
5,384,600

 
$83.57

 
5,384,600

 
(3) 
11/01/2018 - 11/30/2018
3,259,875

 
$92.03

 
3,259,875

 
(3) 
12/01/2018 - 12/31/2018

 

 

 
(3) 
Total
8,644,475

 
$86.76
 
8,644,475

 
 
(1) 
All transactions were made in the open market with large financial institutions. This table excludes shares withheld from employees to satisfy minimum tax withholding requirements on option exercises and other equity-based transactions. The Company administers cashless exercises through an independent third party and does not repurchase stock in connection with cashless exercises.
(2) 
Average price paid per share for open market transactions is calculated on a settlement basis and excludes commission.
(3) 
On January 23, 2019, the Company stated that in fiscal year 2019 the Company expects to reduce outstanding shares through direct share repurchases at a value of up to $5 billion, notwithstanding any purchases under the Company's compensation and benefit plans. Purchases may be made in the open market and/or private transactions and purchases may be increased, decreased or discontinued at any time without prior notice. The share repurchases are authorized pursuant to a resolution issued by the Company's Board of Directors and are expected to be financed by a combination of operating cash flows and issuance of long-term and short-term debt.




Item 6.
Exhibits
 
 
 
3-1

 
Amended Articles of Incorporation (as amended by shareholders at the annual meeting on October 11, 2011 and consolidated by the Board of Directors on April 8, 2016) (Incorporated by reference to Exhibit (3-1) of the Company's Form 10-K for the year ended June 30, 2016)
 
 
 
3-2

 
Regulations (as approved by the Board of Directors on April 8, 2016, pursuant to authority granted by shareholders at the annual meeting on October 13, 2009) (Incorporated by reference to Exhibit (3-2) of the Company's Form 10-K for the year ended June 30, 2016)
 
 
 
4-1

 
Indenture, dated as of September 3, 2009, between the Company and Deutsche Bank Trust Company Americas, as Trustee (Incorporated by reference to Exhibit (4-1) of the Company Annual Report on Form 10-K for the year ended June 30, 2015)
 
 
 
10-1

 
The Procter & Gamble Performance Stock Program Summary * +
 
 
 
10-2

 
Summary of the Company’s Long-Term Incentive Program * +
 
 
 
10-3

 
Company’s Form of Separation Agreement and Release * +
 
 
 
31.1

 
Rule 13a-14(a)/15d-14(a) Certification – Chief Executive Officer +
 
 
 
31.2

 
Rule 13a-14(a)/15d-14(a) Certification – Chief Financial Officer +
 
 
 
32.1

 
Section 1350 Certifications – Chief Executive Officer +
 
 
 
32.2

 
Section 1350 Certifications – Chief Financial Officer +
 
 
 
101.INS  (1)

 
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
 
 
101.SCH (1)

 
XBRL Taxonomy Extension Schema Document
 
 
 
101.CAL (1)

 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
101.DEF (1)

 
XBRL Taxonomy Definition Linkbase Document
 
 
 
101.LAB (1)

 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
101.PRE (1)

 
XBRL Taxonomy Extension Presentation Linkbase Document

*
Compensatory plan or arrangement
 
 
+
Filed herewith
 
 
(1) 
Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.




Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

 
 
 
 
 
 
 
 
 
THE PROCTER & GAMBLE COMPANY
 
 
 
 
 
January 23, 2019
 
 
 
/s/ VALARIE L. SHEPPARD
Date
 
 
 
(Valarie L. Sheppard)
 
 
 
 
Senior Vice President, Comptroller and Treasurer




EXHIBIT INDEX
Exhibit
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
101.INS  (1)
 
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
 
 
 
101.SCH (1)
 
XBRL Taxonomy Extension Schema Document
 
 
 
101.CAL (1)
 
XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
101.DEF (1)
 
XBRL Taxonomy Definition Linkbase Document
 
 
 
101.LAB (1)
 
XBRL Taxonomy Extension Label Linkbase Document
 
 
 
101.PRE (1)
 
XBRL Taxonomy Extension Presentation Linkbase Document
+
Filed herewith
 
 
(1) 
Pursuant to Rule 406T of Regulation S-T, this information is furnished and not filed for purposes of Sections 11 or 12 of the Securities Act of 1933 and Section 18 of the Securities Exchange Act of 1934, and otherwise is not subject to liability under these sections.


EX-10.1 2 fy1819q2ond10-qexhibit101.htm THE PROCTER & GAMBLE PERFORMANCE STOCK PROGRAM SUMMARY Exhibit




EXHIBIT (10-1) 
 
Summary of the Company's Performance Stock Program







PERFORMANCE STOCK PROGRAM SUMMARY
(Effective July 1, 2018)

The Performance Stock Program (“PSP”) is a part of The Procter & Gamble Company’s (the “Company”) long-term incentive (“LTI”) compensation and is designed to provide additional focus on key Company measures for top executives with senior management responsibility for total Company results. Awards granted under the PSP (“PSP Awards”) are made pursuant to authority delegated to the Compensation & Leadership Development Committee (the “C&LD Committee”) by the Board of Directors for determining compensation for the Company’s principal officers and for making awards under the Procter & Gamble 2014 Stock and Incentive Compensation Plan (the “2014 Plan”) or any successor stock plan approved in accordance with applicable listing standards. PSP Awards are Performance-Based Compensation (as defined in Article 15 of the 2014 Plan).

I.    ELIGIBILITY

The Chairman of the Board and/or Chief Executive Officer and those active executives at Band 6 or above as of October 1 prior to the grant date and recommended by management are eligible to participate (“Participants”). In special circumstances such as for acquisitions or experienced hires, the CHRO may authorize participation for Band 6 or above employees who are not active as of October 1 but are active employees as of the grant date.


II.    OVERVIEW

A significant portion of the Band 6 and above compensation is delivered through two long-term incentive programs tied to Company performance: PSP and the Long-term Incentive Program.
Total long-term incentive compensation targets are based on relevant competitive market data considering the median total long-term compensation of comparable positions, regressed for revenue size. The C&LD Committee establishes the Peer Group and sets compensation targets for all Principal Officers including the CEO. The CEO approves compensation targets for non-Principal Officers (generally Band 6 managers).
The C&LD Committee determines the long-term incentive award for the CEO. The CEO recommends all other Principal Officer awards to the C&LD Committee based on benchmarked long-term compensation targets, adjusted for business results and individual contributions attributable to each executive and including that individual’s leadership skills. The C&LD Committee retains full authority to accept, modify, or reject these recommendations. The CEO approves awards for participants who are not Principal Officers based on long-term compensation targets, business results and individual contributions. Long-term incentive awards can be up to 50% above or 50% below the benchmarked target. In exceptional cases, no award will be made. After total LTI award size is determined then approximately half of each Band 7 manager’s long-term compensation is allocated to PSP via an Initial PSU Grant (as defined below). The remaining portion is a Long-term Incentive Program Grant. Approximately 25% of each Band 6 manager’s total LTI is allocated to PSP with the remainder awarded under the Long-term Incentive Program.

PSP rewards Participants for Company performance against certain three-year performance goals in categories established by the C&LD Committee. The C&LD Committee sets these performance goals for each three-year period that begins on July 1 and ends on June 30 three years later (“Performance Period”). In the first year of each Performance Period, the C&LD Committee grants Performance Stock Units (“PSUs”) to Participants that will vest at the end of the Performance Period based on the Company’s performance relative to the pre-established performance goals (“Initial PSU Grant”). The number of PSUs that vest at the end of the Performance Period depends on the Company’s performance against the pre-established performance goals. Vested PSUs, including dividend equivalents, are converted into shares of the Company’s common stock (“Common Stock”) delivered to





the applicable Participant within 60 days following the end of the Performance Period, or such later date as may be elected by the Participant in accordance with Section 409A of the Internal Revenue Code (“Section 409A”).

III.
PERFORMANCE CATEGORIES

The PSP Award is based on the Company’s performance in each of the following categories (each a “Performance Category”) and weighted as indicated:

·
Organic sales growth (percentile rank in the competitive peer group)* - 30%
·
Constant currency core before-tax operating profit growth - 20%
·
Core earnings per share (EPS) growth - 30%
·
Adjusted free cash flow productivity - 20%

Awards will be further adjusted based on the three-year relative total shareholder return (R-TSR) of P&G compared to the competitive peer group*. Awards will be adjusted for top quartile performance using a 125% multiplier to increase awards, and reduced for bottom quartile performance using a 75% multiplier.
* Competitive peer group is defined in the PSP Accounting Guidelines.

Within the first 90 days of each Performance Period, the C&LD Committee sets three-year performance goals (“Performance Goals”) for each Performance Category for such Performance Period and establishes a sliding scale to measure the Company’s performance against each Performance Goal in each Performance Category. The C&LD Committee uses the sliding scale to establish a payout factor between 0% and 200% for each Performance Category ( a “Sales Factor”, “Profit Factor”, “EPS Factor” and “Cash Flow Factor”, collectively, “Performance Factors”).

In all cases, the C&LD Committee retains the discretion to include or exclude certain of the Performance Categories for purposes of determining the PSP Award. The C&LD Committee may reduce or eliminate any payment if it determines that such payout is inconsistent with long-term shareholders’ interests or incongruous with the overall performance of the company.

PSP awards will have the following terms unless otherwise approved by the C&LD Committee:

IV.    THE INITIAL PSU GRANT

The C&LD Committee has the sole discretion to establish the target award (“PSP Target”) for each Participant serving as a Principal Officer. The CEO establishes the PSP Targets for participants who are not Principal Officers. The PSP Target will be a cash amount and will be the basis for the Initial PSU Grant. The C&LD Committee will make the Initial PSU Grant on the last business date in February (“Grant Date”) following the beginning of each Performance Period. If the New York Stock Exchange is closed on the day of the grant, then the C&LD will establish a grant date as soon as practical subsequent to the date previously specified for such award. The Initial PSU Grant will set forth a target and maximum number of PSUs. The target number of PSUs will be determined by dividing the PSP Target by the expense value of one PSU using the same methodology by which the Company expenses PSUs, rounding to the nearest whole unit.

The Initial PSU Grant maximum will be two times the Initial PSU Grant.
                                                                                                                           

V.     PSU VESTING AND PAYMENT

After the Performance Period is complete, the C&LD Committee will establish the Payout Factors for each of the Performance Categories based on the Company’s results versus the pre-established Performance Goals. The number of PSUs that vest will be determined by multiplying the Performance Factors by their respective weightings, summing up the results, then applying the R-TSR multiplier if applicable. The final result will be rounded up or down to the nearest full percentage. The resulting percentage will be applied to the number of PSUs in the Initial PSU Grant target, including dividends that would have accumulated since the initial PSU grant on the vested units, rounding up to the nearest whole share. The number of PSUs that vest may be equal to, above or





below the Initial PSU Grant target depending on the Company’s performance in the Performance Categories, but in no event more than the Initial PSU Grant maximum. Vested PSUs are converted into shares of Common Stock delivered to the applicable Participant within 60 days following the end of the Performance Period, or such later date as may be elected by the Participant if applicable and in accordance with Section 409A.

Participants at Band 7 and above may elect to defer delivery of the Common Stock by electing to receive Restricted Stock Units. PSP RSUs will have the following terms unless otherwise approved by the Committee at grant:

VESTING AND SETTLEMENT: PSP RSUs will be vested on the grant date with a settlement date at least one year following the original PSU delivery date (as elected by the Participant), are eligible for dividend equivalents, and can be further deferred in accordance with Section 409A. These RSUs will be paid on their Original Settlement Date or the Agreed Settlement Date, except in the case of death. In the case of death (except in France and the UK), payment will be made by the later of the end of the calendar year or two and a half months following the date of death. For awards granted in France or the UK, the consequences of death are determined by the local plan supplement, if applicable.

VI.     SEPARATION FROM THE COMPANY (Defined terms shall have the meaning designated in the 2014 Plan or related award documents)

If the Participant’s Termination of Employment occurs for any reason before the Vest Date, except for the reasons listed below, the Award will be forfeited. Participants must remain in compliance with the terms and conditions set forth in the 2014 Plan, including those in Article 6.

Termination on Account of Death (except in France and the UK). The Award is immediately vested and will become deliverable on the Settlement Date or Agreed Settlement Date, whichever is applicable.

Termination on Account of Death for awards granted in France or the UK. The consequences of death are determined by the local plan supplement, if applicable.

Termination on Account of Retirement or Disability after June 30th of the fiscal year in which this Award was granted. PSUs are retained and will be delivered on the Settlement Date.

Termination pursuant to a Written Separation Agreement that provides for retention of the Award, after June 30th of the fiscal year in which this Award was granted. PSUs are retained and will be delivered on the Settlement Date.

Termination in connection with a divestiture or separation of any of the Company’s businesses, as determined by the Company’s Chief Human Resources Officer. PSUs are retained and will be delivered on the Settlement Date.

VII.    CHANGE IN CONTROL

Notwithstanding the foregoing, if there is a Change in Control that meets the requirements of a change in control event under Section 409A, all outstanding PSP Awards will vest at 100% of the Initial PSU Grant target (or 100% of the PSP Target if the Change in Control occurs prior to the Initial PSU Grant) including dividends that would have accumulated since the initial PSU grant on the vested units, and shall be paid in shares of Common Stock at the time of such Change in Control. If there is a Change in Control event that does not meet the requirements of a change in control event under Section 409A, all outstanding PSP Awards will be settled according to the terms and conditions set forth herein, without the application Article 17 of the 2014 Plan. “Change in Control” shall have the same meaning as defined in the 2014 Plan or any successor stock plan approved in accordance with applicable listing standards.

VIII.    GENERAL TERMS AND CONDITIONS






It shall be understood that the PSP does not give to any officer or employee any contract rights, express or implied, against any Company for any PSP Award, or for compensation in addition to the salary paid to him or her, or any right to question the action of the Board of Directors or the C&LD Committee.

Each PSP Award made to an individual at Band 7 and above is subject to the Senior Executive Recoupment Policy adopted by the C&LD Committee in December 2006.

To the extent applicable, it is intended that the PSP comply with the provisions of Section 409A. The PSP will be administered and interpreted in a manner consistent with this intent. Neither a Participant nor any of a Participant’s creditors or beneficiaries will have the right to subject any deferred compensation (within the meaning of Section 409A) payable under the PSP to any anticipation, alienation, sale, transfer, assignment, pledge, encumbrance, attachment or garnishment. Except as permitted under Section 409A, any deferred compensation (within the meaning of Section 409A) payable to a Participant under the PSP may not be reduced by, or offset against, any amount owing by a Participant to the Company.

This program document may be amended at any time by the C&LD Committee



EX-10.2 3 fy1819q2ond10-qexhibit102.htm SUMMARY OF THE COMPANY'S LONG-TERM INCENTIVE PROGRAM Exhibit


EXHIBIT (10-2) 
 
Summary of the Company's Long-Term Incentive Program







LONG-TERM INCENTIVE PROGRAM
(Effective July 1, 2018)

The Long-Term Incentive Program (“LTI Program”) is part of The Procter & Gamble Company’s (the “Company”) long-term incentive compensation and is designed to increase employee ownership and focus employees on the long-term success of the Company. Awards granted under the LTI Program (“LTI Awards”) are made pursuant to authority delegated to the Compensation & Leadership Development Committee (the “Committee”) by the Board of Directors for determining compensation for the Company’s principal officers and for making awards under The Procter & Gamble 2014 Stock and Incentive Compensation Plan (the “2014 Plan”) or any successor stock plan approved in accordance with applicable listing standards.
I.    ELIGIBILITY
Active employees at Band 4 and above as of October 1 prior to grant date are included in the Plan, as well as a select percent of Band 3 employees. In special circumstances such as for acquisitions or experienced hires, the CHRO may authorize grants for employees who are not active as of October 1 but are employees as of the grant date. Employees recommended by management and approved by the Committee or Committee’s delegate are eligible to participate (“Participants”).
II.    OVERVIEW
The LTI Program motivates leaders to achieve results in the long term by driving ownership behavior through the awarding of stock options, stock appreciation rights (SARs), and restricted stock units (RSUs). Participants at Band 4 and above may be provided a choice of a mix of stock options and RSUs, except for the CEO, whose grant form is solely determined by the Committee. The choice must be made before the end of the calendar year preceding the award date. Band 3 participants receive awards in the form of stock options, RSUs, or a mix as authorized by the CEO prior to grant date. Exceptions may exist in some countries where stock options and/or RSUs are not locally allowed or effective as a compensation vehicle.
III.    AWARD DETERMINATION
Market target grant values by Job Band are based on competitive market data from peer companies and analysis of global long-term incentive practices.
CEO - The market analysis is reviewed and a final award value for the CEO is determined solely by the Committee.
Principal Officers - Market target grant values for Principal Officers are authorized by the Committee. Final awards for Principal Officers are recommended by the CEO and approved directly by the Committee.
Band 4-6 - The CEO authorizes market target grant values by band below Band 7. Individual employee award targets are determined based on the employee’s home country and job band. The final award values for Band 4-6 may be further adjusted by Business Unit leaders for individual performance. Final award amounts for employees Band 4-6 are approved by the CEO as delegated by the Committee. Awards for low performers are reduced or eliminated.
Band 3 - The CEO authorizes market grant values, award mix, and participation rates at Band 3. The Business Unit leaders select the Band 3 participants within their organizations. The final award values for Band 3 are set based on home country and approved by the CEO as authorized by the Committee.
The number of stock options or SARs awarded to each employee will be determined on grant date using the same methodology by which the Company expenses stock options. The number of RSUs awarded will be determined based on the price of P&G stock on grant date.
The option price or grant price used for any LTI Award will be the closing price for a share of Common Stock on the New York Stock Exchange on the day of the grant, or such higher price as may be specified in the French





Addendum of the Regulations (the “Grant Price”). If the New York Stock Exchange is closed on the day of the grant, then the date of the Award will be the first day of trading of the Company’s stock subsequent to the date previously specified for such award.
LTI Awards will be granted on the last business day of February each year. Employees who did not receive the appropriate award on this date due to an administrative or data error will receive their appropriate LTI Award on the last business day prior to May 10 each year.
If applicable, Participants must accept their awards according to the terms of the Award Letter or the Award will not be granted.
IV.    VESTING AND SETTLEMENT
Stock options and SARs vest three years following the grant date. They expire ten years after the grant date. RSUs have a vest date and settlement date three years following the grant date, are eligible for dividend equivalents, and cannot be deferred in accordance with Internal Revenue Code 409A unless otherwise determined by the Committee at grant.
V.    SEPARATION FROM THE COMPANY (Defined terms shall have the meaning designated in the 2014 Plan or related award documents)
If the Participant’s Termination of Employment occurs for any reason before the Expiration Date and prior to exercising the Award for stock options and SARs, or before the Vest Date for RSUs, except for the reasons listed below, the Award will be forfeited. Participants must remain in compliance with the terms and conditions set forth in the 2014 Plan, including those in Article 6.
Termination on Account of Death (except in France and the UK). The Vest Date for stock options and SARs becomes the date of death and the Award remains exercisable until the Expiration Date. For RSUs, the Award will be fully vested and payment will be made by the later of the end of the calendar year or two and a half months following the date of death.

Termination on Account of Death for awards granted in France or the UK. The consequences of death are determined by the local plan supplement, if applicable.

Termination on Account of Retirement or Disability after June 30th of the fiscal year in which this Award was granted. Stock options and SARs are retained and will be exercisable on the Vest Date and will expire on the Expiration Date. RSUs are retained and will be delivered on the Settlement Date.

Termination pursuant to a Written Separation Agreement that provides for retention of the Award, after June 30th of the fiscal year in which this Award was granted. Stock options and SARS are retained and will become exercisable on the Vest Date and will expire on the Expiration Date. RSUs are retained and will be delivered on the Settlement Date.

Termination in connection with a divestiture or separation of any of the Company’s businesses, as determined by the Company’s Chief Human Resource’s Officer. All outstanding Stock options and SARs are retained and will become exercisable on the Vest Date and will expire on the Expiration Date. All outstanding RSUs are retained and will be delivered on the Settlement Date.

VI.    CHANGE IN CONTROL
If there is a Change in Control, the provisions of Article 17 of the 2014 Plan will apply.
VII.    GENERAL TERMS AND CONDITIONS





It shall be understood that the LTI Program does not give to any employee any contract rights, express or implied, against the Company for any LTI Award, or for compensation in addition to the salary paid to him or her.
This program document may be amended at any time by the Committee.



EX-10.3 4 fy1819q2ond10-qexhibit103.htm COMPANY'S FORM OF SEPARATION AGREEMENT & RELEASE Exhibit



EXHIBIT (10-3) 
 
Company’s Form of Separation Agreement & Release







SEPARATION AGREEMENT AND RELEASE

To:    «Employee_Name»
Date:    «Actual_Offer_Date»

«Company» (“P&G”) is willing to provide you with certain assistance in connection with your employment separation from the Company. The following, which is subject to your approval, sets forth our proposed agreement to do so. Your receipt of the benefits described below is conditioned upon your accepting, and abiding by, the terms of this Agreement.

Last Day of Employment:
Your last day of employment will be «Exit_Date», referred to as your “Last Day of Employment.” Unless otherwise noted below, your pay and benefits will cease as of your Last Day of Employment.
Separation Payment:
As soon as administratively practical after your Last Day of Employment, P&G will provide you with a Separation Payment of «Total_Amount», less legally required withholdings and deductions. In no event will payment be made before expiration of the seven-day revocation period discussed below or later than the March 15th of the year following the year which includes your last day of employment.

Amounts you owe to P&G as of your Last Day of Employment, including, but not limited to, wage and/or benefit overpayments and unpaid loans, will also be deducted from the Separation Payment.
Payment for Unvested PST:
If you are not fully-vested in the Procter & Gamble Profit Sharing Trust and Employee Stock Ownership Plan (“PST”) as of your Last Day of Employment, as soon as administratively practical after your Last Day of Employment, but no later than the March 15th of the year following the year which includes your Last Day of Employment, you will receive a lump sum payment in an amount substantially equivalent to the non-vested credits in your account in the PST.
STAR Awards:
As of your Last Day of Employment, if you were otherwise eligible for a STAR award and you worked at least 28 days (4 calendar weeks) during that fiscal year, you will receive a pro-rated STAR award for that fiscal year. Your STAR award will be pro-rated by dividing the number of calendar days during the fiscal year from July 1 through your Last Day of Employment by 365. Your STAR award will be paid in cash in the September (but no later than September 15th) immediately following the end of the fiscal year in which you terminate.





Equity Awards
(including Recognition Shares):
Your separation will be treated as a Special Separation for purposes of any outstanding equity awards granted under the Procter & Gamble 2009 Stock and Incentive Compensation Plan, the Procter & Gamble 2001 Stock and Incentive Compensation Plan, the Procter & Gamble 1992 Stock Plan, or the Gillette Company 2004 Long-Term Incentive Plan and as a result the awards will be retained subject to the original terms and conditions of the awards.

Awards granted under the Procter & Gamble 2014 Stock & Incentive Compensation Plan are retained subject to the terms and conditions of the Awards.

This agreement does not alter the rights and obligations that you may have under the Procter & Gamble 2014 Stock & Incentive compensation Plan, the Procter & Gamble 2009 Stock and Incentive Compensation Plan, the Procter & Gamble 2001 Stock and Incentive Plan, the Procter & Gamble 1992 Stock Plan, and the Gillette Company 2004 Long-Term Incentive Plan.
Current Health, Dental, and Life Insurance Benefits:
If you are enrolled in P&G’s active health (including medical, prescription drug, and EAP coverage), active dental, and company-paid life insurance coverage, that coverage will continue under the same terms until «Benefits_End_Date»Note: Any life insurance coverage other than company-paid life insurance coverage will not continue during this time. 

When your extended coverage ends, you may be entitled to continue your health and dental coverage under COBRA.  If you are entitled to COBRA continuation coverage, you will receive a notice of your right to elect COBRA.
Retiree Medical and Dental Benefits:
If you were eligible for P&G retiree healthcare coverage on your Last Day of Employment, you will be eligible to enroll in P&G’s retiree medical and dental insurance coverage. You are eligible for P&G retiree healthcare coverage if you satisfy the regular retiree eligibility rules (i.e., you are a Regular Retiree) as of your Last Day of Employment. Under the terms of this Agreement, you also are eligible for P&G retiree healthcare coverage as a Special Retiree by satisfying the Rule of 70 as of your Last Day of Employment. You satisfy the Rule of 70 when your full years of age plus your full years of service equal 70. Special rules apply to Gillette Heritage Employees with regard to retiree medical eligibility and the retiree medical cost sharing under the retiree medical plan. If you are a Gillette Heritage Employee, you will receive a separate handout on your retiree medical eligibility.  If you are eligible for P&G’s retiree healthcare coverage as either a Regular Retiree or a Special Retiree as of your Last Day of Employment, you should contact P&G Employee Care before your extension of coverage ends to request retiree healthcare enrollment information. For details regarding the terms and conditions of your retiree health coverage, please refer to and review the summary plan descriptions, available at PGOneLife and Career
Important Note: If you become employed by a direct competitor of P&G (as determined by P&G’s Chief Human Resources Officer) in an officer and/or director capacity, you will not be eligible for coverage under P&G’s retiree healthcare coverage as long as you remain employed by such competitor. If you have questions, please contact P&G Employee Care at 1-833-441-4357.





Outplacement Services:
P&G’s outplacement supplier, Right Management Consultants, will provide services to assist you in managing your transition to a new future, based on your interest. Services include pre-decision counseling, career transition programs, and job development opportunities. Right Management Consultants will also assist you in preparing for your job search, including résumé preparation, cover letters, other written materials and interview and networking training.

After accepting this Agreement, and after obtaining your manager’s approval, you may begin utilizing outplacement services on a limited basis prior to your Last Day of Employment, consistent with the needs of the business and your responsibilities to complete and/or transition your work. Note that you must begin utilizing outplacement services within 45 days of your Last Day of Employment to be eligible for this benefit.
Retraining:
You are eligible for reimbursement (up to $5,000) for the cost of tuition, registration and laboratory fees for courses taken at accredited colleges and universities, or at 2-year colleges, trade schools, or vocational schools approved by appropriate accrediting boards. Correspondence courses which result in credit towards diplomas, degrees, etc. may be acceptable if offered by eligible non-profit institutions.
You must have courses approved in advance and submit proof of payment of covered fees and proof (such as a transcript) that the courses were completed successfully. Courses that are recreational in nature, such as golf lessons, will not be approved.
All expenses for retraining must be incurred within twenty-four (24) months of your Last Day of Employment. The retraining reimbursement benefit is administered by Right Management Consultants.
No Consideration Without Executing this Agreement:
You affirm that you understand and agree that you would not receive the separation payment and/or benefits specified in this Agreement without executing this Agreement and fulfilling the promises contained in it.  Except as provided in this Agreement or under the terms and conditions of an applicable benefit plan or policy sponsored by P&G, you shall not be due any payments or benefits from P&G in connection with the termination of your employment.
Continued Employment Through Your Last Day of Employment:
You agree to perform your work and responsibilities as an employee in a satisfactory manner up to and including your Last Day of Employment, including compliance with all provisions of this “Separation Agreement and Release.” If P&G determines that you have engaged in serious misconduct during your employment, you understand and agree that P&G may terminate your employment immediately and will not provide, nor will it be obligated to provide, you with the Separation payment, medical benefits, outplacement, retraining and other benefits described above. If you have already received any such pay or benefits, you agree to repay them to P&G upon demand.
Nonadmission of Wrongdoing:
You affirm that you understand and agree that neither this Agreement nor the furnishing of the consideration for this Agreement, including the Separation Payment, shall be deemed or construed at any time for any purpose as an admission by P&G of wrongdoing or evidence of any liability or unlawful conduct of any kind.





Release of Claims - Including Age Discrimination and Employment Claims:
In consideration of the Separation Payment and other benefits provided above to which you would not have been entitled under any existing P&G Policy, you release P&G from any and all claims you have against P&G. The term “P&G” includes «Company» and any of its present, former and future owners, parents, affiliates and subsidiaries, and its and their directors, officers, shareholders, employees, agents, servants, representatives, predecessors, successors and assigns and their employee benefit plans and programs and their administrators and fiduciaries.

This release applies to claims about which you now know or may later discover, and includes but is not limited to: (1) claims arising under the Age Discrimination in Employment Act, 29 U.S.C. § 621, et seq.; (2) claims arising out of or relating in any way to your employment with P&G or the conclusion of that employment; (3) claims arising under any federal, state and local employment discrimination laws, regulations or ordinances or other orders that relate to the employment relationship and/or employee benefits; and (4) any other federal, state or local law, rule, regulation or ordinance, public policy, contract, tort or common law.
This release does not apply to claims that may arise after the date you accept this Agreement or that may not be released under applicable law.
You are not waiving any rights you may have to: (a) your own vested accrued employee benefits under the P&G health, welfare, or retirement benefit plans as of the Last Day of Employment; (b) benefits and/or the right to seek benefits under applicable workers’ compensation and/or unemployment compensation statutes; (c) pursue claims which by law cannot be waived by signing this Agreement; (d) enforce this Agreement; and/or (e) challenge the validity of this Agreement.
You agree that the decision that your last day of employment would be on the Last Day of Employment was made prior to your accepting and executing this Agreement, and you agree that you are releasing any claim in connection with the separation of your employment.
If any claim is not subject to release, to the extent permitted by law, you agree that you waive any right or ability to be a class or collective action representative or to otherwise participate in any putative or certified class, collective or multi-party action or proceeding based on such a claim in which P&G is a party.

Governmental Agencies: Nothing in this Agreement prohibits or prevents you from filing a charge with or participating, testifying, or assisting in any investigation, hearing, or other proceeding before the U.S. Equal Employment Opportunity Commission, the National Labor Relations Board or a similar agency enforcing federal, state or local anti-discrimination laws. However, to the maximum extent permitted by law, you agree that if such an administrative claim is made to such an anti-discrimination agency, you shall not be entitled to recover any individual monetary relief or other individual remedies.  Nothing in this Agreement, including but not  limited to the “Release of Claims - Including Age Discrimination and Employment Claims” and the “Confidential, Proprietary, Trade Secret Information & Period of Non-Competition” sections of this Agreement, prohibits you from: (1) reporting possible violations of federal law or regulations, including any possible securities laws violations, to any governmental agency or entity, including but not limited to the U.S. Department of Justice, the U.S. Securities and Exchange Commission, the U.S. Congress, or any agency Inspector General; (2) making any other disclosures that are protected under the whistleblower provisions of federal law or regulations; or (3) otherwise fully participating in any federal whistleblower programs, including but not limited to any such programs managed by the U.S. Securities and Exchange Commission and/or the Occupational Safety and Health Administration. You understand you do not need the prior authorization from the Company to make any such reports or disclosures, and you are not required to notify the Company that you have made such reports or disclosures. Moreover, nothing in this Agreement prohibits or prevents you from receiving individual monetary awards or other individual relief by virtue of participating in such federal whistleblower programs.





Confidential, Proprietary, Trade Secret Information & Period of Non-Competition:
Subject to the “Governmental Agencies” portion of the “Release of Claims - Including Age Discrimination and Employment Claims” above, you agree that you will not use or share any confidential, proprietary or trade secret information about any aspect of P&G’s business with any non-P&G employee or business entity at any time in the future. You further agree that you will not obtain or have in your possession any confidential, proprietary or trade secret information on or after your last day of employment. Confidential, proprietary or trade secret information includes, but is not limited to, marketing and advertising plans, pricing information, upstream plans, specific areas of research and development, project work, product formulation, processing methods, assignments of individual employees, testing and evaluation procedures, cost figures, construction plans, and special techniques or methods of any kind.
Notwithstanding the requirements of confidentiality contained in this section, the federal Defend Trade Secrets Act of 2016 immunizes you against criminal and civil liability under federal or state trade secret laws for your disclosure of trade secrets that is made i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney solely for the purpose of reporting or investigating a suspected violation of law; ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal; or iii) to your attorney for use in a lawsuit alleging retaliation for reporting a suspected violation of law, provided that any document containing the trade secret is filed under seal and you do not otherwise disclose the trade secret, except pursuant to court order.

Additional non-compete obligation for management employees only: You understand and agree that, unless you have prior written consent from P&G, you will not engage in any activity or provide any services for a period of three (3) years following your Last Day of Employment in connection with the manufacture, development, advertising, promotion or sale of any product which is the same as, similar to, or competitive with any products of P&G or its subsidiaries (including both existing products as well as products in development which are known to you, as a consequence of your employment with P&G):
With respect to which your work has been directly concerned at any time during the two (2) years preceding your Last Day of Employment; or
With respect to which during that period of time you, as a consequence of your job performance and duties, acquired knowledge of trade secrets or other confidential information of P&G.
For the purposes of this section, it shall be conclusively presumed that you have knowledge or information to which you were directly exposed through the actual receipt of memos or documents containing such information or through actual attendance at meetings at which such information was discussed or disclosed. The provisions of this section are not in lieu of, but are in addition to, your continuing obligation to not use or disclose P&G’s trade secrets and confidential information known to you until any particular trade secret or confidential information becomes generally known (through no fault of yours). Information regarding products in development, in test market or being marketed or promoted in a discrete geographic region, which information P&G is considering for a broader use, shall not be deemed generally known until such broader use is actually commercially implemented. Also, “generally known” means known throughout the domestic United States industry or, if you have job responsibilities outside of the United States, the appropriate foreign country or countries’ industry.
If any restriction in this section is found by any court of competent jurisdiction or arbitrator to be unenforceable because it extends for too long a period of time or over too great a range of activities or in too broad a geographic area, it will be modified and interpreted to extend only over the maximum period of time, range of activities or geographic area so that it may be enforceable.
If you are a participant in the 2009 Stock and Incentive Compensation Plan, the 2001 Stock and Incentive Compensation Plan, or the 1992 Stock Plan, you are also bound by the terms of Article F - Restrictions & Covenants of those plans, which are incorporated herein by reference.
If you are a participant in the 2014 Stock & Incentive Compensation Plan, you are also bound by the terms of Article 6 - Restrictions and Covenants of this plan which are incorporated herein by reference.





Acknowledgements and Affirmations:
Subject to the “Governmental Agencies” portion of the “Release of Claims - Including Age Discrimination and Employment Claims” above, you affirm that you have not filed, caused to be filed, or presently are a party to any claim against P&G.
You affirm that you have been paid and/or have received all compensation, wages, bonuses, commissions, and/or benefits which are due and payable as of the date you sign this Agreement. To the extent that you are required to report hours worked, you affirm that you have reported all hours worked as of the date you sign this Agreement.
You affirm that you have been granted any leave to which you were entitled under the Family and Medical Leave Act or related state or local leave or disability accommodation laws.
You further affirm that you have no known workplace injuries or occupational diseases that have not been reported.
Assignment of Intellectual Property:
You will promptly and fully disclose, transfer and assign to P&G all inventions and any other intellectual property (collectively “Intellectual Property”) made or conceived by you during your employment with P&G. You agree to fully cooperate in executing any papers required for establishing or protecting the Intellectual Property and for establishing P&G’s ownership, even if such cooperation is necessary after your Last Day of Employment.
Return of P&G Property:
You agree that on or before your Last Day of Employment, you will return to P&G in good condition all of its equipment, materials and information that were in your possession, custody or control (including, but not limited to, computers, files, documents, credit cards, keys and identification badges). You further agree that you will provide your manager with all passwords to P&G electronic communication and data systems before your Last Day of Employment. You further agree that on or before your Last Day of Employment, you will return or if directed to do so by your immediate manager, delete (i.e., destroy all copies of) any and all P&G confidential, proprietary or trade secret information you have maintained in your possession, custody, or control in paper, electronic and/or digital formats, including but not limited to, any such confidential, proprietary, or trade secret information (e.g., files, documents, etc.) that you may have electronically or digitally processed or stored on P&G-issued or on personally-owned or maintained digital devices and/or service accounts. Such digital devices and/or service accounts may include, but are not limited to desktop and laptop computers, notebooks, tablets, iPads, mobile phones, smartphones, personal digital assistants (PDAs), USB and flash drives, external hard drives, CDs, DVDs, and/or external file processing or storage provided by cloud service providers such as box.net, dropbox, Google docs, etc.
Ethics Compliance:
Subject to the “Governmental Agencies” portion of the “Release of Claims - Including Age Discrimination and Employment Claims” above, you agree that you provided P&G all information known to you regarding any violations of the Procter & Gamble Worldwide Business Conduct Manual and/or any other violations of P&G policy or the law.





Agreement to Arbitrate Disputes:
Resolving any future differences we may have in the courts can take a long time and be expensive. You and P&G therefore agree that the only remedy for all disputes that are not released by this Agreement or that arise out of your employment with or separation from P&G, or any aspect of this Agreement, will be to submit any such disputes (with the exception noted at the end of this section) to final and binding arbitration in accordance with the National Rules for Resolution of Employment Disputes of the American Arbitration Association then in effect.
You and P&G agree that the aggrieved party must send written notice of any claim to the other party by certified mail, return receipt requested. Written notice for P&G will be sent to: Secretary, One Procter & Gamble Plaza, Cincinnati, OH 45202, and to you at the most current address shown for you in P&G’s records. The arbitrator will apply Ohio law. At your written request, P&G will reimburse you for all fees and costs charged by the American Arbitration Association and its arbitrator to the extent they exceed the applicable fees and costs that would have been charged by a court of competent jurisdiction had your claim been filed in court.
There is one exception to this section. P&G may seek injunctive relief in any court of competent jurisdiction if it has reason to believe that you have violated or are about to violate (1) the terms of the “Confidential, Proprietary, Trade Secret Information & Period of Non-Competition” section above, or (2) if you are a participant in the 2009 Stock and Incentive Compensation Plan, the 2001 Stock and Incentive Compensation Plan, or the 1992 Stock Plan, the terms of Article F - Restrictions & Covenants of those plans or (3) if you are a participant in the 2014 Stock and Incentive Compensation Plan, the terms of Article 6 - Restrictions & Covenants of that plan.
Severability:
If any court of competent jurisdiction or arbitrator should later find that any portion of this Agreement is invalid, that invalidity will not affect the enforceability of any other portion of this Agreement.
Employment References:
You understand that P&G’s historical policy is to not provide employment references to prospective employers. However, P&G is willing to waive that policy in your case on the following basis: You authorize your manager or human resources representative to provide an employment reference upon written or verbal request. In return, you release any claim against P&G and will not bring a lawsuit in court against P&G based upon that employment reference (or lack thereof). You agree that you will refer all reference inquiries to your manager or human resources representative only. You further understand that all disputes regarding employment references or the lack thereof must be resolved through the arbitration process described above.
No Reliance:
This Agreement sets forth the entire agreement between you and P&G and fully supersedes any prior agreements or understanding between the parties except that if you are a participant in the 2009 Stock and Incentive Compensation Plan, the 2001 Stock and Incentive Compensation Plan, or the 1992 Stock Plan, the terms of Article F - Restrictions & Covenants of those plans remain in full force and effect and are incorporated herein by reference and if you are a participant in the 2014 Stock Plan, the terms of Article 6 - Restrictions & Covenants of the plan remain in full force and are in effect and are incorporated herein by reference. In deciding to accept this Agreement, you agree that you have not relied upon any statements or promises by P&G, its managers, agents or employees, other than those set forth in this Agreement. No other promises or agreements concerning the matters described in this Agreement shall be binding unless in a subsequent document signed by these parties.
Your Attorney:
You acknowledge that you have been and hereby are advised to consult with legal counsel before accepting this Agreement and have either done so or have voluntarily declined to do so.





Timing for Acceptance or Revocation:
You have forty-five (45) calendar days in which to consider this Agreement in which you waive important rights, including those under the Age Discrimination in Employment Act of 1967. If you choose to sign this Agreement, please do so by indicating your acceptance of this Agreement with your electronic signature in P&G’s electronic system. We advise you to consult with an attorney of your choosing prior to signing this Agreement. Further, you may within seven (7) calendar days following the date you accept this Agreement, cancel and terminate the Agreement by giving written notice of your intention to revoke the Agreement to your immediate manager, and by returning to P&G any remuneration or benefits that have been advanced to you in anticipation of your not revoking your Agreement and to which you are not entitled. If notice of your revocation is mailed, it must be postmarked within seven (7) calendar days after you sign this Agreement.
You agree that any modifications, material or otherwise, made to this Agreement, do not restart or affect in any manner the original up to forty-five (45) calendar day consideration period.
 
 




The benefits described in this Agreement and pursuant to the summary plan description for the Procter & Gamble Basic Separation Program for U.S. Employees (see embedded document below), are the special benefits you will receive by signing this Agreement.  To the extent this Agreement describes benefits under other benefit plans and policies sponsored by P&G, these special benefits are also described in the summary plan descriptions for those plans.  As such, nothing in this Agreement amends or changes the terms of any P&G-sponsored employee benefit plan or policy.

[Embedded SPD, reproduced below]
 
After your Last Day of Employment, you will no longer be an active P&G employee, which may affect your coverage under those plans and policies.  For example, plans may require that you enroll in Medicare to be eligible for coverage.  For more information on how not being an active P&G employee may affect your coverage, please refer to and review the summary plan descriptions for each plan. 


 
 
 
 
 
 
 
 











Procter & Gamble
Basic Separation Program for
U.S. Employees


Summary Plan Description




July 1, 2016
 
 






 
INTRODUCTION

The Procter & Gamble Company (“Company” or “P&G”) sponsors The Procter & Gamble Insured-Unfunded Welfare Plan (“Plan”), which includes the Procter & Gamble Basic Separation Program for U.S. Employees (“Program”). Under the Program, the Company provides certain eligible employees with financial support and other benefits upon termination of employment with the Company.

This summary plan description (“SPD”) provides the specific terms and conditions of the Program’s benefits. You should read this SPD carefully as it gives you a detailed description of the Program, how it works, what benefits it provides, how those benefits may be obtained, and how those benefits may be lost. If this SPD does not answer your questions or if you need further information, contact the Associate Director, NA Employee Relations Manager, The Procter & Gamble Company, P&G Plaza, TN-3, Cincinnati, OH 45202, [email] [phone number].

You may examine the SPD during regular business hours at the Plan Administrator’s office and obtain a copy of the SPD by written request to the Plan Administrator. You may be charged a fee to cover copying costs.


BASIC INFORMATION

Plan Name: The Procter & Gamble Basic Separation Program for U.S. Employees (“Basic U.S. Separation Program,” “Basic Separation Program,” “Program,” or “Plan”) is a component of the Procter & Gamble Insured-Unfunded Welfare Plan (“Insured-Unfunded Plan”).

Effective Date: July 1, 2016

Plan Sponsor: The Procter & Gamble Company, P&G Plaza, Cincinnati, OH 45202

Employer/Sponsor Tax ID: 31-0411980

Plan Number: 556

Plan Year: For purposes of operating the Insured-Unfunded Plan, the plan year is January 1 through December 31. For purposes of financial reporting (i.e., Form 5500 filing), the plan year is July 1 through June 30

Plan Type: The Basic Separation Program provides severance benefits to eligible employees of the Company (and its subsidiaries). The Insured-Unfunded Plan also provides other employee benefits, the terms of which are described in separate summary plan descriptions.

Plan Administrator: The Procter & Gamble U.S. Business Services Company, c/o U.S. Benefits Manager, P&G Plaza, TE-3, Cincinnati, OH 45202, [phone number].

Claims Administrator: The Company’s Director of Global Employee Relations (or appropriate delegate) handles initial claims for separation benefits under the Basic Separation Program. The Policy Committee handles appeals.

Plan Administration Type: The Plan Administrator, Employee Relations, and the Policy Committee share responsibility for administering the Basic Separation Program. Other benefits under the Plan (not described in this booklet) are provided through a combination of contract administration, insurer administration, and self-administration.

Plan Funding: The Company provides from its general assets 100% of the funding for the benefits under the Basic Separation Program.

Agent for Legal Service of Process: CT Corporation System, 1300 East 9th Street, Cleveland, OH 44114. Legal





service of process may also be served on the Plan Administrator.


ELIGIBILITY, PARTICIPATION & BENEFITS

Who is Eligible? An individual is eligible for benefits under the Program if the individual is an employee of the Company who is based in the United States. For purposes of the Program, the United States means only the 50 states and the District of Columbia (but not territories of the United States, such as Puerto Rico). An employee is “based” in the United States if the employee’s home country (as designated by the Company) is the United States, including an employee who is on an expatriate assignment outside the United States.

What triggers an employee’s right to Separation Benefits? An employee of the Company who is otherwise eligible for separation benefits under the Program becomes entitled to such benefits if the Company, acting through its Chief Human Resources Officer or appropriate delegate, and the employee enter into a Negotiated Separation Agreement and the employee signs it. Employees may sign a Negotiated Separation Agreement via electronic signature through the Global Separation System.
IMPORTANT NOTE: Only the Company can initiate the process of entering a Negotiated Separation Agreement. If the Company wants to provide an employee with an incentive to leave the Company earlier than the employee planned, the Company may choose to initiate the process by offering the employee a Negotiated Separation Agreement.

What is a Negotiated Separation Agreement? For purposes of the Program, a Negotiated Separation Agreement is an agreement between the Company and an employee that provides the terms of an employee’s termination of employment from the Company and must include (1) a Release of Claims; (2) a Last Day of Employment agreed to by the Company; and (3) all other necessary provisions in accordance with the Program. A Negotiated Separation Agreement may include some of the benefits listed in Appendix A, all of which are in addition to the normal benefits an employee would already be entitled to upon separation from the Company. For more information on how separating from the Company impacts your benefits, refer to the applicable summary plan descriptions and policies for such benefits.

IMPORTANT NOTE: Except for certain limited situations involving extenuating circumstances, the Company will not enter a Negotiated Separation Agreement with an individual who is no longer an employee of the Company.

What if an employee refuses to sign (or signs and later revokes) the Release of Claims? If an employee refuses to sign (or signs and later revokes) the Release of Claims, the employee will be disqualified from receiving any benefits under the Program, to the extent permitted by law and the terms of the Program.

If an employee signs a Negotiated Separation Agreement, when does his or her employment with the Company end? If an employee signs a Negotiated Separation Agreement with the Company, his or her employment with the Company ends at the conclusion of the Last Day of Employment specified in the Negotiated Separation Agreement.

If an employee signs a Negotiated Separation Agreement, when does participation in the Program begin? If an employee signs a Negotiated Separation Agreement with the Company, his or her participation in the Program begins on the day he or she signs the agreement. However, certain Program benefits will not be provided until after an employee’s Last Day of Employment.

If an employee signs a Negotiated Separation Agreement, what impact will it have on his or her Company sponsored employee benefits? Except to the extent otherwise described in this document and/or an applicable Negotiated Separation Agreement, the employee benefits for an employee who separates from the Company under the terms of a Negotiated Separation Agreement are impacted in the same manner as other separations from the Company. For example, if an employee signs a Negotiated Separation Agreement, in addition to the normal benefits he or she would otherwise be entitled to after terminating employment, the employee will also be entitled to the benefits specified in the Negotiated Separation Agreement. For more information on how separating from the





Company impacts your benefits, refer to the applicable summary plan descriptions and policies.

IMPORTANT CONSIDERATIONS: Signing a Negotiated Separation Agreement may have a significant impact on your benefits. For example, if you (or your spouse or dependents) are eligible for Medicare, after your Last Day of Employment, P&G medical coverage will be treated as secondary to Medicare, even if you are not enrolled in Medicare. This means that P&G’s medical coverage will cover expenses only after Medicare has covered its share of the expenses. If you (or your spouse or dependents) are not enrolled in Medicare, P&G’s medical coverage will determine what portion of the expense Medicare would have covered when determining the portion that P&G’s medical coverage will pay. This is just one example of how your benefits may be affected by signing a Negotiated Separation Agreement. Therefore, you are encouraged to consult with your family, as well as your legal and financial advisors, before you sign a Negotiated Separation Agreement.

How can an employee who is otherwise eligible for benefits under the Program lose his or her eligibility for such benefits? An employee who is otherwise eligible for benefits under the Program will lose his or her eligibility for such benefits if he or she:

c    Unilaterally and voluntarily resigns from the Company;1  
c     Is terminated from the Company for cause;2 or
c     Fails to comply with the terms of the Negotiated Separation Agreement, including, but not limited to, failing to (a) continue working through the Last Day of Employment without prior written approval from the Company, (b) continue to perform all the required duties of the employee’s position and complete all required reporting and other documentation associated with such position, as determined by the employee’s manager, through the Last Day of Employment, (c) comply with the terms of the non-compete provisions, or (d) return all Company property.

1 If you unilaterally and voluntarily resign from the Company, you will not be eligible for benefits under the Program. For purposes of the Program, if you unilaterally and voluntarily submit an Intent to Retire, the Company will consider such submission to be a unilateral and voluntary resignation.
2 “Cause” means the participant’s (a) conviction or plea of guilty, nolo contendere, or no contest, to a felony; (b) willful misconduct; (c) violation of a material written Company policy; or (d) willful and continued failure or refusal to substantially perform essential job functions.

To the extent an employee has received any benefits under this Program and later loses his or eligibility for benefits under this Program, the employee may be required to repay the value of such benefits received.


NON-ASSIGNABILITY OF PLAN BENEFITS

No benefits under this Program may be assigned or transferred by you or any other person entitled to benefits. If any person attempts to assign, sell, or otherwise transfer any benefits under the Program, the Plan Administrator may terminate that person’s interest in the benefit and dispose of that interest for the benefit of such person or such person’s dependents as it sees fit.

CLAIMS PROCEDURES

The Claims Administrator determines the right of any person to benefits under the Program. If you do not receive a benefit to which you believe you are entitled under the Program, you may file a written claim for benefits with the Claims Administrator. Claims should be sent to: Claims Administrator, Basic Separation Program, The Procter & Gamble Company, c/o Global Employee Relations, P&G Plaza, TN-3, Cincinnati, OH 45202.

The Claims Administrator will process your claim and notify you in writing of its decision within a reasonable time, normally within 90 days after you submitted your written claim. When the Claims Administrator requires additional time (up to an additional 90 days) to process your claim because of special circumstances, it may obtain an extension by notifying you within the initial 90-day period that a decision on the claim will be delayed and when a decision can be expected. If your claim is denied, you will receive a written explanation of the specific findings





and conclusions on which the denial is based.

If you do not agree with the Claims Administrator’s decision, you or your authorized representative may appeal the decision to the Policy Committee. Your appeal must be submitted in writing within 60 days after you receive the initial claim decision. Appeals should be sent to: Policy Committee, Basic Separation Program, The Procter & Gamble Company, c/o Corporate Secretary’s Office, P&G Plaza, C9-159, Cincinnati, OH 45202.

The Policy Committee will review the decision and issue a final written decision, normally within 60 days after the receipt of your appeal, specifying the reasons for its decision. If special circumstances require an extension, the Policy Committee may obtain such an extension by notifying you within the initial 60-day period that the decision on review of the denied claim will be delayed (for up to an additional 60 days), and why and when a decision can be expected.

The claim and appeal procedures are available to any employee or beneficiary who wishes to submit a claim for benefits or request an appeal. To the extent permitted by law, the Policy Committee’s decision on appeal is final, binding, and conclusive as to any fact or interpretation of the Program.

A claim or action to recover benefits, clarify rights under the Program or Plan, or enforce rights under the Program or Plan (collectively, “Action”) may not be filed in any court or other forum3 until these claim procedures have been exhausted with respect to such Action. No Action may be filed in any court or other forum if more than two (2) years has passed since the earlier of (a) the date the first benefit payment was actually made, (b) the date the first benefit payment was allegedly due, (c) for a reimbursement claim, the date on which the expense was incurred, or (d) the date the Plan, the Program, the Company, the Claims Administrator, or the Policy Committee first denied the alleged obligation to provide such benefits. A denial described in (d) above may be made by way of a direct communication with you or a more general oral or written communication related to benefits payable under the Program (such as this summary plan description). If at the end of the two (2) year period described above, the Claims Procedures described above are pending, the deadline for filing an Action will be extended to the date that is 60 calendar days after the final denial (including a deemed denial) by the Policy Committee.

3 If a Negotiated Separation Agreement includes a provision that requires the employee (or former employee) to settle all disputes arising from the Negotiated Separation Agreement through arbitration, then such employee (or former employee) is limited to pursuing such Action in accordance with the terms of such provision (including, but not limited to, whether such arbitration is final and binding).


FUTURE OF THE PROGRAM

Consistent with the terms of the Plan, the Company intends to continue the benefits under this Program indefinitely. However, the Company reserves the right to amend, modify, suspend, or terminate the Program to any extent and in any manner that it may deem advisable at any time or times. Any such action shall be taken by the Board of Directors, or its appropriate delegate, through a formal written statement or through formal action at a Board of Directors meeting.
DEFINITIONS

Last Day of Employment. The Last Day of Employment means the date specified in a Negotiated Separation Agreement as the employee’s last day being employed by the Company. The date must be a date to which the Company has agreed and which will be the last day the employee is employed with the Company. If an employee dies after executing a Negotiated Separation Agreement, but before the Last Day of Employment, such employee’s Last Day of Employment shall be considered the employee’s date of death. All Negotiated Separation Agreements must have a specified Last Day of Employment.

Release of Claims (“Release”). A Release of Claims means a provision in a Negotiated Separation Agreement in which the employee releases legal and other claims against the Company. All Negotiated Separation Agreements must include a Release, which will be in a form approved by the Company. By executing a Negotiated Separation Agreement, an employee also executes and agrees to the terms of the Release therein. Each Release becomes





effective in accordance with its terms.

Regular Retiree. A Regular Retiree means a former employee of the Company who was, on his or her Last Day of Employment, (1) at least 55 years old with his or her full years of age plus full Years of Service equal to at least 75, or (2) at least 60 years old with at least 10 full Years of Service. Regular Retirees are eligible to enroll in retiree medical and dental coverage under The Procter & Gamble Retiree Welfare Benefits Plan (“Retiree Plan”), subject to the terms and conditions of the Retiree Plan, including any amendments to the Retiree Plan. Regular Retirees are automatically enrolled in retiree life insurance benefits under the Retiree Plan when their basic life insurance benefits terminate.

Special Retiree. A Special Retiree means a former employee of the Company who executed a Negotiated Separation Agreement and satisfied the Rule of 70 on his or her Last Day of Employment. The Rule of 70 is satisfied if an employee’s full years of age plus full Years of Service equal at least 70. Special Retirees are eligible to enroll in retiree medical and dental coverage under The Procter & Gamble Retiree Welfare Benefits Plan (“Retiree Plan”), subject to the terms and conditions of the Retiree Plan, including any amendments to the Retiree Plan. Special Retirees are automatically enrolled in retiree life insurance benefits under the Retiree Plan when their basic life insurance benefits terminate.

Special Separation. Special Separation means a former employee of the Company who executed a Negotiated Separation Agreement and was neither a Regular Retiree nor a Special Retiree on his or her Last Day of Employment.

Years of Service. Years of Service means an employee’s adjusted years of service with the Company, as determined by the Company.
  
YOUR RIGHTS UNDER ERISA

As a participant in the Plan, you are entitled to certain rights and protection under the Employee Retirement Income Security Act of 1974 (“ERISA”). ERISA provides that all Plan participants shall be entitled to:
c Examine without charge, at the Plan Administrator’s office and at other specified locations, such as work sites, all documents governing the Plan.
c Obtain a copy of the latest annual report (Form 5500 Series) filed by the Plan with the U.S. Department of Labor, which is available at the Public Disclosure Room of the Employee Benefits Security Administration.
c Obtain, upon written request to the Plan Administrator, copies of documents governing the operation of the Plan, including insurance contracts and collective bargaining agreements, copies of the latest annual report (Form 5500 Series) and an updated Summary Plan Description. The Plan Administrator may make a reasonable charge for the copies.
c Receive a summary of the Plan’s annual financial report. The Plan Administrator is required by law to furnish each participant with a copy of this summary annual report.

Prudent Actions by Plan Fiduciaries

In addition to creating rights for Plan participants, ERISA imposes duties upon the people who are responsible for the operation of the employee benefit plan. The people who operate your Plan, called “fiduciaries” of the Plan, have a duty to do so responsibly and in the interest of you and other Plan participants and beneficiaries. No one, including your employer, your union or any other person, may terminate your employment or otherwise discriminate against you in any way to prevent you from obtaining a benefit or exercising your rights under ERISA.

Enforce Your Rights

If your claim for a benefit is denied or ignored, in whole or in part, you have a right to know why this was done, to





obtain copies of documents relating to the decision without charge and to appeal any denial, all within certain time schedules.

Under ERISA, there are steps you can take to enforce the above rights. For instance, if you make a written request for a copy of Plan documents or the latest annual report from the Plan and do not receive them within 30 days, you may file suit in a federal court. In such a case, the court may require the Plan Administrator to provide the materials and pay you up to $110 a day until you receive the materials, unless the materials were not sent because of reasons beyond the control of the Plan Administrator.

If you have a claim for benefits that is denied or ignored, in whole or in part, you may file suit in a state or federal court. In addition, if you disagree with the Plan’s decision or lack thereof concerning the qualified status of a medical child support order, you may file suit in federal court. If it should happen that the Plan fiduciaries misuse the Plan’s money, or if you are discriminated against for asserting your rights, you may seek assistance from the U.S.
Department of Labor, or you may file suit in a federal court. The court will decide who should pay court costs and legal fees. If you are successful, the court may order the person you have sued to pay these costs and fees. If you lose, the court may order you to pay these costs and fees, for example, if it finds your claim is frivolous.

Assistance with Your Questions
If you have questions about your Plan, you should contact the Plan Administrator. If you have questions about this statement or about your rights under ERISA, or if you need assistance in obtaining documents from the Plan Administrator, you should contact the nearest office of the Employee Benefits Security Administration, U.S. Department of Labor (listed in your local telephone directory), or the Division of Technical Assistance and Inquiries, Employee Benefits Security Administration, U.S. Department of Labor, 200 Constitution Avenue, NW, Washington, DC 20210. You may also obtain certain publications about your rights and responsibilities under ERISA by calling the publications hotline of the Employee Benefits Security Administration.
 

































APPENDIX A:
SEPARATION BENEFITS
The benefits described in this Appendix A are the separation benefits available under the Program. Whether and to what extent you are entitled to any of the benefits below is solely within the Company’s discretion, subject to the limitations described below.
   
SEPARATION PAYMENT 
If the Company offers you Separation Payment as part of your Negotiated Separation Agreement, the amount of the Separation Payment will be specified in the terms of your Negotiated Separation Agreement, but shall not exceed the percentage of your Annual Base Pay provided below, based on your full Years of Service.
 
Years of Service        % Annual Base Pay  
     0-2 25.00%
     3-4 33.33%
     5-9 54.17%
    10-14 75.00%
    15-19 95.83%
    20+ 100.00%

Separation Payments are payable in one lump sum, less tax withholding, and are issued as soon as administratively practical (typically, four to six weeks) after your Last Day of Employment. Separation Payments are not considered “compensation” for purposes of determining any benefits provided under any pension, savings, or other benefit plan sponsored by the Company.
 
 
PAYMENT FOR UNVESTED PST 
If you are not fully-vested in the Procter & Gamble Profit Sharing Trust and Employee Stock Ownership Plan (“PST”) as of your Last Day of Employment, as soon as administratively practical after your Last Day of Employment, but no later than the March 15th of the year following the year which includes your Last Day of Employment, you will receive a lump sum payment in an amount substantially equivalent to the non-vested credits in your account in the PST.
 
 
EXTENSION OF MEDICAL, DENTAL, AND BASIC LIFE COVERAGE 
If you are enrolled in medical, dental, or basic life insurance benefits on your Last Day of Employment, such benefits will be extended through the end of the month in which the Last Day of Employment occurs.
If the Company offers you a further extension of these benefits as part of your Negotiated Separation Agreement, the extension period will begin on the day after your Last Day of Employment and last for the number of months specified in the terms of your Negotiated Separation Agreement, but such period shall not exceed the number of months provided below, based on your full Years of Service.
 
Years of Service     # Months 
     0-2 3
     3-4 4
     5-9 6
    10-14 9
     15+ 12

If the Company offers you a further extension of benefits, you are required to continue paying for those benefits at the same rate you paid while you were employed, but on an after-tax basis.
COBRA: When your medical and dental benefits terminate after your Last Day of Employment (either at the end of that month or, if provided, at the end of your extension of benefits period) you may be eligible for continuation coverage under COBRA, which generally requires a greater premium payment for coverage. If you are a Regular Retiree or Special Retiree, in addition to COBRA, you will be eligible to enroll in retiree medical, dental, and life insurance coverage under The Procter & Gamble Retiree Welfare Benefits Plan. For more information, see definitions of Regular Retiree and Special Retiree.
Surviving Spouse/Domestic Partner & Dependents: If you die during an extension of benefits period and your spouse/domestic partner and other dependents were enrolled in P&G medical or dental coverage at the time of your death, they may continue such coverage for 12 months after your death at the same rate on an after-tax basis. This 12-month continuation period begins on the first of the month following the month in which your death occurs. If you are Regular Retiree or Special Retiree, after the 12-month extension of benefits period, your spouse/domestic partner is eligible to enroll in the National Surviving Spouse Program for medical and dental coverage under The Procter & Gamble Retiree Welfare Benefits Plan.
 
 
OUTPLACEMENT
Outplacement assistance (including pre-decision counseling, career transition programs, and job development services) is available for up to two years after your Last Day of Employment.
 
 
TRAINING
You are eligible to receive reimbursement for the cost of tuition and registration/lab fees at accredited institutions, for up to $5,000 or two years after your Last Day of Employment, whichever comes first. All courses must be approved by Right Management Consultants who administers the benefit.




EX-31.1 5 fy1819q2ond10-qexhibit311.htm EXHIBIT 31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION CHIEF EXECUTIVE OFFICER Exhibit


EXHIBIT 31.1
Rule 13a-14(a)/15d-14(a) Certifications
I, David S. Taylor, certify that:
(1)
I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;
(2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
(4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
(5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ DAVID S. TAYLOR
(David S. Taylor)
Chairman of the Board, President and Chief Executive Officer
 
January 23, 2019
Date




EX-31.2 6 fy1819q2ond10-qexhibit312.htm EXHIBIT 31.1 RULE 13A-14(A)/15D-14(A) CERTIFICATION CHIEF FINANCIAL OFFICER Exhibit


EXHIBIT 31.2
Rule 13a-14(a)/15d-14(a) Certifications
I, Jon R. Moeller, certify that:
(1)
I have reviewed this quarterly report on Form 10-Q of The Procter & Gamble Company;
(2)
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
(3)
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
(4)
The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
(5)
The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.



/s/ JON R. MOELLER
(Jon R. Moeller)
Vice Chairman and Chief Financial Officer
 
January 23, 2019
Date



EX-32.1 7 fy1819q2ond10-qexhibit321.htm SECTION 1350 CERTIFICATION CHIEF EXECUTIVE OFFICER Exhibit


EXHIBIT 32.1
Section 1350 Certifications
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:
(1)
The Quarterly Report on Form 10-Q of the Company for the quarterly period ended December 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.


/s/ DAVID S. TAYLOR
(David S. Taylor)
Chairman of the Board, President and Chief Executive Officer
 
January 23, 2019
Date
A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.



EX-32.2 8 fy1819q2ond10-qexhibit322.htm SECTION 1350 CERTIFICATION-CHIEF FINANCIAL OFFICER Exhibit


EXHIBIT 32.2
Section 1350 Certifications
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officer of The Procter & Gamble Company (the “Company”) certifies to his knowledge that:
(1)
The Quarterly Report on Form 10-Q of the Company for the quarterly period ended December 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in that Form 10-Q fairly presents, in all material respects, the financial conditions and results of operations of the Company.


/s/ JON R. MOELLER
(Jon R. Moeller)
Vice Chairman and Chief Financial Officer
 
January 23, 2019
Date
A signed original of this written statement required by Section 906 has been provided to The Procter & Gamble Company and will be retained by The Procter & Gamble Company and furnished to the Securities and Exchange Commission or its staff upon request.



EX-101.SCH 9 pg-20181231.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2108100 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details) link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - NET OF TAX EXPENSE (BENEFIT) (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - ACQUISITION link:presentationLink link:calculationLink link:definitionLink 2411404 - Disclosure - ACQUISITION ACQUISITION - FAIR VALUE OF INTANGIBLES (Details) link:presentationLink link:calculationLink link:definitionLink 2411405 - Disclosure - ACQUISITION - ADDITIONAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - ACQUISITION - ALLOCATION OF PURCHASE PRICE (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - ACQUISITION - ALLOCATION OF PURCHASE PRICE (Tables) link:presentationLink link:calculationLink link:definitionLink 2311303 - Disclosure - ACQUISITION - FAIR VALUE OF INTANGIBLES (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 2110100 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 2410401 - Disclosure - COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS link:presentationLink link:calculationLink link:definitionLink 1005001 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity FYTD link:presentationLink link:calculationLink link:definitionLink 1005002 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY QTD link:presentationLink link:calculationLink link:definitionLink 1005003 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY YTD link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity QTD link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - DOCUMENT AND ENTITY INFORMATION link:presentationLink link:calculationLink link:definitionLink 2105100 - Disclosure - EARNINGS PER SHARE link:presentationLink link:calculationLink link:definitionLink 2405403 - Disclosure - EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 2405402 - Disclosure - EARNINGS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 2305301 - Disclosure - EARNINGS PER SHARE (Tables) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 2404404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 2404405 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION OTHER (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details) link:presentationLink link:calculationLink link:definitionLink 2404406 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 2102100 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES link:presentationLink link:calculationLink link:definitionLink 2402402 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES - U.S. TAX REFORM (Details) link:presentationLink link:calculationLink link:definitionLink 2109100 - Disclosure - RESTRUCTURING PROGRAM link:presentationLink link:calculationLink link:definitionLink 2409402 - Disclosure - RESTRUCTURING PROGRAM - ADDITIONAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 2409404 - Disclosure - RESTRUCTURING PROGRAM - RESTRUCTURING COSTS PER SEGMENT (Details) link:presentationLink link:calculationLink link:definitionLink 2409403 - Disclosure - RESTRUCTURING PROGRAM - RESTRUCTURING RESERVE BY TYPE OF COSTS (Details) link:presentationLink link:calculationLink link:definitionLink 2309301 - Disclosure - RESTRUCTURING PROGRAM (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 2407407 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - AMOUNT OF GAINS AND LOSSES ON OUTSTANDING DERIVATIVES - ADDITIONAL INFORMATION (Details) (Details) link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE NOTIONAL AMOUNTS AND FAIR VALUE (Details) link:presentationLink link:calculationLink link:definitionLink 2407406 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 2407405 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (EFFECTIVE PORTION) (Details) link:presentationLink link:calculationLink link:definitionLink 2407408 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - NOTIONAL AMOUNTS AND FAIR VALUES OF QUALIFYING AND NON-QUALIFYING FINANCIAL INSTRUMENTS USED IN HEDGING TRANSACTIONS - ADDITIONAL INFORMATION (Details) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 2103100 - Disclosure - SEGMENT INFORMATION link:presentationLink link:calculationLink link:definitionLink 2403403 - Disclosure - SEGMENT INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 2403402 - Disclosure - SEGMENT INFORMATION SEGMENT INFORMATION - SALES (Details) link:presentationLink link:calculationLink link:definitionLink 2303301 - Disclosure - SEGMENT INFORMATION (Tables) link:presentationLink link:calculationLink link:definitionLink 2106100 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS link:presentationLink link:calculationLink link:definitionLink 2406403 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS - ADDITIONAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables) link:presentationLink link:calculationLink link:definitionLink 2402401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - ADDITIONAL INFORMATION (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 10 pg-20181231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 11 pg-20181231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 12 pg-20181231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Business Combinations [Abstract] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] PHC-MERCK ACQUISITION [Member] PHC-MERCK ACQUISITION [Member] PHC-MERCK ACQUISITION [Member] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets [Axis] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Trade Names [Member] Trade Names [Member] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Patents and Developed Technology [Member] Patents and Developed Technology [Member] Patents and Developed Technology [Member] Customer Relationships [Member] Customer Relationships [Member] Other Intangible Assets [Member] Other Intangible Assets [Member] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets Goodwill and Intangible Assets Disclosure [Abstract] Other Significant Noncash Transactions [Table] Other Significant Noncash Transactions [Table] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Shave Care Shave Care [Member] Shave Care [Member] Other Significant Noncash Transactions [Line Items] Other Significant Noncash Transactions [Line Items] Amortization of Intangible Assets Amortization of Intangible Assets Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount Restructuring and Related Activities [Abstract] Schedule of Restructuring and Related Costs [Table] Schedule of Restructuring and Related Costs [Table] Beauty Beauty Segment [Member] Beauty Segment Member Grooming Grooming Segment Member Grooming Segment [Member] Health Care Health Care Segment Member Health Care Segment [Member] Fabric & Home Care Fabric Care And Home Care Segment Member Fabric Care and Home Care Segment [Member] Baby, Feminine & Family Care Baby, Feminine and Family Care Segment Member Baby, Feminine and Family Care Segment [Member] Corporate Corporate Segment [Member] Restructuring Cost and Reserve [Line Items] Restructuring Cost and Reserve [Line Items] Restructuring Charges Restructuring Charges Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Restatement [Axis] Restatement [Axis] Restatement [Domain] Restatement [Domain] Report Date [Axis] Report Date [Axis] Financial Statement Filing Date [Domain] Financial Statement Filing Date [Domain] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Common Stock [Member] Common Stock [Member] Preferred Stock [Member] Preferred Stock [Member] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Reserve for ESOP Debt Retirement [Member] Reserve for ESOP Debt Retirement [Member] Reserve for ESOP Debt Retirement [Member] AOCI Attributable to Parent [Member] AOCI Attributable to Parent [Member] Treasury Stock [Member] Treasury Stock [Member] Retained Earnings [Member] Retained Earnings [Member] Noncontrolling Interest [Member] Noncontrolling Interest [Member] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Adjustments for New Accounting Pronouncements [Axis] Adjustments for New Accounting Pronouncements [Axis] Type of Adoption [Domain] Type of Adoption [Domain] Adjustments for Change in Accounting Principle [Axis] Adjustments for Change in Accounting Principle [Axis] Adjustments for Change in Accounting Principle [Domain] Adjustments for Change in Accounting Principle [Domain] Adjustments for Error Corrections [Axis] Adjustments for Error Corrections [Axis] Adjustments for Error Correction [Domain] Adjustments for Error Correction [Domain] Statement [Line Items] Statement [Line Items] Common Stock, Dividends, Per Share, Cash Paid Common Stock, Dividends, Per Share, Cash Paid Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Net Earnings Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Net of Tax Other Comprehensive Income (Loss), Net of Tax Dividends, Common Stock Dividends, Common Stock Dividends, Preferred Stock Dividends, Preferred Stock Treasury Stock, Shares, Acquired Stock Repurchased During Period, Shares Stock Repurchased During Period, Value Stock Repurchased During Period, Value Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options Stock Issued During Period, Shares, Conversion of Convertible Securities Stock Issued During Period, Shares, Conversion of Convertible Securities Stock Issued During Period, Value, Conversion of Convertible Securities Stock Issued During Period, Value, Conversion of Convertible Securities ESOP Debt Impacts ESOP Debt Impacts ESOP Debt Impacts Noncontrolling Interest, Period Increase (Decrease) Noncontrolling Interest, Period Increase (Decrease) Schedule of Goodwill [Table Text Block] Schedule of Goodwill [Table Text Block] Schedule of Intangible Assets and Goodwill [Table Text Block] Schedule of Intangible Assets and Goodwill [Table Text Block] Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Schedule of Restructuring Reserve by Type of Cost [Table Text Block] Restructuring and Related Costs [Table Text Block] Restructuring and Related Costs [Table Text Block] Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Payments to Acquire Businesses, Gross Payments to Acquire Businesses, Gross Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Goodwill Goodwill Business Acquisition, Goodwill, Expected Tax Deductible Amount Business Acquisition, Goodwill, Expected Tax Deductible Amount Net Sales Revenues Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Statement of Comprehensive Income [Abstract] Scenario [Axis] Scenario [Axis] Scenario, Unspecified [Domain] Scenario, Unspecified [Domain] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Retirement Plan Type [Axis] Retirement Plan Type [Axis] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Pension and Other Retiree Benefits Pension Plan [Member] Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member] Other Comprehensive Income (Loss) before Reclassifications, Tax Other Comprehensive Income (Loss) before Reclassifications, Tax Reclassification from AOCI, Current Period, Tax Reclassification from AOCI, Current Period, Tax Segment Reporting [Abstract] Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Subsegments [Axis] Subsegments [Axis] Subsegments [Domain] Subsegments [Domain] Fabric Care [Member] Fabric Care [Member] Fabric Care [member] Baby Care [Member] Baby Care [Member] Baby Care [Member] Hair Care [Member] Hair Care [Member] Hair Care [Member] Home Care [Member] Home Care [Member] Home Care [Member] Skin and Personal Care [Member] Skin and Personal Care [Member] Skin and Personal Care [Member] Family Care [Member] Family Care [Member] Family Care [Member] Oral Care [Member] Oral Care [Member] Oral Care [Member] Feminine Care [Member] Feminine Care [Member] Feminine Care [Member] All Other [Member] All Other [Member] All Other [Member] Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Axis] Subsegments Consolidation Items [Domain] Subsegments Consolidation Items [Domain] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Accumulated Other Comprehensive Income/(Loss) Accumulated Other Comprehensive Income (Loss), Net of Tax OCI before Reclassifications Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest Statement of Cash Flows [Abstract] Cash and Cash Equivalents, Beginning of Period Cash and Cash Equivalents, at Carrying Value Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Depreciation and Amortization Depreciation, Depletion and Amortization, Nonproduction Share-based Compensation Expense Share-based Compensation Deferred Income Taxes Deferred Income Tax Expense (Benefit) Gain (Loss) on Disposition of Assets Gain (Loss) on Disposition of Assets Changes In: Increase (Decrease) in Operating Capital [Abstract] Accounts Receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Accounts Payable, Accrued and Other Liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Other Operating Assets and Liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Other Noncash Expense Other Noncash Expense Total Operating Activities Net Cash Provided by (Used in) Operating Activities Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Capital Expenditures Payments to Acquire Property, Plant, and Equipment Proceeds from Asset Sales Proceeds from Sale of Productive Assets Acquisitions, Net of Cash Acquired Payments for (Proceeds from) Businesses and Interest in Affiliates Purchases of Short-term Investments Payments to Acquire Short-term Investments Proceeds from Sales of Short-term Investments Proceeds from Sale of Short-term Investments Change in Other Investments Payments for (Proceeds from) Investments Total Investing Activites Net Cash Provided by (Used in) Investing Activities Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Dividends to Shareholders Payments of Dividends Change in Short-term Debt Proceeds from (Repayments of) Short-term Debt Additions to Long-term Debt Proceeds from (Repayments of) Other Long-term Debt Reductions of Long-term Debt Repayments of Long-term Debt Treasury Stock Purchases Payments for Repurchase of Common Stock Impact of Stock Options and Other Proceeds From Stock Options Exercised And Other Financing Activities The cash inflow associated with the amount received from holders exercising their stock options. Also includes, the net cash inflow (outflow) from other financing activities. Total Financing Activities Net Cash Provided by (Used in) Financing Activities Effect of Exchange Rate on Cash and Cash Equivalents Effect of Exchange Rate on Cash and Cash Equivalents Change in Cash and Cash Equivalents Cash and Cash Equivalents, Period Increase (Decrease) Cash and Cash Equivalents, End of Period Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Derivative [Table] Derivative [Table] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Derivatives in Fair Value Hedging Relationships Fair Value Hedging [Member] Derivatives in Net Investment Hedging Relationships Net Investment Hedging [Member] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract Type [Domain] Derivative Contract [Domain] Interest Rate Contracts Interest Rate Contract [Member] Foreign Exchange Contract Foreign Exchange Contract [Member] Derivative [Line Items] Derivative [Line Items] Notional Amount Derivative, Notional Amount Derivative Asset Derivative Asset Derivative Liability Derivative Liability Segment Reporting Disclosure [Text Block] Segment Reporting Disclosure [Text Block] Earnings Per Share [Abstract] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Employee Stock Option Employee Stock Option [Member] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Earnings Per Share [Text Block] Earnings Per Share [Text Block] SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Table] SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Table] SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Table] Goodwill [Axis] Goodwill [Axis] Goodwill [Axis] Goodwill [Domain] Goodwill [Domain] [Domain] for Goodwill [Axis] Goodwill Goodwill [Member] Potential Impacts to Estimated Fair Value [Axis] Potential Impacts to Estimated Fair Value [Axis] Potential Impacts to Estimated Fair Value [Axis] Potential Impacts to Estimated Fair Value [Domain] Potential Impacts to Estimated Fair Value [Domain] [Domain] for Potential Impacts to Estimated Fair Value [Axis] 25 bps Increase Discount Rate [Member] 25 bps Increase Discount Rate [Member] [Member] 25 bps Increase Discount Rate [Member] 25 bps Decrease Long-Term Growth [Member] 25 bps Decrease Long-Term Growth [Member] 25 bps Decrease Long-Term Growth [Member] Intangible Assets with Indefinite Lives Indefinite-lived Intangible Assets [Member] Gillette Gillette [Member] Gillette [Member] SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items] SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items] [Line Items] for SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Table] Percent Change in Estimated Fair Value Percent Change in Estimated Fair Value Percent Change in Estimated Fair Value Text Block [Abstract] Document Information [Table] Document Information [Table] Document Information, Document [Axis] Document Information, Document [Axis] Document [Domain] Document [Domain] Document Information [Line Items] Document Information [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Document Type Document Type Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Amendment Flag Amendment Flag Trading Symbol Trading Symbol Entity Current Reporting Status Entity Current Reporting Status Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Entity Emerging Growth Company Entity Emerging Growth Company Entity Small Business Entity Small Business Schedule of Finite and Indefinite Lived Intangible Assets [Table] Schedule of Finite and Indefinite Lived Intangible Assets [Table] Schedule of Finite and Indefinite Lived Intangible Assets [Table] Intangible Assets with Determinable Lives Finite-Lived Intangible Assets [Member] Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] Schedule of Finite and Indefinite Lived Intangible Assets [Line Items] Gross Carrying Amount Intangible Assets, Gross (Excluding Goodwill) Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest Accounting Policies [Abstract] Payments to Customers [Member] Payments to Customers [Member] Payments to Customers [Member] Customer and Consumer Promotional Spending [Member] Customer and Consumer Promotional Spending [Member] Customer and Consumer Promotional Spending [Member] Reclassification from AOCI to Retained Earnings for Tax Effects [Domain] Reclassification from AOCI to Retained Earnings for Tax Effects [Domain] Reclassification from AOCI to Retained Earnings for Tax Effects [Domain] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other Comprehensive Income (Loss) Other Comprehensive Income (Loss) [Member] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Selling, General and Administrative Expenses [Member] Selling, General and Administrative Expenses [Member] New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification Derivative Instruments, Gain (Loss) [Table] Derivative Instruments, Gain (Loss) [Table] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Foreign Currency Contract Foreign Currency Contracts [Member] Foreign Currency Contracts [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Amount of Gain/(Loss) Recognized in Earnings Derivative, Gain (Loss) on Derivative, Net Assets, Fair Value Disclosure [Abstract] Derivative Contract [Domain] U.S. Government Securities US Treasury and Government [Member] Corporate Bond Securities Corporate Bond Securities [Member] Other Investments Other Investments [Member] Statement [Line Items] Fair Value Asset Investments, Fair Value Disclosure Income Tax Disclosure [Abstract] Income Tax Authority [Axis] Income Tax Authority [Axis] Income Tax Authority [Domain] Income Tax Authority [Domain] U.S. Tax Cuts and Jobs Act, Effective 2018 U.S. Tax Cuts and Jobs Act, Effective 2018 [Member] U.S. Tax Cuts and Jobs Act, Effective 2018 [Member] Scenario, Forecast Scenario, Forecast [Member] Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Base Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Base Rate, Percent Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Base Rate, Percent Income Tax Expense (Benefit) Income Tax Expense (Benefit) Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount Deferred Federal Income Tax Expense (Benefit) Deferred Federal Income Tax Expense (Benefit) Schedule of Goodwill [Table] Schedule of Goodwill [Table] Goodwill [Line Items] Goodwill [Line Items] Goodwill [Roll Forward] Goodwill at June 30, 2018 Goodwill, Acquisitions and Divestitures Goodwill, Acquisitions and Divestitures Goodwill, Acquisitions and Divestitures Goodwill, Translation and Other Goodwill, Translation and Purchase Accounting Adjustments Goodwill at December 31, 2018 Financial Statement Translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Unrealized Gains/(Losses) on Hedges Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Unrealized Gains/(Losses) on Investment Securities Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax Unrealized Gains/(Losses) on Defined Benefit Retirement Plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Total Other Comprehensive Income (Loss), Net of Tax Total Comprehensive Income/(Loss) Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest Less: Total Comprehensive Income Attributable to Noncontrolling Interest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest Total Comprehensive Income/(Loss) Attributable to Procter & Gamble Comprehensive Income (Loss), Net of Tax, Attributable to Parent Fair Value Disclosures [Abstract] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Underlying Asset Class [Axis] Underlying Asset Class [Axis] Underlying Asset Class [Domain] Underlying Asset Class [Domain] Underlying, Other Underlying, Other [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Underlying Debt Obligation, Carrying Amount Underlying Debt Obligation, Carrying Amount Underlying Debt Obligation, Carrying Amount Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost Long-term Debt, Fair Value Long-term Debt, Fair Value Long Term Debt, Current Maturities Measured at Fair Value Long Term Debt, Current Maturities measured at Fair Value Long Term Debt, Current Maturities measured at Fair Value Income Statement [Abstract] Cost of Products Sold Cost of Goods and Services Sold Selling, General and Administrative Expense Selling, General and Administrative Expense Operating Income Operating Income (Loss) Interest Expense Interest Expense Interest Income Investment Income, Interest Other Non-operating Income/(Loss), Net Other Nonoperating Income (Expense) Earnings/(Loss) from Continuing Operations Before Income Taxes Income Loss From Continuing Operations Before Income Taxes Income from continuing operations before income taxes. Income Taxes on Continuing Operations Net Earnings Net Income (Loss) Attributable to Noncontrolling Interest Net Income (Loss) Attributable to Noncontrolling Interest Net Earnings Attributable to Procter & Gamble Net Income (Loss) Attributable to Parent Earnings Per Share [Abstract] Basic Net Earnings Per Common Share Earnings Per Share, Basic [Abstract] Basic Net Earnings Per Common Share Earnings Per Share, Basic Diluted Net Earnings Per Common Share Earnings Per Share, Diluted [Abstract] Diluted Net Earnings Per Common Share Earnings Per Share, Diluted Diluted Weighted Average Common Shares Outstanding Weighted Average Number of Shares Outstanding, Diluted Restructuring and Related Activities Disclosure [Text Block] Restructuring and Related Activities Disclosure [Text Block] Net Income (Loss) Attributable to Parent ESOP Debt Impacts Fabric and Home Care Fabric and Home Care [Member] Fabric and Home Care [Member] Earnings/(Loss) from Continuing Operations Before Income Taxes Net Earnings/(Loss) from Continuing Operations Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Pension Plan Other Postretirement Benefit Plan Other Postretirement Benefits Plan [Member] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Share-based Compensation, Allocation and Classification in Financial Statements [Abstract] Share-based Compensation, Allocation and Classification in Financial Statements [Abstract] Allocated Share-based Compensation Expense Allocated Share-based Compensation Expense Compensation and Employee Benefit Plans [Table Text Block] Compensation and Employee Benefit Plans [Table Text Block] Compensation and Employee Benefit Plans [Table Text Block] Risk Management Activities and Fair Value Measurements [Abstract] Risk Management Activities and Fair Value Measurements [Abstract] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule of Derivative Instruments [Table Text Block] Schedule of Derivative Instruments [Table Text Block] Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Derivative Instruments, Gain (Loss) [Table Text Block] Derivative Instruments, Gain (Loss) [Table Text Block] Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net Accumulated Other Comprehensive Income, Gain (Loss) Accumulated Other Comprehensive Income, Gain (Loss) Accumulated Other Comprehensive Income, Gain (Loss) Business Combination Disclosure [Text Block] Business Combination Disclosure [Text Block] Statement of Financial Position [Abstract] Assets Assets [Abstract] Current Assets Assets, Current [Abstract] Cash and Cash Equivalents Available-for-Sale Investment Securities Available-for-sale Securities, Current Accounts Receivable Accounts Receivable, Net, Current Inventories Inventory, Net [Abstract] Materials and Supplies Inventory, Raw Materials and Supplies, Net of Reserves Work in Process Inventory, Work in Process, Net of Reserves Finished Goods Inventory, Finished Goods, Net of Reserves Total Inventories Inventory, Net Prepaid Expenses and Other Current Assets Prepaid Expense and Other Assets, Current Total Current Assets Assets, Current Property, Plant and Equipment, Net Property, Plant and Equipment, Net Trademarks and Other Intangible Assets, Net Intangible Assets, Net (Excluding Goodwill) Other Noncurrent Assets Other Assets, Noncurrent Total Assets Assets Liabilities and Shareholders' Equity Liabilities and Equity [Abstract] Current Liabilities Liabilities, Current [Abstract] Accounts Payable Accounts Payable, Current Accrued and Other Liabilities Accrued Liabilities, Current Debt Due Within One Year Debt, Current Total Current Liabilities Liabilities, Current Long-Term Debt Long-term Debt, Excluding Current Maturities Deferred Income Taxes Deferred Tax Liabilities, Net, Noncurrent Other Noncurrent Liabilities Other Liabilities, Noncurrent Total Liabilities Liabilities Shareholders' Equity Stockholders' Equity Attributable to Parent [Abstract] Preferred Stock Preferred Stock, Value, Issued Common Stock, Shares, Issued Common Stock, Shares, Issued Common Stock, Value, Issued Common Stock, Value, Issued Additional Paid in Capital Additional Paid in Capital Reserve For ESOP Debt Retirement Reserve For ESOP Debt Retirement Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for the ESOP debt retirement is also recorded. Treasury Stock Treasury Stock, Value Retained Earnings Retained Earnings (Accumulated Deficit) Noncontrolling Interest Stockholders' Equity Attributable to Noncontrolling Interest Total Shareholders' Equity Total Liabilities and Shareholders' Equity Liabilities and Equity Loss Contingencies [Table] Loss Contingencies [Table] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Number of Taxable Jurisdictions Number of Taxable Jurisdictions Number of Taxable Jurisdictions Number of Audits Typically Underway Number of Audits Typically Underway Number of Audits Typically Underway Goodwill and Intangible Assets Disclosure [Text Block] Goodwill and Intangible Assets Disclosure [Text Block] Compensation and Employee Benefit Plans [Text Block] Compensation and Employee Benefit Plans [Text Block] Operating Activities [Axis] Operating Activities [Axis] Operating Activities [Domain] Operating Activities [Domain] Restructuring Type [Axis] Restructuring Type [Axis] Type of Restructuring [Domain] Type of Restructuring [Domain] Separations Employee Severance [Member] Selling, General and Administrative Expense Selling, General and Administrative Expense [Member] The allocation (or location) of expense to (in) general and administrative expense including allocations to selling and marketing expense. Cost of Products Sold Cost of Goods, Segment [Member] Restructuring and Related Cost, Amounts Historically Incurred Restructuring and Related Cost, Amounts Historically Incurred Restructuring and Related Cost, Amounts Historically Incurred Restructuring and Related Cost, Number of Severance Packages Executed Restructuring and Related Cost, Number of Severance Packages Executed Restructuring and Related Cost, Number of Severance Packages Executed Accounting Changes and Error Corrections [Abstract] Accounting Changes and Error Corrections [Text Block] Accounting Changes and Error Corrections [Text Block] Asset-related Costs Asset-Related Costs [Member] Asset-Related Costs consisting of both asset write downs and accelerated depreciation in conjunction with restructuring plan. Other Costs Other Restructuring [Member] Restructuring Reserve [Roll Forward] Restructuring Reserve [Roll Forward] Reserve Balance June 30, 2018 Restructuring Reserve Cash Spent Payments for Restructuring Charges Against Assets Restructuring Reserve, Settled without Cash Reserve Balance December 31, 2018 Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Intangible Assets, Net (Including Goodwill) Intangible Assets, Net (Including Goodwill) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Comprehensive Income (Loss) Note [Text Block] Comprehensive Income (Loss) Note [Text Block] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Earnings Per Share Reconciliation [Abstract] Earnings Per Share Reconciliation [Abstract] Net Earnings Net Earnings/(Loss) Attributable to P&G (Diluted) Net Income (Loss) Attributable to Parent, Diluted Net Earnings/(Loss) Attributable to P&G Available to Common Shareholders (Basic) Net Income (Loss) Available to Common Stockholders, Basic Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Weighted Average Common Shares Outstanding Weighted Average Number of Shares Outstanding, Basic Effect of Dilutive Securities Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract] Conversion of Preferred Shares Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock Exercise of Stock Options and Other Unvested Equity Awards Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements Diluted Weighted Average Common Shares Outstanding Basic Net Earnings/(Loss) Per Common Share Diluted Net Earnings/(Loss) Per Common Share Risk Management And Fair Value [Text Block] Risk Management And Fair Value [Text Block] This element represents the disclosure of all significant concentrations of risk, fair value measurements of financial and non-financial assets and liabilities, and derivative instruments. EX-101.PRE 13 pg-20181231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 14 pglogoa15.jpg PGLOGO begin 644 pglogoa15.jpg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end XML 15 fy1819q2ond10-qreport_htm.xml IDEA: XBRL DOCUMENT 0000080424 2018-07-01 2018-12-31 0000080424 2018-06-30 0000080424 us-gaap:SellingGeneralAndAdministrativeExpensesMember pg:PaymentstoCustomersMember 2017-07-01 2018-06-30 0000080424 us-gaap:RetainedEarningsMember pg:CustomerandConsumerPromotionalSpendingMember 2018-07-01 2018-12-31 0000080424 pg:HomeCareMember 2017-10-01 2017-12-31 0000080424 pg:HairCareMember 2018-10-01 2018-12-31 0000080424 pg:SkinandPersonalCareMember 2018-10-01 2018-12-31 0000080424 pg:HomeCareMember 2017-07-01 2017-12-31 0000080424 pg:AllOtherMember 2017-07-01 2017-12-31 0000080424 pg:FeminineCareMember 2018-10-01 2018-12-31 0000080424 pg:FabricCareMember 2018-10-01 2018-12-31 0000080424 pg:SkinandPersonalCareMember 2017-10-01 2017-12-31 0000080424 us-gaap:RetainedEarningsMember 2017-07-01 2017-12-31 0000080424 pg:SkinandPersonalCareMember 2017-07-01 2017-12-31 0000080424 pg:FeminineCareMember 2017-07-01 2017-12-31 0000080424 pg:BabyCareMember 2017-07-01 2017-12-31 0000080424 pg:HairCareMember 2017-10-01 2017-12-31 0000080424 pg:FabricCareMember 2017-10-01 2017-12-31 0000080424 pg:BabyCareMember 2017-10-01 2017-12-31 0000080424 pg:HomeCareMember 2018-10-01 2018-12-31 0000080424 pg:OralCareMember 2018-07-01 2018-12-31 0000080424 pg:ShaveCareMember 2017-07-01 2017-12-31 0000080424 pg:FamilyCareMember 2018-10-01 2018-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000080424 pg:BabyCareMember 2018-07-01 2018-12-31 0000080424 pg:FamilyCareMember 2017-10-01 2017-12-31 0000080424 pg:ShaveCareMember 2018-10-01 2018-12-31 0000080424 pg:ShaveCareMember 2017-10-01 2017-12-31 0000080424 pg:FamilyCareMember 2018-07-01 2018-12-31 0000080424 pg:FamilyCareMember 2017-07-01 2017-12-31 0000080424 pg:OralCareMember 2017-10-01 2017-12-31 0000080424 pg:OralCareMember 2017-07-01 2017-12-31 0000080424 pg:AllOtherMember 2017-10-01 2017-12-31 0000080424 pg:HomeCareMember 2018-07-01 2018-12-31 0000080424 us-gaap:CommonStockMember 2017-12-31 0000080424 pg:FabricCareMember 2018-07-01 2018-12-31 0000080424 pg:FeminineCareMember 2018-07-01 2018-12-31 0000080424 pg:AllOtherMember 2018-10-01 2018-12-31 0000080424 pg:FabricCareMember 2017-07-01 2017-12-31 0000080424 pg:HairCareMember 2017-07-01 2017-12-31 0000080424 pg:AllOtherMember 2018-07-01 2018-12-31 0000080424 pg:ShaveCareMember 2018-07-01 2018-12-31 0000080424 pg:SkinandPersonalCareMember 2018-07-01 2018-12-31 0000080424 pg:BabyCareMember 2018-10-01 2018-12-31 0000080424 pg:OralCareMember 2018-10-01 2018-12-31 0000080424 us-gaap:PreferredStockMember 2017-06-30 0000080424 pg:HairCareMember 2018-07-01 2018-12-31 0000080424 pg:FeminineCareMember 2017-10-01 2017-12-31 0000080424 pg:BeautySegmentMember 2018-10-01 2018-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-07-01 2018-12-31 0000080424 pg:FabricandHomeCareMember 2017-10-01 2017-12-31 0000080424 pg:HealthCareSegmentMember 2017-10-01 2017-12-31 0000080424 pg:GroomingSegmentMember 2018-07-01 2018-12-31 0000080424 us-gaap:CorporateMember 2018-07-01 2018-12-31 0000080424 us-gaap:CorporateMember 2017-07-01 2017-12-31 0000080424 pg:BeautySegmentMember 2017-10-01 2017-12-31 0000080424 us-gaap:CommonStockMember 2017-07-01 2017-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2017-07-01 2017-12-31 0000080424 us-gaap:CorporateMember 2018-10-01 2018-12-31 0000080424 pg:BeautySegmentMember 2018-07-01 2018-12-31 0000080424 pg:GroomingSegmentMember 2018-10-01 2018-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-10-01 2018-12-31 0000080424 pg:GroomingSegmentMember 2017-07-01 2017-12-31 0000080424 pg:BeautySegmentMember 2017-07-01 2017-12-31 0000080424 pg:FabricandHomeCareMember 2017-07-01 2017-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2017-10-01 2017-12-31 0000080424 pg:FabricandHomeCareMember 2018-07-01 2018-12-31 0000080424 us-gaap:PreferredStockMember 2017-07-01 2017-12-31 0000080424 us-gaap:CorporateMember 2017-10-01 2017-12-31 0000080424 pg:GroomingSegmentMember 2017-10-01 2017-12-31 0000080424 pg:HealthCareSegmentMember 2018-07-01 2018-12-31 0000080424 pg:HealthCareSegmentMember 2018-10-01 2018-12-31 0000080424 pg:HealthCareSegmentMember 2017-07-01 2017-12-31 0000080424 pg:FabricandHomeCareMember 2018-10-01 2018-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember pg:A25bpsDecreaseLongTermGrowthMember 2018-12-31 0000080424 pg:ShaveCareMember us-gaap:GoodwillMember pg:A25bpsIncreaseDiscountRateMemberMember 2018-12-31 0000080424 pg:ShaveCareMember us-gaap:GoodwillMember pg:A25bpsDecreaseLongTermGrowthMember 2018-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember pg:A25bpsIncreaseDiscountRateMemberMember 2018-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2017-07-01 2017-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember 2018-12-31 0000080424 us-gaap:FiniteLivedIntangibleAssetsMember 2018-12-31 0000080424 us-gaap:IndefinitelivedIntangibleAssetsMember pg:GilletteMember 2018-12-31 0000080424 pg:ShaveCareMember 2018-12-31 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-07-01 2018-12-31 0000080424 pg:GroomingSegmentMember 2018-06-30 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-06-30 0000080424 pg:BeautySegmentMember 2018-12-31 0000080424 pg:HealthCareSegmentMember 2018-12-31 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-06-30 0000080424 us-gaap:TreasuryStockMember 2017-07-01 2017-12-31 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-12-31 0000080424 pg:HealthCareSegmentMember 2018-06-30 0000080424 pg:GroomingSegmentMember 2018-12-31 0000080424 pg:BabyFeminineandFamilyCareSegmentMember 2018-12-31 0000080424 pg:BeautySegmentMember 2018-06-30 0000080424 us-gaap:EmployeeStockOptionMember 2017-10-01 2017-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2017-07-01 2017-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2018-10-01 2018-12-31 0000080424 us-gaap:EmployeeStockOptionMember 2018-07-01 2018-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-10-01 2018-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-01 2017-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-10-01 2017-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2018-07-01 2018-12-31 0000080424 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-01 2017-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2018-07-01 2018-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2017-07-01 2017-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2018-10-01 2018-12-31 0000080424 us-gaap:PensionPlansDefinedBenefitMember 2017-10-01 2017-12-31 0000080424 pg:ForeignCurrencyContractsMember us-gaap:NondesignatedMember 2018-10-01 2018-12-31 0000080424 pg:ForeignCurrencyContractsMember us-gaap:NondesignatedMember 2017-07-01 2017-12-31 0000080424 pg:ForeignCurrencyContractsMember us-gaap:NondesignatedMember 2018-07-01 2018-12-31 0000080424 2018-12-31 0000080424 2017-06-30 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-07-01 2018-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-10-01 2018-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2017-07-01 2017-12-31 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2017-10-01 2017-12-31 0000080424 pg:ForeignCurrencyContractsMember us-gaap:NondesignatedMember 2017-10-01 2017-12-31 0000080424 us-gaap:CorporateBondSecuritiesMember 2018-06-30 0000080424 us-gaap:USTreasuryAndGovernmentMember 2018-12-31 0000080424 us-gaap:OtherInvestmentsMember 2018-06-30 0000080424 us-gaap:CorporateBondSecuritiesMember 2018-12-31 0000080424 us-gaap:OtherInvestmentsMember 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-07-01 2017-12-31 0000080424 us-gaap:USTreasuryAndGovernmentMember 2018-06-30 0000080424 us-gaap:NetInvestmentHedgingMember 2018-10-01 2018-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2017-10-01 2017-12-31 0000080424 us-gaap:FairValueHedgingMember us-gaap:UnderlyingOtherMember 2018-07-01 2018-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2018-07-01 2018-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2017-07-01 2017-12-31 0000080424 us-gaap:NetInvestmentHedgingMember us-gaap:UnderlyingOtherMember 2017-07-01 2018-06-30 0000080424 us-gaap:NetInvestmentHedgingMember us-gaap:UnderlyingOtherMember 2018-07-01 2018-12-31 0000080424 us-gaap:FairValueHedgingMember us-gaap:UnderlyingOtherMember 2017-07-01 2018-06-30 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-06-30 0000080424 us-gaap:NoncontrollingInterestMember 2017-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember 2018-06-30 0000080424 us-gaap:DesignatedAsHedgingInstrumentMember 2018-06-30 0000080424 us-gaap:DesignatedAsHedgingInstrumentMember 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember 2018-12-31 0000080424 us-gaap:NetInvestmentHedgingMember 2018-06-30 0000080424 us-gaap:InterestRateContractMember us-gaap:FairValueHedgingMember 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-10-01 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2018-07-01 2018-12-31 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-10-01 2017-12-31 0000080424 us-gaap:CommonStockMember 2017-06-30 0000080424 us-gaap:ForeignExchangeContractMember us-gaap:NetInvestmentHedgingMember 2017-07-01 2017-12-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000080424 us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000080424 2017-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember 2018-06-30 0000080424 pg:FabricCareAndHomeCareSegmentMember 2018-10-01 2018-12-31 0000080424 us-gaap:OtherRestructuringMember 2018-07-01 2018-12-31 0000080424 pg:AssetRelatedCostsMember 2018-06-30 0000080424 us-gaap:OtherRestructuringMember 2018-12-31 0000080424 pg:AssetRelatedCostsMember 2018-07-01 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-07-01 2018-12-31 0000080424 us-gaap:TreasuryStockMember 2017-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-07-01 2018-09-30 0000080424 pg:AssetRelatedCostsMember 2018-07-01 2018-09-30 0000080424 us-gaap:OtherRestructuringMember 2018-10-01 2018-12-31 0000080424 us-gaap:OtherRestructuringMember 2018-07-01 2018-09-30 0000080424 us-gaap:OtherRestructuringMember 2018-06-30 0000080424 pg:AssetRelatedCostsMember 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-10-01 2018-12-31 0000080424 us-gaap:EmployeeSeveranceMember 2018-06-30 0000080424 pg:AssetRelatedCostsMember 2018-10-01 2018-12-31 0000080424 us-gaap:CostOfGoodsSegmentMember 2018-07-01 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-12-31 0000080424 pg:SellingGeneralAndAdministrativeExpenseMember 2018-10-01 2018-12-31 0000080424 srt:MaximumMember 2018-07-01 2018-12-31 0000080424 srt:MinimumMember 2018-07-01 2018-12-31 0000080424 pg:SellingGeneralAndAdministrativeExpenseMember 2018-07-01 2018-12-31 0000080424 us-gaap:CostOfGoodsSegmentMember 2018-10-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-07-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:CustomerRelationshipsMember 2018-07-01 2018-12-31 0000080424 us-gaap:OtherIntangibleAssetsMember 2018-07-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember pg:PatentsandDevelopedTechnologyMember 2018-07-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:CustomerRelationshipsMember 2018-11-30 0000080424 us-gaap:RetainedEarningsMember 2017-12-31 0000080424 pg:PHCMERCKACQUISITIONMember pg:PatentsandDevelopedTechnologyMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-11-30 0000080424 pg:PHCMERCKACQUISITIONMember 2018-01-01 2018-12-31 0000080424 pg:PHCMERCKACQUISITIONMember 2018-11-01 2018-11-30 0000080424 srt:MaximumMember pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-07-01 2018-12-31 0000080424 srt:MinimumMember pg:PHCMERCKACQUISITIONMember us-gaap:TradeNamesMember 2018-07-01 2018-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2017-06-30 0000080424 us-gaap:RetainedEarningsMember 2017-06-30 0000080424 2017-07-01 2017-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-06-30 0000080424 us-gaap:TreasuryStockMember 2017-06-30 0000080424 us-gaap:PreferredStockMember 2017-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-07-01 2017-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-07-01 2018-12-31 0000080424 us-gaap:CommonStockMember 2018-06-30 0000080424 us-gaap:PreferredStockMember 2018-06-30 0000080424 2018-10-01 2018-12-31 0000080424 us-gaap:RetainedEarningsMember 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-06-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-07-01 2018-12-31 0000080424 us-gaap:TreasuryStockMember 2018-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2018-06-30 0000080424 us-gaap:PreferredStockMember 2018-07-01 2018-12-31 0000080424 us-gaap:PreferredStockMember 2018-12-31 0000080424 us-gaap:CommonStockMember 2018-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000080424 us-gaap:NoncontrollingInterestMember 2018-07-01 2018-12-31 0000080424 us-gaap:TreasuryStockMember 2018-07-01 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-07-01 2018-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2018-12-31 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000080424 us-gaap:CommonStockMember 2018-07-01 2018-12-31 0000080424 us-gaap:TreasuryStockMember 2018-06-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-12-31 0000080424 us-gaap:RetainedEarningsMember 2018-06-30 0000080424 us-gaap:CommonStockMember 2017-10-01 2017-12-31 0000080424 2017-10-01 2017-12-31 0000080424 us-gaap:RetainedEarningsMember 2017-10-01 2017-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-10-01 2017-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2017-09-30 0000080424 us-gaap:RetainedEarningsMember 2017-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-09-30 0000080424 us-gaap:PreferredStockMember 2017-09-30 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-10-01 2017-12-31 0000080424 us-gaap:TreasuryStockMember 2017-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2017-10-01 2017-12-31 0000080424 us-gaap:CommonStockMember 2017-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2018-10-01 2018-12-31 0000080424 us-gaap:NoncontrollingInterestMember 2017-09-30 0000080424 2017-09-30 0000080424 us-gaap:PreferredStockMember 2017-10-01 2017-12-31 0000080424 us-gaap:TreasuryStockMember 2017-10-01 2017-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2017-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-10-01 2017-12-31 0000080424 us-gaap:CommonStockMember 2018-10-01 2018-12-31 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-10-01 2018-12-31 0000080424 us-gaap:PreferredStockMember 2018-10-01 2018-12-31 0000080424 us-gaap:TreasuryStockMember 2018-10-01 2018-12-31 0000080424 us-gaap:RetainedEarningsMember 2018-07-01 2018-12-31 0000080424 us-gaap:CommonStockMember 2018-09-30 0000080424 us-gaap:NoncontrollingInterestMember 2018-09-30 0000080424 2018-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-10-01 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-09-30 0000080424 us-gaap:PreferredStockMember 2018-09-30 0000080424 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0000080424 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-09-30 0000080424 us-gaap:TreasuryStockMember 2018-09-30 0000080424 us-gaap:RetainedEarningsMember 2018-09-30 0000080424 us-gaap:RetainedEarningsMember 2018-10-01 2018-12-31 0000080424 pg:ReserveforESOPDebtRetirementMember 2018-10-01 2018-12-31 0000080424 2018-07-01 2018-09-30 0000080424 2017-07-01 2017-09-30 0000080424 us-gaap:OtherComprehensiveIncomeMember pg:ReclassificationfromAOCItoRetainedEarningsforTaxEffectsDomain 2018-07-01 2018-12-31 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2017-07-01 2018-06-30 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2018-01-01 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member us-gaap:ScenarioForecastMember 2018-07-01 2019-06-30 0000080424 pg:U.S.TaxCutsandJobsActEffective2018Member 2017-10-01 2017-12-31 0000080424 us-gaap:SellingGeneralAndAdministrativeExpensesMember pg:PaymentstoCustomersMember 2018-07-01 2018-12-31 0000080424 us-gaap:RetainedEarningsMember pg:ReclassificationfromAOCItoRetainedEarningsforTaxEffectsDomain 2018-07-01 2018-12-31 iso4217:USD shares iso4217:USD shares pure pg:employee pg:audit pg:taxable_jurisdiction false --06-30 Q2 2019 2018-12-31 0000080424 Yes false Large Accelerated Filer PROCTER & GAMBLE Co false PG 0.6896 1.3792 0.7172 1.4344 10-Q 2501579709 17438000000 17395000000 34128000000 34048000000 8919000000 8709000000 17403000000 16978000000 4623000000 4767000000 9275000000 9503000000 3896000000 3919000000 7450000000 7567000000 138000000 122000000 267000000 237000000 63000000 66000000 116000000 115000000 95000000 170000000 557000000 339000000 3916000000 4033000000 7856000000 7784000000 700000000 1472000000 1429000000 2353000000 3216000000 2561000000 6427000000 5431000000 22000000 66000000 34000000 83000000 3194000000 2495000000 6393000000 5348000000 1.25 0.96 2.51 2.05 1.22 0.93 2.44 2.00 2623000000.0 2669600000 2617600000 2680100000 3216000000 2561000000 6427000000 5431000000 -370000000 188000000 -586000000 1028000000 192000000 -167000000 199000000 -630000000 58000000 -61000000 53000000 -65000000 -98000000 -161000000 -250000000 -128000000 -22000000 121000000 -84000000 461000000 3194000000 2682000000 6343000000 5892000000 23000000 66000000 31000000 83000000 3171000000 2616000000 6312000000 5809000000 3696000000 2569000000 8421000000 9281000000 5055000000 4686000000 1524000000 1335000000 593000000 588000000 3164000000 2815000000 5281000000 4738000000 1978000000 2046000000 24431000000 23320000000 20822000000 20600000000 46932000000 45175000000 25947000000 23902000000 5555000000 5313000000 123687000000 118310000000 10266000000 10344000000 8868000000 7470000000 12113000000 10423000000 31247000000 28237000000 21514000000 20863000000 6872000000 6163000000 9611000000 10164000000 69244000000 65427000000 946000000 967000000 4009200000 4009200000 4009000000 4009000000 63679000000 63846000000 1178000000 1204000000 -15156000000 -14749000000 99480000000 99217000000 101170000000 98641000000 453000000 590000000 54443000000 52883000000 123687000000 118310000000 2491408000 4009000000 951000000 63711000000 -1177000000 -15133000000 -99956000000 99831000000 268000000 52504000000 3194000000 22000000 3216000000 -23000000 1000000 -22000000 -1790000000 1790000000 65000000 65000000 8647000 -751000000 751000000 18021000 -73000000 1222000000 1149000000 798000 5000000 0 5000000 0 1000000 0 1000000 41000000 162000000 203000000 2501580000 4009000000 946000000 63679000000 -1178000000 -15156000000 -99480000000 101170000000 453000000 54443000000 2498093000 4009000000 967000000 63846000000 -1204000000 -14749000000 -99217000000 98641000000 590000000 52883000000 -326000000 -200000000 -27000000 -553000000 6393000000 34000000 6427000000 -81000000 -3000000 -84000000 -3581000000 3581000000 131000000 131000000 24337000 -2003000000 2003000000 25389000 -53000000 1722000000 1669000000 2435000 21000000 3000000 18000000 0 26000000 48000000 74000000 -117000000 -141000000 -258000000 2501580000 4009000000 946000000 63679000000 -1178000000 -15156000000 -99480000000 101170000000 453000000 54443000000 2536958000 4009000000 991000000 63705000000 -1229000000 -14292000000 -95563000000 97197000000 597000000 55415000000 2495000000 66000000 2561000000 121000000 0 121000000 -1751000000 1751000000 62000000 62000000 19409000 -1751000000 1751000000 2791000 51000000 189000000 240000000 664000 5000000 1000000 4000000 0 0 2000000 2000000 -54000000 -54000000 2521004000 4009000000 986000000 63757000000 -1229000000 -14171000000 -97121000000 97881000000 609000000 54721000000 2553297000 4009000000 1006000000 63641000000 -1249000000 -14632000000 -93715000000 96124000000 594000000 55778000000 5348000000 83000000 5431000000 461000000 0 461000000 -3512000000 3512000000 124000000 124000000 46736000 -4253000000 4253000000 12239000 113000000 830000000 943000000 2204000 20000000 3000000 17000000 0 20000000 45000000 65000000 -68000000 -68000000 2521004000 4009000000 986000000 63757000000 -1229000000 -14171000000 -97121000000 97881000000 609000000 54721000000 2569000000 5569000000 6427000000 5431000000 1293000000 1368000000 181000000 157000000 37000000 -2008000000 370000000 158000000 398000000 547000000 531000000 457000000 1141000000 857000000 370000000 -2524000000 164000000 148000000 7574000000 7315000000 1781000000 1900000000 18000000 201000000 3848000000 101000000 158000000 3598000000 1117000000 1643000000 58000000 -50000000 -4710000000 -3705000000 3703000000 3636000000 1206000000 1524000000 2368000000 5072000000 978000000 1281000000 2003000000 4253000000 1486000000 698000000 -1624000000 -1876000000 -113000000 129000000 1127000000 1863000000 3696000000 7432000000 Basis of Presentation<span style="font-family:inherit;font-size:10pt;">These statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span> and the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18. For additional details on the impacts of adoption, see Note 2. In the opinion of management, the accompanying unaudited Consolidated Financial Statements of The Procter &amp; Gamble Company and subsidiaries (the "Company," "Procter &amp; Gamble," "P&amp;G," "we" or "our") contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results. New Accounting Pronouncements and Policies and U.S. Tax Reform<div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On </span><span style="font-family:inherit;font-size:10pt;">July 1, 2018</span><span style="font-family:inherit;font-size:10pt;">, we adopted ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)." This guidance outlines a single, comprehensive model of accounting for revenue from contracts with customers. We adopted the standard using the modified retrospective transition method, under which prior periods were not revised to reflect the impacts of the new standard. Our revenue is primarily generated from the sale of finished product to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. Accordingly, the timing of revenue recognition is not materially impacted by the new standard. Trade promotions, consisting primarily of customer pricing allowances, in-store merchandising funds, advertising and other promotional activities, and consumer coupons, are offered through various programs to customers and consumers.  The adoption of the new standard impacts the accrual timing for certain portions of our customer and consumer promotional spending, which resulted in a cumulative adjustment to Retained earnings of </span><span style="font-family:inherit;font-size:10pt;"><span>$534</span></span><span style="font-family:inherit;font-size:10pt;">, net of tax, on the date of adoption. The provisions of the new standard also impact the classification of certain payments to customers, moving an immaterial amount of such payments from expense to a deduction from net sales. Had this standard been effective and adopted during fiscal 2018, the impact would have been to reclassify </span><span style="font-family:inherit;font-size:10pt;"><span>$157</span></span><span style="font-family:inherit;font-size:10pt;"> from Selling, General and Administrative expense (SG&amp;A) to a reduction of Net sales for the six months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2017</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$309</span></span><span style="font-family:inherit;font-size:10pt;"> for the year ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, with no impact to operating profit. This guidance included practical expedients, none of which are material to our Consolidated Financial Statements. This new guidance does not have any other material impacts on our Consolidated Financial Statements, including financial disclosures.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On July 1, 2018, we adopted ASU 2017-07, "Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (Topic 715)." This guidance requires an entity to disaggregate the current service cost component from the other components of net benefit costs in the face of the income statement. It requires the service cost component to be presented with other current compensation costs for the related employees in the operating section of the income statement, with other components of net benefit cost presented outside of income from operations. We adopted the standard retrospectively, using the practical expedient which allows entities to use information previously disclosed in their pension and other postretirement benefit plans footnote as the basis to apply the retrospective presentation requirements. As such, prior periods’ results have been revised to report the other components of net defined benefit costs, previously reported in Cost of products sold and SG&amp;A, in Other non-operating income, net. </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows: Restricted Cash (Topic 230)." This guidance requires the Statement of Cash Flows to present changes in the total of cash, cash equivalents and restricted cash. Prior to the adoption of this ASU, the relevant accounting guidance did not require the Statement of Cash Flows to include changes in restricted cash. We adopted the standard retrospectively on July 1, 2018. We currently have no significant restricted cash balances. Historically, we had restricted cash balances and changes related to divestiture activity. Such balances were presented as Current assets held for sale on the balance sheets, with changes presented as Investing activities on the Statements of Cash Flow. In accordance with ASU 2016-08, such balances are now included in the beginning and ending balances of Cash, cash equivalents and restricted cash for all periods presented. </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2018, the FASB issued ASU 2018-02, "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Topic 220)." This guidance permits companies to make an election to reclassify stranded tax effects from the recently enacted U.S. Tax Cuts and Jobs Act included in Accumulated other comprehensive income (AOCI) to Retained earnings.  ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with early adoption permitted. The Company elected to early adopt this guidance in the quarter ended September 30, 2018. The reclassification from the adoption of this standard resulted in an increase of </span><span style="font-family:inherit;font-size:10pt;"><span>$326</span></span><span style="font-family:inherit;font-size:10pt;"> to Retained earnings and a decrease of </span><span style="font-family:inherit;font-size:10pt;"><span>$326</span></span><span style="font-family:inherit;font-size:10pt;"> to AOCI. </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In October 2016, the FASB issued ASU 2016-16, "Income Taxes (Topic 740): Intra-Entity transfers of Assets other than Inventory." The standard eliminates the prohibition in ASC 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. We have adopted this standard effective July 1, 2018 on a modified </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">retrospective basis. The adoption of ASU 2016-16 did not have a material impact on our Consolidated Financial Statements, including the cumulative effect adjustment required upon adoption. </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)." The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. In July 2018, the FASB issued ASU 2018-11, “Leases (Topic 842) Targeted Improvements”. The updated guidance provides an optional transition method, which allows for the application of the standard as of the adoption date with no restatement of prior period amounts. We plan to adopt the standard on July 1, 2019 under the optional transition method described above. We are currently in the process of implementing lease accounting software as well as assessing the impact that the new standard will have on our Consolidated Financial Statements, which will consist primarily of a balance sheet gross up of our operating leases to show equal and offsetting lease assets and lease liabilities. </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In January 2017, the FASB issued ASU 2017-04, "Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The standard simplifies the accounting for goodwill impairment by requiring a goodwill impairment to be measured using a single step impairment model, whereby the impairment equals the difference between the carrying amount and the fair value of the specified reporting units in their entirety. This eliminates the second step of the current impairment model that requires companies to first estimate the fair value of all assets in a reporting unit and measure impairments based on those fair values and a residual measurement approach. It also specifies that any loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. We will adopt the standard no later than July 1, 2020. The impact of the new standard will be dependent on the specific facts and circumstances of future individual impairments, if any.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">U.S. Tax Reform</span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "U.S. Tax Act"). The U.S. Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering the U.S. corporate income tax rates and implementing a hybrid territorial tax system. As the Company has a June 30 fiscal year-end, the lower corporate income tax rate was phased in, resulting in a U.S. statutory federal rate of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>28%</span></span><span style="font-family:inherit;font-size:10pt;"> for our fiscal year ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>21%</span></span><span style="font-family:inherit;font-size:10pt;"> for subsequent fiscal years. However, the U.S. Tax Act eliminates the domestic manufacturing deduction and moves to a hybrid territorial system, which also largely eliminates the ability to credit certain foreign taxes that existed prior to enactment of the U.S. Tax Act.</span></div><span style="font-family:inherit;font-size:10pt;">There are also certain transitional impacts of the U.S. Tax Act. As part of the transition to the new hybrid territorial tax system, the U.S. Tax Act imposed a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. In addition, the reduction of the U.S. corporate tax rate caused us to adjust our U.S. deferred tax assets and liabilities to the lower federal base rate of </span><span style="font-family:inherit;font-size:10pt;"><span>21%</span></span><span style="font-family:inherit;font-size:10pt;">. These transitional impacts resulted in a provisional net charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$602 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the fiscal year ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, and </span><span style="font-family:inherit;font-size:10pt;"><span>$628 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the three months ended December 31, 2017 (the quarter of enactment), comprised of an estimated repatriation tax charge of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.8 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (comprised of U.S. repatriation taxes and foreign withholding taxes) and an estimated net deferred tax benefit of </span><span style="font-family:inherit;font-size:10pt;"><span>$3.2 billion</span></span><span style="font-family:inherit;font-size:10pt;">. We have finalized our assessment of the transitional impacts of the U.S. Tax Act, which did not have a significant impact on tax expense during the six months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span>. Any legislative changes, including the final Section 965 transition tax regulations issued on January 15, 2019, whose impact is currently being assessed due to the complexity and interdependency of the legislative provisions, as well as any other new or proposed Treasury regulations, which have yet to be issued, may result in additional income tax impacts which could be material in the period any such changes are enacted. 534000000 157000000 309000000 326000000 -326000000 0.28 0.21 0.21 602000000 628000000 3800000000 3200000000 Segment Information<div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Under U.S. GAAP, our Global Business Units (GBUs) are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric &amp; Home Care and 5) Baby, Feminine &amp; Family Care. Our five reportable segments are comprised of:</span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Beauty</span><span style="font-family:inherit;font-size:10pt;">: Hair Care (Conditioner, Shampoo, Styling Aids, Treatments); Skin and Personal Care (Antiperspirant and Deodorant, Personal Cleansing, Skin Care);</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Grooming</span><span style="font-family:inherit;font-size:10pt;">: Shave Care (Female Blades &amp; Razors, Male Blades &amp; Razors, Pre- and Post-Shave Products, Other Shave Care); Appliances</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Health Care</span><span style="font-family:inherit;font-size:10pt;">: Oral Care (Toothbrushes, Toothpaste, Other Oral Care); Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care); </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Fabric &amp; Home Care</span><span style="font-family:inherit;font-size:10pt;">: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&amp;G Professional, Surface Care); and</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-style:italic;">Baby, Feminine &amp; Family Care</span><span style="font-family:inherit;font-size:10pt;">: Baby Care (Baby Wipes, Diapers and Pants); Feminine Care (Adult Incontinence, Feminine Care); Family Care (Paper Towels, Tissues, Toilet Paper).</span></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Our business units are comprised of similar product categories. </span><span style="font-size:10pt;font-weight:normal;">Nine</span><span style="font-family:inherit;font-size:10pt;"> business units individually accounted for 5% or more of consolidated net sales as follows: </span></div><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:49%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:12%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Net sales by Business Unit </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fabric Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>22%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>22%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Baby Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>12%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>12%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Home Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Skin and Personal Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Hair Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>9%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Family Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>9%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>9%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Oral Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>9%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>8%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shave Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>7%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>8%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Feminine Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>5%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>100%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>100%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">% of Net sales by business unit excludes sales held in Corporate.</span></div></td></tr></table><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Following is a summary of reportable segment results:</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"/></tr><tr><td style="width:28%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beauty</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,357</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>964</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>772</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,646</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,911</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,531</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,233</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>853</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>655</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,371</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,689</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,287</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Grooming</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,617</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>448</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>378</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>865</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>718</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,776</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>531</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>423</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,353</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>945</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>752</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,220</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>669</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>520</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>4,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,109</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>852</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,212</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>668</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>455</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,114</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,123</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>760</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fabric &amp; Home Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>5,557</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,134</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>860</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>11,045</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,278</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,737</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,434</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,101</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>714</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,817</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,280</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,483</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Baby, Feminine &amp; Family Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>4,558</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>930</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>707</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>8,948</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,832</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,399</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,613</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>933</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,158</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,897</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,227</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(229</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>245</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(139</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>190</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(53</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(283</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>235</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(150</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(78</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Company</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>17,438</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,916</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,216</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>34,128</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>7,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,427</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,395</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,033</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,561</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34,048</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,784</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,431</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 0.22 0.21 0.22 0.22 0.12 0.13 0.12 0.13 0.10 0.10 0.10 0.10 0.10 0.09 0.10 0.09 0.09 0.10 0.10 0.10 0.09 0.08 0.09 0.08 0.09 0.09 0.08 0.08 0.07 0.08 0.08 0.08 0.06 0.06 0.06 0.06 0.06 0.06 0.05 0.06 1 1 1 1 Following is a summary of reportable segment results:<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="25"/></tr><tr><td style="width:28%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="11" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Earnings/(Loss) Before Income Taxes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Net Earnings/(Loss)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beauty</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,357</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>964</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>772</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,646</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,911</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,531</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,233</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>853</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>655</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,371</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,689</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,287</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Grooming</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,617</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>448</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>378</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>865</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>718</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,776</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>531</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>423</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,353</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>945</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>752</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,220</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>669</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>520</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>4,065</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,109</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>852</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,212</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>668</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>455</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,114</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,123</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>760</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fabric &amp; Home Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>5,557</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,134</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>860</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>11,045</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,278</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,737</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,434</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,101</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>714</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10,817</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,280</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,483</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Baby, Feminine &amp; Family Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>4,558</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>930</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>707</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>8,948</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,832</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,399</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,613</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>933</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>597</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,158</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,897</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,227</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>129</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(229</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>245</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(139</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>190</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>127</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(53</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(283</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>235</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(150</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(78</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Company</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>17,438</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,916</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,216</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>34,128</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>7,856</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,427</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">2017</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17,395</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,033</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,561</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>34,048</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,784</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,431</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div>Our business units are comprised of similar product categories. <span style="font-size:10pt;font-weight:normal;">Nine</span><span style="font-family:inherit;font-size:10pt;"> business units individually accounted for 5% or more of consolidated net sales as follows: </span><div style="line-height:120%;padding-top:4px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:49%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/><td style="width:12%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">% of Net sales by Business Unit </span><span style="font-family:inherit;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fabric Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>22%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>21%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>22%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Baby Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>12%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>12%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Home Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Skin and Personal Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Hair Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>9%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>10%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>10%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Family Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>9%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>9%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Oral Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>9%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>8%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shave Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>7%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>8%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Feminine Care</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6%</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All Other</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>5%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6%</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>100%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>100%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>100%</span></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div>% of Net sales by business unit excludes sales held in Corporate. 3357000000 964000000 772000000 6646000000 1911000000 1531000000 3233000000 853000000 655000000 6371000000 1689000000 1287000000 1617000000 448000000 378000000 3179000000 865000000 718000000 1776000000 531000000 423000000 3353000000 945000000 752000000 2220000000 669000000 520000000 4065000000 1109000000 852000000 2212000000 668000000 455000000 4114000000 1123000000 760000000 5557000000 1134000000 860000000 11045000000 2278000000 1737000000 5434000000 1101000000 714000000 10817000000 2280000000 1483000000 4558000000 930000000 707000000 8948000000 1832000000 1399000000 4613000000 933000000 597000000 9158000000 1897000000 1227000000 129000000 -229000000 -21000000 245000000 -139000000 190000000 127000000 -53000000 -283000000 235000000 -150000000 -78000000 17438000000 3916000000 3216000000 34128000000 7856000000 6427000000 17395000000 4033000000 2561000000 34048000000 7784000000 5431000000 Goodwill and Other Intangible Assets<div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill is allocated by reportable segment as follows:</span></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Beauty</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Grooming</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Health Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fabric &amp; Home Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Baby, Feminine &amp; Family Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Company</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,992</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,820</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,929</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,865</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,569</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,175</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisitions and divestitures</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>132</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,955</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,093</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Translation and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(116</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(135</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(36</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(36</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(336</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill at December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>13,008</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>19,685</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>7,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>4,533</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>46,932</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill from current year acquisitions primarily reflects the acquisition of the over-the-counter (OTC) healthcare business of Merck KGaA (Merck OTC) in the Health Care reportable segment (see Note 11), along with other minor acquisitions in the Beauty and Fabric &amp; Home Care reportable segments. Goodwill increases due to acquisitions was partially offset by the divestiture of the Teva portion of the PGT business in the Health Care reportable segment and currency translation. </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Identifiable intangible assets at </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> were comprised of:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets with determinable lives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,580</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,251</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets with indefinite lives</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,618</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total identifiable intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>31,198</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(5,251</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist of brands. The amortization expense of intangible assets for the three months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> was </span><span style="font-family:inherit;font-size:10pt;"><span>$81</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$75</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. For the six months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, the amortization expense of intangible assets was </span><span style="font-family:inherit;font-size:10pt;"><span>$154</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$152</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill and indefinite lived intangible assets are not amortized, but are tested annually for impairment. The test to evaluate goodwill for impairment is a two-step process. In the first step, we compare the fair value of the reporting unit to its carrying value. If the fair value of the reporting unit is less than its carrying value, we perform a second step to determine the implied fair value of the reporting unit's goodwill. The second step of the impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The business unit valuations used to test goodwill and intangible assets for impairment are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment, margin expansion and Company business plans. We believe these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values. Our annual impairment testing for goodwill and indefinite lived intangible assets occurs during the 3 months ended December 31.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Most of our goodwill reporting units are comprised of a combination of legacy and acquired businesses and as a result have fair value cushions that, at a minimum, exceed two times their underlying carrying values. Certain of our goodwill reporting units, in particular Shave Care and Appliances, are comprised entirely of acquired businesses and as a result, have fair value cushions that are not as high. Both of these wholly acquired reporting units have fair value cushions that currently equal or exceed the underlying carrying values. However, the overall Shave Care goodwill cushion has been reduced in recent years, with the fair value in the current year being reduced to an amount that approximates the reporting unit's carrying value. The related Gillette indefinite-lived intangible asset cushion has also been reduced to below </span><span style="font-family:inherit;font-size:10pt;"><span>5%</span></span><span style="font-family:inherit;font-size:10pt;">. These reductions are due in large part to an increased competitive market environment in the U.S. and certain other markets, a deceleration of category growth caused by changing grooming habits and significant currency devaluations in a number of countries relative to the U.S. dollar, which collectively have resulted in reduced cash flow projections. The current year reduction in the fair value was primarily caused by further currency devaluations, along with competitive activities. As a result of these factors and the reduction in the fair values and related cushions, goodwill for the Shave Care reporting unit and the related indefinite-lived intangible asset are more susceptible to impairment risk.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The most significant assumptions utilized in the determination of the estimated fair values of Shave Care reporting unit and the Gillette indefinite-lived intangible asset are the net sales and earnings growth rates (including residual growth rates) and discount rate. The residual growth rate represents the expected rate at which the reporting unit and Gillette brand are expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the reporting unit and brand operating plans, and approximates expected long term category market growth rates. The residual growth rate is dependent on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S. </span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">While management can and has implemented strategies to address these events, changes in operating plans or adverse changes in the future could reduce the underlying cash flows used to estimate fair values and could result in a decline in fair value that would trigger future impairment charges of the reporting unit's goodwill and indefinite-lived intangibles. As of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the carrying values of Shave Care goodwill and the Gillette indefinite-lived intangible asset were </span><span style="font-family:inherit;font-size:10pt;"><span>$19.4 billion</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$15.7 billion</span></span><span style="font-family:inherit;font-size:10pt;">, respectively.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The table below provides a sensitivity analysis for the Shave Care reporting unit and the Gillette indefinite lived intangible asset, utilizing reasonably possible changes in the assumptions for the shorter term and residual growth rates and the discount rate, to demonstrate the potential impacts to the estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis point increase to discount rate or a 25 basis point decrease to our shorter-term and residual growth rates, both of which would result in impairment charges.</span></div><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:52%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Approximate Percent Change in Estimated Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">+25 bps Discount Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">-25 bps Growth Rate</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shave Care goodwill reporting unit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gillette indefinite-lived intangible asset</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)%</span></div></td></tr></table></div> Goodwill is allocated by reportable segment as follows:<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Beauty</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Grooming</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Health Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fabric &amp; Home Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Baby, Feminine &amp; Family Care</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total Company</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12,992</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>19,820</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,929</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,865</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,569</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>45,175</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Acquisitions and divestitures</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>132</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,955</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,093</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Translation and other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(116</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(135</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(36</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(36</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(336</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Goodwill at December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>13,008</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>19,685</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>7,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,858</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>4,533</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>46,932</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 12992000000 19820000000 5929000000 1865000000 4569000000 45175000000 132000000 0 1955000000 6000000 0 2093000000 -116000000 -135000000 -36000000 -13000000 -36000000 -336000000 13008000000 19685000000 7848000000 1858000000 4533000000 46932000000 Identifiable intangible assets at <span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> were comprised of:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:52%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Gross Carrying Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Accumulated Amortization</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets with determinable lives</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>8,580</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(5,251</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets with indefinite lives</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22,618</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total identifiable intangible assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>31,198</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(5,251</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr></table></div> 8580000000 5251000000 22618000000 0 31198000000 5251000000 81000000 75000000 154000000 152000000 0.05 19400000000 15700000000 The table below provides, in isolation, the estimated fair value impacts related to a 25 basis point increase to discount rate or a 25 basis point decrease to our shorter-term and residual growth rates, both of which would result in impairment charges.<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:52%;"/><td style="width:22%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:22%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="5" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Approximate Percent Change in Estimated Fair Value</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">+25 bps Discount Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">-25 bps Growth Rate</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Shave Care goodwill reporting unit</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Gillette indefinite-lived intangible asset</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)%</span></div></td></tr></table></div> -0.05 -0.06 -0.05 -0.06 Earnings Per Share<div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter &amp; Gamble less preferred dividends (net of related tax benefits) by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated using the treasury stock method on the basis of the weighted average number of common shares outstanding plus the dilutive effect of stock options and other stock-based awards and the assumed conversion of preferred stock.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net earnings per share were as follows:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;text-decoration:underline;">CONSOLIDATED AMOUNTS</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,216</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,561</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,427</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,431</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>83</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings attributable to P&amp;G (Diluted)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,194</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,495</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,393</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,348</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Preferred dividends, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(65</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(62</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(131</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(124</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings attributable to P&amp;G available to common shareholders (Basic)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,129</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,433</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,262</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,224</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">SHARES IN MILLIONS</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic weighted average common shares outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,499.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,533.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,497.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,542.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add: Effect of dilutive securities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Conversion of preferred shares </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>90.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>91.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>96.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of stock options and other unvested equity awards </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>32.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>28.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Diluted weighted average common shares outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,623.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,669.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,617.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,680.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">NET EARNINGS PER SHARE</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1.25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.96</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2.51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.05</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1.22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.93</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2.44</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.00</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average outstanding stock options of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>23 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>24 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the three months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>35 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>22 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the six months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup> </span></div>Net earnings per share are calculated on Net earnings attributable to Procter &amp; Gamble. Net earnings per share were as follows:<div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;font-weight:bold;text-decoration:underline;">CONSOLIDATED AMOUNTS</span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,216</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,561</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,427</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,431</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Net earnings attributable to noncontrolling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>22</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>83</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings attributable to P&amp;G (Diluted)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,194</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,495</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,393</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,348</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Preferred dividends, net of tax</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(65</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(62</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(131</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(124</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Net earnings attributable to P&amp;G available to common shareholders (Basic)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,129</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,433</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,262</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,224</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">SHARES IN MILLIONS</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic weighted average common shares outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,499.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,533.9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,497.8</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,542.2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Add: Effect of dilutive securities</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Conversion of preferred shares </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>90.7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>95.5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>91.3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>96.0</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:20px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Impact of stock options and other unvested equity awards </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>32.6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>40.2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>28.5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41.9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Diluted weighted average common shares outstanding</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,623.0</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,669.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2,617.6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,680.1</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">NET EARNINGS PER SHARE</span><span style="font-family:inherit;font-size:10pt;"> </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Basic</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1.25</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.96</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2.51</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.05</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Diluted</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1.22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>0.93</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>2.44</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2.00</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Weighted average outstanding stock options of approximately </span><span style="font-family:inherit;font-size:10pt;"><span>23 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>24 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the three months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;">, and approximately </span><span style="font-family:inherit;font-size:10pt;"><span>35 million</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>22 million</span></span><span style="font-family:inherit;font-size:10pt;"> for the six months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">2017</span><span style="font-family:inherit;font-size:10pt;"> respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup> </span></div>Net earnings per share are calculated on Net earnings attributable to Procter &amp; Gamble. 3216000000 2561000000 6427000000 5431000000 22000000 66000000 34000000 83000000 3194000000 2495000000 6393000000 5348000000 65000000 62000000 131000000 124000000 3129000000 2433000000 6262000000 5224000000 2499700000 2533900000 2497800000 2542200000 90700000 95500000 91300000 96000000.0 32600000 40200000 28500000 41900000 2623000000.0 2669600000 2617600000 2680100000 1.25 0.96 2.51 2.05 1.22 0.93 2.44 2.00 23000000 24000000 35000000 22000000 Share-Based Compensation and Postretirement Benefits<div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table provides a summary of our share-based compensation expense and postretirement benefit costs:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>79</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">  </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>181</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>157</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost for pension benefits </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>64</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost/(credit) for other retiree benefits </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(83</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div><span style="font-family:inherit;font-size:10pt;">The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span>, as revised by the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18. The following table provides a summary of our share-based compensation expense and postretirement benefit costs:<div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:64%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:6%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Share-based compensation expense</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>79</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">  </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>73</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>181</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>157</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost for pension benefits </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>36</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>52</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>64</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net periodic benefit cost/(credit) for other retiree benefits </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(42</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(83</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(76</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div><span style="font-family:inherit;font-size:10pt;">The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span>, as revised by the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18. 79000000 73000000 181000000 157000000 36000000 52000000 64000000 103000000 -42000000 -38000000 -83000000 -76000000 Risk Management Activities and Fair Value Measurements<div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the </span><span style="font-family:inherit;font-size:10pt;">six</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were remeasured at fair value on a non-recurring basis for the </span><span style="font-family:inherit;font-size:10pt;">six</span><span style="font-family:inherit;font-size:10pt;"> months ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table sets forth the Company’s financial assets as of </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;"> that are measured at fair value on a recurring basis during the period:</span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Asset</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Investments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,544</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate bond securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,244</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,737</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>163</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>8,584</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,422</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment securities are presented in Available-for-sale investment securities and Other noncurrent assets. The amortized cost of U.S. government securities with maturities less than one year was </span><span style="font-family:inherit;font-size:10pt;"><span>$1,601</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$2,003</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">. The amortized cost of U.S. government securities with maturities between one and five years was </span><span style="font-family:inherit;font-size:10pt;"><span>$3,657</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$3,659</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">. The amortized cost of Corporate bond securities with maturities of less than a year was </span><span style="font-family:inherit;font-size:10pt;"><span>$1,525</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$1,291</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">. The amortized cost of Corporate bond securities with maturities between one and five years was </span><span style="font-family:inherit;font-size:10pt;"><span>$1,760</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$2,503</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">. The Company's investments measured at fair value are generally classified as Level 2 within the fair value hierarchy. There are no material investment balances classified as Level 1 or Level 3 within the fair value hierarchy, or that used net asset value as a practical expedient. Fair values are generally estimated based upon quoted market prices for similar instruments.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of long-term debt was </span><span style="font-family:inherit;font-size:10pt;"><span>$24,602</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$23,402</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively. This includes the current portion of debt instruments (</span><span style="font-family:inherit;font-size:10pt;"><span>$2,301</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$1,769</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively). Certain long-term debt (debt tied to derivatives designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost, but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.</span></div><div style="line-height:120%;padding-top:8px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Disclosures about Financial Instruments</span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The notional amounts and fair values of financial instruments used in hedging transactions as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;"> are as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:35%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Asset</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2018</span></div></td></tr><tr><td colspan="24" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>4,550</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,587</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>118</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(53</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td colspan="24" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency interest rate contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,855</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(59</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(75</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,405</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,435</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>139</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(87</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(128</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="24" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>7,025</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,358</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>49</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(29</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">TOTAL DERIVATIVES AT FAIR VALUE</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>13,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,793</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>188</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(116</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(184</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">All derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. All derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities. </span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The fair value of the interest rate derivative asset/liability directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was </span><span style="font-family:inherit;font-size:10pt;"><span>$4,623</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$4,639</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was </span><span style="font-family:inherit;font-size:10pt;"><span>$17,092</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$15,012</span></span><span style="font-family:inherit;font-size:10pt;"> as of </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;">, respectively. All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy. </span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in OCI on Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) (2)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(89</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(262</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9.5pt;padding-left:0px;"><span style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was </span><span style="font-family:inherit;font-size:9.5pt;"><span>$13</span></span><span style="font-family:inherit;font-size:9.5pt;"> and </span><span style="font-family:inherit;font-size:9.5pt;"><span>$42</span></span><span style="font-family:inherit;font-size:9.5pt;"> for the three months ended </span><span style="font-family:inherit;font-size:9.5pt;">December 31, 2018</span><span style="font-family:inherit;font-size:9.5pt;"> and 2017, respectively. The amount of gain/(loss) excluded from effectiveness testing was </span><span style="font-family:inherit;font-size:9.5pt;"><span>$27</span></span><span style="font-family:inherit;font-size:9.5pt;"> and </span><span style="font-family:inherit;font-size:9.5pt;"><span>$73</span></span><span style="font-family:inherit;font-size:9.5pt;"> for the six months ended </span><span style="font-family:inherit;font-size:9.5pt;">December 31, 2018</span><span style="font-family:inherit;font-size:9.5pt;"> and 2017, respectively. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9.5pt;padding-left:0px;"><span style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments was </span><span style="font-family:inherit;font-size:9.5pt;"><span>$228</span></span><span style="font-family:inherit;font-size:9.5pt;"> and </span><span style="font-family:inherit;font-size:9.5pt;"><span>$(176)</span></span><span style="font-family:inherit;font-size:9.5pt;">, for the three months ended </span><span style="font-family:inherit;font-size:9.5pt;">December 31, 2018</span><span style="font-family:inherit;font-size:9.5pt;"> and 2017, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was </span><span style="font-family:inherit;font-size:9.5pt;"><span>$241</span></span><span style="font-family:inherit;font-size:9.5pt;"> and </span><span style="font-family:inherit;font-size:9.5pt;"><span>$(745)</span></span><span style="font-family:inherit;font-size:9.5pt;">, for the six months ended </span><span style="font-family:inherit;font-size:9.5pt;">December 31, 2018</span><span style="font-family:inherit;font-size:9.5pt;"> and 2017, respectively.</span></div></td></tr></table><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>42</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(41</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr><tr><td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div>The gain/(loss) on the derivatives in fair value hedging relationships is fully offset by the mark-to-market impact of the related exposure. These are both recognized in the Consolidated Statements of Earnings in Interest Expense. The gain/(loss) on derivatives not designated as hedging instruments is substantially offset by the currency mark-to-market of the related exposure. These are both recognized in the Consolidated Statements of Earnings in SG&amp;A. The following table sets forth the Company’s financial assets as of <span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;"> that are measured at fair value on a recurring basis during the period:</span><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Asset</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Investments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">U.S. government securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>5,177</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>5,544</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate bond securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>3,244</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,737</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other investments</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>163</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>141</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>8,584</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>9,422</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div> 5177000000 5544000000 3244000000 3737000000 163000000 141000000 8584000000 9422000000 1601000000 2003000000 3657000000 3659000000 1525000000 1291000000 1760000000 2503000000 24602000000 23402000000 2301000000 1769000000 The notional amounts and fair values of financial instruments used in hedging transactions as of <span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span><span style="font-family:inherit;font-size:10pt;"> are as follows:</span><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:35%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:7%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Notional Amount</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value Asset</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Fair Value (Liability)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">June 30, 2018</span></div></td></tr><tr><td colspan="24" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>4,550</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,587</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>118</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>125</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(28</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(53</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td colspan="24" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency interest rate contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>1,855</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,848</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(59</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(75</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>6,405</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>6,435</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>139</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>166</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(87</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(128</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td colspan="24" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>7,025</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7,358</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>49</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(29</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(56</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:17px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">TOTAL DERIVATIVES AT FAIR VALUE</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>13,430</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>13,793</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>188</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(116</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(184</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 4550000000 4587000000 118000000 125000000 -28000000 -53000000 1855000000 1848000000 21000000 41000000 -59000000 -75000000 6405000000 6435000000 139000000 166000000 -87000000 -128000000 7025000000 7358000000 49000000 30000000 -29000000 -56000000 13430000000 13793000000 188000000 196000000 116000000 184000000 4623000000 4639000000 17092000000 15012000000 Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows:<div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in OCI on Derivatives</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td colspan="16" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS </span><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1) (2)</sup></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign exchange contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(89</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>19</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(262</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:9.5pt;padding-left:0px;"><span style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:9.5pt;"><span style="font-family:inherit;font-size:9.5pt;">For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was </span><span style="font-family:inherit;font-size:9.5pt;"><span>$13</span></span><span style="font-family:inherit;font-size:9.5pt;"> and </span><span style="font-family:inherit;font-size:9.5pt;"><span>$42</span></span><span style="font-family:inherit;font-size:9.5pt;"> for the three months ended </span><span style="font-family:inherit;font-size:9.5pt;">December 31, 2018</span><span style="font-family:inherit;font-size:9.5pt;"> and 2017, respectively. The amount of gain/(loss) excluded from effectiveness testing was </span><span style="font-family:inherit;font-size:9.5pt;"><span>$27</span></span><span style="font-family:inherit;font-size:9.5pt;"> and </span><span style="font-family:inherit;font-size:9.5pt;"><span>$73</span></span><span style="font-family:inherit;font-size:9.5pt;"> for the six months ended </span><span style="font-family:inherit;font-size:9.5pt;">December 31, 2018</span><span style="font-family:inherit;font-size:9.5pt;"> and 2017, respectively. </span></div></td></tr></table><div style="line-height:120%;font-size:9.5pt;padding-left:0px;"><span style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(2)</sup> </span></div><span style="font-family:inherit;font-size:9.5pt;">In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments was </span><span style="font-family:inherit;font-size:9.5pt;"><span>$228</span></span><span style="font-family:inherit;font-size:9.5pt;"> and </span><span style="font-family:inherit;font-size:9.5pt;"><span>$(176)</span></span><span style="font-family:inherit;font-size:9.5pt;">, for the three months ended </span><span style="font-family:inherit;font-size:9.5pt;">December 31, 2018</span><span style="font-family:inherit;font-size:9.5pt;"> and 2017, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was </span><span style="font-family:inherit;font-size:9.5pt;"><span>$241</span></span><span style="font-family:inherit;font-size:9.5pt;"> and </span><span style="font-family:inherit;font-size:9.5pt;"><span>$(745)</span></span><span style="font-family:inherit;font-size:9.5pt;">, for the six months ended </span><span style="font-family:inherit;font-size:9.5pt;">December 31, 2018</span> and 2017, respectively. 23000000 -89000000 19000000 -262000000 13000000 42000000 27000000 73000000 228000000 -176000000 241000000 -745000000 <div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:45%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="15" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Amount of Gain/(Loss) Recognized in Earnings</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">2017</span></div></td></tr><tr><td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Interest rate contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>42</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(38</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(41</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr><tr><td colspan="8" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Foreign currency contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(5</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(2</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span> 42000000 -38000000 18000000 -41000000 -5000000 -1000000 -7000000 -2000000 Accumulated Other Comprehensive Income/(Loss)<div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The table below presents the changes in Accumulated other comprehensive income/(loss) (AOCI), including the reclassifications out of Accumulated other comprehensive income/(loss) by component:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Changes in Accumulated Other Comprehensive Income/(Loss) by Component</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Investment Securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension and Other Retiree Benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Financial Statement Translation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total AOCI</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3,246</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(173</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,058</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,272</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14,749</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">OCI before reclassifications </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(587</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(185</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified from AOCI </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net current period OCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>250</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(586</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(84</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reclassification to retained earnings in accordance with ASU 2018-02 </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(308</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(326</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Other comprehensive income/(loss) attributable to non-controlling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(3,065</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(120</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(4,116</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(7,855</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(15,156</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net of tax expense/(benefit) of </span><span style="font-family:inherit;font-size:10pt;"><span>$61</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$38</span></span><span style="font-family:inherit;font-size:10pt;"> for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net of tax expense/(benefit) of </span><span style="font-family:inherit;font-size:10pt;"><span>$0</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$32</span></span><span style="font-family:inherit;font-size:10pt;"> for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Adjustment made to early adopt ASU 2018-02: "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income," as discussed in Note 2.</span></div></td></tr></table><div style="line-height:120%;text-align:justify;padding-left:24px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The below provides additional details on amounts reclassified from AOCI into the Consolidated Statements of Earnings:</span></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Investment securities: amounts reclassified from AOCI into Other non-operating income, net.</span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">•</span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Pension and other retiree benefits: amounts reclassified from AOCI into Other non-operating income, net and included in the computation of net periodic postretirement costs.</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;">•</span></div>Financial statement translation: amounts reclassified from AOCI into SG&amp;A. The table below presents the changes in Accumulated other comprehensive income/(loss) (AOCI), including the reclassifications out of Accumulated other comprehensive income/(loss) by component:<div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="20"/></tr><tr><td style="width:41%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:9%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="19" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Changes in Accumulated Other Comprehensive Income/(Loss) by Component</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Hedges</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Investment Securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Pension and Other Retiree Benefits</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Financial Statement Translation</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Total AOCI</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Balance at June 30, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3,246</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(173</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(4,058</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(7,272</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(14,749</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">OCI before reclassifications </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>54</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>149</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(587</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(185</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Amounts reclassified from AOCI </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>101</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net current period OCI</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>250</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(586</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(84</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Reclassification to retained earnings in accordance with ASU 2018-02 </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(18</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(308</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(326</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Less: Other comprehensive income/(loss) attributable to non-controlling interests</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Balance at December 31, 2018</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(3,065</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(120</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(4,116</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(7,855</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(15,156</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:9.5pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net of tax expense/(benefit) of </span><span style="font-family:inherit;font-size:10pt;"><span>$61</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$38</span></span><span style="font-family:inherit;font-size:10pt;"> for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively. </span></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(2)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Net of tax expense/(benefit) of </span><span style="font-family:inherit;font-size:10pt;"><span>$0</span></span><span style="font-family:inherit;font-size:10pt;">, </span><span style="font-family:inherit;font-size:10pt;"><span>$0</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$32</span></span><span style="font-family:inherit;font-size:10pt;"> for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.</span></div></td></tr></table><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(3)</sup> </span></div>Adjustment made to early adopt ASU 2018-02: "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income," as discussed in Note 2. -3246000000 -173000000 -4058000000 -7272000000 -14749000000 199000000 54000000 149000000 -587000000 -185000000 0 -1000000 101000000 1000000 101000000 199000000 53000000 250000000 -586000000 -84000000 -18000000 0 -308000000 0 -326000000 0 0 0 -3000000 -3000000 -3065000000 -120000000 -4116000000 -7855000000 -15156000000 61000000 0 38000000 0 0 32000000 Restructuring Program<div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before-tax costs incurred under the ongoing program have generally ranged from </span><span style="font-family:inherit;font-size:10pt;"><span>$250</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>$500</span></span><span style="font-family:inherit;font-size:10pt;"> annually.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">In fiscal 2017, the Company announced specific elements of a multi-year productivity and cost savings plan to further reduce costs in the areas of supply chain, certain marketing activities and overhead expenses. This program is expected to result in incremental enrollment reductions, along with further optimization of the supply chain and other manufacturing processes.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Restructuring costs incurred consist primarily of costs to separate employees, asset-related costs to exit facilities and other costs. For the three and six month periods ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;">, the Company incurred total restructuring charges of </span><span style="font-family:inherit;font-size:10pt;"><span>$177</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$314</span></span><span style="font-family:inherit;font-size:10pt;">, respectively. Of these charges incurred, </span><span style="font-family:inherit;font-size:10pt;"><span>$25</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$97</span></span><span style="font-family:inherit;font-size:10pt;"> were recorded in SG&amp;A and </span><span style="font-family:inherit;font-size:10pt;"><span>$143</span></span><span style="font-family:inherit;font-size:10pt;"> and </span><span style="font-family:inherit;font-size:10pt;"><span>$207</span></span><span style="font-family:inherit;font-size:10pt;"> were recorded in Cost of products sold, respectively. The remainder of these charges were recorded in Other non-operating income, net. The following table presents restructuring activity for the </span><span style="font-family:inherit;font-size:10pt;">six</span><span style="font-family:inherit;font-size:10pt;"> months ended December 31, 2018:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:15%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Charges Previously Reported (Three Months Ended September 30, 2018)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Charges for the Three Months Ended December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Six Months Ended December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Reserve Balance June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Cash Spent</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Charges Against Assets</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Reserve Balance December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Separations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>259</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(115</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>253</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset-related costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(50</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>254</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>229</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>513</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>$137</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>177</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(295</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(50</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>482</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Separation Costs</span></div><div style="line-height:120%;padding-top:4px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Employee separation charges for the three and six month periods ended </span><span style="font-family:inherit;font-size:10pt;">December 31, 2018</span><span style="font-family:inherit;font-size:10pt;"> relate to severance packages for approximately </span><span style="font-family:inherit;font-size:10pt;"><span>500</span></span><span style="font-family:inherit;font-size:10pt;"> employees and </span><span style="font-family:inherit;font-size:10pt;"><span>970</span></span><span style="font-family:inherit;font-size:10pt;"> employees, respectively. The packages were predominantly voluntary and the amounts were calculated based on salary levels and past service periods. Severance costs related to voluntary separations are generally charged to earnings when the employee accepts the offer.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Asset-Related Costs</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset-related costs consist of both asset write-downs and accelerated depreciation. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or disposal. These assets were written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. These assets relate primarily to manufacturing consolidations and technology standardizations. The asset-related charges will not have a significant impact on future depreciation charges.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Other Costs</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other restructuring-type charges are incurred as a direct result of the restructuring program. Such charges primarily include asset removal and termination of contracts related to supply chain optimization.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Consistent with our historical policies for ongoing restructuring-type activities, the restructuring program charges are funded by and included within Corporate for both management and segment reporting. Accordingly, all of the charges under the program are included within the Corporate reportable segment. However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beauty</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Grooming</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health Care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fabric &amp; Home Care</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Baby, Feminine &amp; Family Care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Company</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>$177</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>314</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div>Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities. 250000000 500000000 177000000 314000000 25000000 97000000 143000000 207000000 The following table presents restructuring activity for the <span style="font-family:inherit;font-size:10pt;">six</span><span style="font-family:inherit;font-size:10pt;"> months ended December 31, 2018:</span><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="24"/></tr><tr><td style="width:15%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:12%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Charges Previously Reported (Three Months Ended September 30, 2018)</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Charges for the Three Months Ended December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Six Months Ended December 31, 2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Reserve Balance June 30, 2018</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Cash Spent</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Charges Against Assets</span></div></td><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:7.5pt;"><span style="font-family:inherit;font-size:7.5pt;font-weight:bold;">Reserve Balance December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Separations</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>259</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>53</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(115</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>253</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Asset-related costs</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>28</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>22</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(50</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other costs</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>254</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>99</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>(180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>229</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>513</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>$137</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>177</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(295</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>(50</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>482</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 259000000 53000000 56000000 115000000 0 253000000 0 28000000 22000000 0 50000000 0 254000000 56000000 99000000 180000000 0 229000000 513000000 137000000 177000000 295000000 50000000 482000000 500 970 However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments:<div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:69%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Three Months Ended December 31, 2018</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-bottom:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Six Months Ended December 31, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Beauty</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Grooming</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>25</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Health Care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Fabric &amp; Home Care</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>31</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Baby, Feminine &amp; Family Care</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Corporate </span><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>43</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Company</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>$177</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;"><span>314</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;border-bottom:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div>Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities. 17000000 27000000 25000000 31000000 4000000 12000000 18000000 31000000 70000000 91000000 43000000 122000000 177000000 314000000 Commitments and Contingencies<div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Litigation</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark, advertising, contracts, environmental, labor and employment and tax. With respect to these and other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Income Tax Uncertainties</span></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The Company is present in approximately </span><span style="font-family:inherit;font-size:10pt;"><span>150</span></span><span style="font-family:inherit;font-size:10pt;"> taxable jurisdictions and, at any point in time, has </span><span style="font-family:inherit;font-size:10pt;"><span>40</span></span><span style="font-family:inherit;font-size:10pt;"> – </span><span style="font-family:inherit;font-size:10pt;"><span>50</span></span><span style="font-family:inherit;font-size:10pt;"> jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2008 and forward. We are generally not able to reliably estimate the ultimate settlement amounts until the close of the audit. While we do not expect material changes, it is possible that the amount of unrecognized benefit with respect to our uncertain tax positions could increase or decrease within the next 12 months. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items.</span></div><span style="font-family:inherit;font-size:10pt;">Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the year ended </span><span style="font-family:inherit;font-size:10pt;">June 30, 2018</span>. 150 40 50 Merck Acquisition<div style="line-height:120%;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:10px;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">On November 30, 2018, we completed our acquisition of the over the counter (OTC) healthcare business of Merck KGaA (Merck OTC) for </span><span style="font-family:inherit;font-size:10pt;"><span>$3.7 billion</span></span><span style="font-family:inherit;font-size:10pt;"> (based on exchange rates at the time of closing) in an all-cash transaction. This business primarily sells OTC consumer healthcare products, mainly in Europe, Latin America and Asia markets. The results of Merck OTC, which are not material to the Company, are reported in our consolidated financial statements beginning December 1, 2018. Total sales for Merck OTC’s most recently completed fiscal year ended December 31, 2017 were approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$1 billion</span></span><span style="font-family:inherit;font-size:10pt;">. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The following table presents the preliminary allocation of purchase price related to the Merck OTC business as of the date of acquisition. The preliminary allocation of the purchase price is based on the best estimates of management and is subject to revision based on final determination of fair values of the assets and liabilities acquired, which will be completed as we complete our analysis of the underlying assets and acquired liabilities, such as pensions, litigation cases, environmental issues, and tax positions. </span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:80%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Amounts in Millions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">November 30, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,111</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,010</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Assets Acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,779</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>233</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>661</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Total Liabilities Acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>954</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Noncontrolling Interest </span><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>169</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Net Assets Acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,656</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:4px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"/><td/></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><span style="font-family:inherit;font-size:9pt;">Represents a </span><span style="font-family:inherit;font-size:9pt;"><span>48%</span></span><span style="font-family:inherit;font-size:9pt;"> minority ownership interest in the Merck India company.</span></div></td></tr></table><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">The acquisition resulted in </span><span style="font-family:inherit;font-size:10pt;"><span>$2.0 billion</span></span><span style="font-family:inherit;font-size:10pt;"> in goodwill, of which approximately </span><span style="font-family:inherit;font-size:10pt;"><span>$180 million</span></span><span style="font-family:inherit;font-size:10pt;"> is expected to be deductible for tax purposes. All of this goodwill was allocated to the Health Care Segment. The goodwill is primarily attributable to the assembled workforce and synergies we expect to generate by combining the Merck OTC business with the Company’s existing personal health care business. </span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">We have preliminarily estimated the fair value of Merck OTC’s identifiable intangible assets as </span><span style="font-family:inherit;font-size:10pt;"><span>$2.1 billion</span></span><span style="font-family:inherit;font-size:10pt;">. The preliminary allocation of identifiable intangible assets and their average useful lives is as follows:</span></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:20%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Amounts in Millions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Avg Remaining<br/>Useful Life</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets with Determinable Lives</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Brands</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>701</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Patents and technology</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>346</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,165</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets with Indefinite Lives</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Brands</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>946</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Intangible Assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,111</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div><span style="font-family:inherit;font-size:10pt;">The majority of the intangible valuation relates to brand intangibles. Our preliminary assessment as to brand intangibles that have an indefinite life and those that have a definite life was based on a number of factors, including competitive environment, market share, brand history, product life cycles, operating plan and the macroeconomic environment of the countries in which the brands are sold. The indefinite-lived brand intangibles include Neurobion and Dolo Neurobion. The definite-lived brand intangibles primarily include regional or local brands. The definite-lived brand intangibles have estimated lives ranging from </span><span style="font-family:inherit;font-size:10pt;"><span>10</span></span><span style="font-family:inherit;font-size:10pt;"> to </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> years. The technology intangibles are related to R&amp;D and manufacturing know-how; these intangibles have a </span><span style="font-family:inherit;font-size:10pt;"><span>7</span></span><span style="font-family:inherit;font-size:10pt;"> year estimated life. The customer relationships intangibles have a </span><span style="font-family:inherit;font-size:10pt;"><span>20</span></span><span style="font-family:inherit;font-size:10pt;"> year estimated life and reflect the </span>historical and projected attrition rates for Merck OTC’s relationships with health care professionals, retailers and distributors. 3700000000 1000000000 The preliminary allocation of the purchase price is based on the best estimates of management and is subject to revision based on final determination of fair values of the assets and liabilities acquired, which will be completed as we complete our analysis of the underlying assets and acquired liabilities, such as pensions, litigation cases, environmental issues, and tax positions. <div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"/></tr><tr><td style="width:80%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Amounts in Millions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">November 30, 2018</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Property, plant and equipment</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>122</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,111</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,010</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Other non-current assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>143</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Assets Acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>4,779</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Current liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>233</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;">Deferred income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>661</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">Non-current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>60</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Total Liabilities Acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>954</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Noncontrolling Interest </span><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:7pt">(1)</sup></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>169</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;background-color:#cceeff;font-weight:bold;">Net Assets Acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>3,656</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;padding-left:0px;"><span style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">(1)</sup> </span></div><span style="font-family:inherit;font-size:9pt;">Represents a </span><span style="font-family:inherit;font-size:9pt;"><span>48%</span></span> minority ownership interest in the Merck India company. 393000000 122000000 2111000000 2010000000 143000000 4779000000 233000000 661000000 60000000 954000000 169000000 3656000000 0.48 2000000000.0 180000000 2100000000 The preliminary allocation of identifiable intangible assets and their average useful lives is as follows:<div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"/></tr><tr><td style="width:59%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:20%;"/></tr><tr><td style="vertical-align:bottom;background-color:;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;text-decoration:underline;">Amounts in Millions</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Estimated Fair Value</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:8pt;"><span style="font-family:inherit;font-size:8pt;font-weight:bold;">Avg Remaining<br/>Useful Life</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets with Determinable Lives</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Brands</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>701</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>14</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Patents and technology</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>118</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>7</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Customer relationships</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>346</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>20</span></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>1,165</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>15</span></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:10px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Intangible Assets with Indefinite Lives</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">   Brands</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>946</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><span style="font-family:inherit;font-size:10pt;font-weight:bold;">Total Intangible Assets</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><span>2,111</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div> 701000000 P14Y 118000000 P7Y 346000000 P20Y 1165000000 P15Y 946000000 2111000000 P10Y P20Y P7Y P20Y Net of tax expense/(benefit) of $0, $0 and $32 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments was $228 and $(176), for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $241 and $(745), for the six months ended December 31, 2018 and 2017, respectively. For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was $13 and $42 for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) excluded from effectiveness testing was $27 and $73 for the six months ended December 31, 2018 and 2017, respectively. Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble. Net earnings per share are calculated on Net earnings attributable to Procter & Gamble. Net of tax expense/(benefit) of $61, $0 and $38 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively. Weighted average outstanding stock options of approximately 23 million and 24 million for the three months ended December 31, 2018 and 2017, and approximately 35 million and 22 million for the six months ended December 31, 2018 and 2017 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares). The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2018, as revised by the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18. Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035. Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities. Represents a 48% minority ownership interest in the Merck India company. XML 16 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
DOCUMENT AND ENTITY INFORMATION
6 Months Ended
Dec. 31, 2018
shares
Document Information [Line Items]  
Entity Registrant Name PROCTER & GAMBLE Co
Entity Central Index Key 0000080424
Current Fiscal Year End Date --06-30
Entity Filer Category Large Accelerated Filer
Document Type 10-Q
Document Period End Date Dec. 31, 2018
Document Fiscal Year Focus 2019
Document Fiscal Period Focus Q2
Amendment Flag false
Trading Symbol PG
Entity Current Reporting Status Yes
Entity Common Stock, Shares Outstanding 2,501,579,709
Entity Emerging Growth Company false
Entity Small Business false
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF EARNINGS - USD ($)
shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Net Sales $ 17,438 $ 17,395 $ 34,128 $ 34,048
Cost of Products Sold 8,919 8,709 17,403 16,978
Selling, General and Administrative Expense 4,623 4,767 9,275 9,503
Operating Income 3,896 3,919 7,450 7,567
Interest Expense 138 122 267 237
Interest Income 63 66 116 115
Other Non-operating Income/(Loss), Net 95 170 557 339
Earnings/(Loss) from Continuing Operations Before Income Taxes 3,916 4,033 7,856 7,784
Income Taxes on Continuing Operations 700 1,472 1,429 2,353
Net Earnings 3,216 2,561 6,427 5,431
Net Income (Loss) Attributable to Noncontrolling Interest $ 22 66 $ 34 83
Net Earnings Attributable to Procter & Gamble   $ 2,495   $ 5,348
Basic Net Earnings Per Common Share        
Basic Net Earnings Per Common Share [1],[2] $ 1.25 $ 0.96 $ 2.51 $ 2.05
Diluted Net Earnings Per Common Share        
Diluted Net Earnings Per Common Share [1],[2] $ 1.22 $ 0.93 $ 2.44 $ 2.00
Diluted Weighted Average Common Shares Outstanding 2,623.0 2,669.6 2,617.6 2,680.1
[1] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[2] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Net Earnings $ 3,216 $ 2,561 $ 6,427 $ 5,431
Financial Statement Translation (370) 188 (586) 1,028
Unrealized Gains/(Losses) on Hedges 192 (167) 199 (630)
Unrealized Gains/(Losses) on Investment Securities 58 (61) 53 (65)
Unrealized Gains/(Losses) on Defined Benefit Retirement Plans 98 161 250 128
Total Other Comprehensive Income (Loss), Net of Tax (22) 121 (84) 461
Total Comprehensive Income/(Loss) 3,194 2,682 6,343 5,892
Less: Total Comprehensive Income Attributable to Noncontrolling Interest 23 66 31 83
Total Comprehensive Income/(Loss) Attributable to Procter & Gamble $ 3,171 $ 2,616 $ 6,312 $ 5,809
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
shares in Millions, $ in Millions
Dec. 31, 2018
Jun. 30, 2018
Current Assets    
Cash and Cash Equivalents $ 3,696 $ 2,569
Available-for-Sale Investment Securities 8,421 9,281
Accounts Receivable 5,055 4,686
Inventories    
Materials and Supplies 1,524 1,335
Work in Process 593 588
Finished Goods 3,164 2,815
Total Inventories 5,281 4,738
Prepaid Expenses and Other Current Assets 1,978 2,046
Total Current Assets 24,431 23,320
Property, Plant and Equipment, Net 20,822 20,600
Goodwill 46,932 45,175
Trademarks and Other Intangible Assets, Net 25,947 23,902
Other Noncurrent Assets 5,555 5,313
Total Assets 123,687 118,310
Current Liabilities    
Accounts Payable 10,266 10,344
Accrued and Other Liabilities 8,868 7,470
Debt Due Within One Year 12,113 10,423
Total Current Liabilities 31,247 28,237
Long-Term Debt 21,514 20,863
Deferred Income Taxes 6,872 6,163
Other Noncurrent Liabilities 9,611 10,164
Total Liabilities 69,244 65,427
Shareholders' Equity    
Preferred Stock $ 946 $ 967
Common Stock, Shares, Issued 4,009.2 4,009.2
Common Stock, Value, Issued $ 4,009 $ 4,009
Additional Paid in Capital 63,679 63,846
Reserve For ESOP Debt Retirement (1,178) (1,204)
Accumulated Other Comprehensive Income/(Loss) (15,156) (14,749)
Treasury Stock (99,480) (99,217)
Retained Earnings 101,170 98,641
Noncontrolling Interest 453 590
Total Shareholders' Equity 54,443 52,883
Total Liabilities and Shareholders' Equity $ 123,687 $ 118,310
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Statement of Cash Flows [Abstract]    
Cash and Cash Equivalents, Beginning of Period $ 2,569 $ 5,569
Operating Activities    
Net Earnings 6,427 5,431
Depreciation and Amortization 1,293 1,368
Share-based Compensation Expense 181 157
Deferred Income Taxes 37 (2,008)
Gain (Loss) on Disposition of Assets (370) (158)
Changes In:    
Accounts Receivable (398) (547)
Inventories (531) (457)
Accounts Payable, Accrued and Other Liabilities 1,141 857
Other Operating Assets and Liabilities (370) 2,524
Other Noncash Expense 164 148
Total Operating Activities 7,574 7,315
Investing Activities    
Capital Expenditures (1,781) (1,900)
Proceeds from Asset Sales 18 201
Acquisitions, Net of Cash Acquired (3,848) (101)
Purchases of Short-term Investments (158) (3,598)
Proceeds from Sales of Short-term Investments 1,117 1,643
Change in Other Investments (58) 50
Total Investing Activites (4,710) (3,705)
Financing Activities    
Dividends to Shareholders (3,703) (3,636)
Change in Short-term Debt 1,206 1,524
Additions to Long-term Debt 2,368 5,072
Reductions of Long-term Debt (978) (1,281)
Treasury Stock Purchases (2,003) (4,253)
Impact of Stock Options and Other 1,486 698
Total Financing Activities (1,624) (1,876)
Effect of Exchange Rate on Cash and Cash Equivalents (113) 129
Change in Cash and Cash Equivalents 1,127 1,863
Cash and Cash Equivalents, End of Period $ 3,696 $ 7,432
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity QTD - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Reserve for ESOP Debt Retirement [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Common Stock, Shares, Outstanding   2,553,297              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 55,778 $ 4,009 $ 1,006 $ 63,641 $ (1,249) $ (14,632) $ (93,715) $ 96,124 $ 594
Common Stock, Dividends, Per Share, Cash Paid $ 0.6896                
Common Stock, Dividends, Per Share, Cash Paid $ 1.3792                
Net Income (Loss) Attributable to Parent $ 5,348                
Net Income (Loss) Attributable to Noncontrolling Interest 83                
Net Earnings 5,431             5,348 83
Other Comprehensive Income (Loss), Net of Tax 461         461     0
Dividends, Common Stock (3,512)             3,512  
Dividends, Preferred Stock (124)             (124)  
Treasury Stock, Shares, Acquired   (46,736)              
Stock Repurchased During Period, Value (4,253)           4,253    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   12,239              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 943     113     830    
Stock Issued During Period, Shares, Conversion of Convertible Securities   2,204              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (20) (3)     (17)    
ESOP Debt Impacts (65)       (20)     (45)  
Noncontrolling Interest, Period Increase (Decrease) (68)               (68)
Common Stock, Shares, Outstanding   2,536,958              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 55,415 $ 4,009 991 63,705 (1,229) (14,292) (95,563) 97,197 597
Net Income (Loss) Attributable to Parent 2,495                
Net Income (Loss) Attributable to Noncontrolling Interest 66                
Net Earnings 2,561             2,495 66
Other Comprehensive Income (Loss), Net of Tax 121         121     0
Dividends, Common Stock (1,751)             1,751  
Dividends, Preferred Stock (62)             (62)  
Treasury Stock, Shares, Acquired   (19,409)              
Stock Repurchased During Period, Value (1,751)           1,751    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   2,791              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 240     51     189    
Stock Issued During Period, Shares, Conversion of Convertible Securities   664              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (5) (1)     (4)    
ESOP Debt Impacts (2)       0     (2)  
Noncontrolling Interest, Period Increase (Decrease) (54)               (54)
Common Stock, Shares, Outstanding   2,521,004              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 54,721 $ 4,009 986 63,757 (1,229) (14,171) (97,121) 97,881 609
Common Stock, Shares, Outstanding   2,498,093              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 52,883 $ 4,009 967 63,846 (1,204) (14,749) (99,217) 98,641 590
Common Stock, Dividends, Per Share, Cash Paid $ 0.7172                
Common Stock, Dividends, Per Share, Cash Paid $ 1.4344                
Net Income (Loss) Attributable to Parent               6,393  
Net Income (Loss) Attributable to Noncontrolling Interest $ 34               34
Net Earnings 6,427                
Other Comprehensive Income (Loss), Net of Tax (84)         (81)     (3)
Dividends, Common Stock (3,581)             3,581  
Dividends, Preferred Stock (131)             (131)  
Treasury Stock, Shares, Acquired   (24,337)              
Stock Repurchased During Period, Value (2,003)           2,003    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   25,389              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 1,669     (53)     1,722    
Stock Issued During Period, Shares, Conversion of Convertible Securities   2,435              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (21) (3)     (18)    
ESOP Debt Impacts (74)       (26)     (48)  
Noncontrolling Interest, Period Increase (Decrease) (258)     (117)         (141)
Common Stock, Shares, Outstanding   2,491,408              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 52,504 $ 4,009 951 63,711 (1,177) (15,133) (99,956) 99,831 268
Net Income (Loss) Attributable to Parent               3,194  
Net Income (Loss) Attributable to Noncontrolling Interest 22               22
Net Earnings 3,216                
Other Comprehensive Income (Loss), Net of Tax (22)         (23)     1
Dividends, Common Stock (1,790)             1,790  
Dividends, Preferred Stock (65)             (65)  
Treasury Stock, Shares, Acquired   (8,647)              
Stock Repurchased During Period, Value (751)           751    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   18,021              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 1,149     (73)     1,222    
Stock Issued During Period, Shares, Conversion of Convertible Securities   798              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (5) 0     (5)    
ESOP Debt Impacts (1)       (1)     0  
Noncontrolling Interest, Period Increase (Decrease) 203     41         162
Common Stock, Shares, Outstanding   2,501,580              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 54,443 $ 4,009 $ 946 $ 63,679 $ (1,178) $ (15,156) $ (99,480) $ 101,170 $ 453
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity FYTD - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Reserve for ESOP Debt Retirement [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Common Stock, Shares, Outstanding   2,553,297              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 55,778 $ 4,009 $ 1,006 $ 63,641 $ (1,249) $ (14,632) $ (93,715) $ 96,124 $ 594
Common Stock, Dividends, Per Share, Cash Paid $ 0.6896                
Common Stock, Dividends, Per Share, Cash Paid $ 1.3792                
Net Income (Loss) Attributable to Parent $ 5,348                
Net Income (Loss) Attributable to Noncontrolling Interest 83                
Net Earnings 5,431             5,348 83
Other Comprehensive Income (Loss), Net of Tax 461         461     0
Dividends, Common Stock (3,512)             3,512  
Dividends, Preferred Stock (124)             (124)  
Treasury Stock, Shares, Acquired   (46,736)              
Stock Repurchased During Period, Value (4,253)           4,253    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   12,239              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 943     113     830    
Stock Issued During Period, Shares, Conversion of Convertible Securities   2,204              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (20) (3)     (17)    
ESOP Debt Impacts 65       20     45  
Noncontrolling Interest, Period Increase (Decrease) (68)               (68)
Common Stock, Shares, Outstanding   2,536,958              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 55,415 $ 4,009 991 63,705 (1,229) (14,292) (95,563) 97,197 597
Net Income (Loss) Attributable to Parent 2,495                
Net Income (Loss) Attributable to Noncontrolling Interest 66                
Net Earnings 2,561             2,495 66
Other Comprehensive Income (Loss), Net of Tax 121         121     0
Dividends, Common Stock (1,751)             1,751  
Dividends, Preferred Stock (62)             (62)  
Treasury Stock, Shares, Acquired   (19,409)              
Stock Repurchased During Period, Value (1,751)           1,751    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   2,791              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 240     51     189    
Stock Issued During Period, Shares, Conversion of Convertible Securities   664              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (5) (1)     (4)    
ESOP Debt Impacts 2       0     2  
Noncontrolling Interest, Period Increase (Decrease) (54)               (54)
Common Stock, Shares, Outstanding   2,521,004              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 54,721 $ 4,009 986 63,757 (1,229) (14,171) (97,121) 97,881 609
Common Stock, Shares, Outstanding   2,498,093              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 52,883 $ 4,009 967 63,846 (1,204) (14,749) (99,217) 98,641 590
Common Stock, Dividends, Per Share, Cash Paid $ 0.7172                
Common Stock, Dividends, Per Share, Cash Paid $ 1.4344                
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification $ (553)         (326)   (200) (27)
Net Income (Loss) Attributable to Parent               6,393  
Net Income (Loss) Attributable to Noncontrolling Interest 34               34
Net Earnings 6,427                
Other Comprehensive Income (Loss), Net of Tax (84)         (81)     (3)
Dividends, Common Stock (3,581)             3,581  
Dividends, Preferred Stock (131)             (131)  
Treasury Stock, Shares, Acquired   (24,337)              
Stock Repurchased During Period, Value (2,003)           2,003    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   25,389              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 1,669     (53)     1,722    
Stock Issued During Period, Shares, Conversion of Convertible Securities   2,435              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (21) (3)     (18)    
ESOP Debt Impacts 74       26     48  
Noncontrolling Interest, Period Increase (Decrease) (258)     (117)         (141)
Common Stock, Shares, Outstanding   2,491,408              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 52,504 $ 4,009 951 63,711 (1,177) (15,133) (99,956) 99,831 268
Net Income (Loss) Attributable to Parent               3,194  
Net Income (Loss) Attributable to Noncontrolling Interest 22               22
Net Earnings 3,216                
Other Comprehensive Income (Loss), Net of Tax (22)         (23)     1
Dividends, Common Stock (1,790)             1,790  
Dividends, Preferred Stock (65)             (65)  
Treasury Stock, Shares, Acquired   (8,647)              
Stock Repurchased During Period, Value (751)           751    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   18,021              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 1,149     (73)     1,222    
Stock Issued During Period, Shares, Conversion of Convertible Securities   798              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (5) 0     (5)    
ESOP Debt Impacts 1       1     0  
Noncontrolling Interest, Period Increase (Decrease) 203     41         162
Common Stock, Shares, Outstanding   2,501,580              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 54,443 $ 4,009 $ 946 $ 63,679 $ (1,178) $ (15,156) $ (99,480) $ 101,170 $ 453
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY QTD - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Reserve for ESOP Debt Retirement [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Common Stock, Shares, Outstanding   2,553,297              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 55,778 $ 4,009 $ 1,006 $ 63,641 $ (1,249) $ (14,632) $ (93,715) $ 96,124 $ 594
Common Stock, Dividends, Per Share, Cash Paid $ 0.6896                
Common Stock, Dividends, Per Share, Cash Paid $ 1.3792                
Net Earnings $ 5,431             5,348 83
Other Comprehensive Income (Loss), Net of Tax 461         461     0
Dividends, Common Stock (3,512)             3,512  
Dividends, Preferred Stock (124)             (124)  
Treasury Stock, Shares, Acquired   (46,736)              
Stock Repurchased During Period, Value (4,253)           4,253    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   12,239              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 943     113     830    
Stock Issued During Period, Shares, Conversion of Convertible Securities   2,204              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (20) (3)     (17)    
ESOP Debt Impacts 65       20     45  
Noncontrolling Interest, Period Increase (Decrease) (68)               (68)
Common Stock, Shares, Outstanding   2,536,958              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 55,415 $ 4,009 991 63,705 (1,229) (14,292) (95,563) 97,197 597
Net Earnings 2,561             2,495 66
Other Comprehensive Income (Loss), Net of Tax 121         121     0
Dividends, Common Stock (1,751)             1,751  
Dividends, Preferred Stock (62)             (62)  
Treasury Stock, Shares, Acquired   (19,409)              
Stock Repurchased During Period, Value (1,751)           1,751    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   2,791              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 240     51     189    
Stock Issued During Period, Shares, Conversion of Convertible Securities   664              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (5) (1)     (4)    
ESOP Debt Impacts 2       0     2  
Noncontrolling Interest, Period Increase (Decrease) (54)               (54)
Common Stock, Shares, Outstanding   2,521,004              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 54,721 $ 4,009 986 63,757 (1,229) (14,171) (97,121) 97,881 609
Common Stock, Shares, Outstanding   2,498,093              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 52,883 $ 4,009 967 63,846 (1,204) (14,749) (99,217) 98,641 590
Common Stock, Dividends, Per Share, Cash Paid $ 0.7172                
Common Stock, Dividends, Per Share, Cash Paid $ 1.4344                
Net Earnings $ 6,427                
Other Comprehensive Income (Loss), Net of Tax (84)         (81)     (3)
Dividends, Common Stock (3,581)             3,581  
Dividends, Preferred Stock (131)             (131)  
Treasury Stock, Shares, Acquired   (24,337)              
Stock Repurchased During Period, Value (2,003)           2,003    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   25,389              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 1,669     (53)     1,722    
Stock Issued During Period, Shares, Conversion of Convertible Securities   2,435              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (21) (3)     (18)    
ESOP Debt Impacts 74       26     48  
Noncontrolling Interest, Period Increase (Decrease) (258)     (117)         (141)
Common Stock, Shares, Outstanding   2,491,408              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 52,504 $ 4,009 951 63,711 (1,177) (15,133) (99,956) 99,831 268
Net Earnings 3,216                
Other Comprehensive Income (Loss), Net of Tax (22)         (23)     1
Dividends, Common Stock (1,790)             1,790  
Dividends, Preferred Stock (65)             (65)  
Treasury Stock, Shares, Acquired   (8,647)              
Stock Repurchased During Period, Value (751)           751    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   18,021              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 1,149     (73)     1,222    
Stock Issued During Period, Shares, Conversion of Convertible Securities   798              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (5) 0     (5)    
ESOP Debt Impacts 1       1     0  
Noncontrolling Interest, Period Increase (Decrease) 203     41         162
Common Stock, Shares, Outstanding   2,501,580              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 54,443 $ 4,009 $ 946 $ 63,679 $ (1,178) $ (15,156) $ (99,480) $ 101,170 $ 453
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY YTD - USD ($)
shares in Thousands, $ in Millions
Total
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Reserve for ESOP Debt Retirement [Member]
AOCI Attributable to Parent [Member]
Treasury Stock [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Common Stock, Shares, Outstanding   2,553,297              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 55,778 $ 4,009 $ 1,006 $ 63,641 $ (1,249) $ (14,632) $ (93,715) $ 96,124 $ 594
Common Stock, Dividends, Per Share, Cash Paid $ 0.6896                
Common Stock, Dividends, Per Share, Cash Paid $ 1.3792                
Net Earnings $ 5,431             5,348 83
Other Comprehensive Income (Loss), Net of Tax 461         461     0
Dividends, Common Stock (3,512)             3,512  
Dividends, Preferred Stock (124)             (124)  
Treasury Stock, Shares, Acquired   (46,736)              
Stock Repurchased During Period, Value (4,253)           4,253    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   12,239              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 943     113     830    
Stock Issued During Period, Shares, Conversion of Convertible Securities   2,204              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (20) (3)     (17)    
ESOP Debt Impacts 65       20     45  
Noncontrolling Interest, Period Increase (Decrease) (68)               (68)
Common Stock, Shares, Outstanding   2,536,958              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 55,415 $ 4,009 991 63,705 (1,229) (14,292) (95,563) 97,197 597
Net Earnings 2,561             2,495 66
Other Comprehensive Income (Loss), Net of Tax 121         121     0
Dividends, Common Stock (1,751)             1,751  
Dividends, Preferred Stock (62)             (62)  
Treasury Stock, Shares, Acquired   (19,409)              
Stock Repurchased During Period, Value (1,751)           1,751    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   2,791              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 240     51     189    
Stock Issued During Period, Shares, Conversion of Convertible Securities   664              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (5) (1)     (4)    
ESOP Debt Impacts 2       0     2  
Noncontrolling Interest, Period Increase (Decrease) (54)               (54)
Common Stock, Shares, Outstanding   2,521,004              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 54,721 $ 4,009 986 63,757 (1,229) (14,171) (97,121) 97,881 609
Common Stock, Shares, Outstanding   2,498,093              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 52,883 $ 4,009 967 63,846 (1,204) (14,749) (99,217) 98,641 590
Common Stock, Dividends, Per Share, Cash Paid $ 0.7172                
Common Stock, Dividends, Per Share, Cash Paid $ 1.4344                
Net Earnings $ 6,427                
Other Comprehensive Income (Loss), Net of Tax (84)         (81)     (3)
Dividends, Common Stock (3,581)             3,581  
Dividends, Preferred Stock (131)             (131)  
Treasury Stock, Shares, Acquired   (24,337)              
Stock Repurchased During Period, Value (2,003)           2,003    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   25,389              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 1,669     (53)     1,722    
Stock Issued During Period, Shares, Conversion of Convertible Securities   2,435              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (21) (3)     (18)    
ESOP Debt Impacts 74       26     48  
Noncontrolling Interest, Period Increase (Decrease) (258)     (117)         (141)
Common Stock, Shares, Outstanding   2,491,408              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 52,504 $ 4,009 951 63,711 (1,177) (15,133) (99,956) 99,831 268
Net Earnings 3,216                
Other Comprehensive Income (Loss), Net of Tax (22)         (23)     1
Dividends, Common Stock (1,790)             1,790  
Dividends, Preferred Stock (65)             (65)  
Treasury Stock, Shares, Acquired   (8,647)              
Stock Repurchased During Period, Value (751)           751    
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures   18,021              
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options 1,149     (73)     1,222    
Stock Issued During Period, Shares, Conversion of Convertible Securities   798              
Stock Issued During Period, Value, Conversion of Convertible Securities 0   (5) 0     (5)    
ESOP Debt Impacts 1       1     0  
Noncontrolling Interest, Period Increase (Decrease) 203     41         162
Common Stock, Shares, Outstanding   2,501,580              
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $ 54,443 $ 4,009 $ 946 $ 63,679 $ (1,178) $ (15,156) $ (99,480) $ 101,170 $ 453
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
BASIS OF PRESENTATION
6 Months Ended
Dec. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Basis of PresentationThese statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2018 and the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18. For additional details on the impacts of adoption, see Note 2. In the opinion of management, the accompanying unaudited Consolidated Financial Statements of The Procter & Gamble Company and subsidiaries (the "Company," "Procter & Gamble," "P&G," "we" or "our") contain all adjustments necessary to present fairly the financial position, results of operations and cash flows for the interim periods reported. However, the results of operations included in such financial statements may not necessarily be indicative of annual results.
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES
6 Months Ended
Dec. 31, 2018
Accounting Changes and Error Corrections [Abstract]  
Accounting Changes and Error Corrections [Text Block] New Accounting Pronouncements and Policies and U.S. Tax Reform
On July 1, 2018, we adopted ASU 2014-09, "Revenue from Contracts with Customers (Topic 606)." This guidance outlines a single, comprehensive model of accounting for revenue from contracts with customers. We adopted the standard using the modified retrospective transition method, under which prior periods were not revised to reflect the impacts of the new standard. Our revenue is primarily generated from the sale of finished product to customers. Those sales predominantly contain a single delivery element and revenue is recognized at a single point in time when ownership, risks and rewards transfer. Accordingly, the timing of revenue recognition is not materially impacted by the new standard. Trade promotions, consisting primarily of customer pricing allowances, in-store merchandising funds, advertising and other promotional activities, and consumer coupons, are offered through various programs to customers and consumers.  The adoption of the new standard impacts the accrual timing for certain portions of our customer and consumer promotional spending, which resulted in a cumulative adjustment to Retained earnings of $534, net of tax, on the date of adoption. The provisions of the new standard also impact the classification of certain payments to customers, moving an immaterial amount of such payments from expense to a deduction from net sales. Had this standard been effective and adopted during fiscal 2018, the impact would have been to reclassify $157 from Selling, General and Administrative expense (SG&A) to a reduction of Net sales for the six months ended December 31, 2017 and $309 for the year ended June 30, 2018, with no impact to operating profit. This guidance included practical expedients, none of which are material to our Consolidated Financial Statements. This new guidance does not have any other material impacts on our Consolidated Financial Statements, including financial disclosures.
On July 1, 2018, we adopted ASU 2017-07, "Compensation-Retirement Benefits: Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost (Topic 715)." This guidance requires an entity to disaggregate the current service cost component from the other components of net benefit costs in the face of the income statement. It requires the service cost component to be presented with other current compensation costs for the related employees in the operating section of the income statement, with other components of net benefit cost presented outside of income from operations. We adopted the standard retrospectively, using the practical expedient which allows entities to use information previously disclosed in their pension and other postretirement benefit plans footnote as the basis to apply the retrospective presentation requirements. As such, prior periods’ results have been revised to report the other components of net defined benefit costs, previously reported in Cost of products sold and SG&A, in Other non-operating income, net.
In November 2016, the FASB issued ASU 2016-18, "Statement of Cash Flows: Restricted Cash (Topic 230)." This guidance requires the Statement of Cash Flows to present changes in the total of cash, cash equivalents and restricted cash. Prior to the adoption of this ASU, the relevant accounting guidance did not require the Statement of Cash Flows to include changes in restricted cash. We adopted the standard retrospectively on July 1, 2018. We currently have no significant restricted cash balances. Historically, we had restricted cash balances and changes related to divestiture activity. Such balances were presented as Current assets held for sale on the balance sheets, with changes presented as Investing activities on the Statements of Cash Flow. In accordance with ASU 2016-08, such balances are now included in the beginning and ending balances of Cash, cash equivalents and restricted cash for all periods presented.
In February 2018, the FASB issued ASU 2018-02, "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income (Topic 220)." This guidance permits companies to make an election to reclassify stranded tax effects from the recently enacted U.S. Tax Cuts and Jobs Act included in Accumulated other comprehensive income (AOCI) to Retained earnings.  ASU 2018-02 is effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years, with early adoption permitted. The Company elected to early adopt this guidance in the quarter ended September 30, 2018. The reclassification from the adoption of this standard resulted in an increase of $326 to Retained earnings and a decrease of $326 to AOCI.
In October 2016, the FASB issued ASU 2016-16, "Income Taxes (Topic 740): Intra-Entity transfers of Assets other than Inventory." The standard eliminates the prohibition in ASC 740 against the immediate recognition of the current and deferred income tax effects of intra-entity transfers of assets other than inventory. We have adopted this standard effective July 1, 2018 on a modified
retrospective basis. The adoption of ASU 2016-16 did not have a material impact on our Consolidated Financial Statements, including the cumulative effect adjustment required upon adoption.
In February 2016, the FASB issued ASU 2016-02, "Leases (Topic 842)." The standard requires lessees to recognize lease assets and lease liabilities on the balance sheet and requires expanded disclosures about leasing arrangements. In July 2018, the FASB issued ASU 2018-11, “Leases (Topic 842) Targeted Improvements”. The updated guidance provides an optional transition method, which allows for the application of the standard as of the adoption date with no restatement of prior period amounts. We plan to adopt the standard on July 1, 2019 under the optional transition method described above. We are currently in the process of implementing lease accounting software as well as assessing the impact that the new standard will have on our Consolidated Financial Statements, which will consist primarily of a balance sheet gross up of our operating leases to show equal and offsetting lease assets and lease liabilities.
In January 2017, the FASB issued ASU 2017-04, "Intangibles-Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment." The standard simplifies the accounting for goodwill impairment by requiring a goodwill impairment to be measured using a single step impairment model, whereby the impairment equals the difference between the carrying amount and the fair value of the specified reporting units in their entirety. This eliminates the second step of the current impairment model that requires companies to first estimate the fair value of all assets in a reporting unit and measure impairments based on those fair values and a residual measurement approach. It also specifies that any loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. We will adopt the standard no later than July 1, 2020. The impact of the new standard will be dependent on the specific facts and circumstances of future individual impairments, if any.
No other new accounting pronouncement issued or effective during the fiscal year had, or is expected to have, a material impact on our Consolidated Financial Statements.
U.S. Tax Reform
On December 22, 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the "U.S. Tax Act"). The U.S. Tax Act significantly revises the future ongoing U.S. corporate income tax by, among other things, lowering the U.S. corporate income tax rates and implementing a hybrid territorial tax system. As the Company has a June 30 fiscal year-end, the lower corporate income tax rate was phased in, resulting in a U.S. statutory federal rate of approximately 28% for our fiscal year ended June 30, 2018, and 21% for subsequent fiscal years. However, the U.S. Tax Act eliminates the domestic manufacturing deduction and moves to a hybrid territorial system, which also largely eliminates the ability to credit certain foreign taxes that existed prior to enactment of the U.S. Tax Act.
There are also certain transitional impacts of the U.S. Tax Act. As part of the transition to the new hybrid territorial tax system, the U.S. Tax Act imposed a one-time repatriation tax on deemed repatriation of historical earnings of foreign subsidiaries. In addition, the reduction of the U.S. corporate tax rate caused us to adjust our U.S. deferred tax assets and liabilities to the lower federal base rate of 21%. These transitional impacts resulted in a provisional net charge of $602 million for the fiscal year ended June 30, 2018, and $628 million for the three months ended December 31, 2017 (the quarter of enactment), comprised of an estimated repatriation tax charge of $3.8 billion (comprised of U.S. repatriation taxes and foreign withholding taxes) and an estimated net deferred tax benefit of $3.2 billion. We have finalized our assessment of the transitional impacts of the U.S. Tax Act, which did not have a significant impact on tax expense during the six months ended December 31, 2018. Any legislative changes, including the final Section 965 transition tax regulations issued on January 15, 2019, whose impact is currently being assessed due to the complexity and interdependency of the legislative provisions, as well as any other new or proposed Treasury regulations, which have yet to be issued, may result in additional income tax impacts which could be material in the period any such changes are enacted.
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION
6 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block] Segment Information
Under U.S. GAAP, our Global Business Units (GBUs) are aggregated into five reportable segments: 1) Beauty, 2) Grooming, 3) Health Care, 4) Fabric & Home Care and 5) Baby, Feminine & Family Care. Our five reportable segments are comprised of:
Beauty: Hair Care (Conditioner, Shampoo, Styling Aids, Treatments); Skin and Personal Care (Antiperspirant and Deodorant, Personal Cleansing, Skin Care);
Grooming: Shave Care (Female Blades & Razors, Male Blades & Razors, Pre- and Post-Shave Products, Other Shave Care); Appliances
Health Care: Oral Care (Toothbrushes, Toothpaste, Other Oral Care); Personal Health Care (Gastrointestinal, Rapid Diagnostics, Respiratory, Vitamins/Minerals/Supplements, Other Personal Health Care);
Fabric & Home Care: Fabric Care (Fabric Enhancers, Laundry Additives, Laundry Detergents); Home Care (Air Care, Dish Care, P&G Professional, Surface Care); and
Baby, Feminine & Family Care: Baby Care (Baby Wipes, Diapers and Pants); Feminine Care (Adult Incontinence, Feminine Care); Family Care (Paper Towels, Tissues, Toilet Paper).
Our business units are comprised of similar product categories. Nine business units individually accounted for 5% or more of consolidated net sales as follows:
 
% of Net sales by Business Unit (1)
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Fabric Care
22%
 
21%
 
22%
 
22%
Baby Care
12%
 
13%
 
12%
 
13%
Home Care
10%
 
10%
 
10%
 
10%
Skin and Personal Care
10%
 
9%
 
10%
 
9%
Hair Care
9%
 
10%
 
10%
 
10%
Family Care
9%
 
8%
 
9%
 
8%
Oral Care
9%
 
9%
 
8%
 
8%
Shave Care
7%
 
8%
 
8%
 
8%
Feminine Care
6%
 
6%
 
6%
 
6%
All Other
6%
 
6%
 
5%
 
6%
Total
100%
 
100%
 
100%
 
100%
(1) 
% of Net sales by business unit excludes sales held in Corporate.
Following is a summary of reportable segment results:
 
 
Three Months Ended December 31
 
Six Months Ended December 31
 
 
Net Sales
 
Earnings/(Loss) Before Income Taxes
 
Net Earnings/(Loss)
 
Net Sales
 
Earnings/(Loss) Before Income Taxes
 
Net Earnings/(Loss)
Beauty
2018
$
3,357

 
$
964

 
$
772

 
$
6,646

 
$
1,911

 
$
1,531

 
2017
3,233

 
853

 
655

 
6,371

 
1,689

 
1,287

Grooming
2018
1,617

 
448

 
378

 
3,179

 
865

 
718

 
2017
1,776

 
531

 
423

 
3,353

 
945

 
752

Health Care
2018
2,220

 
669

 
520

 
4,065

 
1,109

 
852

 
2017
2,212

 
668

 
455

 
4,114

 
1,123

 
760

Fabric & Home Care
2018
5,557

 
1,134

 
860

 
11,045

 
2,278

 
1,737

 
2017
5,434

 
1,101

 
714

 
10,817

 
2,280

 
1,483

Baby, Feminine & Family Care
2018
4,558

 
930

 
707

 
8,948

 
1,832

 
1,399

 
2017
4,613

 
933

 
597

 
9,158

 
1,897

 
1,227

Corporate
2018
129

 
(229
)
 
(21
)
 
245

 
(139
)
 
190

 
2017
127

 
(53
)
 
(283
)
 
235

 
(150
)
 
(78
)
Total Company
2018
$
17,438

 
$
3,916

 
$
3,216

 
$
34,128

 
$
7,856

 
$
6,427

 
2017
17,395

 
4,033

 
2,561

 
34,048

 
7,784

 
5,431

XML 28 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS
6 Months Ended
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Disclosure [Text Block] Goodwill and Other Intangible Assets
Goodwill is allocated by reportable segment as follows:
 
Beauty
 
Grooming
 
Health Care
 
Fabric & Home Care
 
Baby, Feminine & Family Care
 
Total Company
Goodwill at June 30, 2018
$
12,992

 
$
19,820

 
$
5,929

 
$
1,865

 
$
4,569

 
$
45,175

Acquisitions and divestitures
132

 

 
1,955

 
6

 

 
2,093

Translation and other
(116
)
 
(135
)
 
(36
)
 
(13
)
 
(36
)
 
(336
)
Goodwill at December 31, 2018
$
13,008

 
$
19,685

 
$
7,848

 
$
1,858

 
$
4,533

 
$
46,932


Goodwill from current year acquisitions primarily reflects the acquisition of the over-the-counter (OTC) healthcare business of Merck KGaA (Merck OTC) in the Health Care reportable segment (see Note 11), along with other minor acquisitions in the Beauty and Fabric & Home Care reportable segments. Goodwill increases due to acquisitions was partially offset by the divestiture of the Teva portion of the PGT business in the Health Care reportable segment and currency translation.
Identifiable intangible assets at December 31, 2018 were comprised of:
 
Gross Carrying Amount
 
Accumulated Amortization
Intangible assets with determinable lives
$
8,580

 
$
(5,251
)
Intangible assets with indefinite lives
22,618

 

Total identifiable intangible assets
$
31,198

 
$
(5,251
)

Intangible assets with determinable lives consist of brands, patents, technology and customer relationships. The intangible assets with indefinite lives consist of brands. The amortization expense of intangible assets for the three months ended December 31, 2018 and 2017 was $81 and $75, respectively. For the six months ended December 31, 2018 and 2017, the amortization expense of intangible assets was $154 and $152, respectively.
Goodwill and indefinite lived intangible assets are not amortized, but are tested annually for impairment. The test to evaluate goodwill for impairment is a two-step process. In the first step, we compare the fair value of the reporting unit to its carrying value. If the fair value of the reporting unit is less than its carrying value, we perform a second step to determine the implied fair value of the reporting unit's goodwill. The second step of the impairment analysis requires a valuation of a reporting unit's tangible and intangible assets and liabilities in a manner similar to the allocation of purchase price in a business combination. If the resulting implied fair value of the reporting unit's goodwill is less than its carrying value, that difference represents an impairment.
The business unit valuations used to test goodwill and intangible assets for impairment are dependent on a number of significant estimates and assumptions, including macroeconomic conditions, overall category growth rates, competitive activities, cost containment, margin expansion and Company business plans. We believe these estimates and assumptions are reasonable. However, future changes in the judgments, assumptions and estimates that are used in our impairment testing for goodwill and indefinite-lived intangible assets, including discount and tax rates or future cash flow projections, could result in significantly different estimates of the fair values. Our annual impairment testing for goodwill and indefinite lived intangible assets occurs during the 3 months ended December 31.
Most of our goodwill reporting units are comprised of a combination of legacy and acquired businesses and as a result have fair value cushions that, at a minimum, exceed two times their underlying carrying values. Certain of our goodwill reporting units, in particular Shave Care and Appliances, are comprised entirely of acquired businesses and as a result, have fair value cushions that are not as high. Both of these wholly acquired reporting units have fair value cushions that currently equal or exceed the underlying carrying values. However, the overall Shave Care goodwill cushion has been reduced in recent years, with the fair value in the current year being reduced to an amount that approximates the reporting unit's carrying value. The related Gillette indefinite-lived intangible asset cushion has also been reduced to below 5%. These reductions are due in large part to an increased competitive market environment in the U.S. and certain other markets, a deceleration of category growth caused by changing grooming habits and significant currency devaluations in a number of countries relative to the U.S. dollar, which collectively have resulted in reduced cash flow projections. The current year reduction in the fair value was primarily caused by further currency devaluations, along with competitive activities. As a result of these factors and the reduction in the fair values and related cushions, goodwill for the Shave Care reporting unit and the related indefinite-lived intangible asset are more susceptible to impairment risk.
The most significant assumptions utilized in the determination of the estimated fair values of Shave Care reporting unit and the Gillette indefinite-lived intangible asset are the net sales and earnings growth rates (including residual growth rates) and discount rate. The residual growth rate represents the expected rate at which the reporting unit and Gillette brand are expected to grow beyond the shorter-term business planning period. The residual growth rate utilized in our fair value estimates is consistent with the reporting unit and brand operating plans, and approximates expected long term category market growth rates. The residual growth rate is dependent on overall market growth rates, the competitive environment, inflation, relative currency exchange rates and business activities that impact market share. As a result, the residual growth rate could be adversely impacted by a sustained deceleration in category growth, grooming habit changes, devaluation of currencies against the U.S. dollar or an increased competitive environment. The discount rate, which is consistent with a weighted average cost of capital that is likely to be expected by a market participant, is based upon industry required rates of return, including consideration of both debt and equity components of the capital structure. Our discount rate may be impacted by adverse changes in the macroeconomic environment, volatility in the equity and debt markets or other country specific factors, such as further devaluation of currencies against the U.S. dollar. Spot rates as of the fair value measurement date are utilized in our fair value estimates for cash flows outside the U.S.
While management can and has implemented strategies to address these events, changes in operating plans or adverse changes in the future could reduce the underlying cash flows used to estimate fair values and could result in a decline in fair value that would trigger future impairment charges of the reporting unit's goodwill and indefinite-lived intangibles. As of December 31, 2018, the carrying values of Shave Care goodwill and the Gillette indefinite-lived intangible asset were $19.4 billion and $15.7 billion, respectively.
The table below provides a sensitivity analysis for the Shave Care reporting unit and the Gillette indefinite lived intangible asset, utilizing reasonably possible changes in the assumptions for the shorter term and residual growth rates and the discount rate, to demonstrate the potential impacts to the estimated fair values. The table below provides, in isolation, the estimated fair value impacts related to a 25 basis point increase to discount rate or a 25 basis point decrease to our shorter-term and residual growth rates, both of which would result in impairment charges.
 
Approximate Percent Change in Estimated Fair Value
 
+25 bps Discount Rate
 
-25 bps Growth Rate
Shave Care goodwill reporting unit
(5
)%
 
(6
)%
Gillette indefinite-lived intangible asset
(5
)%
 
(6
)%
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
EARNINGS PER SHARE
6 Months Ended
Dec. 31, 2018
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block] Earnings Per Share
Basic net earnings per common share are calculated by dividing Net earnings attributable to Procter & Gamble less preferred dividends (net of related tax benefits) by the weighted average number of common shares outstanding during the period. Diluted net earnings per common share are calculated using the treasury stock method on the basis of the weighted average number of common shares outstanding plus the dilutive effect of stock options and other stock-based awards and the assumed conversion of preferred stock.
Net earnings per share were as follows:
CONSOLIDATED AMOUNTS
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Net earnings
$
3,216

 
$
2,561

 
$
6,427

 
$
5,431

Less: Net earnings attributable to noncontrolling interests
22

 
66

 
34

 
83

Net earnings attributable to P&G (Diluted)
3,194

 
2,495

 
6,393

 
5,348

Preferred dividends, net of tax
(65
)
 
(62
)
 
(131
)
 
(124
)
Net earnings attributable to P&G available to common shareholders (Basic)
$
3,129

 
$
2,433

 
$
6,262

 
$
5,224

 
 
 
 
 
 
 
 
SHARES IN MILLIONS
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
2,499.7

 
2,533.9

 
2,497.8

 
2,542.2

Add: Effect of dilutive securities
 
 
 
 
 
 
 
Conversion of preferred shares (1)
90.7

 
95.5

 
91.3

 
96.0

Impact of stock options and other unvested equity awards (2)
32.6

 
40.2

 
28.5

 
41.9

Diluted weighted average common shares outstanding
2,623.0

 
2,669.6

 
2,617.6

 
2,680.1

 
 
 
 
 
 
 
 
NET EARNINGS PER SHARE (3)
 
 
 
 
 
 
 
Basic
$
1.25

 
$
0.96

 
$
2.51

 
$
2.05

Diluted
$
1.22

 
$
0.93

 
$
2.44

 
$
2.00

(1) 
Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.
(2) 
Weighted average outstanding stock options of approximately 23 million and 24 million for the three months ended December 31, 2018 and 2017, and approximately 35 million and 22 million for the six months ended December 31, 2018 and 2017 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
(3) 
Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS
6 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Compensation and Employee Benefit Plans [Text Block] Share-Based Compensation and Postretirement Benefits
The following table provides a summary of our share-based compensation expense and postretirement benefit costs:
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Share-based compensation expense
$
79

  
$
73

 
$
181

 
$
157

Net periodic benefit cost for pension benefits (1)
36

 
52

 
64

 
103

Net periodic benefit cost/(credit) for other retiree benefits (1)
(42
)
 
(38
)
 
(83
)
 
(76
)
(1) 
The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2018, as revised by the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18.
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS
6 Months Ended
Dec. 31, 2018
Risk Management Activities and Fair Value Measurements [Abstract]  
Risk Management And Fair Value [Text Block] Risk Management Activities and Fair Value Measurements
As a multinational company with diverse product offerings, we are exposed to market risks, such as changes in interest rates, currency exchange rates and commodity prices. There have been no significant changes in our risk management policies or activities during the six months ended December 31, 2018.
The Company has not changed its valuation techniques used in measuring the fair value of any financial assets and liabilities during the period. The Company recognizes transfers between levels within the fair value hierarchy, if any, at the end of each quarter. There were no transfers between levels during the periods presented. Also, there was no significant activity within the Level 3 assets and liabilities during the periods presented. There were no significant assets or liabilities that were remeasured at fair value on a non-recurring basis for the six months ended December 31, 2018.
The following table sets forth the Company’s financial assets as of December 31, 2018 and June 30, 2018 that are measured at fair value on a recurring basis during the period:
 
Fair Value Asset
 
December 31, 2018
 
June 30, 2018
Investments:
 
 
 
U.S. government securities
$
5,177

 
$
5,544

Corporate bond securities
3,244

 
3,737

Other investments
163

 
141

Total
$
8,584

 
$
9,422


Investment securities are presented in Available-for-sale investment securities and Other noncurrent assets. The amortized cost of U.S. government securities with maturities less than one year was $1,601 as of December 31, 2018 and $2,003 as of June 30, 2018. The amortized cost of U.S. government securities with maturities between one and five years was $3,657 as of December 31, 2018 and $3,659 as of June 30, 2018. The amortized cost of Corporate bond securities with maturities of less than a year was $1,525 as of December 31, 2018 and $1,291 as of June 30, 2018. The amortized cost of Corporate bond securities with maturities between one and five years was $1,760 as of December 31, 2018 and $2,503 as of June 30, 2018. The Company's investments measured at fair value are generally classified as Level 2 within the fair value hierarchy. There are no material investment balances classified as Level 1 or Level 3 within the fair value hierarchy, or that used net asset value as a practical expedient. Fair values are generally estimated based upon quoted market prices for similar instruments.
The fair value of long-term debt was $24,602 and $23,402 as of December 31, 2018 and June 30, 2018, respectively. This includes the current portion of debt instruments ($2,301 and $1,769 as of December 31, 2018 and June 30, 2018, respectively). Certain long-term debt (debt tied to derivatives designated as a fair value hedge) is recorded at fair value. All other long-term debt is recorded at amortized cost, but is measured at fair value for disclosure purposes. We consider our debt to be Level 2 in the fair value hierarchy. Fair values are generally estimated based on quoted market prices for identical or similar instruments.
Disclosures about Financial Instruments
The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2018 and June 30, 2018 are as follows:
 
Notional Amount
 
Fair Value Asset
 
Fair Value (Liability)
 
December 31, 2018
 
June 30, 2018
 
December 31, 2018
 
June 30, 2018
 
December 31, 2018
 
June 30, 2018
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts
$
4,550

 
$
4,587

 
$
118

 
$
125

 
$
(28
)
 
$
(53
)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts
$
1,855

 
$
1,848

 
$
21

 
$
41

 
$
(59
)
 
$
(75
)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS
$
6,405

 
$
6,435

 
$
139

 
$
166

 
$
(87
)
 
$
(128
)
 
 
 
 
 
 
 
 
 
 
 
 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts
$
7,025

 
$
7,358

 
$
49

 
$
30

 
$
(29
)
 
$
(56
)
 
 
 
 
 
 
 
 
 
 
 
 
TOTAL DERIVATIVES AT FAIR VALUE
$
13,430

 
$
13,793

 
$
188

 
$
196

 
$
(116
)
 
$
(184
)

All derivative assets are presented in Prepaid expenses and other current assets or Other noncurrent assets. All derivative liabilities are presented in Accrued and other liabilities or Other noncurrent liabilities.
The fair value of the interest rate derivative asset/liability directly offsets the cumulative amount of the fair value hedging adjustment included in the carrying amount of the underlying debt obligation. The carrying amount of the underlying debt obligation, which includes the unamortized discount or premium and the fair value adjustment, was $4,623 and $4,639 as of December 31, 2018 and June 30, 2018, respectively. In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The carrying value of those debt instruments designated as net investment hedges, which includes the adjustment for the foreign currency transaction gain or loss on those instruments, was $17,092 and $15,012 as of December 31, 2018 and June 30, 2018, respectively. All of the Company's derivative assets and liabilities measured at fair value are classified as Level 2 within the fair value hierarchy.
Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows:
 
Amount of Gain/(Loss) Recognized in OCI on Derivatives
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign exchange contracts
$
23

 
$
(89
)
 
$
19

 
$
(262
)

(1) 
For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was $13 and $42 for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) excluded from effectiveness testing was $27 and $73 for the six months ended December 31, 2018 and 2017, respectively.
(2) 
In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments was $228 and $(176), for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $241 and $(745), for the six months ended December 31, 2018 and 2017, respectively.
 
Amount of Gain/(Loss) Recognized in Earnings
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
 
 
 
 
Interest rate contracts
$
42

 
$
(38
)
 
$
18

 
$
(41
)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
 
 
 
 
Foreign currency contracts
$
(5
)
 
$
(1
)
 
$
(7
)
 
$
(2
)

The gain/(loss) on the derivatives in fair value hedging relationships is fully offset by the mark-to-market impact of the related exposure. These are both recognized in the Consolidated Statements of Earnings in Interest Expense. The gain/(loss) on derivatives not designated as hedging instruments is substantially offset by the currency mark-to-market of the related exposure. These are both recognized in the Consolidated Statements of Earnings in SG&A.
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)
6 Months Ended
Dec. 31, 2018
Statement of Comprehensive Income [Abstract]  
Comprehensive Income (Loss) Note [Text Block] Accumulated Other Comprehensive Income/(Loss)
The table below presents the changes in Accumulated other comprehensive income/(loss) (AOCI), including the reclassifications out of Accumulated other comprehensive income/(loss) by component:
 
Changes in Accumulated Other Comprehensive Income/(Loss) by Component
 
Hedges
 
Investment Securities
 
Pension and Other Retiree Benefits
 
Financial Statement Translation
 
Total AOCI
Balance at June 30, 2018
$
(3,246
)
 
$
(173
)
 
$
(4,058
)
 
$
(7,272
)
 
$
(14,749
)
OCI before reclassifications (1)
199

 
54

 
149

 
(587
)
 
(185
)
Amounts reclassified from AOCI (2)

 
(1
)
 
101

 
1

 
101

Net current period OCI
199

 
53

 
250

 
(586
)
 
(84
)
Reclassification to retained earnings in accordance with ASU 2018-02 (3)
(18
)
 

 
(308
)
 

 
(326
)
Less: Other comprehensive income/(loss) attributable to non-controlling interests

 

 

 
(3
)
 
(3
)
Balance at December 31, 2018
$
(3,065
)
 
$
(120
)
 
$
(4,116
)
 
$
(7,855
)
 
$
(15,156
)

(1) 
Net of tax expense/(benefit) of $61, $0 and $38 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
(2) 
Net of tax expense/(benefit) of $0, $0 and $32 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
(3) 
Adjustment made to early adopt ASU 2018-02: "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income," as discussed in Note 2.

The below provides additional details on amounts reclassified from AOCI into the Consolidated Statements of Earnings:
Investment securities: amounts reclassified from AOCI into Other non-operating income, net.
Pension and other retiree benefits: amounts reclassified from AOCI into Other non-operating income, net and included in the computation of net periodic postretirement costs.
Financial statement translation: amounts reclassified from AOCI into SG&A.
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
RESTRUCTURING PROGRAM
6 Months Ended
Dec. 31, 2018
Restructuring and Related Activities [Abstract]  
Restructuring and Related Activities Disclosure [Text Block] Restructuring Program
The Company has historically incurred an ongoing annual level of restructuring-type activities to maintain a competitive cost structure, including manufacturing and workforce optimization. Before-tax costs incurred under the ongoing program have generally ranged from $250 to $500 annually.
In fiscal 2017, the Company announced specific elements of a multi-year productivity and cost savings plan to further reduce costs in the areas of supply chain, certain marketing activities and overhead expenses. This program is expected to result in incremental enrollment reductions, along with further optimization of the supply chain and other manufacturing processes.
Restructuring costs incurred consist primarily of costs to separate employees, asset-related costs to exit facilities and other costs. For the three and six month periods ended December 31, 2018, the Company incurred total restructuring charges of $177 and $314, respectively. Of these charges incurred, $25 and $97 were recorded in SG&A and $143 and $207 were recorded in Cost of products sold, respectively. The remainder of these charges were recorded in Other non-operating income, net. The following table presents restructuring activity for the six months ended December 31, 2018:
 
 
 
Charges Previously Reported (Three Months Ended September 30, 2018)
 
Charges for the Three Months Ended December 31, 2018
 
Six Months Ended December 31, 2018
 
 
 
Reserve Balance June 30, 2018
 
 
 
Cash Spent
 
Charges Against Assets
 
Reserve Balance December 31, 2018
Separations
$
259

 
$
53

 
$
56

 
$
(115
)
 
$

 
$
253

Asset-related costs

 
28

 
22

 

 
(50
)
 

Other costs
254

 
56

 
99

 
(180
)
 

 
229

Total
$
513

 
$137
 
$
177

 
$
(295
)
 
$
(50
)
 
$
482


Separation Costs
Employee separation charges for the three and six month periods ended December 31, 2018 relate to severance packages for approximately 500 employees and 970 employees, respectively. The packages were predominantly voluntary and the amounts were calculated based on salary levels and past service periods. Severance costs related to voluntary separations are generally charged to earnings when the employee accepts the offer.
Asset-Related Costs
Asset-related costs consist of both asset write-downs and accelerated depreciation. Asset write-downs relate to the establishment of a new fair value basis for assets held-for-sale or disposal. These assets were written down to the lower of their current carrying basis or amounts expected to be realized upon disposal, less minor disposal costs. Charges for accelerated depreciation relate to long-lived assets that will be taken out of service prior to the end of their normal service period. These assets relate primarily to manufacturing consolidations and technology standardizations. The asset-related charges will not have a significant impact on future depreciation charges.
Other Costs
Other restructuring-type charges are incurred as a direct result of the restructuring program. Such charges primarily include asset removal and termination of contracts related to supply chain optimization.
Consistent with our historical policies for ongoing restructuring-type activities, the restructuring program charges are funded by and included within Corporate for both management and segment reporting. Accordingly, all of the charges under the program are included within the Corporate reportable segment. However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments:
 
Three Months Ended December 31, 2018
 
Six Months Ended December 31, 2018
Beauty
$
17

 
$
27

Grooming
25

 
31

Health Care
4

 
12

Fabric & Home Care
18

 
31

Baby, Feminine & Family Care
70

 
91

Corporate (1)
43

 
122

Total Company
$177
 
$
314

(1) 
Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities.
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
COMMITMENTS AND CONTINGENCIES
6 Months Ended
Dec. 31, 2018
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies
Litigation
The Company is subject to various legal proceedings and claims arising out of our business which cover a wide range of matters such as antitrust, trade and other governmental regulations, product liability, patent and trademark, advertising, contracts, environmental, labor and employment and tax. With respect to these and other litigation and claims, while considerable uncertainty exists, in the opinion of management and our counsel, the ultimate resolution of the various lawsuits and claims will not materially affect our financial position, results of operations or cash flows.
We are also subject to contingencies pursuant to environmental laws and regulations that in the future may require us to take action to correct the effects on the environment of prior manufacturing and waste disposal practices. Based on currently available information, we do not believe the ultimate resolution of environmental remediation will materially affect our financial position, results of operations or cash flows.
Income Tax Uncertainties
The Company is present in approximately 150 taxable jurisdictions and, at any point in time, has 4050 jurisdictional audits underway at various stages of completion. We evaluate our tax positions and establish liabilities for uncertain tax positions that may be challenged by local authorities and may not be fully sustained, despite our belief that the underlying tax positions are fully supportable. Uncertain tax positions are reviewed on an ongoing basis and are adjusted in light of changing facts and circumstances, including progress of tax audits, developments in case law and closing of statutes of limitations. Such adjustments are reflected in the tax provision as appropriate. We have tax years open ranging from 2008 and forward. We are generally not able to reliably estimate the ultimate settlement amounts until the close of the audit. While we do not expect material changes, it is possible that the amount of unrecognized benefit with respect to our uncertain tax positions could increase or decrease within the next 12 months. At this time, we are not able to make a reasonable estimate of the range of impact on the balance of uncertain tax positions or the impact on the effective tax rate related to these items.
Additional information on the Commitments and Contingencies of the Company can be found in our Annual Report on Form 10-K for the year ended June 30, 2018.
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACQUISITION
6 Months Ended
Dec. 31, 2018
Business Combinations [Abstract]  
Business Combination Disclosure [Text Block] Merck Acquisition

On November 30, 2018, we completed our acquisition of the over the counter (OTC) healthcare business of Merck KGaA (Merck OTC) for $3.7 billion (based on exchange rates at the time of closing) in an all-cash transaction. This business primarily sells OTC consumer healthcare products, mainly in Europe, Latin America and Asia markets. The results of Merck OTC, which are not material to the Company, are reported in our consolidated financial statements beginning December 1, 2018. Total sales for Merck OTC’s most recently completed fiscal year ended December 31, 2017 were approximately $1 billion.
The following table presents the preliminary allocation of purchase price related to the Merck OTC business as of the date of acquisition. The preliminary allocation of the purchase price is based on the best estimates of management and is subject to revision based on final determination of fair values of the assets and liabilities acquired, which will be completed as we complete our analysis of the underlying assets and acquired liabilities, such as pensions, litigation cases, environmental issues, and tax positions.
Amounts in Millions
November 30, 2018
Current assets
$
393

Property, plant and equipment
122

Intangible assets
2,111

Goodwill
2,010

Other non-current assets
143

Total Assets Acquired
$
4,779

 
 
Current liabilities
$
233

Deferred income taxes
661

Non-current liabilities
60

Total Liabilities Acquired
$
954

 
 
Noncontrolling Interest (1)
$
169

 
 
Net Assets Acquired
$
3,656

(1) 
Represents a 48% minority ownership interest in the Merck India company.

The acquisition resulted in $2.0 billion in goodwill, of which approximately $180 million is expected to be deductible for tax purposes. All of this goodwill was allocated to the Health Care Segment. The goodwill is primarily attributable to the assembled workforce and synergies we expect to generate by combining the Merck OTC business with the Company’s existing personal health care business.

We have preliminarily estimated the fair value of Merck OTC’s identifiable intangible assets as $2.1 billion. The preliminary allocation of identifiable intangible assets and their average useful lives is as follows:
Amounts in Millions
Estimated Fair Value
 
Avg Remaining
Useful Life
Intangible Assets with Determinable Lives
 
 
 
   Brands
$
701

 
14
   Patents and technology
118

 
7
   Customer relationships
346

 
20
   Total
$
1,165

 
15
 
 
 
 
Intangible Assets with Indefinite Lives
 
 
 
   Brands
946

 
 
Total Intangible Assets
$
2,111

 
 


The majority of the intangible valuation relates to brand intangibles. Our preliminary assessment as to brand intangibles that have an indefinite life and those that have a definite life was based on a number of factors, including competitive environment, market share, brand history, product life cycles, operating plan and the macroeconomic environment of the countries in which the brands are sold. The indefinite-lived brand intangibles include Neurobion and Dolo Neurobion. The definite-lived brand intangibles primarily include regional or local brands. The definite-lived brand intangibles have estimated lives ranging from 10 to 20 years. The technology intangibles are related to R&D and manufacturing know-how; these intangibles have a 7 year estimated life. The customer relationships intangibles have a 20 year estimated life and reflect the historical and projected attrition rates for Merck OTC’s relationships with health care professionals, retailers and distributors.
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION (Tables)
6 Months Ended
Dec. 31, 2018
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment Following is a summary of reportable segment results:
 
 
Three Months Ended December 31
 
Six Months Ended December 31
 
 
Net Sales
 
Earnings/(Loss) Before Income Taxes
 
Net Earnings/(Loss)
 
Net Sales
 
Earnings/(Loss) Before Income Taxes
 
Net Earnings/(Loss)
Beauty
2018
$
3,357

 
$
964

 
$
772

 
$
6,646

 
$
1,911

 
$
1,531

 
2017
3,233

 
853

 
655

 
6,371

 
1,689

 
1,287

Grooming
2018
1,617

 
448

 
378

 
3,179

 
865

 
718

 
2017
1,776

 
531

 
423

 
3,353

 
945

 
752

Health Care
2018
2,220

 
669

 
520

 
4,065

 
1,109

 
852

 
2017
2,212

 
668

 
455

 
4,114

 
1,123

 
760

Fabric & Home Care
2018
5,557

 
1,134

 
860

 
11,045

 
2,278

 
1,737

 
2017
5,434

 
1,101

 
714

 
10,817

 
2,280

 
1,483

Baby, Feminine & Family Care
2018
4,558

 
930

 
707

 
8,948

 
1,832

 
1,399

 
2017
4,613

 
933

 
597

 
9,158

 
1,897

 
1,227

Corporate
2018
129

 
(229
)
 
(21
)
 
245

 
(139
)
 
190

 
2017
127

 
(53
)
 
(283
)
 
235

 
(150
)
 
(78
)
Total Company
2018
$
17,438

 
$
3,916

 
$
3,216

 
$
34,128

 
$
7,856

 
$
6,427

 
2017
17,395

 
4,033

 
2,561

 
34,048

 
7,784

 
5,431

Our business units are comprised of similar product categories. Nine business units individually accounted for 5% or more of consolidated net sales as follows:
 
% of Net sales by Business Unit (1)
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Fabric Care
22%
 
21%
 
22%
 
22%
Baby Care
12%
 
13%
 
12%
 
13%
Home Care
10%
 
10%
 
10%
 
10%
Skin and Personal Care
10%
 
9%
 
10%
 
9%
Hair Care
9%
 
10%
 
10%
 
10%
Family Care
9%
 
8%
 
9%
 
8%
Oral Care
9%
 
9%
 
8%
 
8%
Shave Care
7%
 
8%
 
8%
 
8%
Feminine Care
6%
 
6%
 
6%
 
6%
All Other
6%
 
6%
 
5%
 
6%
Total
100%
 
100%
 
100%
 
100%
(1) 
% of Net sales by business unit excludes sales held in Corporate.
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)
6 Months Ended
Dec. 31, 2018
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill [Table Text Block] Goodwill is allocated by reportable segment as follows:
 
Beauty
 
Grooming
 
Health Care
 
Fabric & Home Care
 
Baby, Feminine & Family Care
 
Total Company
Goodwill at June 30, 2018
$
12,992

 
$
19,820

 
$
5,929

 
$
1,865

 
$
4,569

 
$
45,175

Acquisitions and divestitures
132

 

 
1,955

 
6

 

 
2,093

Translation and other
(116
)
 
(135
)
 
(36
)
 
(13
)
 
(36
)
 
(336
)
Goodwill at December 31, 2018
$
13,008

 
$
19,685

 
$
7,848

 
$
1,858

 
$
4,533

 
$
46,932

Schedule of Intangible Assets and Goodwill [Table Text Block] Identifiable intangible assets at December 31, 2018 were comprised of:
 
Gross Carrying Amount
 
Accumulated Amortization
Intangible assets with determinable lives
$
8,580

 
$
(5,251
)
Intangible assets with indefinite lives
22,618

 

Total identifiable intangible assets
$
31,198

 
$
(5,251
)
Schedule of Potential Impacts to Estimated Fair Values [Table Text Block] The table below provides, in isolation, the estimated fair value impacts related to a 25 basis point increase to discount rate or a 25 basis point decrease to our shorter-term and residual growth rates, both of which would result in impairment charges.
 
Approximate Percent Change in Estimated Fair Value
 
+25 bps Discount Rate
 
-25 bps Growth Rate
Shave Care goodwill reporting unit
(5
)%
 
(6
)%
Gillette indefinite-lived intangible asset
(5
)%
 
(6
)%
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
EARNINGS PER SHARE (Tables)
6 Months Ended
Dec. 31, 2018
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Net earnings per share were as follows:
CONSOLIDATED AMOUNTS
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Net earnings
$
3,216

 
$
2,561

 
$
6,427

 
$
5,431

Less: Net earnings attributable to noncontrolling interests
22

 
66

 
34

 
83

Net earnings attributable to P&G (Diluted)
3,194

 
2,495

 
6,393

 
5,348

Preferred dividends, net of tax
(65
)
 
(62
)
 
(131
)
 
(124
)
Net earnings attributable to P&G available to common shareholders (Basic)
$
3,129

 
$
2,433

 
$
6,262

 
$
5,224

 
 
 
 
 
 
 
 
SHARES IN MILLIONS
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
2,499.7

 
2,533.9

 
2,497.8

 
2,542.2

Add: Effect of dilutive securities
 
 
 
 
 
 
 
Conversion of preferred shares (1)
90.7

 
95.5

 
91.3

 
96.0

Impact of stock options and other unvested equity awards (2)
32.6

 
40.2

 
28.5

 
41.9

Diluted weighted average common shares outstanding
2,623.0

 
2,669.6

 
2,617.6

 
2,680.1

 
 
 
 
 
 
 
 
NET EARNINGS PER SHARE (3)
 
 
 
 
 
 
 
Basic
$
1.25

 
$
0.96

 
$
2.51

 
$
2.05

Diluted
$
1.22

 
$
0.93

 
$
2.44

 
$
2.00

(1) 
Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.
(2) 
Weighted average outstanding stock options of approximately 23 million and 24 million for the three months ended December 31, 2018 and 2017, and approximately 35 million and 22 million for the six months ended December 31, 2018 and 2017 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
(3) 
Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables)
6 Months Ended
Dec. 31, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Compensation and Employee Benefit Plans [Table Text Block] The following table provides a summary of our share-based compensation expense and postretirement benefit costs:
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
Share-based compensation expense
$
79

  
$
73

 
$
181

 
$
157

Net periodic benefit cost for pension benefits (1)
36

 
52

 
64

 
103

Net periodic benefit cost/(credit) for other retiree benefits (1)
(42
)
 
(38
)
 
(83
)
 
(76
)
(1) 
The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2018, as revised by the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18.
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables)
6 Months Ended
Dec. 31, 2018
Risk Management Activities and Fair Value Measurements [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] The following table sets forth the Company’s financial assets as of December 31, 2018 and June 30, 2018 that are measured at fair value on a recurring basis during the period:
 
Fair Value Asset
 
December 31, 2018
 
June 30, 2018
Investments:
 
 
 
U.S. government securities
$
5,177

 
$
5,544

Corporate bond securities
3,244

 
3,737

Other investments
163

 
141

Total
$
8,584

 
$
9,422

Schedule of Derivative Instruments [Table Text Block] The notional amounts and fair values of financial instruments used in hedging transactions as of December 31, 2018 and June 30, 2018 are as follows:
 
Notional Amount
 
Fair Value Asset
 
Fair Value (Liability)
 
December 31, 2018
 
June 30, 2018
 
December 31, 2018
 
June 30, 2018
 
December 31, 2018
 
June 30, 2018
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
Interest rate contracts
$
4,550

 
$
4,587

 
$
118

 
$
125

 
$
(28
)
 
$
(53
)
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS
Foreign currency interest rate contracts
$
1,855

 
$
1,848

 
$
21

 
$
41

 
$
(59
)
 
$
(75
)
TOTAL DERIVATIVES DESIGNATED AS HEDGING INSTRUMENTS
$
6,405

 
$
6,435

 
$
139

 
$
166

 
$
(87
)
 
$
(128
)
 
 
 
 
 
 
 
 
 
 
 
 
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
Foreign currency contracts
$
7,025

 
$
7,358

 
$
49

 
$
30

 
$
(29
)
 
$
(56
)
 
 
 
 
 
 
 
 
 
 
 
 
TOTAL DERIVATIVES AT FAIR VALUE
$
13,430

 
$
13,793

 
$
188

 
$
196

 
$
(116
)
 
$
(184
)

Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block] Before tax gains/(losses) on our financial instruments in hedging relationships are categorized as follows:
 
Amount of Gain/(Loss) Recognized in OCI on Derivatives
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
DERIVATIVES IN NET INVESTMENT HEDGING RELATIONSHIPS (1) (2)
Foreign exchange contracts
$
23

 
$
(89
)
 
$
19

 
$
(262
)

(1) 
For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was $13 and $42 for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) excluded from effectiveness testing was $27 and $73 for the six months ended December 31, 2018 and 2017, respectively.
(2) 
In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments was $228 and $(176), for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $241 and $(745), for the six months ended December 31, 2018 and 2017, respectively.
Derivative Instruments, Gain (Loss) [Table Text Block]
 
Amount of Gain/(Loss) Recognized in Earnings
 
Three Months Ended December 31
 
Six Months Ended December 31
 
2018
 
2017
 
2018
 
2017
DERIVATIVES IN FAIR VALUE HEDGING RELATIONSHIPS
 
 
 
 
Interest rate contracts
$
42

 
$
(38
)
 
$
18

 
$
(41
)
DERIVATIVES NOT DESIGNATED AS HEDGING INSTRUMENTS
 
 
 
 
Foreign currency contracts
$
(5
)
 
$
(1
)
 
$
(7
)
 
$
(2
)

XML 41 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)
6 Months Ended
Dec. 31, 2018
Statement of Comprehensive Income [Abstract]  
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] The table below presents the changes in Accumulated other comprehensive income/(loss) (AOCI), including the reclassifications out of Accumulated other comprehensive income/(loss) by component:
 
Changes in Accumulated Other Comprehensive Income/(Loss) by Component
 
Hedges
 
Investment Securities
 
Pension and Other Retiree Benefits
 
Financial Statement Translation
 
Total AOCI
Balance at June 30, 2018
$
(3,246
)
 
$
(173
)
 
$
(4,058
)
 
$
(7,272
)
 
$
(14,749
)
OCI before reclassifications (1)
199

 
54

 
149

 
(587
)
 
(185
)
Amounts reclassified from AOCI (2)

 
(1
)
 
101

 
1

 
101

Net current period OCI
199

 
53

 
250

 
(586
)
 
(84
)
Reclassification to retained earnings in accordance with ASU 2018-02 (3)
(18
)
 

 
(308
)
 

 
(326
)
Less: Other comprehensive income/(loss) attributable to non-controlling interests

 

 

 
(3
)
 
(3
)
Balance at December 31, 2018
$
(3,065
)
 
$
(120
)
 
$
(4,116
)
 
$
(7,855
)
 
$
(15,156
)

(1) 
Net of tax expense/(benefit) of $61, $0 and $38 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
(2) 
Net of tax expense/(benefit) of $0, $0 and $32 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
(3) 
Adjustment made to early adopt ASU 2018-02: "Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income," as discussed in Note 2.
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
RESTRUCTURING PROGRAM (Tables)
6 Months Ended
Dec. 31, 2018
Restructuring and Related Activities [Abstract]  
Schedule of Restructuring Reserve by Type of Cost [Table Text Block] The following table presents restructuring activity for the six months ended December 31, 2018:
 
 
 
Charges Previously Reported (Three Months Ended September 30, 2018)
 
Charges for the Three Months Ended December 31, 2018
 
Six Months Ended December 31, 2018
 
 
 
Reserve Balance June 30, 2018
 
 
 
Cash Spent
 
Charges Against Assets
 
Reserve Balance December 31, 2018
Separations
$
259

 
$
53

 
$
56

 
$
(115
)
 
$

 
$
253

Asset-related costs

 
28

 
22

 

 
(50
)
 

Other costs
254

 
56

 
99

 
(180
)
 

 
229

Total
$
513

 
$137
 
$
177

 
$
(295
)
 
$
(50
)
 
$
482


Restructuring and Related Costs [Table Text Block] However, for informative purposes, the following table summarizes the total restructuring costs related to our reportable segments:
 
Three Months Ended December 31, 2018
 
Six Months Ended December 31, 2018
Beauty
$
17

 
$
27

Grooming
25

 
31

Health Care
4

 
12

Fabric & Home Care
18

 
31

Baby, Feminine & Family Care
70

 
91

Corporate (1)
43

 
122

Total Company
$177
 
$
314

(1) 
Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities.
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACQUISITION - ALLOCATION OF PURCHASE PRICE (Tables)
6 Months Ended
Dec. 31, 2018
Business Combinations [Abstract]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] The preliminary allocation of the purchase price is based on the best estimates of management and is subject to revision based on final determination of fair values of the assets and liabilities acquired, which will be completed as we complete our analysis of the underlying assets and acquired liabilities, such as pensions, litigation cases, environmental issues, and tax positions.
Amounts in Millions
November 30, 2018
Current assets
$
393

Property, plant and equipment
122

Intangible assets
2,111

Goodwill
2,010

Other non-current assets
143

Total Assets Acquired
$
4,779

 
 
Current liabilities
$
233

Deferred income taxes
661

Non-current liabilities
60

Total Liabilities Acquired
$
954

 
 
Noncontrolling Interest (1)
$
169

 
 
Net Assets Acquired
$
3,656

(1) 
Represents a 48% minority ownership interest in the Merck India company.
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACQUISITION - FAIR VALUE OF INTANGIBLES (Tables)
6 Months Ended
Dec. 31, 2018
Business Combinations [Abstract]  
Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block] The preliminary allocation of identifiable intangible assets and their average useful lives is as follows:
Amounts in Millions
Estimated Fair Value
 
Avg Remaining
Useful Life
Intangible Assets with Determinable Lives
 
 
 
   Brands
$
701

 
14
   Patents and technology
118

 
7
   Customer relationships
346

 
20
   Total
$
1,165

 
15
 
 
 
 
Intangible Assets with Indefinite Lives
 
 
 
   Brands
946

 
 
Total Intangible Assets
$
2,111

 
 
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - ADDITIONAL INFORMATION (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Dec. 31, 2018
Jun. 30, 2018
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification $ (553)  
Payments to Customers [Member] | Selling, General and Administrative Expenses [Member]    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification 157 $ 309
Customer and Consumer Promotional Spending [Member] | Retained Earnings [Member]    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification 534  
Reclassification from AOCI to Retained Earnings for Tax Effects [Domain] | Retained Earnings [Member]    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification 326  
Reclassification from AOCI to Retained Earnings for Tax Effects [Domain] | Other Comprehensive Income (Loss)    
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification $ (326)  
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES - U.S. TAX REFORM (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Jun. 30, 2019
Jun. 30, 2018
Jan. 01, 2018
Income Tax Expense (Benefit) $ 700 $ 1,472 $ 1,429 $ 2,353      
U.S. Tax Cuts and Jobs Act, Effective 2018              
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent           28.00%  
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Base Rate, Percent             21.00%
Income Tax Expense (Benefit)   $ 628       $ 602  
Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount           3,800  
Deferred Federal Income Tax Expense (Benefit)           $ 3,200  
U.S. Tax Cuts and Jobs Act, Effective 2018 | Scenario, Forecast              
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent         21.00%    
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION SEGMENT INFORMATION - SALES (Details)
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 100.00% 100.00% 100.00% 100.00%
Fabric Care [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 22.00% 21.00% 22.00% 22.00%
Baby Care [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 12.00% 13.00% 12.00% 13.00%
Hair Care [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 9.00% 10.00% 10.00% 10.00%
Home Care [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 10.00% 10.00% 10.00% 10.00%
Skin and Personal Care [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 10.00% 9.00% 10.00% 9.00%
Family Care [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 9.00% 8.00% 9.00% 8.00%
Shave Care        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 7.00% 8.00% 8.00% 8.00%
Oral Care [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 9.00% 9.00% 8.00% 8.00%
Feminine Care [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 6.00% 6.00% 6.00% 6.00%
All Other [Member]        
Segment Reporting Information [Line Items]        
Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit 6.00% 6.00% 5.00% 6.00%
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
SEGMENT INFORMATION (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Segment Reporting Information [Line Items]        
Net Sales $ 17,438 $ 17,395 $ 34,128 $ 34,048
Earnings/(Loss) from Continuing Operations Before Income Taxes 3,916 4,033 7,856 7,784
Net Earnings/(Loss) from Continuing Operations 3,216 2,561 6,427 5,431
Beauty        
Segment Reporting Information [Line Items]        
Net Sales 3,357 3,233 6,646 6,371
Earnings/(Loss) from Continuing Operations Before Income Taxes 964 853 1,911 1,689
Net Earnings/(Loss) from Continuing Operations 772 655 1,531 1,287
Grooming        
Segment Reporting Information [Line Items]        
Net Sales 1,617 1,776 3,179 3,353
Earnings/(Loss) from Continuing Operations Before Income Taxes 448 531 865 945
Net Earnings/(Loss) from Continuing Operations 378 423 718 752
Health Care        
Segment Reporting Information [Line Items]        
Net Sales 2,220 2,212 4,065 4,114
Earnings/(Loss) from Continuing Operations Before Income Taxes 669 668 1,109 1,123
Net Earnings/(Loss) from Continuing Operations 520 455 852 760
Fabric and Home Care        
Segment Reporting Information [Line Items]        
Net Sales 5,557 5,434 11,045 10,817
Earnings/(Loss) from Continuing Operations Before Income Taxes 1,134 1,101 2,278 2,280
Net Earnings/(Loss) from Continuing Operations 860 714 1,737 1,483
Baby, Feminine & Family Care        
Segment Reporting Information [Line Items]        
Net Sales 4,558 4,613 8,948 9,158
Earnings/(Loss) from Continuing Operations Before Income Taxes 930 933 1,832 1,897
Net Earnings/(Loss) from Continuing Operations 707 597 1,399 1,227
Corporate        
Segment Reporting Information [Line Items]        
Net Sales 129 127 245 235
Earnings/(Loss) from Continuing Operations Before Income Taxes (229) (53) (139) (150)
Net Earnings/(Loss) from Continuing Operations $ (21) $ (283) $ 190 $ (78)
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details)
$ in Millions
6 Months Ended
Dec. 31, 2018
USD ($)
Goodwill [Roll Forward]  
Goodwill at June 30, 2018 $ 45,175
Goodwill, Acquisitions and Divestitures 2,093
Goodwill, Translation and Other (336)
Goodwill at December 31, 2018 46,932
Beauty  
Goodwill [Roll Forward]  
Goodwill at June 30, 2018 12,992
Goodwill, Acquisitions and Divestitures 132
Goodwill, Translation and Other (116)
Goodwill at December 31, 2018 13,008
Grooming  
Goodwill [Roll Forward]  
Goodwill at June 30, 2018 19,820
Goodwill, Acquisitions and Divestitures 0
Goodwill, Translation and Other (135)
Goodwill at December 31, 2018 19,685
Health Care  
Goodwill [Roll Forward]  
Goodwill at June 30, 2018 5,929
Goodwill, Acquisitions and Divestitures 1,955
Goodwill, Translation and Other (36)
Goodwill at December 31, 2018 7,848
Fabric & Home Care  
Goodwill [Roll Forward]  
Goodwill at June 30, 2018 1,865
Goodwill, Acquisitions and Divestitures 6
Goodwill, Translation and Other (13)
Goodwill at December 31, 2018 1,858
Baby, Feminine & Family Care  
Goodwill [Roll Forward]  
Goodwill at June 30, 2018 4,569
Goodwill, Acquisitions and Divestitures 0
Goodwill, Translation and Other (36)
Goodwill at December 31, 2018 $ 4,533
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details)
$ in Millions
Dec. 31, 2018
USD ($)
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]  
Gross Carrying Amount $ 31,198
Accumulated Amortization (5,251)
Intangible Assets with Indefinite Lives  
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]  
Gross Carrying Amount 22,618
Accumulated Amortization 0
Intangible Assets with Determinable Lives  
Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]  
Gross Carrying Amount 8,580
Accumulated Amortization $ (5,251)
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Jun. 30, 2018
Other Significant Noncash Transactions [Line Items]          
Amortization of Intangible Assets $ 81 $ 75 $ 154 $ 152  
Goodwill 46,932   46,932   $ 45,175
Shave Care          
Other Significant Noncash Transactions [Line Items]          
Goodwill $ 19,400   $ 19,400    
Intangible Assets with Indefinite Lives | Gillette          
Other Significant Noncash Transactions [Line Items]          
Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount 5.00%   5.00%    
Intangible Assets, Net (Including Goodwill) $ 15,700   $ 15,700    
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.10.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION OTHER (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Other Significant Noncash Transactions [Line Items]        
Amortization of Intangible Assets $ 81 $ 75 $ 154 $ 152
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.10.0.1
GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details)
Dec. 31, 2018
25 bps Increase Discount Rate [Member] | Intangible Assets with Indefinite Lives | Gillette  
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]  
Percent Change in Estimated Fair Value (5.00%)
25 bps Decrease Long-Term Growth [Member] | Intangible Assets with Indefinite Lives | Gillette  
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]  
Percent Change in Estimated Fair Value (6.00%)
Goodwill | 25 bps Increase Discount Rate [Member] | Shave Care  
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]  
Percent Change in Estimated Fair Value (5.00%)
Goodwill | 25 bps Decrease Long-Term Growth [Member] | Shave Care  
SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]  
Percent Change in Estimated Fair Value (6.00%)
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.10.0.1
EARNINGS PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Earnings Per Share Reconciliation [Abstract]        
Net Earnings $ 3,216 $ 2,561 $ 6,427 $ 5,431
Net Income (Loss) Attributable to Noncontrolling Interest 22 66 34 83
Net Earnings/(Loss) Attributable to P&G (Diluted) 3,194 2,495 6,393 5,348
Dividends, Preferred Stock (65) (62) (131) (124)
Net Earnings/(Loss) Attributable to P&G Available to Common Shareholders (Basic) $ 3,129 $ 2,433 $ 6,262 $ 5,224
Weighted Average Number of Shares Outstanding, Diluted [Abstract]        
Basic Weighted Average Common Shares Outstanding 2,499.7 2,533.9 2,497.8 2,542.2
Effect of Dilutive Securities        
Conversion of Preferred Shares [1] 90.7 95.5 91.3 96.0
Exercise of Stock Options and Other Unvested Equity Awards [2] 32.6 40.2 28.5 41.9
Diluted Weighted Average Common Shares Outstanding 2,623.0 2,669.6 2,617.6 2,680.1
Basic Net Earnings/(Loss) Per Common Share [3],[4] $ 1.25 $ 0.96 $ 2.51 $ 2.05
Diluted Net Earnings/(Loss) Per Common Share [3],[4] $ 1.22 $ 0.93 $ 2.44 $ 2.00
[1] Despite being included currently in Diluted net earnings per common share, the actual conversion to common stock occurs when the preferred shares are sold. Shares may only be sold after being allocated to the ESOP participants pursuant to the repayment of the ESOP's obligations through 2035.
[2] Weighted average outstanding stock options of approximately 23 million and 24 million for the three months ended December 31, 2018 and 2017, and approximately 35 million and 22 million for the six months ended December 31, 2018 and 2017 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
[3] Basic net earnings per share and Diluted net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
[4] Net earnings per share are calculated on Net earnings attributable to Procter & Gamble.
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.10.0.1
EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details) - shares
shares in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Employee Stock Option        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount [1] 23 24 35 22
[1] Weighted average outstanding stock options of approximately 23 million and 24 million for the three months ended December 31, 2018 and 2017, and approximately 35 million and 22 million for the six months ended December 31, 2018 and 2017 respectively, were not included in the Diluted net earnings per share calculation because the options were out of the money or to do so would have been antidilutive (i.e., the total proceeds upon exercise would have exceeded the market value of the underlying common shares).
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.10.0.1
SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]        
Allocated Share-based Compensation Expense $ 79 $ 73 $ 181 $ 157
Pension Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [1] 36 52 64 103
Other Postretirement Benefit Plan        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [1] $ (42) $ (38) $ (83) $ (76)
[1] The components of the total net periodic benefit cost for both pension benefits and other retiree benefits for those interim periods, on an annualized basis, do not differ materially from the amounts disclosed in the Annual Report on Form 10-K for the fiscal year ended June 30, 2018, as revised by the Form 8-K filed October 22, 2018 to update the Form 10-K to revise disclosures to reflect the adoption of the Financial Accounting Standards Board (FASB) ASU 2017-07 and 2016-18.
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) - USD ($)
$ in Millions
Dec. 31, 2018
Jun. 30, 2018
Fair Value Asset $ 8,584 $ 9,422
U.S. Government Securities    
Fair Value Asset 5,177 5,544
Corporate Bond Securities    
Fair Value Asset 3,244 3,737
Other Investments    
Fair Value Asset $ 163 $ 141
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Dec. 31, 2018
Jun. 30, 2018
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Long-term Debt, Fair Value $ 24,602 $ 23,402
Long Term Debt, Current Maturities Measured at Fair Value 2,301 1,769
U.S. Government Securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost 1,601 2,003
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost 3,657 3,659
Corporate Bond Securities    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost 1,525 1,291
Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost 1,760 2,503
Derivatives in Fair Value Hedging Relationships | Underlying, Other    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Underlying Debt Obligation, Carrying Amount 4,623 4,639
Derivatives in Net Investment Hedging Relationships | Underlying, Other    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Underlying Debt Obligation, Carrying Amount $ 17,092 $ 15,012
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE NOTIONAL AMOUNTS AND FAIR VALUE (Details) - USD ($)
$ in Millions
Dec. 31, 2018
Jun. 30, 2018
Derivative [Line Items]    
Notional Amount $ 13,430 $ 13,793
Derivative Asset 188 196
Derivative Liability (116) (184)
Foreign Exchange Contract    
Derivative [Line Items]    
Notional Amount 7,025 7,358
Derivative Asset 49 30
Derivative Liability 29 56
Derivatives in Fair Value Hedging Relationships | Interest Rate Contracts    
Derivative [Line Items]    
Notional Amount 4,550 4,587
Derivative Asset 118 125
Derivative Liability 28 53
Derivatives in Net Investment Hedging Relationships    
Derivative [Line Items]    
Notional Amount 1,855 1,848
Derivative Asset 21 41
Derivative Liability 59 75
Designated as Hedging Instrument    
Derivative [Line Items]    
Notional Amount 6,405 6,435
Derivative Asset 139 166
Derivative Liability $ 87 $ 128
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (EFFECTIVE PORTION) (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Foreign Exchange Contract | Derivatives in Net Investment Hedging Relationships        
Derivative Instruments, Gain (Loss) [Line Items]        
Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax [1],[2] $ 23 $ (89) $ 19 $ (262)
[1] For the derivatives in net investment hedging relationships, the amount of gain/(loss) excluded from effectiveness testing, which was recognized in earnings, was $13 and $42 for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) excluded from effectiveness testing was $27 and $73 for the six months ended December 31, 2018 and 2017, respectively.
[2] In addition to the foreign currency derivative contracts designated as net investment hedges, certain of our foreign currency denominated debt instruments are designated as net investment hedges. The amount of gain/(loss) recognized in AOCI for such instruments was $228 and $(176), for the three months ended December 31, 2018 and 2017, respectively. The amount of gain/(loss) recognized in AOCI for such instruments was $241 and $(745), for the six months ended December 31, 2018 and 2017, respectively.
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Not Designated as Hedging Instrument | Foreign Currency Contract        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings $ (5) $ (1) $ (7) $ (2)
Derivatives in Fair Value Hedging Relationships | Interest Rate Contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of Gain/(Loss) Recognized in Earnings $ 42 $ (38) $ 18 $ (41)
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - AMOUNT OF GAINS AND LOSSES ON OUTSTANDING DERIVATIVES - ADDITIONAL INFORMATION (Details) (Details) - Derivatives in Net Investment Hedging Relationships - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net $ 13 $ 42 $ 27 $ 73
Accumulated Other Comprehensive Income, Gain (Loss) $ 228 $ (176) $ 241 $ (745)
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.10.0.1
RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - NOTIONAL AMOUNTS AND FAIR VALUES OF QUALIFYING AND NON-QUALIFYING FINANCIAL INSTRUMENTS USED IN HEDGING TRANSACTIONS - ADDITIONAL INFORMATION (Details) (Details) - Underlying, Other - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Dec. 31, 2018
Jun. 30, 2018
Derivatives in Fair Value Hedging Relationships    
Derivative [Line Items]    
Underlying Debt Obligation, Carrying Amount $ 4,623 $ 4,639
Derivatives in Net Investment Hedging Relationships    
Derivative [Line Items]    
Underlying Debt Obligation, Carrying Amount $ 17,092 $ 15,012
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Jun. 30, 2018
Accumulated Other Comprehensive Income/(Loss) $ (15,156)   $ (15,156)   $ (14,749)
OCI before Reclassifications     (185)    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax     101    
Other Comprehensive Income (Loss), Net of Tax (22) $ 121 (84) $ 461  
Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings     (326)    
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest     (3)    
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member]          
Accumulated Other Comprehensive Income/(Loss) (3,065)   (3,065)   (3,246)
OCI before Reclassifications [1]     199    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax [2]     0    
Other Comprehensive Income (Loss), Net of Tax     199    
Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings     (18)    
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest     0    
Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]          
Accumulated Other Comprehensive Income/(Loss) (120)   (120)   (173)
OCI before Reclassifications [1]     54    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax [2]     (1)    
Other Comprehensive Income (Loss), Net of Tax     53    
Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings     0    
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest     0    
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest          
Accumulated Other Comprehensive Income/(Loss) (4,116)   (4,116)   (4,058)
OCI before Reclassifications [1]     149    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax [2]     101    
Other Comprehensive Income (Loss), Net of Tax     250    
Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings     (308)    
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest     0    
Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]          
Accumulated Other Comprehensive Income/(Loss) $ (7,855)   (7,855)   $ (7,272)
OCI before Reclassifications     (587)    
Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax     1    
Other Comprehensive Income (Loss), Net of Tax     (586)    
Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings     0    
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest     $ (3)    
[1] Net of tax expense/(benefit) of $61, $0 and $38 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
[2] Net of tax expense/(benefit) of $0, $0 and $32 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - NET OF TAX EXPENSE (BENEFIT) (Details)
$ in Millions
6 Months Ended
Dec. 31, 2018
USD ($)
Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member]  
Other Comprehensive Income (Loss) before Reclassifications, Tax $ 61 [1]
Reclassification from AOCI, Current Period, Tax 0 [2]
Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]  
Other Comprehensive Income (Loss) before Reclassifications, Tax 0 [1]
Reclassification from AOCI, Current Period, Tax 0 [2]
Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest  
Other Comprehensive Income (Loss) before Reclassifications, Tax 38 [1]
Reclassification from AOCI, Current Period, Tax $ 32 [2]
[1] Net of tax expense/(benefit) of $61, $0 and $38 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
[2] Net of tax expense/(benefit) of $0, $0 and $32 for gains/losses on hedges, investment securities and pension and other retiree benefit items, respectively.
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.10.0.1
RESTRUCTURING PROGRAM - ADDITIONAL INFORMATION (Details)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
USD ($)
employee
Sep. 30, 2018
USD ($)
employee
Dec. 31, 2018
USD ($)
Restructuring Charges $ 177 $ 137 $ 314
Minimum      
Restructuring and Related Cost, Amounts Historically Incurred     250
Maximum      
Restructuring and Related Cost, Amounts Historically Incurred     500
Selling, General and Administrative Expense      
Restructuring Charges 25   97
Cost of Products Sold      
Restructuring Charges 143   $ 207
Separations      
Restructuring Charges $ 56 $ 53  
Restructuring and Related Cost, Number of Severance Packages Executed | employee 970 500  
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.10.0.1
RESTRUCTURING PROGRAM - RESTRUCTURING RESERVE BY TYPE OF COSTS (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Dec. 31, 2018
Restructuring Reserve [Roll Forward]      
Reserve Balance June 30, 2018   $ 513 $ 513
Restructuring Charges $ 177 137 314
Cash Spent     (295)
Charges Against Assets     (50)
Reserve Balance December 31, 2018 482   482
Separations      
Restructuring Reserve [Roll Forward]      
Reserve Balance June 30, 2018   259 259
Restructuring Charges 56 53  
Cash Spent     (115)
Charges Against Assets     0
Reserve Balance December 31, 2018 253   253
Asset-related Costs      
Restructuring Reserve [Roll Forward]      
Reserve Balance June 30, 2018   0 0
Restructuring Charges 22 28  
Cash Spent     0
Charges Against Assets     (50)
Reserve Balance December 31, 2018 0   0
Other Costs      
Restructuring Reserve [Roll Forward]      
Reserve Balance June 30, 2018   254 254
Restructuring Charges 99 $ 56  
Cash Spent     (180)
Charges Against Assets     0
Reserve Balance December 31, 2018 $ 229   $ 229
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.10.0.1
RESTRUCTURING PROGRAM - RESTRUCTURING COSTS PER SEGMENT (Details) - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges $ 177 $ 137 $ 314
Beauty      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges 17   27
Grooming      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges 25   31
Health Care      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges 4   12
Fabric & Home Care      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges 18   31
Baby, Feminine & Family Care      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges 70   91
Corporate      
Restructuring Cost and Reserve [Line Items]      
Restructuring Charges $ 43   $ 122 [1]
[1] Corporate includes costs related to allocated overheads, including charges related to our Sales and Market Operations, Global Business Services and Corporate Functions activities.
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.10.0.1
COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details)
6 Months Ended
Dec. 31, 2018
audit
taxable_jurisdiction
Loss Contingencies [Line Items]  
Number of Taxable Jurisdictions | taxable_jurisdiction 150
Minimum  
Loss Contingencies [Line Items]  
Number of Audits Typically Underway 40
Maximum  
Loss Contingencies [Line Items]  
Number of Audits Typically Underway 50
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACQUISITION - ALLOCATION OF PURCHASE PRICE (Details) - USD ($)
$ in Millions
Dec. 31, 2018
Nov. 30, 2018
Jun. 30, 2018
Business Acquisition [Line Items]      
Goodwill $ 46,932   $ 45,175
PHC-MERCK ACQUISITION [Member]      
Business Acquisition [Line Items]      
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents   $ 393  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment   122  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill   2,111  
Goodwill   2,010  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets   143  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets   4,779  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities   233  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent   661  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities   60  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities   954  
Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value [1]   169  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net   $ 3,656  
[1] Represents a 48% minority ownership interest in the Merck India company.
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACQUISITION ACQUISITION - FAIR VALUE OF INTANGIBLES (Details) - USD ($)
$ in Millions
6 Months Ended
Dec. 31, 2018
Nov. 30, 2018
Other Intangible Assets [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 15 years  
PHC-MERCK ACQUISITION [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   $ 1,165
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill   2,111
PHC-MERCK ACQUISITION [Member] | Trade Names [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   701
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 14 years  
PHC-MERCK ACQUISITION [Member] | Patents and Developed Technology [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   118
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 7 years  
PHC-MERCK ACQUISITION [Member] | Customer Relationships [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles   346
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 20 years  
PHC-MERCK ACQUISITION [Member] | Trade Names [Member]    
Acquired Finite-Lived Intangible Assets [Line Items]    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets   $ 946
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.10.0.1
ACQUISITION - ADDITIONAL INFORMATION (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Nov. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2018
Jun. 30, 2018
Business Acquisition [Line Items]              
Goodwill   $ 46,932   $ 46,932   $ 46,932 $ 45,175
Net Sales   $ 17,438 $ 17,395 $ 34,128 $ 34,048    
PHC-MERCK ACQUISITION [Member]              
Business Acquisition [Line Items]              
Payments to Acquire Businesses, Gross $ 3,700            
Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage 48.00%            
Goodwill $ 2,010            
Business Acquisition, Goodwill, Expected Tax Deductible Amount 180            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill $ 2,111            
Net Sales           $ 1,000  
Trade Names [Member] | PHC-MERCK ACQUISITION [Member]              
Business Acquisition [Line Items]              
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life       14 years      
Trade Names [Member] | Minimum | PHC-MERCK ACQUISITION [Member]              
Business Acquisition [Line Items]              
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life       10 years      
Trade Names [Member] | Maximum | PHC-MERCK ACQUISITION [Member]              
Business Acquisition [Line Items]              
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life       20 years      
Patents and Developed Technology [Member] | PHC-MERCK ACQUISITION [Member]              
Business Acquisition [Line Items]              
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life       7 years      
Customer Relationships [Member] | PHC-MERCK ACQUISITION [Member]              
Business Acquisition [Line Items]              
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life       20 years      
EXCEL 73 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 74 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 75 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 77 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 277 201 1 true 71 0 false 7 false false R1.htm 0001000 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.pg.com/role/DocumentAndEntityInformation DOCUMENT AND ENTITY INFORMATION Cover 1 false false R2.htm 1001000 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS Sheet http://www.pg.com/role/ConsolidatedStatementsOfEarnings CONSOLIDATED STATEMENTS OF EARNINGS Statements 2 false false R3.htm 1002000 - Statement - CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Statements 3 false false R4.htm 1003000 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://www.pg.com/role/ConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 4 false false R5.htm 1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.pg.com/role/ConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 5 false false R6.htm 1005000 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity QTD Sheet http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity QTD Statements 6 false false R7.htm 1005001 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity FYTD Sheet http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity FYTD Statements 7 false false R8.htm 1005002 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY QTD Sheet http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY QTD Statements 8 false false R9.htm 1005003 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY YTD Sheet http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY YTD Statements 9 false false R10.htm 2101100 - Disclosure - BASIS OF PRESENTATION Sheet http://www.pg.com/role/BasisOfPresentation BASIS OF PRESENTATION Notes 10 false false R11.htm 2102100 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES Sheet http://www.pg.com/role/NewAccountingPronouncementsAndPolicies NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES Notes 11 false false R12.htm 2103100 - Disclosure - SEGMENT INFORMATION Sheet http://www.pg.com/role/SegmentInformation SEGMENT INFORMATION Notes 12 false false R13.htm 2104100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS Sheet http://www.pg.com/role/GoodwillAndOtherIntangibleAssets GOODWILL AND OTHER INTANGIBLE ASSETS Notes 13 false false R14.htm 2105100 - Disclosure - EARNINGS PER SHARE Sheet http://www.pg.com/role/EarningsPerShare EARNINGS PER SHARE Notes 14 false false R15.htm 2106100 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS Sheet http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefits SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS Notes 15 false false R16.htm 2107100 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurements RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS Notes 16 false false R17.htm 2108100 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Notes 17 false false R18.htm 2109100 - Disclosure - RESTRUCTURING PROGRAM Sheet http://www.pg.com/role/RestructuringProgram RESTRUCTURING PROGRAM Notes 18 false false R19.htm 2110100 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.pg.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 19 false false R20.htm 2111100 - Disclosure - ACQUISITION Sheet http://www.pg.com/role/Acquisition ACQUISITION Notes 20 false false R21.htm 2303301 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://www.pg.com/role/SegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://www.pg.com/role/SegmentInformation 21 false false R22.htm 2304301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Sheet http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsTables GOODWILL AND OTHER INTANGIBLE ASSETS (Tables) Tables http://www.pg.com/role/GoodwillAndOtherIntangibleAssets 22 false false R23.htm 2305301 - Disclosure - EARNINGS PER SHARE (Tables) Sheet http://www.pg.com/role/EarningsPerShareTables EARNINGS PER SHARE (Tables) Tables http://www.pg.com/role/EarningsPerShare 23 false false R24.htm 2306301 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables) Sheet http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsTables SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables) Tables http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefits 24 false false R25.htm 2307301 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables) Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsTables RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables) Tables http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurements 25 false false R26.htm 2308301 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables) Tables http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss 26 false false R27.htm 2309301 - Disclosure - RESTRUCTURING PROGRAM (Tables) Sheet http://www.pg.com/role/RestructuringProgramTables RESTRUCTURING PROGRAM (Tables) Tables http://www.pg.com/role/RestructuringProgram 27 false false R28.htm 2311301 - Disclosure - ACQUISITION - ALLOCATION OF PURCHASE PRICE (Tables) Sheet http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceTables ACQUISITION - ALLOCATION OF PURCHASE PRICE (Tables) Tables 28 false false R29.htm 2311303 - Disclosure - ACQUISITION - FAIR VALUE OF INTANGIBLES (Tables) Sheet http://www.pg.com/role/AcquisitionFairValueOfIntangiblesTables ACQUISITION - FAIR VALUE OF INTANGIBLES (Tables) Tables 29 false false R30.htm 2402401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - ADDITIONAL INFORMATION (Details) Sheet http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - ADDITIONAL INFORMATION (Details) Details 30 false false R31.htm 2402402 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES - U.S. TAX REFORM (Details) Sheet http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES - U.S. TAX REFORM (Details) Details 31 false false R32.htm 2403402 - Disclosure - SEGMENT INFORMATION SEGMENT INFORMATION - SALES (Details) Sheet http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails SEGMENT INFORMATION SEGMENT INFORMATION - SALES (Details) Details 32 false false R33.htm 2403403 - Disclosure - SEGMENT INFORMATION (Details) Sheet http://www.pg.com/role/SegmentInformationDetails SEGMENT INFORMATION (Details) Details http://www.pg.com/role/SegmentInformationTables 33 false false R34.htm 2404402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details) Sheet http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details) Details 34 false false R35.htm 2404403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details) Sheet http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details) Details 35 false false R36.htm 2404404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details) Sheet http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details) Details 36 false false R37.htm 2404405 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION OTHER (Details) Sheet http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION OTHER (Details) Details 37 false false R38.htm 2404406 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details) Sheet http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details) Details 38 false false R39.htm 2405402 - Disclosure - EARNINGS PER SHARE (Details) Sheet http://www.pg.com/role/EarningsPerShareDetails EARNINGS PER SHARE (Details) Details http://www.pg.com/role/EarningsPerShareTables 39 false false R40.htm 2405403 - Disclosure - EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details) Sheet http://www.pg.com/role/EarningsPerShareAntidilutiveSecuritiesDetails EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details) Details 40 false false R41.htm 2406402 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details) Sheet http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details) Details http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsTables 41 false false R42.htm 2407402 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details) Details 42 false false R43.htm 2407403 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details) Details 43 false false R44.htm 2407404 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE NOTIONAL AMOUNTS AND FAIR VALUE (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE NOTIONAL AMOUNTS AND FAIR VALUE (Details) Details 44 false false R45.htm 2407405 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (EFFECTIVE PORTION) (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (EFFECTIVE PORTION) (Details) Details http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsTables 45 false false R46.htm 2407406 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (Details) Details http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsTables 46 false false R47.htm 2407407 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - AMOUNT OF GAINS AND LOSSES ON OUTSTANDING DERIVATIVES - ADDITIONAL INFORMATION (Details) (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - AMOUNT OF GAINS AND LOSSES ON OUTSTANDING DERIVATIVES - ADDITIONAL INFORMATION (Details) (Details) Details 47 false false R48.htm 2407408 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - NOTIONAL AMOUNTS AND FAIR VALUES OF QUALIFYING AND NON-QUALIFYING FINANCIAL INSTRUMENTS USED IN HEDGING TRANSACTIONS - ADDITIONAL INFORMATION (Details) (Details) Sheet http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - NOTIONAL AMOUNTS AND FAIR VALUES OF QUALIFYING AND NON-QUALIFYING FINANCIAL INSTRUMENTS USED IN HEDGING TRANSACTIONS - ADDITIONAL INFORMATION (Details) (Details) Details 48 false false R49.htm 2408402 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details) Details http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables 49 false false R50.htm 2408403 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - NET OF TAX EXPENSE (BENEFIT) (Details) Sheet http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - NET OF TAX EXPENSE (BENEFIT) (Details) Details http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables 50 false false R51.htm 2409402 - Disclosure - RESTRUCTURING PROGRAM - ADDITIONAL INFORMATION (Details) Sheet http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails RESTRUCTURING PROGRAM - ADDITIONAL INFORMATION (Details) Details 51 false false R52.htm 2409403 - Disclosure - RESTRUCTURING PROGRAM - RESTRUCTURING RESERVE BY TYPE OF COSTS (Details) Sheet http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails RESTRUCTURING PROGRAM - RESTRUCTURING RESERVE BY TYPE OF COSTS (Details) Details 52 false false R53.htm 2409404 - Disclosure - RESTRUCTURING PROGRAM - RESTRUCTURING COSTS PER SEGMENT (Details) Sheet http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails RESTRUCTURING PROGRAM - RESTRUCTURING COSTS PER SEGMENT (Details) Details 53 false false R54.htm 2410401 - Disclosure - COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details) Sheet http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details) Details 54 false false R55.htm 2411402 - Disclosure - ACQUISITION - ALLOCATION OF PURCHASE PRICE (Details) Sheet http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails ACQUISITION - ALLOCATION OF PURCHASE PRICE (Details) Details http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceTables 55 false false R56.htm 2411404 - Disclosure - ACQUISITION ACQUISITION - FAIR VALUE OF INTANGIBLES (Details) Sheet http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails ACQUISITION ACQUISITION - FAIR VALUE OF INTANGIBLES (Details) Details 56 false false R57.htm 2411405 - Disclosure - ACQUISITION - ADDITIONAL INFORMATION (Details) Sheet http://www.pg.com/role/AcquisitionAdditionalInformationDetails ACQUISITION - ADDITIONAL INFORMATION (Details) Details 57 false false All Reports Book All Reports fy1819q2ond10-qreport.htm fy1819q2ond10-qexhibit101.htm fy1819q2ond10-qexhibit102.htm fy1819q2ond10-qexhibit103.htm fy1819q2ond10-qexhibit311.htm fy1819q2ond10-qexhibit312.htm fy1819q2ond10-qexhibit321.htm fy1819q2ond10-qexhibit322.htm pg-20181231.xsd pg-20181231_cal.xml pg-20181231_def.xml pg-20181231_lab.xml pg-20181231_pre.xml http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 http://xbrl.sec.gov/invest/2013-01-31 http://fasb.org/srt/2018-01-31 true true JSON 79 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "fy1819q2ond10-qreport.htm": { "axisCustom": 2, "axisStandard": 18, "contextCount": 277, "dts": { "calculationLink": { "local": [ "pg-20181231_cal.xml" ] }, "definitionLink": { "local": [ "pg-20181231_def.xml" ], "remote": [ "http://xbrl.fasb.org/srt/2018/elts/srt-eedm1-def-2018-01-31.xml", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-eedm-def-2018-01-31.xml" ] }, "inline": { "local": [ "fy1819q2ond10-qreport.htm" ] }, "labelLink": { "local": [ "pg-20181231_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-doc-2018-01-31.xml", "http://xbrl.sec.gov/invest/2013/invest-doc-2013-01-31.xml", "https://xbrl.sec.gov/dei/2018/dei-doc-2018-01-31.xml" ] }, "presentationLink": { "local": [ "pg-20181231_pre.xml" ] }, "referenceLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-ref-2018-01-31.xml", "http://xbrl.sec.gov/invest/2013/invest-ref-2013-01-31.xml", "https://xbrl.sec.gov/dei/2018/dei-ref-2018-01-31.xml" ] }, "schema": { "local": [ "pg-20181231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-roles-2018-01-31.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-parts-codification-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd", "http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd", "http://xbrl.sec.gov/invest/2013/invest-2013-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/dei/2018/dei-2018-01-31.xsd", "https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" ] } }, "elementCount": 402, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2018-01-31": 4, "http://xbrl.sec.gov/dei/2018-01-31": 12, "total": 16 }, "keyCustom": 19, "keyStandard": 182, "memberCustom": 29, "memberStandard": 39, "nsprefix": "pg", "nsuri": "http://www.pg.com/20181231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - DOCUMENT AND ENTITY INFORMATION", "role": "http://www.pg.com/role/DocumentAndEntityInformation", "shortName": "DOCUMENT AND ENTITY INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - BASIS OF PRESENTATION", "role": "http://www.pg.com/role/BasisOfPresentation", "shortName": "BASIS OF PRESENTATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountingChangesAndErrorCorrectionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2102100 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES", "role": "http://www.pg.com/role/NewAccountingPronouncementsAndPolicies", "shortName": "NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountingChangesAndErrorCorrectionsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2103100 - Disclosure - SEGMENT INFORMATION", "role": "http://www.pg.com/role/SegmentInformation", "shortName": "SEGMENT INFORMATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104100 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS", "role": "http://www.pg.com/role/GoodwillAndOtherIntangibleAssets", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2105100 - Disclosure - EARNINGS PER SHARE", "role": "http://www.pg.com/role/EarningsPerShare", "shortName": "EARNINGS PER SHARE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS", "role": "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefits", "shortName": "SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "pg:RiskManagementAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurements", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "pg:RiskManagementAndFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)", "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2109100 - Disclosure - RESTRUCTURING PROGRAM", "role": "http://www.pg.com/role/RestructuringProgram", "shortName": "RESTRUCTURING PROGRAM", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2110100 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://www.pg.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - CONSOLIDATED STATEMENTS OF EARNINGS", "role": "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "shortName": "CONSOLIDATED STATEMENTS OF EARNINGS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "lang": null, "name": "us-gaap:CostOfGoodsAndServicesSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - ACQUISITION", "role": "http://www.pg.com/role/Acquisition", "shortName": "ACQUISITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2303301 - Disclosure - SEGMENT INFORMATION (Tables)", "role": "http://www.pg.com/role/SegmentInformationTables", "shortName": "SEGMENT INFORMATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "role": "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsTables", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2305301 - Disclosure - EARNINGS PER SHARE (Tables)", "role": "http://www.pg.com/role/EarningsPerShareTables", "shortName": "EARNINGS PER SHARE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables)", "role": "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsTables", "shortName": "SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "pg:CompensationandEmployeeBenefitPlansTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2307301 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables)", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsTables", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)", "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2309301 - Disclosure - RESTRUCTURING PROGRAM (Tables)", "role": "http://www.pg.com/role/RestructuringProgramTables", "shortName": "RESTRUCTURING PROGRAM (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311301 - Disclosure - ACQUISITION - ALLOCATION OF PURCHASE PRICE (Tables)", "role": "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceTables", "shortName": "ACQUISITION - ALLOCATION OF PURCHASE PRICE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311303 - Disclosure - ACQUISITION - FAIR VALUE OF INTANGIBLES (Tables)", "role": "http://www.pg.com/role/AcquisitionFairValueOfIntangiblesTables", "shortName": "ACQUISITION - FAIR VALUE OF INTANGIBLES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "role": "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome", "shortName": "CONDOLIDATED STATEMENTS OF COMPREHENSIVE INCOME", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402401 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - ADDITIONAL INFORMATION (Details)", "role": "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - ADDITIONAL INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD_us-gaap_IncomeStatementLocationAxis_us-gaap_SellingGeneralAndAdministrativeExpensesMember_us-gaap_StatementScenarioAxis_pg_PaymentstoCustomersMember", "decimals": "-6", "lang": null, "name": "us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2402402 - Disclosure - NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES - U.S. TAX REFORM (Details)", "role": "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails", "shortName": "NEW ACCOUNTING PRONOUNCEMENTS AND POLICIES - U.S. TAX REFORM (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2018Q4YTD_us-gaap_IncomeTaxAuthorityAxis_pg_U.S.TaxCutsandJobsActEffective2018Member", "decimals": "2", "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "ratio", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "2", "first": true, "lang": null, "name": "pg:SegmentReportingAdditionalInformationaboutEntitysReportableSegmentsPercentofSalesbyBusinessUnit", "reportCount": 1, "unique": true, "unitRef": "ratio", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403402 - Disclosure - SEGMENT INFORMATION SEGMENT INFORMATION - SALES (Details)", "role": "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails", "shortName": "SEGMENT INFORMATION SEGMENT INFORMATION - SALES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "2", "first": true, "lang": null, "name": "pg:SegmentReportingAdditionalInformationaboutEntitysReportableSegmentsPercentofSalesbyBusinessUnit", "reportCount": 1, "unique": true, "unitRef": "ratio", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2403403 - Disclosure - SEGMENT INFORMATION (Details)", "role": "http://www.pg.com/role/SegmentInformationDetails", "shortName": "SEGMENT INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "lang": null, "name": "us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404402 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details)", "role": "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - CHANGE IN THE NET CARRYING AMOUNT OF GOODWILL BY GLOBAL BUSINESS UNIT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": "-6", "lang": null, "name": "pg:GoodwillAcquisitionsandDivestitures", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404403 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details)", "role": "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - IDENTIFIABLE INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404404 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details)", "role": "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404405 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION OTHER (Details)", "role": "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - ADDITIONAL INFORMATION OTHER (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "FI2019Q2_pg_PotentialImpactstoEstimatedFairValueAxis_pg_A25bpsIncreaseDiscountRateMemberMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_IndefinitelivedIntangibleAssetsMember_us-gaap_StatementBusinessSegmentsAxis_pg_GilletteMember", "decimals": "2", "first": true, "lang": null, "name": "pg:PercentChangeinEstimatedFairValue", "reportCount": 1, "unique": true, "unitRef": "ratio", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404406 - Disclosure - GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details)", "role": "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails", "shortName": "GOODWILL AND OTHER INTANGIBLE ASSETS - FAIR VALUE SENSITIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "div", "body", "html" ], "contextRef": "FI2019Q2_pg_PotentialImpactstoEstimatedFairValueAxis_pg_A25bpsIncreaseDiscountRateMemberMember_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_IndefinitelivedIntangibleAssetsMember_us-gaap_StatementBusinessSegmentsAxis_pg_GilletteMember", "decimals": "2", "first": true, "lang": null, "name": "pg:PercentChangeinEstimatedFairValue", "reportCount": 1, "unique": true, "unitRef": "ratio", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405402 - Disclosure - EARNINGS PER SHARE (Details)", "role": "http://www.pg.com/role/EarningsPerShareDetails", "shortName": "EARNINGS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "lang": null, "name": "us-gaap:NetIncomeLossAttributableToParentDiluted", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - CONSOLIDATED BALANCE SHEETS", "role": "http://www.pg.com/role/ConsolidatedBalanceSheets", "shortName": "CONSOLIDATED BALANCE SHEETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2405403 - Disclosure - EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details)", "role": "http://www.pg.com/role/EarningsPerShareAntidilutiveSecuritiesDetails", "shortName": "EARNINGS PER SHARE - ANTIDILUTIVE SECURITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_us-gaap_EmployeeStockOptionMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details)", "role": "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails", "shortName": "SHARE-BASED COMPENSATION AND POSTRETIREMENT BENEFITS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:InvestmentsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details)", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - ADDITIONAL INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LongTermDebtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "invest:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407404 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE NOTIONAL AMOUNTS AND FAIR VALUE (Details)", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - DERIVATIVE NOTIONAL AMOUNTS AND FAIR VALUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "invest:DerivativeNotionalAmount", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407405 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (EFFECTIVE PORTION) (Details)", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (EFFECTIVE PORTION) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_pg_ForeignCurrencyContractsMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407406 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (Details)", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - GAIN (LOSS) ON DERIVATIVE INSTRUMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_DerivativeInstrumentRiskAxis_pg_ForeignCurrencyContractsMember_us-gaap_HedgingDesignationAxis_us-gaap_NondesignatedMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeGainLossOnDerivativeNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407407 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - AMOUNT OF GAINS AND LOSSES ON OUTSTANDING DERIVATIVES - ADDITIONAL INFORMATION (Details) (Details)", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - AMOUNT OF GAINS AND LOSSES ON OUTSTANDING DERIVATIVES - ADDITIONAL INFORMATION (Details) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_NetInvestmentHedgingMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis_us-gaap_FairValueHedgingMember_us-gaap_UnderlyingAssetClassAxis_us-gaap_UnderlyingOtherMember", "decimals": "-6", "first": true, "lang": null, "name": "pg:UnderlyingDebtObligationCarryingAmount", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407408 - Disclosure - RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - NOTIONAL AMOUNTS AND FAIR VALUES OF QUALIFYING AND NON-QUALIFYING FINANCIAL INSTRUMENTS USED IN HEDGING TRANSACTIONS - ADDITIONAL INFORMATION (Details) (Details)", "role": "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails", "shortName": "RISK MANAGEMENT ACTIVITIES AND FAIR VALUE MEASUREMENTS - NOTIONAL AMOUNTS AND FAIR VALUES OF QUALIFYING AND NON-QUALIFYING FINANCIAL INSTRUMENTS USED IN HEDGING TRANSACTIONS - ADDITIONAL INFORMATION (Details) (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R49": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details)", "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - CHANGES IN AOCI AND RECLASSIFICATION OUT OF AOCI (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS", "role": "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows", "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2017Q4", "decimals": "-6", "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - NET OF TAX EXPENSE (BENEFIT) (Details)", "role": "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "shortName": "ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) - NET OF TAX EXPENSE (BENEFIT) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "td", "tr", "table", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409402 - Disclosure - RESTRUCTURING PROGRAM - ADDITIONAL INFORMATION (Details)", "role": "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "shortName": "RESTRUCTURING PROGRAM - ADDITIONAL INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD_srt_RangeAxis_srt_MinimumMember", "decimals": "-6", "lang": null, "name": "pg:RestructuringandRelatedCostAmountsHistoricallyIncurred", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FI2018Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringReserve", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409403 - Disclosure - RESTRUCTURING PROGRAM - RESTRUCTURING RESERVE BY TYPE OF COSTS (Details)", "role": "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails", "shortName": "RESTRUCTURING PROGRAM - RESTRUCTURING RESERVE BY TYPE OF COSTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": "-6", "lang": null, "name": "us-gaap:PaymentsForRestructuring", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2409404 - Disclosure - RESTRUCTURING PROGRAM - RESTRUCTURING COSTS PER SEGMENT (Details)", "role": "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "shortName": "RESTRUCTURING PROGRAM - RESTRUCTURING COSTS PER SEGMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2QTD_us-gaap_StatementBusinessSegmentsAxis_pg_BeautySegmentMember", "decimals": "-6", "lang": null, "name": "us-gaap:RestructuringCharges", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": "0", "first": true, "lang": null, "name": "pg:NumberofTaxableJurisdictions", "reportCount": 1, "unique": true, "unitRef": "taxable_jurisdiction", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2410401 - Disclosure - COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details)", "role": "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "shortName": "COMMITMENTS AND CONTINGENCIES - ADDITIONAL INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD", "decimals": "0", "first": true, "lang": null, "name": "pg:NumberofTaxableJurisdictions", "reportCount": 1, "unique": true, "unitRef": "taxable_jurisdiction", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411402 - Disclosure - ACQUISITION - ALLOCATION OF PURCHASE PRICE (Details)", "role": "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails", "shortName": "ACQUISITION - ALLOCATION OF PURCHASE PRICE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "body", "html" ], "contextRef": "I2019Q2_us-gaap_BusinessAcquisitionAxis_pg_PHCMERCKACQUISITIONMember", "decimals": "-6", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411404 - Disclosure - ACQUISITION ACQUISITION - FAIR VALUE OF INTANGIBLES (Details)", "role": "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "shortName": "ACQUISITION ACQUISITION - FAIR VALUE OF INTANGIBLES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FD2019Q2YTD_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap_OtherIntangibleAssetsMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "ix:continuation", "div", "ix:continuation", "body", "html" ], "contextRef": "FI2019Q2", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411405 - Disclosure - ACQUISITION - ADDITIONAL INFORMATION (Details)", "role": "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "shortName": "ACQUISITION - ADDITIONAL INFORMATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "body", "html" ], "contextRef": "D2019Q2_us-gaap_BusinessAcquisitionAxis_pg_PHCMERCKACQUISITIONMember", "decimals": "-8", "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005000 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity QTD", "role": "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd", "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity QTD", "subGroupType": "", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005001 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity FYTD", "role": "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity FYTD", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FD2019Q2YTD_us-gaap_StatementEquityComponentsAxis_us-gaap_AccumulatedOtherComprehensiveIncomeMember", "decimals": "-6", "lang": null, "name": "us-gaap:NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005002 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY QTD", "role": "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY QTD", "subGroupType": "", "uniqueAnchor": null }, "R9": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "body", "html" ], "contextRef": "FI2017Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesOutstanding", "reportCount": 1, "unitRef": "shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005003 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY YTD", "role": "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "shortName": "CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY Consolidated Statements of Shareholders' Equity PY YTD", "subGroupType": "", "uniqueAnchor": null } }, "segmentCount": 71, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "If the value is true, then the document is an amendment to previously-filed/accepted document.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards.", "label": "Document [Domain]", "terseLabel": "Document [Domain]" } } }, "localname": "DocumentDomain", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationDocumentAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.", "label": "Document Information, Document [Axis]", "terseLabel": "Document Information, Document [Axis]" } } }, "localname": "DocumentInformationDocumentAxis", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated), (5) Smaller Reporting Accelerated Filer or (6) Smaller Reporting Company and Large Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r301" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a smaller reporting company with both a public float and revenues of less than $75 million.", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2018-01-31", "presentation": [ "http://www.pg.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "invest_DerivativeNotionalAmount": { "auth_ref": [ "r302" ], "lang": { "en-US": { "role": { "documentation": "Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.", "label": "Derivative, Notional Amount", "terseLabel": "Notional Amount" } } }, "localname": "DerivativeNotionalAmount", "nsuri": "http://xbrl.sec.gov/invest/2013-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails" ], "xbrltype": "monetaryItemType" }, "pg_A25bpsDecreaseLongTermGrowthMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "25 bps Decrease Long-Term Growth [Member]", "label": "25 bps Decrease Long-Term Growth [Member]", "terseLabel": "25 bps Decrease Long-Term Growth [Member]" } } }, "localname": "A25bpsDecreaseLongTermGrowthMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "domainItemType" }, "pg_A25bpsIncreaseDiscountRateMemberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "25 bps Increase Discount Rate [Member]", "label": "25 bps Increase Discount Rate [Member] [Member]", "terseLabel": "25 bps Increase Discount Rate [Member]" } } }, "localname": "A25bpsIncreaseDiscountRateMemberMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "domainItemType" }, "pg_AccumulatedOtherComprehensiveIncomeGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated Other Comprehensive Income, Gain (Loss)", "label": "Accumulated Other Comprehensive Income, Gain (Loss)", "terseLabel": "Accumulated Other Comprehensive Income, Gain (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeGainLoss", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails" ], "xbrltype": "monetaryItemType" }, "pg_AdoptionofNewAccountingStandard_ReclassfromAOCItoRetainedEarnings": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings", "label": "Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings", "terseLabel": "Adoption of New Accounting Standard_Reclass from AOCI to Retained Earnings" } } }, "localname": "AdoptionofNewAccountingStandard_ReclassfromAOCItoRetainedEarnings", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails" ], "xbrltype": "monetaryItemType" }, "pg_AllOtherMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "All Other [Member]", "label": "All Other [Member]", "terseLabel": "All Other [Member]" } } }, "localname": "AllOtherMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_AssetRelatedCostsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Asset-Related Costs consisting of both asset write downs and accelerated depreciation in conjunction with restructuring plan.", "label": "Asset-Related Costs [Member]", "terseLabel": "Asset-related Costs" } } }, "localname": "AssetRelatedCostsMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "domainItemType" }, "pg_BabyCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Baby Care [Member]", "label": "Baby Care [Member]", "terseLabel": "Baby Care [Member]" } } }, "localname": "BabyCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_BabyFeminineandFamilyCareSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Baby, Feminine and Family Care Segment [Member]", "label": "Baby, Feminine and Family Care Segment Member", "terseLabel": "Baby, Feminine & Family Care" } } }, "localname": "BabyFeminineandFamilyCareSegmentMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "pg_BeautySegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Beauty Segment Member", "label": "Beauty Segment [Member]", "terseLabel": "Beauty" } } }, "localname": "BeautySegmentMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "pg_CompensationandEmployeeBenefitPlansTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Compensation and Employee Benefit Plans [Table Text Block]", "label": "Compensation and Employee Benefit Plans [Table Text Block]", "terseLabel": "Compensation and Employee Benefit Plans [Table Text Block]" } } }, "localname": "CompensationandEmployeeBenefitPlansTableTextBlock", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsTables" ], "xbrltype": "textBlockItemType" }, "pg_CustomerandConsumerPromotionalSpendingMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Customer and Consumer Promotional Spending [Member]", "label": "Customer and Consumer Promotional Spending [Member]", "terseLabel": "Customer and Consumer Promotional Spending [Member]" } } }, "localname": "CustomerandConsumerPromotionalSpendingMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pg_ESOPDebtImpacts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "ESOP Debt Impacts", "label": "ESOP Debt Impacts", "negatedTerseLabel": "ESOP Debt Impacts", "terseLabel": "ESOP Debt Impacts" } } }, "localname": "ESOPDebtImpacts", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "pg_EffectiveIncomeTaxRateReconciliationatFederalStatutoryIncomeTaxRateBaseRatePercent": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Base Rate, Percent", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Base Rate, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Base Rate, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationatFederalStatutoryIncomeTaxRateBaseRatePercent", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails" ], "xbrltype": "percentItemType" }, "pg_FabricCareAndHomeCareSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fabric Care and Home Care Segment [Member]", "label": "Fabric Care And Home Care Segment Member", "terseLabel": "Fabric & Home Care" } } }, "localname": "FabricCareAndHomeCareSegmentMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails" ], "xbrltype": "domainItemType" }, "pg_FabricCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fabric Care [member]", "label": "Fabric Care [Member]", "terseLabel": "Fabric Care [Member]" } } }, "localname": "FabricCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_FabricandHomeCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fabric and Home Care [Member]", "label": "Fabric and Home Care [Member]", "terseLabel": "Fabric and Home Care" } } }, "localname": "FabricandHomeCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "pg_FamilyCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Family Care [Member]", "label": "Family Care [Member]", "terseLabel": "Family Care [Member]" } } }, "localname": "FamilyCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_FeminineCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Feminine Care [Member]", "label": "Feminine Care [Member]", "terseLabel": "Feminine Care [Member]" } } }, "localname": "FeminineCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_ForeignCurrencyContractsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Foreign Currency Contracts [Member]", "label": "Foreign Currency Contracts [Member]", "terseLabel": "Foreign Currency Contract" } } }, "localname": "ForeignCurrencyContractsMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "pg_GilletteMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Gillette [Member]", "label": "Gillette [Member]", "terseLabel": "Gillette" } } }, "localname": "GilletteMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "domainItemType" }, "pg_GoodwillAcquisitionsandDivestitures": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Goodwill, Acquisitions and Divestitures", "label": "Goodwill, Acquisitions and Divestitures", "terseLabel": "Goodwill, Acquisitions and Divestitures" } } }, "localname": "GoodwillAcquisitionsandDivestitures", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails" ], "xbrltype": "monetaryItemType" }, "pg_GoodwillAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Goodwill [Axis]", "label": "Goodwill [Axis]", "terseLabel": "Goodwill [Axis]" } } }, "localname": "GoodwillAxis", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "stringItemType" }, "pg_GoodwillDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Goodwill [Axis]", "label": "Goodwill [Domain]", "terseLabel": "Goodwill [Domain]" } } }, "localname": "GoodwillDomain", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "domainItemType" }, "pg_GroomingSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Grooming Segment [Member]", "label": "Grooming Segment Member", "terseLabel": "Grooming" } } }, "localname": "GroomingSegmentMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "pg_HairCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Hair Care [Member]", "label": "Hair Care [Member]", "terseLabel": "Hair Care [Member]" } } }, "localname": "HairCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_HealthCareSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Health Care Segment [Member]", "label": "Health Care Segment Member", "terseLabel": "Health Care" } } }, "localname": "HealthCareSegmentMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "pg_HomeCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Home Care [Member]", "label": "Home Care [Member]", "terseLabel": "Home Care [Member]" } } }, "localname": "HomeCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_IncomeLossFromContinuingOperationsBeforeIncomeTaxes": { "auth_ref": [], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Income from continuing operations before income taxes.", "label": "Income Loss From Continuing Operations Before Income Taxes", "terseLabel": "Earnings/(Loss) from Continuing Operations Before Income Taxes", "totalLabel": "Earnings/(Loss) from Continuing Operations Before Income Taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxes", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "pg_LongTermDebtCurrentMaturitiesMeasuredAtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Long Term Debt, Current Maturities measured at Fair Value", "label": "Long Term Debt, Current Maturities measured at Fair Value", "terseLabel": "Long Term Debt, Current Maturities Measured at Fair Value" } } }, "localname": "LongTermDebtCurrentMaturitiesMeasuredAtFairValue", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "pg_NumberofAuditsTypicallyUnderway": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Audits Typically Underway", "label": "Number of Audits Typically Underway", "terseLabel": "Number of Audits Typically Underway" } } }, "localname": "NumberofAuditsTypicallyUnderway", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "pg_NumberofTaxableJurisdictions": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Number of Taxable Jurisdictions", "label": "Number of Taxable Jurisdictions", "terseLabel": "Number of Taxable Jurisdictions" } } }, "localname": "NumberofTaxableJurisdictions", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "pg_OralCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Oral Care [Member]", "label": "Oral Care [Member]", "terseLabel": "Oral Care [Member]" } } }, "localname": "OralCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_PHCMERCKACQUISITIONMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "PHC-MERCK ACQUISITION [Member]", "label": "PHC-MERCK ACQUISITION [Member]", "terseLabel": "PHC-MERCK ACQUISITION [Member]" } } }, "localname": "PHCMERCKACQUISITIONMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "domainItemType" }, "pg_PatentsandDevelopedTechnologyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Patents and Developed Technology [Member]", "label": "Patents and Developed Technology [Member]", "terseLabel": "Patents and Developed Technology [Member]" } } }, "localname": "PatentsandDevelopedTechnologyMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pg_PaymentstoCustomersMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Payments to Customers [Member]", "label": "Payments to Customers [Member]", "terseLabel": "Payments to Customers [Member]" } } }, "localname": "PaymentstoCustomersMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pg_PercentChangeinEstimatedFairValue": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percent Change in Estimated Fair Value", "label": "Percent Change in Estimated Fair Value", "terseLabel": "Percent Change in Estimated Fair Value" } } }, "localname": "PercentChangeinEstimatedFairValue", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "percentItemType" }, "pg_PotentialImpactstoEstimatedFairValueAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Potential Impacts to Estimated Fair Value [Axis]", "label": "Potential Impacts to Estimated Fair Value [Axis]", "terseLabel": "Potential Impacts to Estimated Fair Value [Axis]" } } }, "localname": "PotentialImpactstoEstimatedFairValueAxis", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "stringItemType" }, "pg_PotentialImpactstoEstimatedFairValueDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Domain] for Potential Impacts to Estimated Fair Value [Axis]", "label": "Potential Impacts to Estimated Fair Value [Domain]", "terseLabel": "Potential Impacts to Estimated Fair Value [Domain]" } } }, "localname": "PotentialImpactstoEstimatedFairValueDomain", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "domainItemType" }, "pg_ProceedsFromStockOptionsExercisedAndOtherFinancingActivities": { "auth_ref": [], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock options. Also includes, the net cash inflow (outflow) from other financing activities.", "label": "Proceeds From Stock Options Exercised And Other Financing Activities", "terseLabel": "Impact of Stock Options and Other" } } }, "localname": "ProceedsFromStockOptionsExercisedAndOtherFinancingActivities", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "pg_ReclassificationfromAOCItoRetainedEarningsforTaxEffectsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Reclassification from AOCI to Retained Earnings for Tax Effects [Domain]", "label": "Reclassification from AOCI to Retained Earnings for Tax Effects [Domain]", "terseLabel": "Reclassification from AOCI to Retained Earnings for Tax Effects [Domain]" } } }, "localname": "ReclassificationfromAOCItoRetainedEarningsforTaxEffectsDomain", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pg_ReserveForEsopDebtRetirement": { "auth_ref": [], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount corresponds to the amount of leveraged ESOP debt guaranteed by the company. When the debt is recorded on the company's books, the equity reserve for the ESOP debt retirement is also recorded.", "label": "Reserve For ESOP Debt Retirement", "negatedTerseLabel": "Reserve For ESOP Debt Retirement" } } }, "localname": "ReserveForEsopDebtRetirement", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "pg_ReserveforESOPDebtRetirementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Reserve for ESOP Debt Retirement [Member]", "label": "Reserve for ESOP Debt Retirement [Member]", "terseLabel": "Reserve for ESOP Debt Retirement [Member]" } } }, "localname": "ReserveforESOPDebtRetirementMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "domainItemType" }, "pg_RestructuringandRelatedCostAmountsHistoricallyIncurred": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Restructuring and Related Cost, Amounts Historically Incurred", "label": "Restructuring and Related Cost, Amounts Historically Incurred", "terseLabel": "Restructuring and Related Cost, Amounts Historically Incurred" } } }, "localname": "RestructuringandRelatedCostAmountsHistoricallyIncurred", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "pg_RestructuringandRelatedCostNumberofSeverancePackagesExecuted": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restructuring and Related Cost, Number of Severance Packages Executed", "label": "Restructuring and Related Cost, Number of Severance Packages Executed", "terseLabel": "Restructuring and Related Cost, Number of Severance Packages Executed" } } }, "localname": "RestructuringandRelatedCostNumberofSeverancePackagesExecuted", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "pg_RiskManagementActivitiesAndFairValueMeasurementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Risk Management Activities and Fair Value Measurements [Abstract]", "label": "Risk Management Activities and Fair Value Measurements [Abstract]" } } }, "localname": "RiskManagementActivitiesAndFairValueMeasurementsAbstract", "nsuri": "http://www.pg.com/20181231", "xbrltype": "stringItemType" }, "pg_RiskManagementAndFairValueTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This element represents the disclosure of all significant concentrations of risk, fair value measurements of financial and non-financial assets and liabilities, and derivative instruments.", "label": "Risk Management And Fair Value [Text Block]", "terseLabel": "Risk Management And Fair Value [Text Block]" } } }, "localname": "RiskManagementAndFairValueTextBlock", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "pg_SCHEDULEOFPOTENTIALIMPACTSTOESTIMATEDFAIRVALUESLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "[Line Items] for SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Table]", "label": "SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]", "terseLabel": "SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Line Items]" } } }, "localname": "SCHEDULEOFPOTENTIALIMPACTSTOESTIMATEDFAIRVALUESLineItems", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "stringItemType" }, "pg_SCHEDULEOFPOTENTIALIMPACTSTOESTIMATEDFAIRVALUESTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Table]", "label": "SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Table]", "terseLabel": "SCHEDULE OF POTENTIAL IMPACTS TO ESTIMATED FAIR VALUES [Table]" } } }, "localname": "SCHEDULEOFPOTENTIALIMPACTSTOESTIMATEDFAIRVALUESTable", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "stringItemType" }, "pg_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]", "label": "Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]", "terseLabel": "Schedule of Finite and Indefinite Lived Intangible Assets [Line Items]" } } }, "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsLineItems", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "pg_ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Finite and Indefinite Lived Intangible Assets [Table]", "label": "Schedule of Finite and Indefinite Lived Intangible Assets [Table]", "terseLabel": "Schedule of Finite and Indefinite Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteAndIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "pg_ScheduleofPotentialImpactstoEstimatedFairValuesTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]", "label": "Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]", "terseLabel": "Schedule of Potential Impacts to Estimated Fair Values [Table Text Block]" } } }, "localname": "ScheduleofPotentialImpactstoEstimatedFairValuesTableTextBlock", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "pg_SegmentReportingAdditionalInformationaboutEntitysReportableSegmentsPercentofSalesbyBusinessUnit": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit", "label": "Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit", "terseLabel": "Segment Reporting, Additional Information about Entity's Reportable Segments - Percent of Sales by Business Unit" } } }, "localname": "SegmentReportingAdditionalInformationaboutEntitysReportableSegmentsPercentofSalesbyBusinessUnit", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "percentItemType" }, "pg_SellingGeneralAndAdministrativeExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The allocation (or location) of expense to (in) general and administrative expense including allocations to selling and marketing expense.", "label": "Selling, General and Administrative Expense [Member]", "terseLabel": "Selling, General and Administrative Expense" } } }, "localname": "SellingGeneralAndAdministrativeExpenseMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "pg_ShaveCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Shave Care [Member]", "label": "Shave Care [Member]", "terseLabel": "Shave Care" } } }, "localname": "ShaveCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails", "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_SkinandPersonalCareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Skin and Personal Care [Member]", "label": "Skin and Personal Care [Member]", "terseLabel": "Skin and Personal Care [Member]" } } }, "localname": "SkinandPersonalCareMember", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "pg_U.S.TaxCutsandJobsActEffective2018Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "U.S. Tax Cuts and Jobs Act, Effective 2018 [Member]", "label": "U.S. Tax Cuts and Jobs Act, Effective 2018 [Member]", "terseLabel": "U.S. Tax Cuts and Jobs Act, Effective 2018" } } }, "localname": "U.S.TaxCutsandJobsActEffective2018Member", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails" ], "xbrltype": "domainItemType" }, "pg_UnderlyingDebtObligationCarryingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Underlying Debt Obligation, Carrying Amount", "label": "Underlying Debt Obligation, Carrying Amount", "terseLabel": "Underlying Debt Obligation, Carrying Amount" } } }, "localname": "UnderlyingDebtObligationCarryingAmount", "nsuri": "http://www.pg.com/20181231", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "monetaryItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r115", "r123" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Range [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Range [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restatement [Axis]", "terseLabel": "Restatement [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restatement [Domain]", "terseLabel": "Restatement [Domain]" } } }, "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Changes and Error Corrections [Abstract]" } } }, "localname": "AccountingChangesAndErrorCorrectionsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountingChangesAndErrorCorrectionsTextBlock": { "auth_ref": [ "r98" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting accounting changes and error corrections. It includes the conveyance of information necessary for a user of the Company's financial information to understand all aspects and required disclosure information concerning all changes and error corrections reported in the Company's financial statements for the period.", "label": "Accounting Changes and Error Corrections [Text Block]", "terseLabel": "Accounting Changes and Error Corrections [Text Block]" } } }, "localname": "AccountingChangesAndErrorCorrectionsTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r23" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts Payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r11", "r183" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts Receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued and Other Liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r45", "r51", "r53", "r190", "r236" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) related to gain (loss) component of defined benefit plans including the portion attributable to the noncontrolling interest.", "label": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentNetGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r39", "r51", "r53", "r236" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, including the portion attributable to the noncontrolling interest.", "label": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Accumulated Foreign Currency Adjustment Including Portion Attributable to Noncontrolling Interest [Member]" } } }, "localname": "AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r42", "r43", "r44", "r51", "r53" ], "lang": { "en-US": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), including portion attributable to noncontrolling interest.", "label": "Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Accumulated Net Investment Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member]" } } }, "localname": "AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember": { "auth_ref": [ "r51", "r272" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) from increase (decrease) in value of excluded component of derivative hedge, including portion attributable to noncontrolling interest.", "label": "Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss), Derivative Qualifying as Hedge, Excluded Component, Including Portion Attributable to Noncontrolling Interest [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossDerivativeQualifyingAsHedgeExcludedComponentIncludingPortionAttributableToNoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r48", "r50", "r51" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Accumulated Other Comprehensive Income/(Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r47", "r51", "r53", "r236" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]", "terseLabel": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r140" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "terseLabel": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r12" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional Paid in Capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForChangeInAccountingPrincipleAxis": { "auth_ref": [ "r93" ], "lang": { "en-US": { "role": { "documentation": "Information by type of change in accounting principle. Does not include error corrections.", "label": "Adjustments for Change in Accounting Principle [Axis]", "terseLabel": "Adjustments for Change in Accounting Principle [Axis]" } } }, "localname": "AdjustmentsForChangeInAccountingPrincipleAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "stringItemType" }, "us-gaap_AdjustmentsForErrorCorrectionDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Represents the types error corrections made to the financial statements.", "label": "Adjustments for Error Correction [Domain]", "terseLabel": "Adjustments for Error Correction [Domain]" } } }, "localname": "AdjustmentsForErrorCorrectionDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": { "auth_ref": [ "r93" ], "lang": { "en-US": { "role": { "documentation": "Information by new accounting pronouncement.", "label": "Adjustments for New Accounting Pronouncements [Axis]", "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]" } } }, "localname": "AdjustmentsForNewAccountingPronouncementsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r197", "r199", "r202" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.", "label": "Allocated Share-based Compensation Expense", "terseLabel": "Allocated Share-based Compensation Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r84", "r138", "r146" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "terseLabel": "Amortization of Intangible Assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r108" ], "lang": { "en-US": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r108" ], "lang": { "en-US": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]", "terseLabel": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r108" ], "lang": { "en-US": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.", "label": "Antidilutive Securities, Name [Domain]", "terseLabel": "Antidilutive Securities, Name [Domain]" } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r119", "r285", "r293" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r5", "r35" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total Current Assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Fair Value Disclosure [Abstract]" } } }, "localname": "AssetsFairValueDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_AvailableForSaleSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.", "label": "Available-for-sale Securities, Current", "terseLabel": "Available-for-Sale Investment Securities" } } }, "localname": "AvailableForSaleSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost": { "auth_ref": [ "r127" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in second through fifth fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost", "terseLabel": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, after One Through Five Years, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost": { "auth_ref": [ "r126" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amortized cost of investment in debt security measured at fair value with change recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost", "terseLabel": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Amortized Cost" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r248", "r252" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r216", "r217" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount": { "auth_ref": [ "r225" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of goodwill arising from a business combination that is expected to be deductible for tax purposes.", "label": "Business Acquisition, Goodwill, Expected Tax Deductible Amount", "terseLabel": "Business Acquisition, Goodwill, Expected Tax Deductible Amount" } } }, "localname": "BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": { "auth_ref": [ "r220" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.", "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value", "terseLabel": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value" } } }, "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r226" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combination Disclosure [Text Block]" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/Acquisition" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets": { "auth_ref": [ "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities": { "auth_ref": [ "r219" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent": { "auth_ref": [ "r219" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary difference assumed at the acquisition date that are classified as noncurrent.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "auth_ref": [ "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r218", "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r219" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": { "auth_ref": [ "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities": { "auth_ref": [ "r219" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities due after one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r218", "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": { "auth_ref": [ "r219" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest", "terseLabel": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r21", "r86" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and Cash Equivalents, End of Period", "periodStartLabel": "Cash and Cash Equivalents, Beginning of Period", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "Change in Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ChangeInAccountingPrincipleMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A change from one generally accepted accounting principle to another generally accepted accounting principle when there are two or more generally accepted accounting principles that apply or when the accounting principle formerly used is no longer generally accepted. A change in the method of applying an accounting principle that is not treated as a change in accounting estimate also is considered a change in accounting principle.", "label": "Adjustments for Change in Accounting Principle [Domain]", "terseLabel": "Adjustments for Change in Accounting Principle [Domain]" } } }, "localname": "ChangeInAccountingPrincipleMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r167", "r175" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies Disclosure [Text Block]" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "auth_ref": [ "r180" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Cash Paid", "terseLabel": "Common Stock, Dividends, Per Share, Cash Paid" } } }, "localname": "CommonStockDividendsPerShareCashPaid", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-US": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r10", "r178" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r10" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common Stock, Value, Issued" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": { "auth_ref": [ "r184", "r187", "r196", "r203" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.", "label": "Compensation and Employee Benefit Plans [Text Block]", "terseLabel": "Compensation and Employee Benefit Plans [Text Block]" } } }, "localname": "CompensationAndEmployeeBenefitPlansTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefits" ], "xbrltype": "textBlockItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r56", "r58", "r59" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Total Comprehensive Income/(Loss) Attributable to Procter & Gamble" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r56", "r58", "r230", "r231", "r239" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest", "terseLabel": "Less: Total Comprehensive Income Attributable to Noncontrolling Interest" } } }, "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r56", "r58", "r229", "r239" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total Comprehensive Income/(Loss)" } } }, "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r70" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Comprehensive Income (Loss) Note [Text Block]" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLoss" ], "xbrltype": "textBlockItemType" }, "us-gaap_CorporateBondSecuritiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This category includes information about long-term debt securities that are issued by either a domestic or foreign corporate business entity with a date certain promise of repayment and a return to the holder for the time value of money (for example, variable or fixed interest, original issue discount).", "label": "Corporate Bond Securities [Member]", "terseLabel": "Corporate Bond Securities" } } }, "localname": "CorporateBondSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CorporateMember": { "auth_ref": [ "r112" ], "lang": { "en-US": { "role": { "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.", "label": "Corporate Segment [Member]", "terseLabel": "Corporate" } } }, "localname": "CorporateMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r65" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost of Goods and Services Sold", "terseLabel": "Cost of Products Sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfGoodsSegmentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cost of goods (such as cost of goods sold, or purchases) for the specified business segment for the period after providing for returns, allowances and discounts, when it serves as a benchmark in a concentration of risk calculation.", "label": "Cost of Goods, Segment [Member]", "terseLabel": "Cost of Products Sold" } } }, "localname": "CostOfGoodsSegmentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreationDateAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information about two or more restatements of a single financial reporting concept where restated amounts have been reported in a prior filing.", "label": "Report Date [Axis]", "terseLabel": "Report Date [Axis]" } } }, "localname": "CreationDateAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r223" ], "lang": { "en-US": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt, Current", "terseLabel": "Debt Due Within One Year" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefaultFinancialStatementsDateMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Date the financial statement was made available and submitted, in CCYY-MM-DD format.", "label": "Financial Statement Filing Date [Domain]", "terseLabel": "Financial Statement Filing Date [Domain]" } } }, "localname": "DefaultFinancialStatementsDateMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "domainItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r90", "r210", "r212" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Federal Income Tax Expense (Benefit)", "terseLabel": "Deferred Federal Income Tax Expense (Benefit)" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r84", "r90", "r210", "r212" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Income Tax Expense (Benefit)", "terseLabel": "Deferred Income Taxes" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesNoncurrent": { "auth_ref": [ "r204", "r205", "r206" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting and classified as noncurrent.", "label": "Deferred Tax Liabilities, Net, Noncurrent", "terseLabel": "Deferred Income Taxes" } } }, "localname": "DeferredTaxLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r189", "r193", "r194" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)", "terseLabel": "Defined Benefit Plan, Net Periodic Benefit Cost (Credit)" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r84", "r150" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and Amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r36", "r37", "r279" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative Asset" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]", "verboseLabel": "Derivative Contract Type [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r250" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Derivative, Gain (Loss) on Derivative, Net", "terseLabel": "Amount of Gain/(Loss) Recognized in Earnings" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r249", "r251", "r256", "r261" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r246", "r249", "r256" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r246", "r249", "r256", "r261", "r262", "r269", "r271" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet": { "auth_ref": [ "r255", "r270" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments representing (a) the amount of the hedge ineffectiveness and (b) the amount, if any, excluded from the assessment of hedge effectiveness.", "label": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net", "terseLabel": "Derivative Instruments, Gain (Loss) Recognized in Income, Ineffective Portion and Amount Excluded from Effectiveness Testing, Net" } } }, "localname": "DerivativeInstrumentsGainLossRecognizedInIncomeIneffectivePortionAndAmountExcludedFromEffectivenessTestingNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLiabilities": { "auth_ref": [ "r36", "r37", "r279" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Liability", "negatedTerseLabel": "Derivative Liability" } } }, "localname": "DerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r91", "r241", "r242", "r243", "r246", "r247", "r253", "r256", "r267", "r268", "r271" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r246" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Disclosure of Compensation Related Costs, Share-based Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_DividendsCommonStock": { "auth_ref": [ "r180", "r292" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Common Stock", "negatedTerseLabel": "Dividends, Common Stock" } } }, "localname": "DividendsCommonStock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r180", "r292" ], "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedTerseLabel": "Dividends, Preferred Stock" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd", "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings Per Share [Abstract]" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r63", "r94", "r102", "r105", "r106", "r107", "r110", "r290", "r299" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic Net Earnings/(Loss) Per Common Share", "totalLabel": "Basic Net Earnings Per Common Share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Basic [Abstract]", "terseLabel": "Basic Net Earnings Per Common Share" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r63", "r94", "r102", "r105", "r106", "r107", "r110", "r290", "r299" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted Net Earnings/(Loss) Per Common Share", "totalLabel": "Diluted Net Earnings Per Common Share" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share, Diluted [Abstract]", "terseLabel": "Diluted Net Earnings Per Common Share" } } }, "localname": "EarningsPerShareDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareReconciliationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share Reconciliation [Abstract]", "terseLabel": "Earnings Per Share Reconciliation [Abstract]" } } }, "localname": "EarningsPerShareReconciliationAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r111" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings Per Share [Text Block]" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": { "auth_ref": [ "r280" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.", "label": "Effect of Exchange Rate on Cash and Cash Equivalents", "terseLabel": "Effect of Exchange Rate on Cash and Cash Equivalents" } } }, "localname": "EffectOfExchangeRateOnCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r207", "r208", "r211" ], "lang": { "en-US": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent", "terseLabel": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeSeveranceMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Termination of an employee associated with exit from or disposal of business activities or restructurings pursuant to a plan.", "label": "Employee Severance [Member]", "terseLabel": "Separations" } } }, "localname": "EmployeeSeveranceMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EmployeeStockOptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "An arrangement whereby an employee is entitled to receive in the future, subject to vesting and other restrictions, a number of shares in the entity at a specified price, as defined in the agreement. Although there are variations, normally, after vesting, when an option is exercised, the employee-holder pays the strike value in cash to the issuing employer-entity and receives equity shares. The equity shares can be sold into the market for cash at the current market price without restriction. Options may be used to attract, retain and incentivize employees, in addition to their regular salary and other benefits.", "label": "Employee Stock Option [Member]", "terseLabel": "Employee Stock Option" } } }, "localname": "EmployeeStockOptionMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r178" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "domainItemType" }, "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": { "auth_ref": [ "r95", "r96", "r97" ], "lang": { "en-US": { "role": { "documentation": "Information by type of error correction.", "label": "Adjustments for Error Corrections [Axis]", "terseLabel": "Adjustments for Error Corrections [Axis]" } } }, "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r273", "r274", "r275", "r276", "r277", "r278" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueHedgingMember": { "auth_ref": [ "r244" ], "lang": { "en-US": { "role": { "documentation": "A hedge of the exposure to changes in the fair value of a recognized asset or liability, or of an unrecognized firm commitment, that are attributable to a particular risk.", "label": "Fair Value Hedging [Member]", "terseLabel": "Derivatives in Fair Value Hedging Relationships" } } }, "localname": "FairValueHedgingMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of finite-lived and indefinite-lived intangible assets acquired as part of a business combination.", "label": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "terseLabel": "Finite-Lived and Indefinite-Lived Intangible Assets Acquired as Part of Business Combination [Table Text Block]" } } }, "localname": "FiniteLivedAndIndefiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionFairValueOfIntangiblesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r145" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "negatedTerseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r139", "r142", "r145", "r148", "r284" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r139", "r144" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-Lived Intangible Assets [Member]", "terseLabel": "Intangible Assets with Determinable Lives" } } }, "localname": "FiniteLivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r188", "r259" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contract" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r84" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Gain (Loss) on Disposition of Assets", "negatedTerseLabel": "Gain (Loss) on Disposition of Assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r131", "r132" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "periodEndLabel": "Goodwill at December 31, 2018", "periodStartLabel": "Goodwill at June 30, 2018", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails", "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r149" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for goodwill and intangible assets.", "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "terseLabel": "Goodwill and Intangible Assets Disclosure [Text Block]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Goodwill [Line Items]", "terseLabel": "Goodwill [Line Items]" } } }, "localname": "GoodwillLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Member]", "terseLabel": "Goodwill" } } }, "localname": "GoodwillMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GoodwillRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Goodwill [Roll Forward]" } } }, "localname": "GoodwillRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_GoodwillTranslationAndPurchaseAccountingAdjustments": { "auth_ref": [ "r133", "r134", "r215" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from foreign currency translation adjustments and purchase accounting adjustments of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Translation and Purchase Accounting Adjustments", "terseLabel": "Goodwill, Translation and Other" } } }, "localname": "GoodwillTranslationAndPurchaseAccountingAdjustments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r246", "r262" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r246" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r246" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r229" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net Earnings/(Loss) from Continuing Operations" } } }, "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r152" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r209" ], "lang": { "en-US": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]", "terseLabel": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.", "label": "Income Tax Authority [Domain]", "terseLabel": "Income Tax Authority [Domain]" } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r90", "r118", "r214" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "terseLabel": "Income Taxes on Continuing Operations", "verboseLabel": "Income Tax Expense (Benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r207", "r208" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to repatriation of foreign earnings.", "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount", "terseLabel": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount" } } }, "localname": "IncomeTaxReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r83" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts Payable, Accrued and Other Liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r83" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedTerseLabel": "Accounts Receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r83" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedTerseLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes In:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r83" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedTerseLabel": "Other Operating Assets and Liabilities" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncrementalCommonSharesAttributableToConversionOfPreferredStock": { "auth_ref": [ "r104", "r109" ], "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of convertible preferred stock using the if-converted method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock", "terseLabel": "Conversion of Preferred Shares" } } }, "localname": "IncrementalCommonSharesAttributableToConversionOfPreferredStock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "auth_ref": [ "r103", "r109" ], "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "order": 3.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements", "terseLabel": "Exercise of Stock Options and Other Unvested Equity Awards" } } }, "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r141", "r147" ], "lang": { "en-US": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Axis]", "terseLabel": "Indefinite-lived Intangible Assets [Axis]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r141", "r147" ], "lang": { "en-US": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit.", "label": "Indefinite-lived Intangible Assets [Member]", "terseLabel": "Intangible Assets with Indefinite Lives" } } }, "localname": "IndefinitelivedIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "terseLabel": "Gross Carrying Amount" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsIdentifiableIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r137", "r143" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Trademarks and Other Intangible Assets, Net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetIncludingGoodwill": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount of finite-lived intangible assets, indefinite-lived intangible assets and goodwill. Goodwill is an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Intangible assets are assets, not including financial assets, lacking physical substance.", "label": "Intangible Assets, Net (Including Goodwill)", "terseLabel": "Intangible Assets, Net (Including Goodwill)" } } }, "localname": "IntangibleAssetsNetIncludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r61", "r117", "r282", "r283", "r291" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "pg_IncomeLossFromContinuingOperationsBeforeIncomeTaxes", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest Expense" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateContractMember": { "auth_ref": [ "r188", "r258" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to the right to receive or pay a sum of money at a given interest rate.", "label": "Interest Rate Contract [Member]", "terseLabel": "Interest Rate Contracts" } } }, "localname": "InterestRateContractMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r15", "r130" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished Goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r34", "r129" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "totalLabel": "Total Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory, Net [Abstract]", "terseLabel": "Inventories" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r17", "r18", "r130" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Materials and Supplies" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r16", "r130" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in Process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r67", "r116" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 3.0, "parentTag": "pg_IncomeLossFromContinuingOperationsBeforeIncomeTaxes", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "terseLabel": "Interest Income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentsFairValueDisclosure": { "auth_ref": [ "r274" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.", "label": "Investments, Fair Value Disclosure", "terseLabel": "Fair Value Asset" } } }, "localname": "InvestmentsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r25" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r14", "r287", "r296" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Shareholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r27" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total Current Liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtFairValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The fair value amount of long-term debt whether such amount is presented as a separate caption or as a parenthetical disclosure. Additionally, this element may be used in connection with the fair value disclosures required in the footnote disclosures to the financial statements. The element may be used in both the balance sheet and disclosure in the same submission.", "label": "Long-term Debt, Fair Value", "terseLabel": "Long-term Debt, Fair Value" } } }, "localname": "LongTermDebtFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r28" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-Term Debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r176", "r177" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CommitmentsAndContingenciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r33", "r286", "r295" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling Interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The equity interest of noncontrolling shareholders, partners or other equity holders in consolidated entity.", "label": "Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners", "terseLabel": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage" } } }, "localname": "MinorityInterestOwnershipPercentageByNoncontrollingOwners", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_MinorityInterestPeriodIncreaseDecrease": { "auth_ref": [ "r228" ], "lang": { "en-US": { "role": { "documentation": "Net Increase or Decrease in balance of noncontrolling interest in the subsidiary during the reporting period.", "label": "Noncontrolling Interest, Period Increase (Decrease)", "terseLabel": "Noncontrolling Interest, Period Increase (Decrease)" } } }, "localname": "MinorityInterestPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r81" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Total Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r81" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Total Investing Activites" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r81", "r82", "r85" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Total Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r54", "r57", "r62", "r85", "r109", "r289", "r298" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net Earnings Attributable to Procter & Gamble" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r54", "r57", "r233", "r238" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 }, "http://www.pg.com/role/EarningsPerShareDetails": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Net Income (Loss) Attributable to Noncontrolling Interest" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd", "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToParentDiluted": { "auth_ref": [ "r101" ], "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.", "label": "Net Income (Loss) Attributable to Parent, Diluted", "totalLabel": "Net Earnings/(Loss) Attributable to P&G (Diluted)" } } }, "localname": "NetIncomeLossAttributableToParentDiluted", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r94", "r100" ], "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "totalLabel": "Net Earnings/(Loss) Attributable to P&G Available to Common Shareholders (Basic)" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r245" ], "lang": { "en-US": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Derivatives in Net Investment Hedging Relationships" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the quantification of the effect of adopting the new accounting standard or change in accounting principle expected by the entity to have a significant effect on the entity's financial statements.", "label": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification", "terseLabel": "New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification" } } }, "localname": "NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r227" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r246" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Not Designated as Hedging Instrument" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsDerivativeNotionalAmountsAndFairValueDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "pg_IncomeLossFromContinuingOperationsBeforeIncomeTaxes", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating Income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r240" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r22" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other Noncurrent Assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": { "auth_ref": [ "r42" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of appreciation (loss) in value of unsold available-for-sale securities. Excludes amounts related to other than temporary impairment (OTTI) loss.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-sale, Adjustment, after Tax", "terseLabel": "Unrealized Gains/(Losses) on Investment Securities" } } }, "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r51", "r60" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "terseLabel": "OCI before Reclassifications" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r49", "r213" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "terseLabel": "Other Comprehensive Income (Loss) before Reclassifications, Tax" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": { "auth_ref": [ "r41" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax", "terseLabel": "Unrealized Gains/(Losses) on Hedges" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r38", "r281" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Financial Statement Translation" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r55", "r58", "r60", "r178" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other Comprehensive Income (Loss), Net of Tax", "totalLabel": "Total Other Comprehensive Income (Loss), Net of Tax" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r55", "r58", "r229", "r230", "r235" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest", "terseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r46", "r48" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Unrealized Gains/(Losses) on Defined Benefit Retirement Plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeMember": { "auth_ref": [ "r260" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption in which reported facts about other comprehensive income have been included.", "label": "Other Comprehensive Income (Loss) [Member]", "terseLabel": "Other Comprehensive Income (Loss)" } } }, "localname": "OtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]", "terseLabel": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherInvestmentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other investments.", "label": "Other Investments [Member]", "terseLabel": "Other Investments" } } }, "localname": "OtherInvestmentsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r29" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other Noncurrent Liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncashExpense": { "auth_ref": [ "r85" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expense or loss included in net income that result in no cash flow, classified as other.", "label": "Other Noncash Expense", "terseLabel": "Other Noncash Expense" } } }, "localname": "OtherNoncashExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r68" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 4.0, "parentTag": "pg_IncomeLossFromContinuingOperationsBeforeIncomeTaxes", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "terseLabel": "Other Non-operating Income/(Loss), Net" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherPostretirementBenefitPlansDefinedBenefitMember": { "auth_ref": [ "r186", "r191", "r192", "r195" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide other postretirement benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes pension benefits.", "label": "Other Postretirement Benefits Plan [Member]", "terseLabel": "Other Postretirement Benefit Plan" } } }, "localname": "OtherPostretirementBenefitPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsAdditionalInformationDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherRestructuringMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Restructuring and related activities classified as other.", "label": "Other Restructuring [Member]", "terseLabel": "Other Costs" } } }, "localname": "OtherRestructuringMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherSignificantNoncashTransactionsLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Other Significant Noncash Transactions [Line Items]", "terseLabel": "Other Significant Noncash Transactions [Line Items]" } } }, "localname": "OtherSignificantNoncashTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_OtherSignificantNoncashTransactionsTable": { "auth_ref": [ "r87", "r88", "r89" ], "lang": { "en-US": { "role": { "documentation": "This table may contain information related to other significant noncash investing and financing activities that occurred during the accounting period and are not otherwise listed in the existing taxonomy. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of a transaction not resulting in cash receipts or cash payments in the period.", "label": "Other Significant Noncash Transactions [Table]", "terseLabel": "Other Significant Noncash Transactions [Table]" } } }, "localname": "OtherSignificantNoncashTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForProceedsFromBusinessesAndInterestInAffiliates": { "auth_ref": [ "r92" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net cash outflow or inflow associated with the acquisition or sale of a business segment during the period.", "label": "Payments for (Proceeds from) Businesses and Interest in Affiliates", "negatedLabel": "Acquisitions, Net of Cash Acquired" } } }, "localname": "PaymentsForProceedsFromBusinessesAndInterestInAffiliates", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromInvestments": { "auth_ref": [ "r92" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.", "label": "Payments for (Proceeds from) Investments", "negatedLabel": "Change in Other Investments" } } }, "localname": "PaymentsForProceedsFromInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r77" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedTerseLabel": "Treasury Stock Purchases" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRestructuring": { "auth_ref": [ "r79", "r155" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash payments made as the result of exit or disposal activities. Excludes payments associated with a discontinued operation or an asset retirement obligation.", "label": "Payments for Restructuring", "negatedTerseLabel": "Cash Spent" } } }, "localname": "PaymentsForRestructuring", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r77" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedTerseLabel": "Dividends to Shareholders" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r73", "r224" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Payments to Acquire Businesses, Gross", "terseLabel": "Payments to Acquire Businesses, Gross" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r74" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Capital Expenditures" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireShortTermInvestments": { "auth_ref": [ "r75" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Payments to Acquire Short-term Investments", "negatedTerseLabel": "Purchases of Short-term Investments" } } }, "localname": "PaymentsToAcquireShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionPlansDefinedBenefitMember": { "auth_ref": [ "r185", "r191", "r192", "r195" ], "lang": { "en-US": { "role": { "documentation": "Plan designed to provide participant with pension benefits. Includes, but is not limited to, defined benefit and defined contribution plans. Excludes other postretirement benefits.", "label": "Pension Plan [Member]", "terseLabel": "Pension Plan", "verboseLabel": "Pension and Other Retiree Benefits" } } }, "localname": "PensionPlansDefinedBenefitMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsAdditionalInformationDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r9" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred Stock" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r4", "r19", "r20" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense and Other Assets, Current", "terseLabel": "Prepaid Expenses and Other Current Assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": { "auth_ref": [ "r76", "r201" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from issuance of shares under share-based compensation arrangement. Issuance includes, but is not limited to, exercise of stock options and similar instruments.", "label": "Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options", "terseLabel": "Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options" } } }, "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt": { "auth_ref": [ "r92" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from other long-term debt.", "label": "Proceeds from (Repayments of) Other Long-term Debt", "terseLabel": "Additions to Long-term Debt" } } }, "localname": "ProceedsFromRepaymentsOfOtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebt": { "auth_ref": [ "r92" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The net cash inflow or outflow for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Proceeds from (Repayments of) Short-term Debt", "terseLabel": "Change in Short-term Debt" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfProductiveAssets": { "auth_ref": [ "r71" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.", "label": "Proceeds from Sale of Productive Assets", "terseLabel": "Proceeds from Asset Sales" } } }, "localname": "ProceedsFromSaleOfProductiveAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfShortTermInvestments": { "auth_ref": [ "r72" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from sales of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.", "label": "Proceeds from Sale of Short-term Investments", "terseLabel": "Proceeds from Sales of Short-term Investments" } } }, "localname": "ProceedsFromSaleOfShortTermInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r54", "r57", "r80", "r119", "r124", "r229", "r232", "r234", "r238", "r239" ], "calculation": { "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 }, "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 }, "http://www.pg.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net Earnings", "totalLabel": "Net Earnings", "verboseLabel": "Net Earnings" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome", "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows", "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd", "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r6", "r7", "r151", "r297" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property, Plant and Equipment, Net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": { "auth_ref": [ "r51", "r53", "r60" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).", "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax", "terseLabel": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax" } } }, "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationFromAociCurrentPeriodTax": { "auth_ref": [ "r49", "r52", "r213" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) of reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Reclassification from AOCI, Current Period, Tax", "terseLabel": "Reclassification from AOCI, Current Period, Tax" } } }, "localname": "ReclassificationFromAociCurrentPeriodTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r78" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedTerseLabel": "Reductions of Long-term Debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Percentage of fair value of reporting unit in excess of carrying amount.", "label": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount", "terseLabel": "Reporting Unit, Percentage of Fair Value in Excess of Carrying Amount" } } }, "localname": "ReportingUnitPercentageOfFairValueInExcessOfCarryingAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails" ], "xbrltype": "percentItemType" }, "us-gaap_RestructuringAndRelatedActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Restructuring and Related Activities [Abstract]" } } }, "localname": "RestructuringAndRelatedActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": { "auth_ref": [ "r166" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.", "label": "Restructuring and Related Activities Disclosure [Text Block]", "terseLabel": "Restructuring and Related Activities Disclosure [Text Block]" } } }, "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgram" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r84", "r154", "r159", "r164" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "terseLabel": "Restructuring Charges" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCostAndReserveAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of restructuring cost.", "label": "Restructuring Type [Axis]", "terseLabel": "Restructuring Type [Axis]" } } }, "localname": "RestructuringCostAndReserveAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringCostAndReserveLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Restructuring Cost and Reserve [Line Items]", "terseLabel": "Restructuring Cost and Reserve [Line Items]" } } }, "localname": "RestructuringCostAndReserveLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserve": { "auth_ref": [ "r155", "r161" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount (including both current and noncurrent portions of the accrual) as of the balance sheet date pertaining to a specified type of cost associated with exit from or disposal of business activities or restructuring pursuant to a duly authorized plan.", "label": "Restructuring Reserve", "periodEndLabel": "Reserve Balance December 31, 2018", "periodStartLabel": "Reserve Balance June 30, 2018" } } }, "localname": "RestructuringReserve", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringReserveRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Restructuring Reserve [Roll Forward]", "terseLabel": "Restructuring Reserve [Roll Forward]" } } }, "localname": "RestructuringReserveRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RestructuringReserveSettledWithoutCash2": { "auth_ref": [ "r154", "r160" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of decrease in the reserve for full or partial settlement through consideration other than cash.", "label": "Restructuring Reserve, Settled without Cash", "negatedTerseLabel": "Charges Against Assets" } } }, "localname": "RestructuringReserveSettledWithoutCash2", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r13", "r180", "r294" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd", "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RetirementPlanTypeAxis": { "auth_ref": [ "r185", "r186", "r191", "r192", "r195" ], "lang": { "en-US": { "role": { "documentation": "Information by type of retirement benefit plan. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Axis]", "terseLabel": "Retirement Plan Type [Axis]" } } }, "localname": "RetirementPlanTypeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsAdditionalInformationDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RetirementPlanTypeDomain": { "auth_ref": [ "r185", "r186", "r191", "r192", "r195" ], "lang": { "en-US": { "role": { "documentation": "Type of plan designed to provide participants with retirement benefits. Includes, but is not limited to, retirement benefit arrangement for defined benefit pension and other postretirement plans, retirement benefit arrangement for defined contribution pension and other postretirement plans, and special and contractual termination benefits payable upon retirement.", "label": "Retirement Plan Type [Domain]", "terseLabel": "Retirement Plan Type [Domain]" } } }, "localname": "RetirementPlanTypeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsAdditionalInformationDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r64", "r114", "r115", "r122" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net Sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/SegmentInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScenarioForecastMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The reporting scenario used to indicate financial results forecast for a future period.", "label": "Scenario, Forecast [Member]", "terseLabel": "Scenario, Forecast" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScenarioUnspecifiedDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Any scenario, that is, the particular reporting scenario is left unspecified. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.", "label": "Scenario, Unspecified [Domain]", "terseLabel": "Scenario, Unspecified [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome", "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/SegmentInformationDetails", "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r51" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable": { "auth_ref": [ "r139" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the major classes of acquired finite-lived intangible assets showing the amount, any significant residual value, weighted average amortization period, and other characteristics. A major class is composed of intangible assets that can be grouped together because they are similar, either by nature or by their use in the operations of the company.", "label": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]", "terseLabel": "Schedule of Acquired Finite-Lived Intangible Asset by Major Class [Table]" } } }, "localname": "ScheduleOfAcquiredFiniteLivedIntangibleAssetByMajorClassTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r108" ], "lang": { "en-US": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]", "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareAntidilutiveSecuritiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r216", "r217" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAdditionalInformationDetails", "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r254" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the effective portion of the gains and losses on derivative instruments designated (and non-derivative instruments) designated and qualifying in cash flow hedges and net investment hedges that was recognized in other comprehensive income (loss) during the current period.", "label": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments, Effect on Other Comprehensive Income (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfDerivativeInstrumentsEffectOnOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": { "auth_ref": [ "r249", "r256", "r262" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table Text Block]", "terseLabel": "Derivative Instruments, Gain (Loss) [Table Text Block]" } } }, "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": { "auth_ref": [ "r91", "r241", "r242", "r243", "r246", "r247", "r253", "r256", "r267", "r268" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Schedule of Derivative Instruments [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments [Table Text Block]" } } }, "localname": "ScheduleOfDerivativeInstrumentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r109" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r273" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTable": { "auth_ref": [ "r135", "r136" ], "lang": { "en-US": { "role": { "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.", "label": "Schedule of Goodwill [Table]", "terseLabel": "Schedule of Goodwill [Table]" } } }, "localname": "ScheduleOfGoodwillTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r135", "r136" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "Schedule of Goodwill [Table Text Block]", "terseLabel": "Schedule of Goodwill [Table Text Block]" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock": { "auth_ref": [ "r135" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.", "label": "Schedule of Intangible Assets and Goodwill [Table Text Block]", "terseLabel": "Schedule of Intangible Assets and Goodwill [Table Text Block]" } } }, "localname": "ScheduleOfIntangibleAssetsAndGoodwillTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAllocationOfPurchasePriceTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": { "auth_ref": [ "r157", "r158", "r162" ], "lang": { "en-US": { "role": { "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.", "label": "Schedule of Restructuring and Related Costs [Table]", "terseLabel": "Schedule of Restructuring and Related Costs [Table]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock": { "auth_ref": [ "r157", "r158", "r162" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.", "label": "Restructuring and Related Costs [Table Text Block]", "terseLabel": "Restructuring and Related Costs [Table Text Block]" } } }, "localname": "ScheduleOfRestructuringAndRelatedCostsTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock": { "auth_ref": [ "r155", "r163" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.", "label": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]", "terseLabel": "Schedule of Restructuring Reserve by Type of Cost [Table Text Block]" } } }, "localname": "ScheduleOfRestructuringReserveByTypeOfCostTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r113", "r119", "r120", "r121", "r135" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationDetails", "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r113", "r119", "r120", "r121", "r135" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Schedule of Segment Reporting Information, by Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r198", "r200" ], "lang": { "en-US": { "role": { "documentation": "Components of an equity-based arrangement under which compensation is awarded to employees, typically comprised of compensation expense; changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan; and cash flow effects resulting from the equity-based payment arrangement. Component disclosures are by type of award and plan name.", "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsAdditionalInformationDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails", "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/SegmentInformationDetails", "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentOperatingActivitiesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Operations of an entity including continuing and discontinued operations.", "label": "Operating Activities [Domain]", "terseLabel": "Operating Activities [Domain]" } } }, "localname": "SegmentOperatingActivitiesDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r125" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Reporting Disclosure [Text Block]" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationDetails", "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r66", "r128" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfEarnings": { "order": 3.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "terseLabel": "Selling, General and Administrative Expense" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings" ], "xbrltype": "monetaryItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "auth_ref": [ "r69" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.", "label": "Selling, General and Administrative Expenses [Member]", "terseLabel": "Selling, General and Administrative Expenses [Member]" } } }, "localname": "SellingGeneralAndAdministrativeExpensesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r83" ], "calculation": { "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.", "label": "Share-based Compensation", "terseLabel": "Share-based Compensation Expense" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]", "terseLabel": "Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]" } } }, "localname": "ShareBasedCompensationAllocationAndClassificationInFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]", "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsAdditionalInformationDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r119", "r135", "r153", "r156", "r165", "r300" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationOtherDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsChangeInNetCarryingAmountOfGoodwillByGlobalBusinessUnitDetails", "http://www.pg.com/role/GoodwillAndOtherIntangibleAssetsFairValueSensitivityDetails", "http://www.pg.com/role/RestructuringProgramRestructuringCostsPerSegmentDetails", "http://www.pg.com/role/SegmentInformationDetails", "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r8", "r9", "r10", "r178" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r32", "r178" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]", "verboseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome", "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd", "http://www.pg.com/role/EarningsPerShareDetails", "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails", "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOperatingActivitiesSegmentAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by continuing and discontinuing operations.", "label": "Operating Activities [Axis]", "terseLabel": "Operating Activities [Axis]" } } }, "localname": "StatementOperatingActivitiesSegmentAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails", "http://www.pg.com/role/ShareBasedCompensationAndPostretirementBenefitsAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementScenarioAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by scenario to be reported. Scenarios distinguish among different kinds of business reporting facts, as for example actual versus budgeted figures.", "label": "Scenario [Axis]", "terseLabel": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome", "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/SegmentInformationDetails", "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossChangesInAociAndReclassificationOutOfAociDetails", "http://www.pg.com/role/AccumulatedOtherComprehensiveIncomeLossNetOfTaxExpenseBenefitDetails", "http://www.pg.com/role/CondolidatedStatementsOfComprehensiveIncome", "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd", "http://www.pg.com/role/EarningsPerShareDetails", "http://www.pg.com/role/NewAccountingPronouncementsAndPoliciesUSTaxReformDetails", "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAmountOfGainsAndLossesOnOutstandingDerivativesAdditionalInformationDetailsDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails", "http://www.pg.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r31", "r178", "r179", "r180" ], "lang": { "en-US": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r9", "r10", "r178", "r180" ], "lang": { "en-US": { "role": { "documentation": "Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.", "label": "Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures", "terseLabel": "Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r32", "r178", "r180" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "negatedTerseLabel": "Stock Issued During Period, Value, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r9", "r10", "r178", "r180" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Shares", "negatedTerseLabel": "Treasury Stock, Shares, Acquired" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r9", "r10", "r178", "r180" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Stock Repurchased During Period, Value", "negatedTerseLabel": "Stock Repurchased During Period, Value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r227", "r228", "r237" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total Shareholders' Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsegmentsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by business subsegments.", "label": "Subsegments [Axis]", "terseLabel": "Subsegments [Axis]" } } }, "localname": "SubsegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsConsolidationItemsAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.", "label": "Subsegments Consolidation Items [Axis]", "terseLabel": "Subsegments Consolidation Items [Axis]" } } }, "localname": "SubsegmentsConsolidationItemsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsegmentsConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Subsegments, eliminations and reconciling items used in consolidating a reportable segment and its subsegments.", "label": "Subsegments Consolidation Items [Domain]", "terseLabel": "Subsegments Consolidation Items [Domain]" } } }, "localname": "SubsegmentsConsolidationItemsDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsegmentsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Subsegments [Domain]", "terseLabel": "Subsegments [Domain]" } } }, "localname": "SubsegmentsDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/SegmentInformationSegmentInformationSalesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TextBlockAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Text Block [Abstract]" } } }, "localname": "TextBlockAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r222" ], "lang": { "en-US": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade Names [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/AcquisitionAcquisitionFairValueOfIntangiblesDetails", "http://www.pg.com/role/AcquisitionAdditionalInformationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax": { "auth_ref": [ "r40", "r257" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax, of reclassification from accumulated other comprehensive income (AOCI) of gain (loss) from increase (decrease) in fair value of net investment hedge.", "label": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax", "terseLabel": "Gain (Loss) on Derivative Used in Net Investment Hedge, after Tax" } } }, "localname": "TranslationAdjustmentForNetInvestmentHedgeIncreaseDecreaseNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsGainLossOnDerivativeInstrumentsEffectivePortionDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r30", "r181" ], "lang": { "en-US": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]", "terseLabel": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityFytd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityQtd" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r30", "r181", "r182" ], "calculation": { "http://www.pg.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedTerseLabel": "Treasury Stock" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfAdoptionMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Adoption and early adoption of sources of change to generally accepted accounting principles (GAAP) in the United States. The FASB released the FASB Accounting Standards Codification as the authoritative source of literature effective for interim and annual periods ending after September 15, 2009. As part of the Codification process, the FASB issues Accounting Standards Updates to amend the Codification but otherwise the Accounting Standards Updates are not authoritative in their own right. All previous accounting standards (such as FASB Statements of Financial Accounting Standards, FASB Interpretations, FASB Staff Positions, Emerging Issues Task Force Consensuses, other pronouncements of the FASB or other designated bodies, or other forms of GAAP are considered accounting pronouncements) were superseded upon the adoption of the Codification. For an interim period, references to the superseded standards are included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.", "label": "Type of Adoption [Domain]", "terseLabel": "Type of Adoption [Domain]" } } }, "localname": "TypeOfAdoptionMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyQtd", "http://www.pg.com/role/ConsolidatedStatementsOfShareholdersEquityConsolidatedStatementsOfShareholdersEquityPyYtd" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfRestructuringDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the types of restructuring costs.", "label": "Type of Restructuring [Domain]", "terseLabel": "Type of Restructuring [Domain]" } } }, "localname": "TypeOfRestructuringDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RestructuringProgramAdditionalInformationDetails", "http://www.pg.com/role/RestructuringProgramRestructuringReserveByTypeOfCostsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasuryAndGovernmentMember": { "auth_ref": [ "r188", "r288" ], "lang": { "en-US": { "role": { "documentation": "This category includes investments in debt securities issued by the United States Department of the Treasury, US Government Agencies and US Government-sponsored Enterprises. Such securities may include treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years), debt securities issued by the Government National Mortgage Association (Ginnie Mae) and debt securities issued by the Federal National Mortgage Association (Fannie Mae) or the Federal Home Loan Mortgage Corporation (Freddie Mac).", "label": "US Treasury and Government [Member]", "terseLabel": "U.S. Government Securities" } } }, "localname": "USTreasuryAndGovernmentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAssetsMeasuredAtFairValueOnRecurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnderlyingAssetClassAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by underlying asset class.", "label": "Underlying Asset Class [Axis]", "terseLabel": "Underlying Asset Class [Axis]" } } }, "localname": "UnderlyingAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UnderlyingAssetClassDomain": { "auth_ref": [ "r264" ], "lang": { "en-US": { "role": { "documentation": "Major types of referenced/underlying asset classes (for example, corporate debt, sovereign debt, and structured finance).", "label": "Underlying Asset Class [Domain]", "terseLabel": "Underlying Asset Class [Domain]" } } }, "localname": "UnderlyingAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnderlyingOtherMember": { "auth_ref": [ "r263", "r265", "r266" ], "lang": { "en-US": { "role": { "documentation": "Represents a subset of hybrid instruments that have embedded credit derivatives with an underlying(s) other than corporate or sovereign debt or a structured finance product.", "label": "Underlying, Other [Member]", "terseLabel": "Underlying, Other" } } }, "localname": "UnderlyingOtherMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsAdditionalInformationDetails", "http://www.pg.com/role/RiskManagementActivitiesAndFairValueMeasurementsNotionalAmountsAndFairValuesOfQualifyingAndNonQualifyingFinancialInstrumentsUsedInHedgingTransactionsAdditionalInformationDetailsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Incremental Weighted Average Shares Attributable to Dilutive Effect [Abstract]", "terseLabel": "Effect of Dilutive Securities" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustmentAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r101", "r107" ], "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Diluted Weighted Average Common Shares Outstanding", "totalLabel": "Diluted Weighted Average Common Shares Outstanding" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/ConsolidatedStatementsOfEarnings", "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r99", "r107" ], "calculation": { "http://www.pg.com/role/EarningsPerShareDetails": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Basic Weighted Average Common Shares Outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.pg.com/role/EarningsPerShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1377-109256" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1505-109256" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "28A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1500-109256" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1930-109256" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258" }, "r111": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "http://asc.fasb.org/topic&trid=2144383" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8657-108599" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r125": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27198-111563" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27198-111563" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13854-109267" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r149": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "350", "URI": "http://asc.fasb.org/topic&trid=2144416" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.P.4)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b)(2))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r166": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "420", "URI": "http://asc.fasb.org/topic&trid=2175745" }, "r167": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14615-108349" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14394-108349" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14453-108349" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14472-108349" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=115931803&loc=d3e12021-110248" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=115931803&loc=d3e12053-110248" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045" }, "r184": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "710", "URI": "http://asc.fasb.org/topic&trid=2127225" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "http://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r187": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "712", "URI": "http://asc.fasb.org/topic&trid=2197446" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i),(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e2410-114920" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e2709-114920" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "715", "URI": "http://asc.fasb.org/topic&trid=2235017" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "2A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=SL79508275-113901" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.F)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "http://asc.fasb.org/topic&trid=2228938" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e31917-109318" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e31931-109318" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84176650&loc=d3e31958-109318" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84229725&loc=d3e961-128460" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=108330185&loc=d3e2207-128464" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r226": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4613674-111683" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4590271-111686" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4591551-111686" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4591552-111686" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(i)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "4CCC", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL109998896-113959" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5708773-113959" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5708775-113959" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5708775-113959" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "4L", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5708777-113959" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109975725&loc=SL5629052-113961" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Subparagraph": "(a)(1),(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80784-113994" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=SL7498348-110258" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13433-108611" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240241&loc=d3e32211-110900" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775744&loc=d3e28555-108399" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6)(a)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99384497&loc=SL65671331-158438" }, "r301": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r302": { "Article": "12", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "13", "Sentence": "Column B" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e640-108580" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "17A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL34724391-108580" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL34724394-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e557-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3179-108585" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3179-108585" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3367-108585" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3000-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4304-108586" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4313-108586" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=d3e4332-108586" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1448-109256" } }, "version": "2.0" } ZIP 80 0000080424-19-000014-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000080424-19-000014-xbrl.zip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�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�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end

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